<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006237.pub3" GROUP_ID="OCCHEALTH" ID="877905021509501771" MERGED_FROM="" MODIFIED="2014-12-02 08:56:53 +0000" MODIFIED_BY="Jani Ruotsalainen" NOTES="&lt;p&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;/p&gt;&lt;p&gt;Old title: Occupational Health Interventions for depressive disorders&lt;/p&gt;" NOTES_MODIFIED="2014-12-02 10:52:59 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" REVIEW_NO="036" REVMAN_SUB_VERSION="5.3.4 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="5.0">
<COVER_SHEET MODIFIED="2014-12-02 08:56:53 +0000" MODIFIED_BY="Jani Ruotsalainen">
<TITLE MODIFIED="2014-10-22 09:46:33 +0300" MODIFIED_BY="Jos H Verbeek">Interventions to improve return to work in depressed people</TITLE>
<CONTACT MODIFIED="2014-12-02 08:56:53 +0000" MODIFIED_BY="Jani Ruotsalainen"><PERSON ID="DC86397D82E26AA201DAB7D831353271" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Karen</FIRST_NAME><LAST_NAME>Nieuwenhuijsen</LAST_NAME><EMAIL_1>K.Nieuwenhuijsen@amc.nl</EMAIL_1><ADDRESS><DEPARTMENT>Coronel Institute of Occupational Health/Dutch Research Center for Insurance Medicine</DEPARTMENT><ORGANISATION>Academic Medical Center, University of Amsterdam</ORGANISATION><ADDRESS_1>PO Box 22700</ADDRESS_1><CITY>Amsterdam</CITY><ZIP>1100 DE</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY><PHONE_1>+31 20 5665320</PHONE_1><FAX_1>+31 20 6977161</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2014-12-02 08:56:53 +0000" MODIFIED_BY="Jani Ruotsalainen"><PERSON ID="DC86397D82E26AA201DAB7D831353271" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Karen</FIRST_NAME><LAST_NAME>Nieuwenhuijsen</LAST_NAME><EMAIL_1>K.Nieuwenhuijsen@amc.nl</EMAIL_1><ADDRESS><DEPARTMENT>Coronel Institute of Occupational Health/Dutch Research Center for Insurance Medicine</DEPARTMENT><ORGANISATION>Academic Medical Center, University of Amsterdam</ORGANISATION><ADDRESS_1>PO Box 22700</ADDRESS_1><CITY>Amsterdam</CITY><ZIP>1100 DE</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY><PHONE_1>+31 20 5665320</PHONE_1><FAX_1>+31 20 6977161</FAX_1></ADDRESS></PERSON><PERSON ID="z1304190652256896989742905275201" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>Babs</FIRST_NAME><LAST_NAME>Faber</LAST_NAME><POSITION>Research Assistant</POSITION><EMAIL_1>b.j.faber@amc.uva.nl</EMAIL_1><ADDRESS><ORGANISATION>Coronel Institute of Occupational Health/Dutch Research Center for Insurance Medicine, Academic Medical Center, University of Amsterdam</ORGANISATION><ADDRESS_1>Meibergdreef 9</ADDRESS_1><CITY>Amsterdam</CITY><ZIP>1105 AZ</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY></ADDRESS></PERSON><PERSON ID="17406" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Jos</FIRST_NAME><MIDDLE_INITIALS>H</MIDDLE_INITIALS><LAST_NAME>Verbeek</LAST_NAME><POSITION>Senior Researcher</POSITION><EMAIL_1>jos.verbeek@ttl.fi</EMAIL_1><MOBILE_PHONE>+358 46 8108709</MOBILE_PHONE><ADDRESS><DEPARTMENT>Cochrane Occupational Safety and Health Review Group</DEPARTMENT><ORGANISATION>Finnish Institute of Occupational Health</ORGANISATION><ADDRESS_1>PO Box 310</ADDRESS_1><CITY>Kuopio</CITY><ZIP>70101</ZIP><COUNTRY CODE="FI">Finland</COUNTRY><PHONE_1>+358 30 4747289</PHONE_1><PHONE_2>+358 46 8108709</PHONE_2></ADDRESS></PERSON><PERSON ID="C213604282E26AA2007834EB2F9AD5E4" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Angela</FIRST_NAME><LAST_NAME>Neumeyer-Gromen</LAST_NAME><EMAIL_1>angela_neumeyer@yahoo.de</EMAIL_1><EMAIL_2>a.neumeyer-gromen@dkgev.de</EMAIL_2><ADDRESS><ORGANISATION>Deutsche Krankenhausgesellschaft (The German Hospital Federation)</ORGANISATION><ADDRESS_1>Wegelystraße 3</ADDRESS_1><CITY>Berlin</CITY><ZIP>10623</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>030-39801-1524</PHONE_1></ADDRESS></PERSON><PERSON ID="z1405150920180271642347939731931" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Hiske</FIRST_NAME><MIDDLE_INITIALS>L</MIDDLE_INITIALS><LAST_NAME>Hees</LAST_NAME><SUFFIX>PhD</SUFFIX><POSITION>Researcher</POSITION><EMAIL_1>h.hees@propersona.nl</EMAIL_1><EMAIL_2>h.l.hees@amc.uva.nl</EMAIL_2><ADDRESS><DEPARTMENT>Program for Mood Disorders</DEPARTMENT><ORGANISATION>Academic Medical Center, University of Amsterdam</ORGANISATION><ADDRESS_1>Meibergdreef 5</ADDRESS_1><CITY>Amsterdam</CITY><ZIP>1105 AZ</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY></ADDRESS></PERSON><PERSON ID="3A3A595682E26AA200D5E26B7F3A26A9" ROLE="AUTHOR"><FIRST_NAME>Arco</FIRST_NAME><MIDDLE_INITIALS>C</MIDDLE_INITIALS><LAST_NAME>Verhoeven</LAST_NAME><SUFFIX>MD, PhD</SUFFIX><POSITION>Project Manager Guidelines</POSITION><EMAIL_1>arco.verhoeven@xs4all.nl</EMAIL_1><EMAIL_2>a.verhoeven@nvab-online.nl</EMAIL_2><MOBILE_PHONE>+31 6 38514487</MOBILE_PHONE><ADDRESS><DEPARTMENT>NVAB Centre of Excellence</DEPARTMENT><ORGANISATION>Netherlands Society of Occupational Medicine</ORGANISATION><ADDRESS_1>PO Box 2113</ADDRESS_1><CITY>Utrecht</CITY><ZIP>3500GC</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY><PHONE_1>+31 30 2040620</PHONE_1><PHONE_2>+31 6 38514487</PHONE_2></ADDRESS></PERSON><PERSON ID="8A89B2B282E26AA20071EDC049006648" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Christina</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>van der Feltz-Cornelis</LAST_NAME><POSITION>Medical doctor, Full Professor of Social Psychiatry</POSITION><EMAIL_1>c.m.vdrfeltz@uvt.nl</EMAIL_1><ADDRESS><DEPARTMENT>Department Tranzo, Faculty of Social and Behavioural Sciences</DEPARTMENT><ORGANISATION>Tilburg University</ORGANISATION><ADDRESS_1>PO Box 90153</ADDRESS_1><ADDRESS_2>TIAS Building T307</ADDRESS_2><CITY>Tilburg</CITY><ZIP>5000 LE</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY></ADDRESS></PERSON><PERSON ID="8A89B43882E26AA20071EDC0B81E73F5" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Ute</FIRST_NAME><LAST_NAME>Bültmann</LAST_NAME><EMAIL_1>u.bultmann@med.umcg.nl</EMAIL_1><ADDRESS><DEPARTMENT>Department of Health Sciences, Community and Occupational Medicine</DEPARTMENT><ORGANISATION>University Medical Center Groningen, University of Groningen</ORGANISATION><CITY>Groningen</CITY><COUNTRY CODE="NL">Netherlands</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2014-06-03 14:28:39 +0300" MODIFIED_BY="Babs J.M.  Faber" NOTES="&lt;p&gt;Minor update: 24/10/07&lt;/p&gt;&lt;p&gt;New studies found and included or excluded: 02/08/06&lt;/p&gt;" NOTES_MODIFIED="2014-06-03 14:28:39 +0300" NOTES_MODIFIED_BY="Babs J.M.  Faber">
<UP_TO_DATE>
<DATE DAY="1" MONTH="1" YEAR="2014"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="1" MONTH="1" YEAR="2014"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="1" MONTH="7" YEAR="2016"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2006"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2008"/>
<LAST_CITATION_ISSUE ISSUE="12" YEAR="2014"/>
</DATES>
<WHATS_NEW MODIFIED="2014-11-08 03:42:08 +0200" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2014-11-08 03:42:08 +0200" MODIFIED_BY="[Empty name]">
<DATE DAY="6" MONTH="6" YEAR="2014"/>
<DESCRIPTION>
<P>Full update. This updated review includes 12 new studies with 3440 new participants (added to the 11 studies with 2556 participants of the former version). We have modified the names of the interventions in the comparisons: we now include work-directed and clinical interventions, while in the 2008 version clinical interventions were under worker-directed interventions. In the update, we refrained from handsearching journals as this strategy did not yield additional studies in the 2008 version. We have re-assessed all studies that we originally included to be able to use the GRADE method. Two new authors have joined the review team: Babs Faber and Hiske Hees.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2014-06-06 13:33:23 +0300" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2014-06-06 13:33:23 +0300" MODIFIED_BY="[Empty name]">
<DATE DAY="2" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="20" MONTH="11" YEAR="2007"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2014-12-02 09:52:37 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<INTERNAL_SOURCES MODIFIED="2014-12-02 09:52:37 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<SOURCE MODIFIED="2014-12-01 15:00:57 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<NAME>Coronel Institute of Occupational Health</NAME>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<DESCRIPTION>
<P>Salary for Karen Nieuwenhuijsen and Babs Faber</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2014-12-01 15:01:26 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<NAME>Trimbos Instituut - Netherlands Institute of Mental Health and Addiction</NAME>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<DESCRIPTION>
<P>Salary for Christina van der Feltz-Cornelis</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2014-12-01 15:01:54 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<NAME>Federal Institute for Occupational Safety and Health</NAME>
<COUNTRY CODE="DE">Germany</COUNTRY>
<DESCRIPTION>
<P>Salary for Angela Neumeyer-Gromen</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2014-12-02 09:52:32 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<NAME>Finnish Institute of Occupational Health</NAME>
<COUNTRY CODE="FI">Finland</COUNTRY>
<DESCRIPTION>
<P>Salary for Jos Verbeek</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2014-12-02 09:52:37 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<NAME>University Medical Center Groningen</NAME>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<DESCRIPTION>
<P>Salary for Ute Bültmann</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2014-12-02 09:52:37 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<NAME>Dutch Research Center for Insurance Medicine</NAME>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<DESCRIPTION>
<P>Support and training for authors</P>
</DESCRIPTION>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2014-12-01 15:18:08 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<SOURCE MODIFIED="2014-12-01 15:18:08 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<NAME>KIS programme, Ministry of Social Affairs and Employment</NAME>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<DESCRIPTION>
<P>A small grant to Karen Nieuwenhuijsen to help her finish the first version of this review</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2014-12-01 14:04:00 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<SUMMARY MODIFIED="2014-11-08 04:28:20 +0200" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2014-11-08 04:12:15 +0200" MODIFIED_BY="[Empty name]">Interventions to help depressed people resume work</TITLE>
<SUMMARY_BODY MODIFIED="2014-11-08 04:28:20 +0200" MODIFIED_BY="[Empty name]">
<P>Depression is a major problem that affects about 300 million people globally. Symptoms of depression include the core symptoms of low mood or loss of interest coupled with other symptoms such as feelings of inadequacy and hopelessness or sleep problems. These symptoms usually impair functioning and therefore sickness absence is common in people with depression. We evaluated the effectiveness of interventions that can help depressed workers to resume work activities.</P>
<P>
<B>Studies we found</B>
</P>
<P>We found 23 studies, involving 5996 participants, that looked at the effects on sick leave of changes at work that were in addition to regular treatment, better psychological treatment, improving primary care, antidepressant pills and exercise.</P>
<P>
<B>Effects of changes at work in addition to regular care</B>
</P>
<P>In three studies with 251 participants, researchers looked at changes at work such as work modification or coaching in addition to regular care and found that these reduced sickness absence to a moderate extent.</P>
<P>In two studies, researchers tried to improve care that was already directed at changes at work but did not find any effects of these improvements on sick leave. </P>
<P>
<B>Effects of psychological treatment</B>
</P>
<P>In three studies with 326 participants, researchers found that cognitive behavioural therapy that was provided online or by telephone reduced sickness absence to a moderate extent compared to regular care.</P>
<P>In one high quality study, a special care programme carried out via the workplace also reduced sick leave when compared to regular care.</P>
<P>
<B>Effects of antidepressant pills</B>
</P>
<P>Three studies compared antidepressant pills with each other but there were no consistent effects on sickness absence.</P>
<P>
<B>Improving primary care</B>
</P>
<P>Improving primary care through quality improvement programs for general practitioners did not reduce sickness absence in three studies.</P>
<P>
<B>Exercise</B>
</P>
<P>One study found that participants had a reduction in sick leave after doing stretching exercises. Two other studies did not find an effect on sick leave after physical exercises such as running or using the gymnasium. </P>
<P>More studies should look at the effects of changes at work. Regular clinical studies should also measure the effects on sick leave because this is an important consequence of depression.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2014-11-21 14:17:16 +0200" MODIFIED_BY="Jos H Verbeek">
<ABS_BACKGROUND MODIFIED="2014-11-21 08:34:28 +0200" MODIFIED_BY="[Empty name]">
<P>Work disability such as sickness absence is common in people with depression.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2014-11-08 04:47:40 +0200" MODIFIED_BY="[Empty name]">
<P>To evaluate the effectiveness of interventions aimed at reducing work disability in employees with depressive disorders.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2014-11-21 14:17:16 +0200" MODIFIED_BY="Jos H Verbeek">
<P>We searched CENTRAL (The Cochrane Library), MEDLINE, EMBASE, CINAHL, and PsycINFO until January 2014.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2014-06-03 20:36:30 +0300" MODIFIED_BY="[Empty name]">
<P>We included randomised controlled trials (RCTs) and cluster RCTs of work-directed and clinical interventions for depressed people that included sickness absence as an outcome.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2014-11-08 03:49:55 +0200" MODIFIED_BY="[Empty name]">
<P>Two authors independently extracted the data and assessed trial quality. We used standardised mean differences (SMDs) with 95% confidence intervals (CIs) to pool study results in the studies we judged to be sufficiently similar. We used GRADE to rate the quality of the evidence.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2014-11-08 04:40:57 +0200" MODIFIED_BY="[Empty name]">
<P>We included 23 studies with 26 study arms, involving 5996 participants with either a major depressive disorder or a high level of depressive symptoms. We judged 14 studies to have a high risk of bias and nine to have a low risk of bias.</P>
<P>
<B>Work-directed interventions</B>
</P>
<P>We identified five work-directed interventions. There was moderate quality evidence that a work-directed intervention added to a clinical intervention reduced sickness absence (SMD -0.40; 95% CI -0.66 to -0.14; 3 studies) compared to a clinical intervention alone.</P>
<P>There was moderate quality evidence based on a single study that enhancing the clinical care in addition to regular work-directed care was not more effective than work-directed care alone (SMD -0.14; 95% CI -0.49 to 0.21).</P>
<P>There was very low quality evidence based on one study that regular care by occupational physicians that was enhanced with an exposure-based return to work program did not reduce sickness absence compared to regular care by occupational physicians (non-significant finding: SMD 0.45; 95% CI -0.00 to 0.91).</P>
<P>
<B>Clinical interventions, antidepressant medication</B>
</P>
<P>Three studies compared the effectiveness of selective serotonin reuptake inhibitor (SSRI) to selective norepinephrine reuptake inhibitor (SNRI) medication on reducing sickness absence and yielded highly inconsistent results.</P>
<P>
<B>Clinical interventions, psychological </B>
</P>
<P>We found moderate quality evidence based on three studies that telephone or online cognitive behavioural therapy was more effective in reducing sick leave than usual primary or occupational care (SMD -0.23; 95% CI -0.45 to -0.01).</P>
<P>
<B>Clinical interventions, psychological</B> <B>combined with antidepressant medication</B>
</P>
<P>We found low quality evidence based on two studies that enhanced primary care did not substantially decrease sickness absence in the medium term (4 to 12 months) (SMD -0.02; 95% CI -0.15 to 0.12). A third study found no substantial effect on sickness absence in favour of this intervention in the long term (24 months).</P>
<P>We found high quality evidence, based on one study, that a structured telephone outreach and care management program was more effective in reducing sickness absence than usual care (SMD - 0.21; 95% CI -0.37 to -0.05).</P>
<P>
<B>Clinical interventions, exercise</B>
</P>
<P>We found low quality evidence based on one study that supervised strength exercise reduced sickness absence compared to relaxation (SMD -1.11; 95% CI -1.68 to -0.54). We found moderate quality evidence based on two studies that aerobic exercise was no more effective in reducing sickness absence than relaxation or stretching (SMD -0.06; 95% CI -0.36 to 0.24).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2014-11-08 04:10:19 +0200" MODIFIED_BY="[Empty name]">
<P>We found moderate quality evidence that adding a work-directed intervention to a clinical intervention reduced the number of days on sick leave compared to a clinical intervention alone. We also found moderate quality evidence that enhancing primary or occupational care with cognitive behavioural therapy reduced sick leave compared to the usual care. A structured telephone outreach and care management program that included medication reduced sickness absence compared to usual care. However, enhancing primary care with a quality improvement program did not have a considerable effect on sickness absence. There was no evidence of a difference in effect on sickness absence of one antidepressant medication compared to another. More studies are needed on work-directed interventions. Clinical intervention studies should also include work outcomes to increase our knowledge on reducing sickness absence in depressed workers.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2014-11-21 14:25:22 +0200" MODIFIED_BY="Jos H Verbeek">
<BACKGROUND MODIFIED="2014-11-08 04:44:43 +0200" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2014-11-08 04:36:19 +0200" MODIFIED_BY="[Empty name]">
<P>Depression is a major public health problem, with 298 million cases of major depressive disorders at any time point in 2010 (<LINK REF="REF-Ferrari-2013" TYPE="REFERENCE">Ferrari 2013</LINK>). The worldwide point prevalences of depressive disorder were 4.4% in both 2005 and 2010 (<LINK REF="REF-Ferrari-2013" TYPE="REFERENCE">Ferrari 2013</LINK>). Symptoms of depressive disorder include the presence of one or two core symptoms of low mood and loss of interest, coupled with other symptoms such as feelings of inadequacy and hopelessness, sleep disturbance, weight change, fatigue, impaired concentration, agitation or slowing down of movement and thought, and suicidal ideation (<LINK REF="REF-APA-2013" TYPE="REFERENCE">APA 2013</LINK>). Depressive disorders can be classified along a continuum by the levels of symptom severity, number of mental or physical symptoms, and duration. Corresponding diagnostic categories range from persistent depression (dysthymia) and subclinical states (minor depressive disorder) to major depressive disorder (<LINK REF="REF-APA-1994" TYPE="REFERENCE">APA 1994</LINK>; <LINK REF="REF-APA-2013" TYPE="REFERENCE">APA 2013</LINK>).</P>
<P>Besides the serious consequences in terms of individual suffering, depression has a large impact on social functioning and the ability of patients to work (<LINK REF="REF-Hirschfeld-2000" TYPE="REFERENCE">Hirschfeld 2000</LINK>; <LINK REF="REF-Lerner-2008" TYPE="REFERENCE">Lerner 2008</LINK>). In a population of US workers, the 12-month prevalence of major depressive disorder was found to be 6% and was associated with 27.2 lost workdays per ill worker per year (<LINK REF="REF-Kessler-2006" TYPE="REFERENCE">Kessler 2006</LINK>). In terms of annualised human capital loss to employers in the US labour force, this amounted to about USD 36 billion (<LINK REF="REF-Kessler-2009" TYPE="REFERENCE">Kessler 2009</LINK>). The high prevalence of depressive disorders, combined with the impact on work disability, has extensive societal consequences. In 1990, major depressive disorders were the 15th leading contributor to the global burden of disease in terms of 'Disability Adjusted Life Years' (DALYs), which is the sum of years of productive life lost due to premature mortality and the years of productive life lost due to disability. Data from the global burden of disease study in 2010 showed that depressive disorders are now ranked 11th (<LINK REF="REF-Murray-2012" TYPE="REFERENCE">Murray 2012</LINK>).</P>
<P>While working is important from a societal point of view, work is also an important aspect of the quality of life of individuals (<LINK REF="REF-Bowling-1995" TYPE="REFERENCE">Bowling 1995</LINK>). Work provides income, structure, and social interactions. One salient consequence of depression is absenteeism, but depression can also affect the at-work productivity for workers (<LINK REF="REF-Lerner-2008" TYPE="REFERENCE">Lerner 2008</LINK>). Depressed workers experience specific limitations in their ability to function at work. These limitations include performing mental and interpersonal tasks (<LINK REF="REF-Adler-2006" TYPE="REFERENCE">Adler 2006</LINK>; <LINK REF="REF-Burton-2004" TYPE="REFERENCE">Burton 2004</LINK>). The quality of work performance can also be affected, as was shown in studies focusing on errors and safety issues (<LINK REF="REF-Haslam-2005" TYPE="REFERENCE">Haslam 2005</LINK>; <LINK REF="REF-Suzuki-2004" TYPE="REFERENCE">Suzuki 2004</LINK>). Depressed workers may need to make an extra effort to be productive during their work (<LINK REF="REF-Dewa-2000" TYPE="REFERENCE">Dewa 2000</LINK>), which may lead to spillover effects of fatigue after work.</P>
</CONDITION>
<INTERVENTION MODIFIED="2014-11-08 04:39:16 +0200" MODIFIED_BY="[Empty name]">
<P>Work ability of depressed workers can be targeted by interventions. First of all, work-directed interventions aim to ameliorate the consequences of the depressive disorder on the ability to work. These types of interventions either target the work itself, by modifying the job task, or (temporarily) reduce the working hours. Work-directed interventions can also support the worker in dealing with the consequences of their depression at the workplace.</P>
<P>Second, clinical interventions aimed at reducing depression symptoms may improve work ability (<LINK REF="REF-Hees-2013b" TYPE="REFERENCE">Hees 2013b</LINK>). Current clinical practice guidelines for the treatment of major depressive disorder recommend pharmacotherapy, psychotherapy, or a combination of both (<LINK REF="REF-APA-2010" TYPE="REFERENCE">APA 2010</LINK>; <LINK REF="REF-NICE-2010" TYPE="REFERENCE">NICE 2010</LINK>). Pharmacologic treatment for major depressive disorder includes antidepressant medication such as tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), monoamine oxidase inhibitors (MAO inhibitors), and selective norepinephrine reuptake inhibitors (SNRIs). With regard to psychotherapy, cognitive behavioural therapy (CBT) and interpersonal therapy are considered effective treatment options (<LINK REF="REF-NICE-2010" TYPE="REFERENCE">NICE 2010</LINK>). Exercise has been increasingly used as an alternative to pharmacological or psychotherapeutic interventions (<LINK REF="REF-Cooney-2013" TYPE="REFERENCE">Cooney 2013</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2014-11-08 04:43:38 +0200" MODIFIED_BY="[Empty name]">
<P>Work-directed interventions are deemed to reduce work disability by creating a work environment better suited for a depressed worker, such as modifying work tasks or working hours. Moreover, the worker can be supported in dealing with the depression at work by a gradual return to work program or by enhancing skills to cope with work situations (<LINK REF="STD-Lagerveld-2012" TYPE="STUDY">Lagerveld 2012</LINK>). Clinical interventions may reduce work disability by reducing depressive symptoms, thereby eliminating the obstacles to working.</P>
</THEORY>
<IMPORTANCE MODIFIED="2014-11-08 04:44:43 +0200" MODIFIED_BY="[Empty name]">
<P>Considering the impact of depressive disorders on the occupational health of many affected workers, it is vital to know what types of interventions are effective in improving occupational health. In the first version of this review, in 2008, we concluded that there was an urgent need to evaluate interventions that address work issues in future research. Since then, several such studies have been published underpinning the need for an update of the review.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2014-11-08 04:49:35 +0200" MODIFIED_BY="[Empty name]">
<P>The goal of this review was to evaluate the effectiveness of interventions aimed at reducing work disability in employees with depressive disorders. </P>
<P>We considered the effectiveness of two types of interventions: </P>
<OL>
<LI>work-directed interventions, i.e. addressing the work or the work-worker interface as part of the clinical treatment or as a stand-alone intervention; and</LI>
<LI>clinical interventions, i.e. treatment of depressive disorder without a focus on work.</LI>
</OL>
</OBJECTIVES>
<METHODS MODIFIED="2014-11-21 08:50:11 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<SELECTION_CRITERIA MODIFIED="2014-11-08 05:10:47 +0200" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2014-11-08 04:50:04 +0200" MODIFIED_BY="[Empty name]">
<P>We included all randomised controlled trials (RCTs), including cluster RCTs, in this review. We did not use any language restrictions.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2014-11-08 04:57:45 +0200" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Patient characteristics and setting</HEADING>
<P>The population was limited to adult (that is over 17 years old) workers (employees or self-employed). We included participants from occupational health settings, primary care, or outpatient care settings. We based the selection of the studies on the primary outcome only.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Diagnosis</HEADING>
<P>We defined depressive disorder as a main diagnosis fulfilling the criteria of the Diagnostic and Statistical Manual (DSM-IV) (<LINK REF="REF-APA-1994" TYPE="REFERENCE">APA 1994</LINK>; <LINK REF="REF-APA-2013" TYPE="REFERENCE">APA 2013</LINK>), the Research Diagnostic Criteria (RDC) (<LINK REF="REF-Spitzer-1979" TYPE="REFERENCE">Spitzer 1979</LINK>), or the International Classification of Disease (ICD-10) (<LINK REF="REF-WHO-1992" TYPE="REFERENCE">WHO 1992</LINK>) for one of the following disorders: dysthymic disorder, minor depressive disorder, or major depressive disorder. We also included studies that defined depressive disorder as a level of depressive symptoms assessed by validated self-report instruments published in peer-reviewed journals. An examples is the Beck Depression Inventory (BDI) (<LINK REF="REF-Beck-1987" TYPE="REFERENCE">Beck 1987</LINK>); or clinician-rated instruments such as the Hamilton Depression Rating Scale (HDRS) (<LINK REF="REF-Hamilton-1967" TYPE="REFERENCE">Hamilton 1967</LINK>) or the Montgomery&#8211;Åsberg Depression Rating Scale (MADRS) (<LINK REF="REF-Montgomery-1979" TYPE="REFERENCE">Montgomery 1979</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Exclusion criteria</HEADING>
<P>We excluded studies involving workers with a primary diagnosis of a common mental disorder other than a depressive disorder. We did not exclude workers with a co-morbidity from other common mental disorders (such as anxiety disorders), but we did exclude workers with bipolar disorders or depressive disorders with psychotic features.</P>
</SUBSECTION>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2014-11-08 05:03:32 +0200" MODIFIED_BY="[Empty name]">
<P>We included all interventions aimed at reducing work disability, thereby differentiating work-directed interventions from clinical interventions. Examples of work-directed interventions are light duty, graded work exposure, or supportive interventions enhancing the coping of the worker with depression in the workplace. We categorised work-directed interventions as:</P>
<OL>
<LI>modified work, modified working hours or job tasks;</LI>
<LI>supportive, supporting the worker in coping with depression at the workplace; and</LI>
<LI>a combination of modified work and supportive interventions.</LI>
</OL>
<P>We divided clinical interventions into:</P>
<OL>
<LI>antidepressant medication, interventions that use any type of antidepressant medication at any dose;</LI>
<LI>psychological, where psychological interventions are restricted to cognitive behavioural interventions (CBT), interpersonal therapy (IPT), problem solving therapy (PST), psychodynamic therapy, counselling, and occupational therapy, undertaken by qualified trained therapists; and</LI>
<LI>physical, where physical interventions are restricted to those using exercise, i.e. strength or aerobic training.</LI>
</OL>
<SUBSECTION>
<HEADING LEVEL="4">Main comparisons</HEADING>
<P>We conducted, where data were available, the following treatment comparisons in order to address the review&#8217;s objectives.</P>
<SUBSECTION>
<HEADING LEVEL="5">1. Work-directed interventions</HEADING>
<UL>
<LI>Work-directed intervention plus clinical intervention versus clinical intervention alone</LI>
<LI>Work-directed intervention plus clinical intervention versus work-directed alone</LI>
<LI>Any work-directed intervention versus no intervention or care as usual</LI>
<LI>Any work-directed intervention versus an alternative work-directed intervention</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. Clinical interventions, antidepressant medication</HEADING>
<UL>
<LI>Any antidepressant medication versus any other antidepressant medication</LI>
<LI>Any antidepressant medication versus placebo</LI>
<LI>Any antidepressant medication versus any psychological intervention</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3. Clinical interventions, psychological</HEADING>
<UL>
<LI>Any psychological intervention versus other psychological intervention</LI>
<LI>Any psychological intervention versus no intervention or care as usual</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4. Clinical interventions, psychological plus antidepressant medication</HEADING>
<UL>
<LI>Psychological intervention combined with antidepressant medication versus antidepressant medication alone</LI>
<LI>Psychological intervention combined with antidepressant medication versus no intervention or care as usual</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5. Clinical interventions, exercise</HEADING>
<UL>
<LI>Exercise intervention versus any other exercise intervention</LI>
<LI>Exercise intervention versus no intervention or care as usual</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2014-11-08 05:10:47 +0200" MODIFIED_BY="[Empty name]">
<P>In this review, we operationalised reduction in work disability as a reduction in sickness absence and as enhancement in work functioning.</P>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2014-11-08 05:05:11 +0200" MODIFIED_BY="[Empty name]">
<P>The main outcome measure in this review was days of sickness absence during the follow-up period. Sickness absence data could be extracted from the employee attendance records or the files of a compensation board, or could be self-reported.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2014-11-08 05:10:47 +0200" MODIFIED_BY="[Empty name]">
<P>When available, we included the following secondary outcomes from the included studies.</P>
<OL>
<LI>Depression (either dichotomously or continuously measured).</LI>
<LI>Work functioning (<LINK REF="REF-Nieuwenhuijsen-2010" TYPE="REFERENCE">Nieuwenhuijsen 2010</LINK>). Examples of work functioning measures are the Endicott Work Productivity Scale (EWPS) (<LINK REF="REF-Endicott-1997" TYPE="REFERENCE">Endicott 1997</LINK>) and the Sheehan Disability Scale (SDS) (<LINK REF="REF-Sheehan-1996" TYPE="REFERENCE">Sheehan 1996</LINK>). We only included instruments that separately measured work functioning (instead of work and other activities combined).</LI>
<LI>Employment status after a period of time (categories being: 'not working', 'working less hours than the contract hours or having modified duties', or 'working all contract hours without modified duties'.</LI>
</OL>
<P>We did not include other outcomes such as employee satisfaction, general social functioning (not work specific), or quality of life scales.</P>
<P>We considered the effects measured with all the above instruments on the following timescales:</P>
<UL>
<LI>short term, up to one month;</LI>
<LI>medium term, from one month to a year; and</LI>
<LI>long term, over a year.</LI>
</UL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2014-11-08 05:18:16 +0200" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2014-11-08 05:18:16 +0200" MODIFIED_BY="[Empty name]">
<P>The updated search included all publications from January 2006 up until January 2014 (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>). For this update, we searched the following electronic databases: CENTRAL (The Cochrane Library), MEDLINE, PsycINFO, EMBASE, and CINAHL. We used three types of terms: depression-related words combined with work-related words and database-specific methodological filter terms. We adapted search terms for PsycINFO, EMBASE, and CINAHL from the MEDLINE search to fit the specific requirements of those databases. For CENTRAL, we replaced the methodological filter by a filter to identify trials.</P>
<P>We based the selected work-related search terms on previous studies. Work* and occupation* are sensitive single terms used to locate occupational health studies, as advocated by Verbeek (<LINK REF="REF-Verbeek-2005" TYPE="REFERENCE">Verbeek 2005</LINK>). Furthermore, we selected database-specific terms relevant to our objective from a study testing which work-related search terms are best suited for literature searching on chronic disease (rheumatoid arthritis, diabetes mellitus, hearing problems, and depression) and work (<LINK REF="REF-Haafkens-2006" TYPE="REFERENCE">Haafkens 2006</LINK>).</P>
<P>We conducted the original search strategy for the first version of this review in 2006, using no limits on publication date (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2014-06-17 09:49:26 +0300" MODIFIED_BY="[Empty name]">
<P>We checked the reference lists of all articles that we retrieved as full papers and of all retrieved systematic and narrative reviews in order to identify further potentially eligible studies.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2014-11-21 08:50:11 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<STUDY_SELECTION MODIFIED="2014-11-08 05:22:29 +0200" MODIFIED_BY="[Empty name]">
<P>Pairs of authors (KN, BF, CF, UB, AV) independently reviewed all studies retrieved from the searches for eligibility. If the title and abstract provided sufficient information to decide that the study did not fulfil the criteria for selection, we excluded the study at that point. We excluded studies in this phase only if the study did not include participants with depressive disorders or it was not a controlled intervention study. When it was not clear whether sickness absence was measured, we retrieved the full article before deciding upon exclusion. We then examined the full text publications of the remaining studies in order to decide which studies fulfilled all inclusion criteria. We documented the reasons for exclusion at that stage. The two authors discussed any disagreement about the inclusion of studies until they reached consensus. If they could not resolve their difference of opinion, they consulted a third author (JV). We had all articles published in languages other than English translated or assessed for inclusion by a native speaker.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2014-11-08 05:24:58 +0200" MODIFIED_BY="[Empty name]">
<P>We constructed a data extraction form that enabled the authors to extract the data from the included studies. For each study, one author filled out the forms and this form was checked by a second author (AN, AV, BF, CF, HH, KN, and UB participated in data extraction) and they solved differences of opinion by discussion. When only a proportion of the study population was workers, we extracted the data for that subgroup from the article. In the case where these data were not reported, we asked the original authors to provide the data for this subgroup. We used the same procedure for studies where only a proportion of the study population was depressed.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2014-11-08 05:30:15 +0200" MODIFIED_BY="[Empty name]">
<P>Pairs of authors (AN, AV, CH, HH, or UB with either KN or BF) independently assessed the risk of bias of the included studies. We used the following items to assess risk of bias in the included studies: random sequence generation (selection bias), allocation concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), and selective reporting (reporting bias). We evaluated risk associated with incomplete outcome data or with blinding of outcome assessments separately for depressive symptoms and the sickness absence data. We assessed the risk of bias in RCTs and cluster RCTs by using the Cochrane Collaboration&#8217;s risk of bias tool (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>With regard to the risk of attrition bias, we calculated the percentage lost to follow up taking the number randomised as the starting point and the number analysed at the latest follow-up measurement as the endpoint. We assigned a high risk of attrition bias to studies with a percentage of participants lost to follow up of more than 20%, and a low risk for studies with less than 10% lost to follow. The risk of attrition bias for studies with 10% to 20% lost to follow up depended on whether the analyses of results accounted for attrition sufficiently.</P>
<P>We rated each potential source of bias as &#8216;high risk&#8217; of bias, &#8216;low risk&#8217; of bias, or &#8216;unclear risk&#8217; of bias in the &#8216;Risk of bias&#8217; table. Next, we constructed a &#8216;Risk of bias' summary figure together with an overview &#8216;risk of bias' graph as described in the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). Where information on risk of bias related to unpublished data or correspondence with a researcher, we noted this in the risk of bias table.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2014-11-08 05:35:38 +0200" MODIFIED_BY="[Empty name]">
<P>We plotted the results of each trial as means and standard deviations (SD) for continuous outcomes. For each timescale (short term, medium term, and long term), we selected the last available observation within this period for the meta-analysis. For the primary outcome measure, that is days of sickness absence, we transformed the number of days or hours worked during the follow up into days of sickness absence. To do so, we extracted the hours or days worked from the maximum of hours an employee would work in that specific country. When transforming the data from days worked to days not worked, the SDs did not need to be transformed. When transforming the data from hours to days, we divided both the means and SDs by eight. Studies used different time spans during which they measured the number of days of sickness absence. Therefore, for days of sickness absence we used the standardised mean difference (SMD) with a 95% confidence interval (CI)) between the intervention and control groups as the summary effect measure.</P>
<P>For the secondary outcome measures, we also used SMDs because it is likely that these outcomes were measured with different instruments. We chose to treat ordinal variables using a scale of more than five categories as continuous variables (it should be noted that this choice was based on arbitrary criteria). We dichotomised scales with less than five categories. For dichotomous data, we calculated the risk ratios (RRs) and 95% CIs.</P>
<P>For depression data, where studies presented both dichotomous and continuous data, we preferred the continuous outcome measures since the majority of the studies presented these.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2014-11-08 05:37:27 +0200" MODIFIED_BY="[Empty name]">
<P>For studies that employed a cluster randomised design and did not consider the design effect in the analyses, we planned to calculate the design effect by following the methods stated in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Donner-2002" TYPE="REFERENCE">Donner 2002</LINK>) based on a fairly large assumed intra-cluster correlation of 0.10. However, the cluster RCTs included in the review reported negligible intra-cluster correlations. Therefore, we did not adjust the measures of effect presented by the authors.<B>
<BR/>
</B>
</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2014-11-08 05:39:50 +0200" MODIFIED_BY="[Empty name]">
<P>If the SDs (continuous data) or numbers of outcomes for each group (dichotomous data) were not presented in the publication, we contacted the authors with a request to provide these data. Whenever authors were unable or unwilling to provide this information, we calculated SDs from P values and CIs following the instructions of the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>We sought additional information regarding study details or statistical data, or both, from the authors of 20 studies and received information from 15 authors. Ten of the authors provided statistical data that had not been published in their articles, which enabled us to include nine of these studies in the meta-analyses. In the case of two studies the correspondence led to the exclusion of the study because essential information on the primary outcome measure could not be provided (<LINK REF="STD-Simon-2000" TYPE="STUDY">Simon 2000</LINK>; <LINK REF="STD-Stant-2009" TYPE="STUDY">Stant 2009</LINK>). Whenever essential information concerning the risk of bias could not be obtained within four weeks of contacting the authors, we listed the corresponding details as 'unclear'.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2014-11-21 08:50:00 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<P>We assessed statistical heterogeneity in the meta-analyses with the I² statistic. If we observed considerable heterogeneity (I² &gt; 75%), we refrained from statistical pooling of the studies within that comparison. Substantial inconsistency (I² statistic) also led to downgrading of the quality of the evidence (see <LINK TAG="DATA_SYNTHESIS" TYPE="SECTION">Data synthesis</LINK> for details).</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2014-11-08 05:41:23 +0200" MODIFIED_BY="[Empty name]">
<P>We planned to produce funnel plots for visual inspection of possible publication bias. However, due to the small number of studies in each comparison we did not perform these.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2014-11-21 08:50:11 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<P>For each predefined comparison, we analysed data for each outcome measure separately. Whenever interventions belonged to the same category in the comparison but two authors (KN and JV, or KN and BF) judged them to be dissimilar, we defined subcategories for these types of intervention. We conducted meta-analysis if two authors (KN and BF) judged a group of trials sufficiently homogeneous in terms of participants, interventions, and outcomes to provide a meaningful summary. In such cases we calculated pooled SMDs for the predefined outcome measures using the Review Manager software (<LINK REF="REF-RevMan-2012" TYPE="REFERENCE">RevMan 2012</LINK>) with a random-effects model. For three-armed trials contributing evidence to two different comparisons, we divided the number of participants of the arm used in both comparisons by two.</P>
<P>We used the GRADE approach to assess the quality of a body of evidence regarding the primary outcome category of the comparisons addressed in the review. At the start of the GRADE assessment process we assumed high quality for all studies and we downgraded the quality of the evidence for each comparison by one to three levels depending on the seriousness of the violations in each domain.</P>
<P>To assess the risk of bias for a comparison, we considered the risk of bias tables for each study in that comparison. We saw Items related to selection bias, detection bias, and attrition bias as prerequisites for high quality. We only considered studies with low risks on these items to have a low risk of bias. For each comparison we considered the risk of bias serious (-1) if a majority of the evidence in the studies included in the meta-analysis (in terms of weights) were of low quality. We applied a -2 downgrade in cases where the majority of the studies did not have adequate random sequence generation and allocation concealment. For consistency, we considered an I<SUP>2</SUP> value of 50% to 75% to indicate substantial inconsistency, which lead us to downgrade (-1). If the I² value exceeded 75%, we refrained from pooling the results and we analysed the results for each study separately. Indirectness of the evidence was not an issue in our review as all comparisons in the included studies directly addressed the comparison. For imprecision of results, we judged serious imprecision leading to downgrading (-1) if a comparison either included a number of fewer than 400 participants or a wide CI around the effect estimate. For a non-significant effect, we considered a CI to be wide if it included an SMD of both 0 and a moderate effect size (SMD &gt; 0.5 or &lt; -0.5). For a significant effect, we considered a CI to be wide if it included both a small and large effect size (SMD small = -0.2 or 0.2; SMD large = 0.8 or -0.8). We could not detect publication bias in our review due to the low number of studies per comparison.</P>
<P>The resulting interpretation of the quality of the level of evidence per comparison was as follows.</P>
<P>High: further research is very unlikely to change our confidence in the estimate of effect.<BR/>Moderate: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>Low: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>Very low: any estimate of effect is very uncertain.<BR/>
</P>
<P>We created a &#8216;Summary of findings&#8217; table with GRADEpro software (<LINK REF="REF-GRADEpro-2008" TYPE="REFERENCE">GRADEpro 2008</LINK>) for the main comparisons using the primary outcome categories.</P>
</DATA_SYNTHESIS>
<SENSITIVITY_ANALYSIS MODIFIED="2014-11-08 05:49:32 +0200" MODIFIED_BY="[Empty name]">
<P>We planned to conduct sensitivity analyses by excluding:</P>
<OL>
<LI>low quality studies,</LI>
<LI>studies with skewed data,</LI>
<LI>cluster randomised trials, and</LI>
<LI>studies in which workers were a small subgroup of the study population.</LI>
</OL>
<P>However, the small numbers of studies in each comparison did not allow for this.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2014-11-21 08:50:14 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<STUDY_DESCRIPTION MODIFIED="2014-11-09 07:33:48 +0200" MODIFIED_BY="[Empty name]">
<P>
<I>
<BR/>
</I>
</P>
<SEARCH_RESULTS MODIFIED="2014-11-08 05:51:32 +0200" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> displays a PRISMA study flow chart of the inclusion process. The original and updated electronic searches resulted in 6392 plus 4917 hits. We assessed the titles and abstracts of these combined searches (n = 11,776) for eligibility. This resulted in the full text assessment of 73 (30 plus 43) publications. We excluded fifty (19 plus 31) studies after further scrutiny (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>). In addition, we identified five ongoing studies (see <LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>).</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2014-11-09 07:33:48 +0200" MODIFIED_BY="[Empty name]">
<P>We included 23 studies in the review (see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>). Three of these studies included three study arms (<LINK REF="STD-Kendrick-2005" TYPE="STUDY">Kendrick 2005</LINK>; <LINK REF="STD-Knekt-2013" TYPE="STUDY">Knekt 2013</LINK>; <LINK REF="STD-Krogh-2009" TYPE="STUDY">Krogh 2009</LINK>). Therefore, we included a total of 26 intervention groups in this review.</P>
<SUBSECTION>
<HEADING LEVEL="5">Designs</HEADING>
<P>Of the included studies, 20 were RCTs and three were cluster RCTs (<LINK REF="STD-Noordik-2013" TYPE="STUDY">Noordik 2013</LINK>; <LINK REF="STD-Rost-2004" TYPE="STUDY">Rost 2004</LINK>; <LINK REF="STD-Schoenbaum-2001" TYPE="STUDY">Schoenbaum 2001</LINK>). Intra-class correlations for these studies were reported to be negligible and therefore we did not adjust the data.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Sample sizes</HEADING>
<P>The total number of participants in the included studies was 6278. The number of participants included in the analysis was lower (5996) as we reported on the subgroup of 'employed and depressed participants only' in cases where studies included other subgroups as well. The number of participants in the smallest intervention (sub)group was lower than 20 in one study, between 20 and 100 in 13 studies, between 100 and 200 in six studies, and more than 200 in three.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Time period, setting and participants</HEADING>
<P>Three studies were published before 2000, seven between 2000 and 2005, and 13 after 2005. Five studies were conducted in the US, while 18 were conducted in Europe. Participants were recruited in primary care settings (seven studies), outpatient settings (10 studies), workplace settings (two studies), occupational health care (two studies), a managed care setting (one study), and one study was conducted in a community mental health centre. In 18 studies, all participants had a major depressive disorder. In five studies (<LINK REF="STD-Bee-2010" TYPE="STUDY">Bee 2010</LINK>; <LINK REF="STD-Kendrick-2005" TYPE="STUDY">Kendrick 2005</LINK>; <LINK REF="STD-Knekt-2013" TYPE="STUDY">Knekt 2013</LINK>; <LINK REF="STD-McCrone-2004" TYPE="STUDY">McCrone 2004</LINK>; <LINK REF="STD-Noordik-2013" TYPE="STUDY">Noordik 2013</LINK>) depressed patients constituted a subgroup of the study participants.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Interventions</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Work-directed interventions</HEADING>
<P>We identified five work-directed interventions (<LINK REF="STD-Hees-2013" TYPE="STUDY">Hees 2013</LINK>; <LINK REF="STD-Lerner-2012" TYPE="STUDY">Lerner 2012</LINK>; <LINK REF="STD-Noordik-2013" TYPE="STUDY">Noordik 2013</LINK>; <LINK REF="STD-Schene-2006" TYPE="STUDY">Schene 2006</LINK>; <LINK REF="STD-Vlasveld-2013" TYPE="STUDY">Vlasveld 2013</LINK>). The first three compared the addition of a work-directed intervention to clinical care with clinical care alone, whereas one study (<LINK REF="STD-Vlasveld-2013" TYPE="STUDY">Vlasveld 2013</LINK>) compared work-directed and clinical care with work-directed care alone, and another study (<LINK REF="STD-Noordik-2013" TYPE="STUDY">Noordik 2013</LINK>) compared two alternative work-directed interventions. The <LINK REF="STD-Hees-2013" TYPE="STUDY">Hees 2013</LINK> and <LINK REF="STD-Schene-2006" TYPE="STUDY">Schene 2006</LINK> studies compared fairly similar interventions, an occupational therapy program focusing on work reintegration and combining modified work and supportive interventions. The intervention in both studies included contact with the occupational physician and the employer, exploration and solving of work problems, and preparation and start of work reintegration. The <LINK REF="STD-Lerner-2012" TYPE="STUDY">Lerner 2012</LINK> study compared an extension of Employee Assistance Counselling (EAP) to regular EAP. This program incorporated both work modification and support and consisted of: 1) work coaching and modification, 2) care co-ordination, and 3) cognitive behavioural strategies. The <LINK REF="STD-Vlasveld-2013" TYPE="STUDY">Vlasveld 2013</LINK> study compared the addition of enhanced clinical care to regular support by the occupational physician who had been trained and had access to the psychiatric consultation. The program contained the following elements: 6 to 12 sessions of Problem Solving Therapy, manual-guided self-help, a workplace intervention and, depending on patient preference, prescription of antidepressant medication according to a treatment algorithm. The <LINK REF="STD-Noordik-2013" TYPE="STUDY">Noordik 2013</LINK> study compared an exposure-based return to work intervention (RTW-E) conducted by occupational physicians (OPs), gradually exposing the participants to more demanding work situations, to regular support by the OP. The RTW-E program provided workers with several homework assignments aimed at preparing, executing, and evaluating an exposure-based RTW plan. The work-directed 'care as usual' by OPs in the <LINK REF="STD-Vlasveld-2013" TYPE="STUDY">Vlasveld 2013</LINK> and <LINK REF="STD-Noordik-2013" TYPE="STUDY">Noordik 2013</LINK> studies was based on a national guideline and usually included both work modification and support.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Clinical interventions</HEADING>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Antidepressant medication</HEADING>
<P>Six studies examined the effectiveness of antidepressant medication. Three studies compared a SSRI with SNRI medication (<LINK REF="STD-Fernandez-2005" TYPE="STUDY">Fernandez 2005</LINK>; <LINK REF="STD-Romeo-2004" TYPE="STUDY">Romeo 2004</LINK>; <LINK REF="STD-Wade-2008" TYPE="STUDY">Wade 2008</LINK>), one study compared a SSRI with TCA (<LINK REF="STD-Miller-1998" TYPE="STUDY">Miller 1998</LINK>), one study compared two different SSRIs (<LINK REF="STD-Fantino-2007" TYPE="STUDY">Fantino 2007</LINK>), and a fourth study compared TCA or MAO inhibitors with placebo (<LINK REF="STD-Agosti-1991" TYPE="STUDY">Agosti 1991</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Psychological interventions</HEADING>
<P>One study (<LINK REF="STD-Knekt-2013" TYPE="STUDY">Knekt 2013</LINK>) with three study arms compared two psychological interventions (short-term and long-term psychodynamic psychotherapy) with an alternative psychological intervention, solution-focused therapy. Four studies looked at the effects of a specific psychological intervention as compared to care as usual (<LINK REF="STD-Bee-2010" TYPE="STUDY">Bee 2010</LINK>; <LINK REF="STD-Hollinghurst-2010" TYPE="STUDY">Hollinghurst 2010</LINK>; <LINK REF="STD-Kendrick-2005" TYPE="STUDY">Kendrick 2005</LINK>; <LINK REF="STD-McCrone-2004" TYPE="STUDY">McCrone 2004</LINK>).</P>
<P>The <LINK REF="STD-Kendrick-2005" TYPE="STUDY">Kendrick 2005</LINK> study had three intervention arms and compared two types of psychological interventions performed by community mental health nurses (Problem Solving Therapy and generic counselling) with general practitioner care as usual. Two studies (<LINK REF="STD-Hollinghurst-2010" TYPE="STUDY">Hollinghurst 2010</LINK>; <LINK REF="STD-McCrone-2004" TYPE="STUDY">McCrone 2004</LINK>) compared a computerised form of CBT with general practitioner care as usual. In the <LINK REF="STD-Hollinghurst-2010" TYPE="STUDY">Hollinghurst 2010</LINK> study, participants receiving online CBT were offered up to 10 sessions each having a duration of 55 minutes. Each participant was assigned their own therapist for the duration of the study. Participants and therapists typed free text into the computer, with messages sent instantaneously, and only used this means of communication. Online CBT in the <LINK REF="STD-McCrone-2004" TYPE="STUDY">McCrone 2004</LINK> study included a 15-minute introductory video, eight 50-minute sessions of CBT, and homework projects between sessions. The program was interactive and feedback was provided to both the patient and general practitioner after each session. One study (<LINK REF="STD-Bee-2010" TYPE="STUDY">Bee 2010</LINK>) compared telephone CBT to usual primary and occupational health services. Telephone CBT was delivered over 12 weeks by registered graduate mental health workers. Participants worked with therapists through regular phone calls to identify and challenge negative thoughts, develop self-care skills, and complete workbook exercises emphasizing behavioural activation.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Psychological interventions plus antidepressant medication</HEADING>
<P>Five studies included interventions with a combination of psychological interventions and antidepressant medication. One study (<LINK REF="STD-Burnand-2002" TYPE="STUDY">Burnand 2002</LINK>) compared the effect of psychodynamic therapy combined with TCA medication with TCA medication alone. The intervention included individual sessions by a nurse combined with clomipramine for a duration of 10 weeks. The frequency of the psychotherapy sessions was not fixed. This was compared to a group receiving the same medication and who received supportive care (an individual session with empathic listening, guidance, and support).</P>
<P>Three studies (<LINK REF="STD-Rost-2004" TYPE="STUDY">Rost 2004</LINK>; 
<LINK REF="STD-Schoenbaum-2001" TYPE="STUDY">Schoenbaum 2001</LINK>; 
<LINK REF="STD-Simon-1998" TYPE="STUDY">Simon 1998</LINK>) compared enhanced primary care with primary care as usual. In these types of interventions general practitioners were enrolled in a quality improvement program and were expected to provide enhanced care including antidepressant medication and psychological interventions, according to primary care guidelines.</P>
<P>One study (<LINK REF="STD-Wang-2007" TYPE="STUDY">Wang 2007</LINK>) compared a structured telephone outreach and care management program to usual managed care. The telephone outreach systematically assessed needs for treatment, facilitated entry into in-person treatment (both psychotherapy and antidepressant medication), monitored and supported treatment adherence, and (for those declining in-person treatment) provided a structured psychotherapy intervention by telephone. Intervention participants declining in-person treatment and experiencing significant depressive symptoms after two months were offered a structured eight-session cognitive behavioural psychotherapy program.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Exercise</HEADING>
<P>Two studies (<LINK REF="STD-Krogh-2009" TYPE="STUDY">Krogh 2009</LINK>; <LINK REF="STD-Krogh-2012" TYPE="STUDY">Krogh 2012</LINK>), of which the first one included three study arms, looked at the effect of exercise interventions. <LINK REF="STD-Krogh-2009" TYPE="STUDY">Krogh 2009</LINK> compared supervised strength training or aerobic training to relaxation training. The strength training was designed to increase muscular strength. The training was a circuit training program with six exercises involving large muscle groups on machines. The aerobic training was designed to increase fitness, as measured by maximal oxygen uptake. The program involved 10 different aerobic exercises using large muscle groups. Machines were used for cycling, running, stepping, abdominal exercises, and rowing. In both exercise interventions, all patients were scheduled to meet twice per week during a four-month period for a total of 32 sessions. The relaxation training was designed to avoid muscular contractions or stimulation of the cardiovascular system and included exercises on mattresses followed by light balance exercises and by relaxation exercises with alternating muscle contraction and relaxation in different muscle groups while lying down.</P>
<P>In the <LINK REF="STD-Krogh-2012" TYPE="STUDY">Krogh 2012</LINK> study, aerobic training was compared to an attention control group (stretching exercises at low intensity). The aerobic training was designed to increase fitness as measured by maximal oxygen uptake. After an initial 10 minutes of general low-intensity warm-up, the participants did 30 minutes of aerobic exercise on a stationary cycle ergometer followed by a five-minute low-intensity cool down period. Both groups were scheduled to meet three times per week for three months, for a total of 36 sessions.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Outcomes</HEADING>
<P>Studies were only selected if they reported on sickness absence. Of the 23 included studies, six studies (<LINK REF="STD-Agosti-1991" TYPE="STUDY">Agosti 1991</LINK>; <LINK REF="STD-Bee-2010" TYPE="STUDY">Bee 2010</LINK>; <LINK REF="STD-Krogh-2012" TYPE="STUDY">Krogh 2012</LINK>; <LINK REF="STD-Miller-1998" TYPE="STUDY">Miller 1998</LINK>; <LINK REF="STD-Schene-2006" TYPE="STUDY">Schene 2006</LINK>; <LINK REF="STD-Wang-2007" TYPE="STUDY">Wang 2007</LINK>) reported days or hours worked instead of days of sickness absence. These measures were transformed into days of sickness absence as described in the 'Methods' section (see <LINK TAG="EFFECT_MEASURES" TYPE="SECTION">Measures of treatment effect</LINK>).</P>
<P>We were able to collect data on depression for all but one of the included studies (<LINK REF="STD-Agosti-1991" TYPE="STUDY">Agosti 1991</LINK>). Of all studies reporting on depression, one study (<LINK REF="STD-Schoenbaum-2001" TYPE="STUDY">Schoenbaum 2001</LINK>) presented only dichotomous depression data while all others presented continuous data.</P>
<P>Eight studies (<LINK REF="STD-Agosti-1991" TYPE="STUDY">Agosti 1991</LINK>; <LINK REF="STD-Burnand-2002" TYPE="STUDY">Burnand 2002</LINK>; <LINK REF="STD-Hees-2013" TYPE="STUDY">Hees 2013</LINK>; <LINK REF="STD-Lerner-2012" TYPE="STUDY">Lerner 2012</LINK>; <LINK REF="STD-Miller-1998" TYPE="STUDY">Miller 1998</LINK>; <LINK REF="STD-Rost-2004" TYPE="STUDY">Rost 2004</LINK>; <LINK REF="STD-Wade-2008" TYPE="STUDY">Wade 2008</LINK>; <LINK REF="STD-Wang-2007" TYPE="STUDY">Wang 2007</LINK>) reported on work functioning using a (sub)scale that separately measured work instead of work and other activities combined.</P>
<P>None of the included studies reported on employment status after a period of time with the predefined categories: 'not working', 'working fewer hours than the contract hours or having modified duties' or 'working all contract hours without modified duties'. However, three studies (<LINK REF="STD-Krogh-2012" TYPE="STUDY">Krogh 2012</LINK>; <LINK REF="STD-Schoenbaum-2001" TYPE="STUDY">Schoenbaum 2001</LINK>; <LINK REF="STD-Wade-2008" TYPE="STUDY">Wade 2008</LINK>) did report 'not working' or 'working' at the end of follow up.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Follow up</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">(a) Short term</HEADING>
<P>None of the included studies had the last outcome measurement within one month.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">(b) Medium term</HEADING>
<P>In 19 studies the last follow-up measurement was between one month and a year after inclusion. Four studies had the last follow-up measurement later than one year but provided data on earlier time points as well (<LINK REF="STD-Hees-2013" TYPE="STUDY">Hees 2013</LINK>; <LINK REF="STD-Knekt-2013" TYPE="STUDY">Knekt 2013</LINK>; <LINK REF="STD-Rost-2004" TYPE="STUDY">Rost 2004</LINK>; <LINK REF="STD-Schene-2006" TYPE="STUDY">Schene 2006</LINK>). We included these outcomes in the medium-term analysis. We used the last available observation within the first year for this purpose.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">(c) Long term</HEADING>
<P>In five studies, the last follow-up measurement was later than one year after inclusion. One study reported on a follow-up period of 18 months (<LINK REF="STD-Hees-2013" TYPE="STUDY">Hees 2013</LINK>), two on 24 months (<LINK REF="STD-Rost-2004" TYPE="STUDY">Rost 2004</LINK>; <LINK REF="STD-Schoenbaum-2001" TYPE="STUDY">Schoenbaum 2001</LINK>), one on 42 months (<LINK REF="STD-Schene-2006" TYPE="STUDY">Schene 2006</LINK>), and one on five years (<LINK REF="STD-Knekt-2013" TYPE="STUDY">Knekt 2013</LINK>). However, only depression data and not the days of sickness absence were reported at two years in the Schoenbaum study. We therefore refrained from using the depression data at this time point, leaving four studies with long-term outcome data.<BR/>
</P>
</SUBSECTION>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2014-11-09 07:16:24 +0200" MODIFIED_BY="[Empty name]">
<P>We excluded a total of 50 studies from the review. Reasons for excluding studies were:</P>
<UL>
<LI>sickness absence not measured as an outcome (<LINK REF="STD-Ahola-2012" TYPE="STUDY">Ahola 2012</LINK>; <LINK REF="STD-Amore-2001" TYPE="STUDY">Amore 2001</LINK>; <LINK REF="STD-Barbui-2009" TYPE="STUDY">Barbui 2009</LINK>; <LINK REF="STD-Boyer-1998" TYPE="STUDY">Boyer 1998</LINK>; <LINK REF="STD-Brandes-2011" TYPE="STUDY">Brandes 2011</LINK>; <LINK REF="STD-Carlin-2010" TYPE="STUDY">Carlin 2010</LINK>; <LINK REF="STD-Castillo_x002d_P_x00e9_rez-2010" TYPE="STUDY">Castillo-Pérez 2010</LINK>; <LINK REF="STD-Dunlop-2011" TYPE="STUDY">Dunlop 2011</LINK>; <LINK REF="STD-Erkkil_x00e4_-2011" TYPE="STUDY">Erkkilä 2011</LINK>; <LINK REF="STD-Finley-2003" TYPE="STUDY">Finley 2003</LINK>; <LINK REF="STD-Hirani-2010" TYPE="STUDY">Hirani 2010</LINK>; <LINK REF="STD-Kojima-2010" TYPE="STUDY">Kojima 2010</LINK>; <LINK REF="STD-Kroenke-2001" TYPE="STUDY">Kroenke 2001</LINK>; <LINK REF="STD-Kuhs-1996" TYPE="STUDY">Kuhs 1996</LINK>; <LINK REF="STD-Lam-2012" TYPE="STUDY">Lam 2012</LINK>; <LINK REF="STD-Martinez-2011" TYPE="STUDY">Martinez 2011</LINK>; <LINK REF="STD-Meyer-2009" TYPE="STUDY">Meyer 2009</LINK>; <LINK REF="STD-Mundt-2001" TYPE="STUDY">Mundt 2001</LINK>; <LINK REF="STD-Oakes-2012" TYPE="STUDY">Oakes 2012</LINK>; <LINK REF="STD-Salminen-2008" TYPE="STUDY">Salminen 2008</LINK>; <LINK REF="STD-Sandahl-2011" TYPE="STUDY">Sandahl 2011</LINK>; <LINK REF="STD-Simon-2000" TYPE="STUDY">Simon 2000</LINK>; <LINK REF="STD-Sir-2005" TYPE="STUDY">Sir 2005</LINK>; <LINK REF="STD-Stant-2009" TYPE="STUDY">Stant 2009</LINK>);</LI>
<LI>participants had a mild depressive disorder or were not diagnosed with a depressive disorder at all (<LINK REF="STD-Aelfers-2013" TYPE="STUDY">Aelfers 2013</LINK>; <LINK REF="STD-Bakker-2007" TYPE="STUDY">Bakker 2007</LINK>; <LINK REF="STD-Blonk-2007" TYPE="STUDY">Blonk 2007</LINK>; <LINK REF="STD-Brouwers-2007" TYPE="STUDY">Brouwers 2007</LINK>; <LINK REF="STD-Furukawa-2012" TYPE="STUDY">Furukawa 2012</LINK>; <LINK REF="STD-Hackett-1987" TYPE="STUDY">Hackett 1987</LINK>; <LINK REF="STD-Lagerveld-2012" TYPE="STUDY">Lagerveld 2012</LINK>; <LINK REF="STD-Lexis-2011" TYPE="STUDY">Lexis 2011</LINK>; <LINK REF="STD-Mino-2006" TYPE="STUDY">Mino 2006</LINK>; <LINK REF="STD-Morgan-2011" TYPE="STUDY">Morgan 2011</LINK>; <LINK REF="STD-Zeeuw-2010" TYPE="STUDY">Zeeuw 2010</LINK>);</LI>
<LI>not a RCT design (<LINK REF="STD-Bech-2000" TYPE="STUDY">Bech 2000</LINK>; <LINK REF="STD-Eklund-2012" TYPE="STUDY">Eklund 2012</LINK>; <LINK REF="STD-Knekt-2011" TYPE="STUDY">Knekt 2011</LINK>; <LINK REF="STD-Schmitt-2008" TYPE="STUDY">Schmitt 2008</LINK>; <LINK REF="STD-Zambori-2002" TYPE="STUDY">Zambori 2002</LINK>);</LI>
<LI>no worker population (<LINK REF="STD-Alexopoulos" TYPE="STUDY">Alexopoulos</LINK>; <LINK REF="STD-Folke-2012" TYPE="STUDY">Folke 2012</LINK>; <LINK REF="STD-Forman-2012" TYPE="STUDY">Forman 2012</LINK>);</LI>
<LI>study took place in an inpatient care setting (<LINK REF="STD-Dick-1985" TYPE="STUDY">Dick 1985</LINK>; <LINK REF="STD-Hordern-1964" TYPE="STUDY">Hordern 1964</LINK>);</LI>
<LI>participants had a severe mental disorder such as schizophrenia (<LINK REF="STD-Becker-1998" TYPE="STUDY">Becker 1998</LINK>);</LI>
<LI>not able to define a subgroup of depressed patients (<LINK REF="STD-Gournay-1995" TYPE="STUDY">Gournay 1995</LINK>); and</LI>
<LI>a double publication (<LINK REF="STD-Schoenbaum-2002" TYPE="STUDY">Schoenbaum 2002</LINK>; <LINK REF="STD-Wells-2000" TYPE="STUDY">Wells 2000</LINK>).</LI>
</UL>
<SUBSECTION>
<HEADING LEVEL="4">Studies awaiting assessment</HEADING>
<P>There were five ongoing studies awaiting further assessment (<LINK REF="STD-Beurden-2013" TYPE="STUDY">Beurden 2013</LINK>; <LINK REF="STD-Geraedts-2013" TYPE="STUDY">Geraedts 2013</LINK>; <LINK REF="STD-Heer-2013" TYPE="STUDY">Heer 2013</LINK>; <LINK REF="STD-Hellstrom-2013" TYPE="STUDY">Hellstrom 2013</LINK>; <LINK REF="STD-Warmerdam-2007" TYPE="STUDY">Warmerdam 2007</LINK>).</P>
</SUBSECTION>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2014-11-09 07:30:26 +0200" MODIFIED_BY="[Empty name]">
<P>We judged studies to have an overall high risk of bias when the items for random sequence generation, allocation concealment, and incomplete outcome data for our primary outcome measure all scored a rating of high risk of bias. We considered the overall risk of bias to be high in 14 studies (<LINK REF="STD-Agosti-1991" TYPE="STUDY">Agosti 1991</LINK>; <LINK REF="STD-Burnand-2002" TYPE="STUDY">Burnand 2002</LINK>; <LINK REF="STD-Hollinghurst-2010" TYPE="STUDY">Hollinghurst 2010</LINK>; <LINK REF="STD-Kendrick-2005" TYPE="STUDY">Kendrick 2005</LINK>; <LINK REF="STD-Knekt-2013" TYPE="STUDY">Knekt 2013</LINK>; <LINK REF="STD-Krogh-2009" TYPE="STUDY">Krogh 2009</LINK>; <LINK REF="STD-Miller-1998" TYPE="STUDY">Miller 1998</LINK>; <LINK REF="STD-Noordik-2013" TYPE="STUDY">Noordik 2013</LINK>; <LINK REF="STD-Romeo-2004" TYPE="STUDY">Romeo 2004</LINK>; <LINK REF="STD-Rost-2004" TYPE="STUDY">Rost 2004</LINK>; <LINK REF="STD-Schene-2006" TYPE="STUDY">Schene 2006</LINK>; <LINK REF="STD-Schoenbaum-2001" TYPE="STUDY">Schoenbaum 2001</LINK>; <LINK REF="STD-Simon-1998" TYPE="STUDY">Simon 1998</LINK>; <LINK REF="STD-Wade-2008" TYPE="STUDY">Wade 2008</LINK>), Of these 14 studies, six studies (<LINK REF="STD-Agosti-1991" TYPE="STUDY">Agosti 1991</LINK>; <LINK REF="STD-Burnand-2002" TYPE="STUDY">Burnand 2002</LINK>; <LINK REF="STD-Miller-1998" TYPE="STUDY">Miller 1998</LINK>; <LINK REF="STD-Noordik-2013" TYPE="STUDY">Noordik 2013</LINK>; <LINK REF="STD-Rost-2004" TYPE="STUDY">Rost 2004</LINK>; <LINK REF="STD-Schoenbaum-2001" TYPE="STUDY">Schoenbaum 2001</LINK>) had either unclear or inadequate random sequence generation or allocation concealment, causing us to classify these studies as having a very high risk of bias. We considered nine studies to have an overall low risk of bias (<LINK REF="STD-Bee-2010" TYPE="STUDY">Bee 2010</LINK>; <LINK REF="STD-Fantino-2007" TYPE="STUDY">Fantino 2007</LINK>; <LINK REF="STD-Fernandez-2005" TYPE="STUDY">Fernandez 2005</LINK>; <LINK REF="STD-Hees-2013" TYPE="STUDY">Hees 2013</LINK>; <LINK REF="STD-Krogh-2012" TYPE="STUDY">Krogh 2012</LINK>; <LINK REF="STD-Lerner-2012" TYPE="STUDY">Lerner 2012</LINK>; <LINK REF="STD-McCrone-2004" TYPE="STUDY">McCrone 2004</LINK>; <LINK REF="STD-Vlasveld-2013" TYPE="STUDY">Vlasveld 2013</LINK>; <LINK REF="STD-Wang-2007" TYPE="STUDY">Wang 2007</LINK>). See <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK> for an overview of the risk of bias per study and the 'Risk of bias' tables that form part of the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> for details.<BR/>
</P>
<ALLOCATION MODIFIED="2014-11-09 07:24:37 +0200" MODIFIED_BY="[Empty name]">
<P>The method for generating random numbers was not adequately described in eight studies. However, personal communications with the authors revealed that in four studies the chosen method was adequate. In the other four studies this information could not be retrieved, which led us to rate the studies as having an unclear risk of bias for this item.</P>
<P>In the three cluster RCTs (<LINK REF="STD-Noordik-2013" TYPE="STUDY">Noordik 2013</LINK>; <LINK REF="STD-Rost-2004" TYPE="STUDY">Rost 2004</LINK>; <LINK REF="STD-Schoenbaum-2001" TYPE="STUDY">Schoenbaum 2001</LINK>) allocation concealment was not adequate, which was probably indicative of the non-feasibility of allocation concealment in this type of design. In three further studies (<LINK REF="STD-Agosti-1991" TYPE="STUDY">Agosti 1991</LINK>; <LINK REF="STD-Burnand-2002" TYPE="STUDY">Burnand 2002</LINK>; <LINK REF="STD-Miller-1998" TYPE="STUDY">Miller 1998</LINK>) information on allocation concealment could not be retrieved, leading to a judgment of unclear risk of bias.</P>
</ALLOCATION>
<BLINDING MODIFIED="2014-11-09 07:28:50 +0200" MODIFIED_BY="[Empty name]">
<P>Risk of performance bias was low in studies using a double-blind design (blinding of participant and care provider). This design was feasible in studies comparing the occupational health effects of antidepressant medications. This type of study has a low risk of performance bias (<LINK REF="STD-Agosti-1991" TYPE="STUDY">Agosti 1991</LINK>; <LINK REF="STD-Fantino-2007" TYPE="STUDY">Fantino 2007</LINK>; <LINK REF="STD-Fernandez-2005" TYPE="STUDY">Fernandez 2005</LINK>; <LINK REF="STD-Miller-1998" TYPE="STUDY">Miller 1998</LINK>; <LINK REF="STD-Romeo-2004" TYPE="STUDY">Romeo 2004</LINK>; <LINK REF="STD-Wade-2008" TYPE="STUDY">Wade 2008</LINK>). In work-directed, psychological, or exercise interventions blinding of the participant or care provider is not feasible. However, we considered the risk of performance bias high only in those studies where the control intervention could be considered less desirable by participants or care provider. One study (<LINK REF="STD-Burnand-2002" TYPE="STUDY">Burnand 2002</LINK>) managed to compose two evenly desirable psychological interventions, leading to an assessment of low risk of performance bias.</P>
<P>Our primary outcome measure (days of sickness absence) could be measured either by self-report or retrieval from attendance records. In the case of self-report, the outcome could be biased by unblinded participants&#8217; knowledge of the intervention. In 15 studies we considered the risk of detection bias to be high, and in one case this risk was unclear.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2014-11-09 07:29:35 +0200" MODIFIED_BY="[Empty name]">
<P>We found nine of the 23 studies to have a low risk of attrition bias, with some studies (<LINK REF="STD-Knekt-2013" TYPE="STUDY">Knekt 2013</LINK>; <LINK REF="STD-McCrone-2004" TYPE="STUDY">McCrone 2004</LINK>; <LINK REF="STD-Vlasveld-2013" TYPE="STUDY">Vlasveld 2013</LINK>) showing different levels of risk of bias for sickness absence and depressive symptoms. Studies with attrition between 10% and 20% could still be classified as having low risk of attrition bias if adequate analyses were conducted to take selective attrition into account. Examples of such analyses are multiple imputation methods or sensitivity analyses.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2014-11-09 07:30:26 +0200" MODIFIED_BY="[Empty name]">
<P>For the majority of the studies (19), no design paper or trial registration could be identified in order to assess the risk of selective reporting. In three studies we considered the risk to be low (<LINK REF="STD-Hees-2013" TYPE="STUDY">Hees 2013</LINK>; <LINK REF="STD-Kendrick-2005" TYPE="STUDY">Kendrick 2005</LINK>; <LINK REF="STD-Vlasveld-2013" TYPE="STUDY">Vlasveld 2013</LINK>) and in one study an outcome measure that was presented in the study design was not reported as an outcome (<LINK REF="STD-Noordik-2013" TYPE="STUDY">Noordik 2013</LINK>).</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2014-06-17 12:23:57 +0300" MODIFIED_BY="[Empty name]">
<P>We did not identify other potential sources of bias.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2014-11-21 08:50:14 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<P>The 23 studies included in the review examined work-directed and clinical interventions. The clinical interventions studied were antidepressant medication, psychological or exercise intervention, or a combination of two. We present summary of findings tables for the comparisons with more than two included studies. <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK> presents the GRADE assessment of the quality of the evidence per comparison.</P>
<P>We did not identify any studies for the comparisons: 'any work-directed intervention versus no intervention or care as usual', 'any antidepressant medication versus any psychological intervention', 'exercise intervention versus any other exercise intervention'. We refrained from conducting sensitivity analyses due to the small number of studies in each comparison.</P>
<P>Below we present the results for our primary outcome, sickness absence, for each of the comparisons. We present our secondary outcomes, depressive symptoms and work functioning, for each of the work-directed interventions as well. For the clinical interventions we chose to only present the effect on depressive symptoms if the intervention reduced sickness absence.</P>
<SUBSECTION>
<HEADING LEVEL="4">1. Work-directed interventions</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1.1 Work-directed intervention combined with a clinical intervention versus clinical intervention alone (medium term)</HEADING>
<P>Three studies looked at the effectiveness of a work-directed intervention combined with a clinical intervention in comparison to a clinical intervention alone (<LINK REF="STD-Hees-2013" TYPE="STUDY">Hees 2013</LINK>; <LINK REF="STD-Lerner-2012" TYPE="STUDY">Lerner 2012</LINK>; <LINK REF="STD-Schene-2006" TYPE="STUDY">Schene 2006</LINK>). The summarised sickness absence results showed moderate quality evidence of a positive effect of adding a work-directed intervention to a clinical intervention (SMD -0.40; 95% CI -0.66 to - 0.14). The two studies adding occupational therapy to clinical depression care (<LINK REF="STD-Hees-2013" TYPE="STUDY">Hees 2013</LINK>; <LINK REF="STD-Schene-2006" TYPE="STUDY">Schene 2006</LINK>) alone did not find a statistically significant effect on sickness absence (SMD -0.30; 95% CI -0.61 to 0.01), while the single study evaluating a multicomponent work-focused intervention (<LINK REF="STD-Lerner-2012" TYPE="STUDY">Lerner 2012</LINK>) did find a reduction of sickness absence days (SMD -0.66; 95% CI -1.15 to -0.16; <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK> and <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>.</P>
<P>The combined results of these three studies showed no difference between the interventions when evaluating depressive symptoms (SMD -0.32; 95% CI -0.88 to 0.25) or work functioning (SMD -0.31; 95% CI -0.79 to 0.16; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.2 Work-directed intervention combined with clinical intervention versus clinical intervention alone (long term)</HEADING>
<P>Two studies also reported long-term effects. We combined these in a separate comparison (<LINK REF="STD-Hees-2013" TYPE="STUDY">Hees 2013</LINK>; <LINK REF="STD-Schene-2006" TYPE="STUDY">Schene 2006</LINK>). These two studies provided moderate quality evidence that adding a work-directed intervention to a clinical intervention did not reduce sickness absence in the long term (SMD -0.19; 95% CI: -0.49 to 0.12; <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>). However, one of the two studies (<LINK REF="STD-Hees-2013" TYPE="STUDY">Hees 2013</LINK>) found that the work-directed intervention reduced depressive symptoms in the long term (SMD -0.63; 95% CI -1.02 to -0.24; <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.3 Work-directed intervention combined with clinical intervention versus work-directed alone (medium term)</HEADING>
<P>We included one study in this comparison (<LINK REF="STD-Vlasveld-2013" TYPE="STUDY">Vlasveld 2013</LINK>). The study compared the addition of enhanced clinical care (collaborative care model) to regular support by the occupational physician only. This single study provided moderate quality evidence that the intervention was not more effective in reducing sickness absence (SMD -0.14; 95% CI -0.49 to 0.21) or depressive symptoms (SMD 0.26; 95% CI -0.20 to 0.72) than the control intervention (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>; <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.4 Any work-directed intervention versus alternative work-directed intervention</HEADING>
<P>We included one study (<LINK REF="STD-Noordik-2013" TYPE="STUDY">Noordik 2013</LINK>) in this comparison; an exposure-based return to work program was compared to regular occupational physician support. The study provided very low quality evidence that sickness absence could have been reduced more in the control group but this effect was not statistically significant (SMD 0.45; 95% CI -0.00 to 0.91; <LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>). The exposure-based return to work program also did not reduce depressive symptoms (SMD -0.18; 95% CI -0.84 to 0.49; <LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Clinical interventions, antidepressant medication</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">2.1 Any antidepressant medication versus any other antidepressant medication (medium term)</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">2.1.1 SSRI versus SNRI</HEADING>
<P>Three studies compared a SSRI to SNRI in depressed workers (<LINK REF="STD-Fernandez-2005" TYPE="STUDY">Fernandez 2005</LINK>; <LINK REF="STD-Romeo-2004" TYPE="STUDY">Romeo 2004</LINK>; <LINK REF="STD-Wade-2008" TYPE="STUDY">Wade 2008</LINK>). In the meta-analysis, the inconsistency of results between these three studies (I²) was 83% and so we did not pool them (<LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>). The results of the single studies were highly inconsistent. We found no difference in sickness absence between a SSRI and SNRI in the <LINK REF="STD-Fernandez-2005" TYPE="STUDY">Fernandez 2005</LINK> study (SMD -0.03; 95% CI -0.37 to 0.31) as well as in the <LINK REF="STD-Romeo-2004" TYPE="STUDY">Romeo 2004</LINK> study (SMD 0.28; 95% CI -0.13 to 0.69). The <LINK REF="STD-Wade-2008" TYPE="STUDY">Wade 2008</LINK> study revealed evidence of an effect on sickness absence favouring a SSRI (SMD -0.57; 95% CI -0.88 to -0.26; <LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>). Measured with the Sheehan disability scale, this study also reported a favourable effect on work functioning (difference of 2.4; 95% CI 0.4 to 4.1) but the reported data did not allow for inclusion in the meta-analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">2.1.2 SSRI versus TCA</HEADING>
<P>
<LINK REF="STD-Miller-1998" TYPE="STUDY">Miller 1998</LINK> was the only study comparing a SSRI to TCA medication in depressed workers. This study found no difference between a SSRI and TCA in reducing sickness absence (SMD 0.08; 95% CI -0.08 to 0.25; <LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>). The <LINK REF="STD-Miller-1998" TYPE="STUDY">Miller 1998</LINK> study measured work functioning using the SAS work composite (<LINK REF="REF-Wells-1989" TYPE="REFERENCE">Wells 1989</LINK>). A higher score on this measure reflects a higher level of impairment. The study reported no significant difference on work functioning between the groups (difference of -0.08; 95% CI -0.24 to 0.09; <LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">2.1.3 SSRI versus SSRI</HEADING>
<P>One study (<LINK REF="STD-Fantino-2007" TYPE="STUDY">Fantino 2007</LINK>) compared one SSRI to another SSRI. This study found evidence of a greater reduction in sickness absence with escitalopram compared to citalopram (SMD -0.31; 95% CI -0.54 to -0.07; <LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.2 Any antidepressant medication versus placebo</HEADING>
<P>One study compared a TCA or MAO to placebo (<LINK REF="STD-Agosti-1991" TYPE="STUDY">Agosti 1991</LINK>). We found very low quality evidence, based on one study, that antidepressant medication did not reduce sickness absence. The effect may even have been in favour of the placebo condition (SMD 0.48; 95% CI -0.05 to 1.00) but this was not statistically significant (<LINK REF="CMP-006.01" TYPE="ANALYSIS">Analysis 6.1</LINK>). Measured with the Work functioning subscale of the LIFE interview, <LINK REF="STD-Agosti-1991" TYPE="STUDY">Agosti 1991</LINK> did find a statistically significant positive effect in favour of antidepressant medication (SMD -0.58; 95% CI -1.11 to -0.05; <LINK REF="CMP-006.02" TYPE="ANALYSIS">Analysis 6.2</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Clinical interventions, psychological</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">3.1 Any psychological intervention versus other psychological intervention (medium term)</HEADING>
<P>One study (<LINK REF="STD-Knekt-2013" TYPE="STUDY">Knekt 2013</LINK>) with three treatment arms evaluated the effect of alternative psychological interventions. Two study arms assessed psychodynamic therapy, where one study arm examined short-term and the other long-term therapy. Both were compared to solution focused therapy. The inconsistency (I²) in this meta-analysis was 97%, therefore we refrained from pooling the results of the two psychodynamic therapy conditions.</P>
<P>We found low quality evidence of short-term psychodynamic therapy not being more effective than solution focused therapy in reducing sick leave (SMD 0.25; 95% CI -0.39 to 0.89) and of solution focused therapy being more effective in reducing sick leave than long-term psychodynamic therapy (SMD 1.16; 95% CI 0.49 to 1.83; <LINK REF="CMP-007.01" TYPE="ANALYSIS">Analysis 7.1</LINK>).</P>
<P>The depressive symptoms and work functioning outcomes were better for the short-term psychodynamic therapy than for solution focused therapy (SMD -0.66; 95% CI -1.03 to -0.30), but solution focused therapy showed better results than the long-term psychodynamic therapy (SMD 1.00; 95% CI 0.63 to 1.36; <LINK REF="CMP-007.01" TYPE="ANALYSIS">Analysis 7.1</LINK>; <LINK REF="CMP-007.02" TYPE="ANALYSIS">Analysis 7.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.1 Any psychological intervention versus other psychological intervention (long term)</HEADING>
<P>The <LINK REF="STD-Knekt-2013" TYPE="STUDY">Knekt 2013</LINK> study also had long-term results (five-year follow up). We refrained from statistically pooling the results due to high inconsistency (I² = 99%). The separate analyses yielded low quality evidence of long-term (SMD -0.91; 95% CI -1.62 to -0.19) and short-term psychodynamic psychotherapy (SMD -4.61; 95% CI -5.84 to -3.39) reducing sickness absence more effectively than solution focused therapy in the long term (<LINK REF="CMP-008.01" TYPE="ANALYSIS">Analysis 8.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.1 Any psychological intervention versus no intervention or care as usual (medium term)</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">3.1.1 Online or telephone CBT versus care as usual</HEADING>
<P>Three studies compared online or telephone CBT with care as usual (<LINK REF="STD-Bee-2010" TYPE="STUDY">Bee 2010</LINK>; <LINK REF="STD-Hollinghurst-2010" TYPE="STUDY">Hollinghurst 2010</LINK>; <LINK REF="STD-McCrone-2004" TYPE="STUDY">McCrone 2004</LINK>). The pooled results showed that there was moderate quality evidence (SMD -0.23; 95% CI -0.45 to -0.01) that online or telephone CBT reduced sickness absence more than usual primary or occupational care. See <LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK> and <LINK REF="CMP-009.01" TYPE="ANALYSIS">Analysis 9.1</LINK>. Online or telephone CBT also reduced depressive symptoms (SMD -0.56; 95% CI -0.76 to -0.36; <LINK REF="CMP-009.02" TYPE="ANALYSIS">Analysis 9.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">3.1.2 Problem solving or counselling by community mental health nurse versus general practitioner</HEADING>
<P>One study (<LINK REF="STD-Kendrick-2005" TYPE="STUDY">Kendrick 2005</LINK>) looked at two types of psychological interventions performed by community mental health nurses (Problem Solving Therapy and generic counselling) and compared these interventions with general practitioner care as usual. The pooled results from the two psychological interventions yielded low quality evidence (SMD 0.22; 95% CI -0.36 to 0.79) that these interventions were no better in reducing sickness absence than care by general practitioners (<LINK REF="CMP-009.01" TYPE="ANALYSIS">Analysis 9.1</LINK>).</P>
<P>See <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK> for the forest plot of this comparison.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4. Clinical interventions, psychological plus antidepressant medication</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">4.1 Psychological intervention combined with antidepressant medication versus antidepressant medication alone (medium term)</HEADING>
<P>One study (<LINK REF="STD-Burnand-2002" TYPE="STUDY">Burnand 2002</LINK>) evaluated the effectiveness of psychodynamic therapy combined with TCA medication versus TCA medication alone. This study provided very low quality evidence of psychodynamic therapy combined with TCA medication reducing sickness absence more than TCA medication alone (SMD -0.71; 95% CI -1.25 to -0.17; <LINK REF="CMP-010.01" TYPE="ANALYSIS">Analysis 10.1</LINK>).</P>
<P>The effects of the intervention on work functioning (SMD -0.11; 95% CI -0.57 to 0.35) and depressive symptoms (SMD -0.49; 95% CI -1.02 to 0.04) were both not significant (<LINK REF="CMP-010.02" TYPE="ANALYSIS">Analysis 10.2</LINK>; <LINK REF="CMP-010.03" TYPE="ANALYSIS">Analysis 10.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4.2 Psychological intervention combined with antidepressant medication versus no intervention or care as usual (medium term)</HEADING>
<P>The findings for this comparison are displayed in <LINK REF="SOF-03" TYPE="SOF">Summary of findings table 3</LINK>.</P>
<P>Three studies tested enhanced primary care interventions, which were deemed similar enough for statistical pooling (<LINK REF="STD-Rost-2004" TYPE="STUDY">Rost 2004</LINK>; <LINK REF="STD-Schoenbaum-2001" TYPE="STUDY">Schoenbaum 2001</LINK>; <LINK REF="STD-Simon-1998" TYPE="STUDY">Simon 1998</LINK>). However, for the study by <LINK REF="STD-Rost-2004" TYPE="STUDY">Rost 2004</LINK> we could not obtain from the author the SDs around the mean estimates, nor could we calculate them. Therefore, we could not include this study in the meta-analysis. Because the publication itself only presented data over two years, we qualitatively described the results of this study for the long-term outcome only.<BR/>
</P>
<P>Both trials with usable data (<LINK REF="STD-Schoenbaum-2001" TYPE="STUDY">Schoenbaum 2001</LINK>; <LINK REF="STD-Simon-1998" TYPE="STUDY">Simon 1998</LINK>) failed to show a significant difference in days of sickness absence between the intervention and comparison groups. The pooled results of these two trials provided low quality evidence of no effect of enhanced primary care on sickness absence (SMD -0.02; 95% CI -0.15 to 0.12; <LINK REF="CMP-011.01" TYPE="ANALYSIS">Analysis 11.1</LINK>). In addition, <LINK REF="STD-Schoenbaum-2001" TYPE="STUDY">Schoenbaum 2001</LINK> did not find a significant difference in employment status between the intervention and the control groups in the medium term (RR 1.08; 95% CI 0.99 to 1.18; <LINK REF="CMP-011.02" TYPE="ANALYSIS">Analysis 11.2</LINK>).</P>
<P>One study (<LINK REF="STD-Wang-2007" TYPE="STUDY">Wang 2007</LINK>) looked at a different type of intervention, a structured telephone outreach and care management program, in comparison to usual care. We found high quality evidence of an effect on sickness absence in favour of the intervention (SMD -0.21; 95% CI -0.37 to -0.05; <LINK REF="CMP-011.01" TYPE="ANALYSIS">Analysis 11.1</LINK>) based on this study. The effect on depressive symptoms was similar (SMD -0.23; 95% CI -0.39 to -0.07; <LINK REF="CMP-011.03" TYPE="ANALYSIS">Analysis 11.3</LINK>). However, the effect on work functioning favoured the control condition (SMD 0.50; 95% CI 0.34 to 0.66; <LINK REF="CMP-011.05" TYPE="ANALYSIS">Analysis 11.5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4.3 Psychological intervention combined with antidepressant medication versus no intervention or care as usual (long term)</HEADING>
<P>Only one study (<LINK REF="STD-Rost-2004" TYPE="STUDY">Rost 2004</LINK>) reported long-term outcomes. Data were insufficient for us to calculate a SMD in days of sickness absence. The authors reported no statistically significant effect on sickness absence and depression but did report that work functioning was significantly improved using a subjective rating on a 0 to 10 scale at work.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5 Clinical interventions, exercise</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">5.1 Exercise intervention versus no intervention or care as usual</HEADING>
<P>We included two studies in this comparison (<LINK REF="STD-Krogh-2009" TYPE="STUDY">Krogh 2009</LINK>; <LINK REF="STD-Krogh-2012" TYPE="STUDY">Krogh 2012</LINK>), of which one (<LINK REF="STD-Krogh-2009" TYPE="STUDY">Krogh 2009</LINK>) had two study arms.</P>
<SUBSECTION>
<HEADING LEVEL="6">5.1.1 Strength exercise versus relaxation</HEADING>
<P>We found low quality evidence, based on one study, that supervised strength exercise was more effective than relaxation in reducing sickness absence (SMD -1.11; 95% CI -1.68 to -0.54; <LINK REF="CMP-012.01" TYPE="ANALYSIS">Analysis 12.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">5.1.2. Aerobic exercise versus relaxation or stretching</HEADING>
<P>The pooled effect of two studies yielded moderate quality evidence that aerobic exercise was not more effective than relaxation or stretching in reducing sickness absence (SMD -0.06; 95% CI -0.36 to 0.24; <LINK REF="CMP-012.01" TYPE="ANALYSIS">Analysis 12.1</LINK>).<BR/>
</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2014-11-21 08:34:33 +0200" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2014-11-09 08:19:44 +0200" MODIFIED_BY="[Empty name]">
<P>We included 20 RCTs and three cluster RCTs in the review, with five studies evaluating work-directed interventions and 18 evaluating clinical interventions. Within these broad categories, the type of intervention varied widely from one study to another, which limited the number of studies in each predefined comparison. This review showed that there is moderate quality evidence that adding a work-directed intervention to a clinical intervention reduces the number of days on sick leave in the medium term (4 to 12 months; SMD -0.40). Similar effects on depressive symptoms and work functioning could not be demonstrated. The absolute difference in days absent from work differed in each of the studies. The <LINK REF="STD-Hees-2013" TYPE="STUDY">Hees 2013</LINK> study found the smallest absolute difference, 1.7 versus 2.1 days over a 12-month period. <LINK REF="STD-Schene-2006" TYPE="STUDY">Schene 2006</LINK> found a difference of 66 versus 83 days absence over a period of six months; and <LINK REF="STD-Lerner-2012" TYPE="STUDY">Lerner 2012</LINK> found an absolute difference of one versus 2.2 days over a period of two weeks. Moderate quality evidence, from a comparison including a single study, showed that enhancing the clinical care in addition to regular work-directed care did not reduce sickness absence more than work-directed care alone (with regular access to clinical care). There was very low quality evidence, based on one study, that regular care by occupational physicians that is enhanced with an exposure-based return to work program does not reduce sickness absence compared to regular care by occupational physicians.</P>
<P>With regard to antidepressant medication, this review found highly inconsistent results regarding the effect of SSRIs compared to other medications on days of sickness absence (four studies). Compared to SNRI medication (three studies), one single study found that SSRI reduced sickness absence (<LINK REF="STD-Wade-2008" TYPE="STUDY">Wade 2008</LINK>), no difference in effect on sickness absence was found in another (<LINK REF="STD-Fernandez-2005" TYPE="STUDY">Fernandez 2005</LINK>), and a non-significant difference in effect on sickness absence was found in the last (<LINK REF="STD-Romeo-2004" TYPE="STUDY">Romeo 2004</LINK>). One single study found that a SSRI did not reduce sickness absence more than TCA medication (<LINK REF="STD-Miller-1998" TYPE="STUDY">Miller 1998</LINK>). One study (<LINK REF="STD-Fantino-2007" TYPE="STUDY">Fantino 2007</LINK>) compared one SSRI to another SSRI. This study found that escitalopram reduced sickness absence more than citalopram (SMD -0.31). One study compared a TCA or MAO to placebo (<LINK REF="STD-Agosti-1991" TYPE="STUDY">Agosti 1991</LINK>). This study found that the antidepressant medication did not reduce sickness absence more than placebo.</P>
<P>This review found moderate quality evidence based on three studies that telephone or online CBT reduced sick leave more than usual primary or occupational care in the medium term (three to eight months; SMD -0.23). These interventions also reduced depressive symptoms compared to usual primary or occupational care (SMD -0.56). The absolute differences in days of sickness absence were 3.9 versus 4.3 over four weeks (<LINK REF="STD-Bee-2010" TYPE="STUDY">Bee 2010</LINK>); 3.8 versus 11.2 over eight months (<LINK REF="STD-McCrone-2004" TYPE="STUDY">McCrone 2004</LINK>); and 7.6 versus 12.7 over eight months (<LINK REF="STD-Hollinghurst-2010" TYPE="STUDY">Hollinghurst 2010</LINK>).</P>
<P>This review found low quality evidence of no effect of enhanced primary care on sickness absence in the medium term (four to 12 months), based on the pooled results of two studies (SMD -0.02). A third study found no statistically significant effect on sickness absence of this intervention in the long term (24 months).</P>
<P>This review found high quality evidence from one study that a structured telephone outreach and care management program reduced sickness absence when compared to usual care (SMD -0.21). The absolute difference on the original scale was 42.3 (intervention) versus 39.5 (control) hours worked per week over the last four weeks.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2014-11-09 08:38:38 +0200" MODIFIED_BY="[Empty name]">
<P>The studies included in this review have been conducted in Europe and the United States of America only. Therefore, the generalisability of our findings to other parts of the world remains unclear. In line with our inclusion criteria, the included studies cover a range of clinical states. In 13 studies a major depressive disorder according to the DSM-IV or III was used as an inclusion criterion, while others included patients based on their symptom severity as measured by a questionnaire. Moreover, study setting is likely to be a source of clinical heterogeneity. Most studies were conducted in primary care settings (seven studies) and in outpatient settings (10 studies). In only two studies patients were recruited in a workplace setting, and in another two in occupational health care. In many instances the occupation of the participants was not reported even though it is conceivable that the effect of interventions partly depends on the specific work situation. A lack of studies on work-related factors which may be predictors for work outcomes in depressed workers has already been pointed out (<LINK REF="REF-Lagerveld-2010" TYPE="REFERENCE">Lagerveld 2010</LINK>). Therefore, we cannot assess the potential impact of work situations on the effectiveness of the included interventions.</P>
<P>In this updated review, we were able to include studies on work-directed interventions as well as clinical interventions. While it is important to assess the effects of clinical interventions on occupational health, we are aware that the primary reason to choose between one or another clinical intervention is clinical effectiveness. However, in line with the emerging paradigm of value-based medicine, it is central to care to offer interventions to patients providing the greatest patient value (<LINK REF="REF-Brown-2013" TYPE="REFERENCE">Brown 2013</LINK>). As being able to work may be one of the factors on which patient preference is based, assessing occupational health outcomes for clinical interventions is key. Moreover, from the point of view of patient preference, work functioning may be as important as sickness absence. However, in most included studies this outcome was not measured. Evaluating the effect of interventions on work functioning would further enable us to assess the patient value of these interventions.</P>
<P>In contrast to the first version of this review, we were able to include studies in most of the predefined comparisons. However, the number of studies within each comparison was small, and even within some of the comparisons the interventions were too dissimilar to pool the results. One example is the comparison 'psychological intervention combined with antidepressant medication versus no intervention or usual care'. Two studies were on interventions indirectly targeting the worker by enhancing the care of the care provider (<LINK REF="STD-Schoenbaum-2001" TYPE="STUDY">Schoenbaum 2001</LINK>; <LINK REF="STD-Simon-1998" TYPE="STUDY">Simon 1998</LINK>). One other study (<LINK REF="STD-Wang-2007" TYPE="STUDY">Wang 2007</LINK>) evaluated an intervention in which the workers were directly targeted as they received psychotherapy by telephone. Only the latter intervention reduced the days of sickness absence more than care as usual. Another consequence of the low number of studies per comparison is that we were unable to perform subgroup analyses for participant and intervention characteristics, which impedes generalisation of the results.</P>
<P>The clinical relevance of the observed effects can best be evaluated by looking at the absolute differences in days of sickness absence. It should, however, be noted that these differences vary from one study to another. Part of the explanation is that the outcome measure 'days of sickness absence' is by definition partly determined by the length of follow up. Nonetheless, variations in the absolute difference between studies are not always explained by differences in length of follow up (see <LINK REF="STD-Hees-2013" TYPE="STUDY">Hees 2013</LINK>; <LINK REF="STD-Schene-2006" TYPE="STUDY">Schene 2006</LINK>). The relevance of reductions in days of sick leave depends on the perspective of the stakeholder. A reduction in sick leave of one day may not be relevant from the worker's point of view but can be relevant for stakeholders who bear the costs of the lost productivity, such as employers or insurance companies.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2014-11-09 08:53:23 +0200" MODIFIED_BY="[Empty name]">
<P>Of the included studies, 20 were RCTs and three were cluster RCTs. The number of participants per study was fairly small, less than 100 in 14 studies, between 100 and 200 in six, and more than 200 in three. In some cases the low number of participants was due to our need to focus only on a subgroup of the study population, either disregarding participants with other mental disorders or participants who did not work.</P>
<P>We considered the overall risk of bias to be low in nine studies. In 14 studies we considered it to be high as either random sequence generation, allocation concealment, or incomplete sickness absence data were inadequate. In six of these the random sequence generation or allocation concealment was unclear or inadequate.<BR/>
</P>
<P>In the three cluster RCTs allocation concealment was not adequate, probably indicative of the non-feasibility of allocation concealment in this type of design due to all participants in one cluster (for example in a practice or with a healthcare provider) being automatically assigned to the same study arm. In three further studies information on random sequence generation or allocation concealment could not be retrieved, leading to a judgment of unclear risk of bias.</P>
<P>We found a high risk of performance bias in 14 of the included studies. In work-directed, psychological, or exercise interventions, blinding of the participant or care provider is not feasible. However, the risk of performance bias also depends on how desirable the intervention is compared to the control group, according to either care providers or participants. One study evaluating a psychological intervention in addition to medication managed to compose two evenly desirable psychological interventions by ensuring an equal number of supportive instead of therapeutic sessions.</P>
<P>In this review, we chose to assess detection and attrition bias separately for sickness absence and depressive symptoms. We felt that not being blind to allocation may bias a self-report assessment of depressive symptoms more than the reporting of a more factual outcome such as the days absent from work in a given period. Also, sickness absence may be retrieved from employee attendance records while depression is measured with a self-report questionnaire. In those instances the lack of blinding of outcome assessment cannot influence the sickness absence but may well bias the depressive outcome.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2014-11-21 08:34:33 +0200" MODIFIED_BY="[Empty name]">
<P>This review included studies with a study population of both workers and non-workers. This means that subgroups of the original sample were used for measuring the effect on sickness absence. These studies did not usually present all data for workers separately, but their sickness absence reports were by definition based on the workers in the study population. Some studies included participants with mental disorders other than depression. We included the studies in this review if the authors were willing to provide data for the depressed subgroup.</P>
<P>Subgroup analyses in individual studies may lead to biased results for the following three reasons (<LINK REF="REF-Freemantle-2001" TYPE="REFERENCE">Freemantle 2001</LINK>). First, in the event that no effect is found for the primary outcome it is common that researchers look for a more positive outcome among possible subgroups. Thus the chance for a positive subgroup result would be spuriously increased. Next, in the event of a positive main effect the power for finding an effect in a subgroup would be substantially reduced, and finding no effect for a subgroup could just be a matter of lack of power. Further, testing many subgroups would increase the likelihood of finding a statistically significant result by chance alone. In 19 of the included studies the primary outcome was not work-related and we had to base our conclusions on subgroups of the original sample for which data on work-related outcomes were collected. However, none of the authors specifically looked for a work-related outcome because of the absence of an effect for the primary outcome, and neither did we. Therefore, we are not concerned that this would have influenced our results. This similarly holds for the other argument against the use of subgroups, the testing of multiple groups. We predefined the subgroups; we did not test multiple potential subgroups in the hope of finding a statistically significant group. However, we do agree that a lack of power leading to statistically non-significant findings may have occurred in our review. We were, therefore, careful to not describe non-significant findings with wide confidence intervals as evidence of no effect.</P>
<P>This review evaluates the effectiveness of a range of interventions aiming to reduce sickness absence in depressed workers rather than one specific intervention. While we believe this is appropriate for a complex and multifactorial outcome such as sickness absence, the categorisation of interventions under the comparisons has been challenging. This categorisation is likely to influence the results as it determines, for each intervention, with which other interventions the results will be pooled and to which other interventions it will be compared. The way interventions are categorised entails a potential bias in the review process.</P>
<P>Another methodological issue concerns the handling of sickness absence data. We accepted both self-report and administrative databases as sources of data on sickness absence. Administrative databases are sometimes considered the gold standard. Agreement between the two sources has been reported to be good (<LINK REF="REF-Ferrie-2005" TYPE="REFERENCE">Ferrie 2005</LINK>; <LINK REF="REF-Severens-2000" TYPE="REFERENCE">Severens 2000</LINK>) but also limited (<LINK REF="REF-Pole-2006" TYPE="REFERENCE">Pole 2006</LINK>; <LINK REF="REF-van-Poppel-2002" TYPE="REFERENCE">van Poppel 2002</LINK>). Furthermore, for the purpose of calculating standardised mean differences (SMDs) we considered sickness absence a construct for which different instruments could be used, as long as they provided information on absenteeism. This meant that as long as we reported SMDs we could incorporate studies with different time spans (and therefore with a different maximum of sickness absence days during follow up) and scales that differed in the maximum score. Also, this enabled us to compare studies from various countries as we know that days of sickness absence tend to be calculated differently in different countries (for instance due to differences in whether calendar days or only work days are included as absenteeism days). Moreover, we transformed reports of days worked into days of sickness absence by extracting the days worked from the days that should have been worked ('the scale maximum'). This is analogous to transforming the scores of a scale in which a high score indicates a good outcome into a scale where a high score indicates a bad outcome. However, for this transformation we had to make inferences about the mean number of hours and the number of hours a day an employee would work in a specific country. In summary, caution is recommended when interpreting sickness absence data in meta-analyses as this is a relatively new field and the methodological issues have not been thoroughly investigated.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2014-11-09 09:08:03 +0200" MODIFIED_BY="[Empty name]">
<P>A review of the effects of interventions for major depressive disorder on occupational health outcomes was published some years ago (<LINK REF="REF-Timbie-2006" TYPE="REFERENCE">Timbie 2006</LINK>). Compared to the previous review we were able to identify seven additional studies. Furthermore, Timbie and colleagues chose to combine all studies in their meta-analysis, while we judged the interventions to be too dissimilar for this purpose. Finally, they did not distinguish between time missed from work and workforce participation (both were called labour output). Therefore, we find their conclusion that interventions for depressive disorder have a small but positive effect on labour output too general and believe that we have been able to make better inferences. A more recently published review (<LINK REF="REF-Furlan-2012" TYPE="REFERENCE">Furlan 2012</LINK>) searched the literature until 2010 and concluded that the evidence was of insufficient quality to determine which interventions are effective and are of value for the management of depression in the workplace. This conclusion was similar to the first published version of this review (<LINK REF="REF-Nieuwenhuijsen-2008" TYPE="REFERENCE">Nieuwenhuijsen 2008</LINK>). This updated version of our review has markedly different conclusions due to the inclusion of a substantially greater number of studies.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2014-11-21 14:25:22 +0200" MODIFIED_BY="Jos H Verbeek">
<IMPLICATIONS_PRACTICE MODIFIED="2014-11-21 14:24:23 +0200" MODIFIED_BY="Jos H Verbeek">
<P>We found moderate quality evidence based on three studies that adding a work-directed intervention to a clinical intervention reduces the number of days on sick leave in the medium term when compared to a clinical intervention alone. </P>
<P>There is currently no evidence of a difference in effect on sickness absence of one antidepressant medication compared to another. </P>
<P>We found moderate quality evidence that enhancing primary or occupational care by providing workers with a structured telephone or online cognitive behavioural therapy reduces sickness absence compared to regular care. </P>
<P>We found low quality evidence of no considerable effect for enhanced primary care targeting general practitioners through a quality improvement program. </P>
<P>Based on a single study yielding high quality evidence, we found that a structured telephone outreach and care management program may also lead to reductions in sickness absence of depressed workers.<BR/>
</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2014-11-21 14:25:22 +0200" MODIFIED_BY="Jos H Verbeek">
<P>More research is needed on the addition of work-directed interventions to the clinical care provided. This review shows that such interventions have the potential to reduce sickness absence but the number of studies evaluating these types of interventions is still limited. </P>
<P>More often including occupational outcomes such as sickness absence and work functioning in clinical intervention studies will reveal which clinical interventions can be effective in reducing sickness absence. </P>
<P>To facilitate the synthesis of evidence from various intervention studies, the occupational health field should work towards standardising and validating measures of sickness absence. For future reviews including absenteeism as an outcome measure, it is advisable to report standardised mean differences instead of means as this takes into account the differences in measurement methods.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2014-11-21 08:34:36 +0200" MODIFIED_BY="[Empty name]">
<P>We are grateful to José Luis Fernandez, Martin Keller, Tony Kendrick, Paul Knekt, Paul McCrone, Judith Proudfoot, Renee Romeo, Kathryn Rost, Aart Schene, Gregory Simon, Alan Wade, Penny Bee, Clément Francois, Nicholas Moore, and Ken Wells for kindly providing further information about their studies. We thank the CCDAN group for their support with the first version of this review. We thank Janet Wale for copy editing the text of the updated review. To conclude, we are very grateful for the help of the Cochrane Occupational Safety and Health Review Group and Jani Ruotsalainen in particular.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2014-12-01 14:03:20 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<P>Karen Nieuwenhuijsen was an author of one of the included studies: <LINK REF="STD-Noordik-2013" TYPE="STUDY">Noordik 2013</LINK>.</P>
<P>Babs Faber: none known.</P>
<P>Jos Verbeek: none known.</P>
<P>Angela Neumeyer-Gromen: none known.</P>
<P>Hiske Hees was an author of one of the included studies: <LINK REF="STD-Hees-2013" TYPE="STUDY">Hees 2013</LINK>.</P>
<P>Arco Verhoeven: none known.</P>
<P>Christina van der Feltz-Cornelis was an author of one of the included studies: <LINK REF="STD-Vlasveld-2013" TYPE="STUDY">Vlasveld 2013</LINK>. Her employer received an unrestricted grant from Eli Lilly for an investigator-initiated trial on depression and pain. She also received payment from Benecke for speaking at a symposium on chronic pain. She has received royalties from various publishers on her books on psychiatry.</P>
<P>Ute Bültmann: none known.</P>
<P>None of the authors assessed studies they were authors of for eligibility or risk of bias.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2014-11-08 15:33:00 +0200" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="6">Original review</HEADING>
<P>KN wrote the initial draft of the protocol and will write subsequent drafts of the protocol and review. She and AN designed and conducted the search strategy. AV, UB, CF, AN, and JV contributed to the draft version of the protocol and contributed to subsequent versions and revisions of the protocol and review. KN, AV, and UB included eligible studies. UB and CF conducted the quality assessment of eligible studies. KN and AN extracted the data from the original studies. KN, CF, and JV conducted the data synthesis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Update 2014</HEADING>
<P>BF adapted the search strategy and conducted the searches. BF, KN, CF, UB, and AV checked resulting studies for eligibility. BF, KN, AN, AV CF, HH, and UB conducted data extraction. BF, KN, AN, AV, CH, HH, UB, and JV assessed included studies for risk of bias. BF, KN, and JV ran the analyses. KN wrote the draft of the updated review and all others commented on this draft. JV acted as an advisor on the whole review process and several specific topics such as meaningful comparisons, GRADE, and meta-analysis.<BR/>
</P>
</SUBSECTION>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2014-12-01 14:04:00 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<P>In order to reflect the latest guidance available in the <I>Cochrane Handbook for Systematic Teviews of Interventions</I>, we used the GRADE approach. In the former version of the protocol and the published review, we used the Downs and Black checklist to assess quality, while in this update we used the Cochrane Collaboration&#8217;s risk of bias tool. Also, we no longer formally tested heterogeneity but rather assessed the I² statistic. Furthermore, our search strategy was simplified and we no longer handsearched journals as these were indexed in MEDLINE and did not yield additional studies. Instead of searching the CCDAN registers, we now directly searched CENTRAL.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2014-12-02 10:41:33 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<STUDIES MODIFIED="2014-12-01 14:02:34 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<INCLUDED_STUDIES MODIFIED="2014-12-01 14:02:34 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<STUDY DATA_SOURCE="PUB" ID="STD-Agosti-1991" MODIFIED="2014-12-01 14:02:23 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Agosti 1991" YEAR="1991">
<REFERENCE MODIFIED="2014-12-01 14:02:23 +0200" MODIFIED_BY="Jani H Ruotsalainen" NOTES="&lt;p&gt;DA - 19920228&lt;/p&gt;" NOTES_MODIFIED="2014-12-01 14:02:23 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Agosti V, Stewart JW, Quitkin FM</AU>
<TI>Life satisfaction and psychosocial functioning in chronic depression: effect of acute treatment with antidepressants</TI>
<SO>Journal of Affective.Disorders</SO>
<YR>1991</YR>
<VL>23</VL>
<NO>1</NO>
<PG>35-41</PG>
<IDENTIFIERS MODIFIED="2014-12-01 14:02:23 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bee-2010" MODIFIED="2014-12-01 14:02:28 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Bee 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-12-01 14:02:28 +0200" MODIFIED_BY="Jani H Ruotsalainen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bee PE, Bower P, Gilbody S, Lovell K</AU>
<TI>Improving health and productivity of depressed workers: a pilot randomized controlled trial of telephone cognitive behavioral therapy delivery in workplace settings</TI>
<SO>General Hospital Psychiatry</SO>
<YR>2010</YR>
<VL>32</VL>
<PG>337-40</PG>
<IDENTIFIERS MODIFIED="2014-12-01 14:02:28 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burnand-2002" MODIFIED="2014-12-01 14:02:34 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Burnand 2002" YEAR="2002">
<REFERENCE MODIFIED="2014-12-01 14:02:34 +0200" MODIFIED_BY="Jani H Ruotsalainen" NOTES="&lt;p&gt;DA - 20020502&lt;/p&gt;" NOTES_MODIFIED="2014-12-01 14:02:34 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Burnand Y, Andreoli A, Kolatte E, Venturini A, Rosset N</AU>
<TI>Psychodynamic psychotherapy and clomipramine in the treatment of major depression</TI>
<SO>Psychiatric Services</SO>
<YR>2002</YR>
<VL>53</VL>
<NO>5</NO>
<PG>585-90</PG>
<IDENTIFIERS MODIFIED="2014-12-01 14:02:34 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fantino-2007" MODIFIED="2014-06-10 19:22:42 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Fantino 2007" YEAR="2007">
<REFERENCE MODIFIED="2014-06-10 19:22:42 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fantino B, Moore N, Verdoux H, Auray J</AU>
<TI>Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder</TI>
<SO>Journal of Psychopharmacology</SO>
<YR>2007</YR>
<VL>22</VL>
<PG>107-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fernandez-2005" MODIFIED="2014-12-01 12:46:04 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Fernandez 2005" YEAR="2005">
<REFERENCE MODIFIED="2014-12-01 12:46:04 +0200" MODIFIED_BY="Jani H Ruotsalainen" NOTES="&lt;p&gt;DA - 20050307&lt;/p&gt;" NOTES_MODIFIED="2014-12-01 12:46:04 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Fernandez JL, Montgomery S, Francois C</AU>
<TI>Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder</TI>
<SO>Pharmacoeconomics</SO>
<YR>2005</YR>
<VL>23</VL>
<NO>2</NO>
<PG>155-67</PG>
<IDENTIFIERS MODIFIED="2014-12-01 12:46:04 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hees-2013" MODIFIED="2014-12-01 12:45:40 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Hees 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-12-01 12:45:40 +0200" MODIFIED_BY="Jani H Ruotsalainen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hees HL, Vries de G, Koeter MW, Schene AH</AU>
<TI>Adjuvant occupational therapy improves long-term depression recovery and return-to-work in good health in sick-listed employees with major depression: results of a randomised controlled trial</TI>
<SO>Occupational and Environmental Medicine</SO>
<YR>2013</YR>
<VL>70</VL>
<PG>252-60</PG>
<IDENTIFIERS MODIFIED="2014-12-01 12:45:40 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hollinghurst-2010" MODIFIED="2014-11-08 15:17:41 +0200" MODIFIED_BY="[Empty name]" NAME="Hollinghurst 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-11-08 15:17:41 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hollinghurst S, Peters TJ, Kaur S, Wiles N, Lewis G</AU>
<TI>Cost-effectiveness of therapist-delivered online cognitive-behavioural therapy for depression: randomized controlled trial</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2010</YR>
<VL>197</VL>
<PG>297-304</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kendrick-2005" MODIFIED="2014-12-01 12:46:16 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Kendrick 2005" YEAR="2005">
<REFERENCE MODIFIED="2014-12-01 12:46:16 +0200" MODIFIED_BY="Jani H Ruotsalainen" NOTES="&lt;p&gt;DA - 20050912&lt;/p&gt;" NOTES_MODIFIED="2014-12-01 12:46:16 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kendrick T, Simons L, Mynors-Wallis L, Gray A, Lathlean J, Pickering R et al</AU>
<TI>A trial of problem-solving by community mental health nurses for anxiety, depression and life difficulties among general practice patients. The CPN-GP study</TI>
<SO>Health Technology Assessment</SO>
<YR>2005</YR>
<VL>9</VL>
<NO>37</NO>
<PG>1-104</PG>
<IDENTIFIERS MODIFIED="2014-12-01 12:46:16 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Knekt-2013" MODIFIED="2014-12-01 12:45:32 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Knekt 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-12-01 12:45:32 +0200" MODIFIED_BY="Jani H Ruotsalainen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Knekt P, Lindfors O, Sares- Jäske L, Virtala E, Härkänen</AU>
<TI>Randomized trial on the effectiveness of long- and short-term psychotherapy on psychiatric symptoms and working ability during a 5-year follow-up</TI>
<SO>Nordic Journal of Psychiatry</SO>
<YR>2013</YR>
<VL>67</VL>
<PG>59-68</PG>
<IDENTIFIERS MODIFIED="2014-12-01 12:45:32 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krogh-2009" MODIFIED="2014-06-10 19:24:43 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Krogh 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-06-10 19:24:43 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krogh J, Saltin B, Gluud C, Nordentoft M</AU>
<TI>The DEMO trial: a randomized, parallel-group, observer-blinded clinical trial of strength versus aerobic versus relaxation training for patients with mild to moderate depression</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2009</YR>
<VL>70</VL>
<PG>790-800</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krogh-2012" MODIFIED="2014-11-08 15:16:59 +0200" MODIFIED_BY="[Empty name]" NAME="Krogh 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-11-08 15:16:59 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krogh J, Videbech P, Thomsen C, Gluud C, Nordentoft M</AU>
<TI>DEMO-II trial. Aerobic exercise versus stretching exercise in patients with major depression - a randomized clinical trial</TI>
<SO>PLOS ONE</SO>
<YR>2012</YR>
<VL>7</VL>
<NO>10</NO>
<PG>e48316</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lerner-2012" MODIFIED="2014-06-17 10:17:45 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Lerner 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-06-17 10:17:45 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lerner D, Adler A, Hermann RC, Hong Chang MS, Ludman EJ, Greenhill A et al</AU>
<TI>Impact of a work-focused intervention on the productivity and symptoms of employees with depression</TI>
<SO>Journal of Occupational and Environmental Medicine</SO>
<YR>2012</YR>
<VL>54</VL>
<PG>128-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McCrone-2004" MODIFIED="2014-12-01 12:46:25 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="McCrone 2004" YEAR="2004">
<REFERENCE MODIFIED="2014-12-01 12:46:25 +0200" MODIFIED_BY="Jani H Ruotsalainen" NOTES="&lt;p&gt;2004310672&amp;#182;&lt;/p&gt;" NOTES_MODIFIED="2014-12-01 12:46:25 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McCrone P, Knapp M, Proudfoot J, Ryden C, Cavanagh K, Shapiro DA et al</AU>
<TI>Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: Randomised controlled trial</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2004</YR>
<VL>185</VL>
<PG>55-62</PG>
<IDENTIFIERS MODIFIED="2014-12-01 12:46:25 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miller-1998" MODIFIED="2014-12-01 12:46:37 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Miller 1998" YEAR="1998">
<REFERENCE MODIFIED="2014-12-01 12:46:37 +0200" MODIFIED_BY="Jani H Ruotsalainen" NOTES="&lt;p&gt;DA - 19990105&lt;/p&gt;" NOTES_MODIFIED="2014-12-01 12:46:37 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miller IW, Keitner GI, Schatzberg AF, Klein DN, Thase ME, Rush AJ et al</AU>
<TI>The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>1998</YR>
<VL>59</VL>
<NO>11</NO>
<PG>608-19</PG>
<IDENTIFIERS MODIFIED="2014-12-01 12:46:37 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Noordik-2013" MODIFIED="2014-06-10 19:28:04 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Noordik 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-06-10 19:28:04 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Noordik E, Klink JJ van der, Geskus RB, Boer MR de, Dijk FJ van, Nieuwenhuijsen K</AU>
<TI>Effectiveness of an exposure-based return-to-work program for workers on sick leave due to common mental disorders: a cluster-randomized controlled trial</TI>
<SO>Scandinavian Journal of Work, Environment &amp; Health</SO>
<YR>2013</YR>
<VL>39</VL>
<PG>144-54</PG>
<IDENTIFIERS MODIFIED="2014-05-13 12:22:39 +0300" MODIFIED_BY="Babs J.M.  Faber"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Romeo-2004" MODIFIED="2014-12-01 12:46:44 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Romeo 2004" YEAR="2004">
<REFERENCE MODIFIED="2014-12-01 12:46:44 +0200" MODIFIED_BY="Jani H Ruotsalainen" NOTES="&lt;p&gt;DA - 20040426&lt;/p&gt;" NOTES_MODIFIED="2014-12-01 12:46:44 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Romeo R, Patel A, Knapp M, Thomas C</AU>
<TI>The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care</TI>
<SO>International Clinical Psychopharmacology</SO>
<YR>2004</YR>
<VL>19</VL>
<NO>3</NO>
<PG>125-34</PG>
<IDENTIFIERS MODIFIED="2014-12-01 12:46:44 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rost-2004" MODIFIED="2014-12-01 12:46:57 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Rost 2004" YEAR="2004">
<REFERENCE MODIFIED="2014-12-01 12:46:57 +0200" MODIFIED_BY="Jani H Ruotsalainen" NOTES="&lt;p&gt;15550800&lt;/p&gt;" NOTES_MODIFIED="2014-12-01 12:46:57 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rost K, Smith JL, Dickinson M</AU>
<TI>The effect of improving primary care depression management on employee absenteeism and productivity. A randomized trial</TI>
<SO>Medical Care</SO>
<YR>2004</YR>
<VL>42</VL>
<NO>12</NO>
<PG>1202-10</PG>
<IDENTIFIERS MODIFIED="2014-12-01 12:46:57 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schene-2006" NAME="Schene 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schene AH, Koeter MWJ, Kikkert MJ, Swinkels JA, Mc Crone P</AU>
<TI>Adjuvant occupational therapy for work-related major depression works: randomized trial including economic evaluation</TI>
<SO>Psychological Medicine</SO>
<YR>2006</YR>
<VL>2007</VL>
<NO>37</NO>
<PG>3</PG>
<EN>351-62</EN>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schoenbaum-2001" MODIFIED="2014-12-01 12:47:06 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Schoenbaum 2001" YEAR="1998">
<REFERENCE MODIFIED="2014-12-01 12:47:06 +0200" MODIFIED_BY="Jani H Ruotsalainen" NOTES="&lt;p&gt;2002160759 NLM Unique Identifier: 11560537&amp;#182;&lt;/p&gt;" NOTES_MODIFIED="2014-12-01 12:47:06 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schoenbaum M, Unutzer J, Sherbourne C, Duan N, Rubenstein LV, Miranda J et al</AU>
<TI>Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial</TI>
<SO>JAMA</SO>
<YR>2001</YR>
<VL>286</VL>
<NO>11</NO>
<PG>1325-30</PG>
<EN>Abstract: Context: Depression is a leading cause of disability worldwide, but treatment rates in primary care are low. Objective: To determine the cost-effectiveness from a societal perspective of 2 quality improvement (QI) interventions to improve treatment of depression in primary care and their effects on patient employment. Design: Group-level randomized controlled trial conducted June 1996 to July 1999. Setting: Forty-six primary care clinics in 6 community-based managed care organizations. Participants: One hundred eighty-one primary care clinicians and 1356 patients with positive screening results for current depression. Interventions: Matched practices were randomly assigned to provide usual care (n = 443 patients) or to 1 of 2 QI interventions offering training to practice leaders and nurses, enhanced educational and assessment resources, and either nurses for medication follow-up (QI-meds; n = 424 patients) or trained local psychotherapists (QI-therapy; n = 489). Practices could flexibly implement the interventions, which did not assign type of treatment. Main Outcome Measures: Total health care costs, costs per quality-adjusted life-year (QALY), days with depression burden, and employment over 24 months, compared between usual care and the 2 interventions. Results: Relative to usual care, average health care costs increased $419 (11%) in QI-meds (P = .35) and $485 (13%) in QI-therapy (P = .28); estimated costs per QALY gained were between $15331 and $36467 for QI-meds and $9478 and $21 478 for QI-therapy; and patients had 25 (P = .19) and 47 (P = .01) fewer days with depression burden and were employed 17.9 (P = .07) and 20.9 (P = .03) more days during the study period. Conclusions: Societal cost-effectiveness of practice-initiated QI efforts for depression is comparable with that of accepted medical interventions. The intervention effects on employment may be of particular interest to employers and other stakeholders.</EN>
<IDENTIFIERS MODIFIED="2014-12-01 12:47:06 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Simon-1998" MODIFIED="2014-12-01 12:47:13 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Simon 1998" YEAR="1998">
<REFERENCE MODIFIED="2014-12-01 12:47:13 +0200" MODIFIED_BY="Jani H Ruotsalainen" NOTES="&lt;p&gt;9626725&lt;/p&gt;" NOTES_MODIFIED="2014-12-01 12:47:13 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Simon GE, Katon W, Rutter C, Von Korff M, Lin E, Robinson P et al</AU>
<TI>Impact of improved depression treatment in primary care on daily functioning and disability</TI>
<SO>Psychological Medicine</SO>
<YR>1998</YR>
<VL>28</VL>
<NO>3</NO>
<PG>693-701</PG>
<IDENTIFIERS MODIFIED="2014-12-01 12:47:13 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vlasveld-2013" MODIFIED="2014-11-08 15:15:22 +0200" MODIFIED_BY="[Empty name]" NAME="Vlasveld 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-11-08 15:15:22 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vlasveld MC, Feltz-Cornelis CM van der, Adèr HJ, Anema JR, Hoedeman R, Mechelen W van et al</AU>
<TI>Collaborative care for sick-listed workers with major depressive disorder: a randomised controlled trial from the Netherlands Depression Initiative aimed at return to work and depressive symptoms</TI>
<SO>Occupational and Environmental Medicine</SO>
<YR>2013</YR>
<VL>70</VL>
<PG>223-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wade-2008" MODIFIED="2014-06-10 19:30:07 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Wade 2008" YEAR="2008">
<REFERENCE MODIFIED="2014-06-10 19:30:07 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wade AG, Fernandez J, Francois C, Hansen K, Danchenko N, Despiegel N</AU>
<TI>Escitalopram and duloxetine in major depressive disorder - A pharmacoeconomic comparison using UK cost data</TI>
<SO>Pharmacoeconomics</SO>
<YR>2008</YR>
<VL>26</VL>
<PG>969-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2007" MODIFIED="2014-06-10 20:01:43 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Wang 2007" YEAR="2007">
<REFERENCE MODIFIED="2014-06-10 20:01:43 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang PS, Simon SE, Avorn J, Azocar F, Ludman EJ, McCulloch J et al</AU>
<TI>Telephone screening, outreach, and care management for depressed workers and impact on clinical and work productivity outcomes</TI>
<SO>JAMA</SO>
<YR>2007</YR>
<VL>298</VL>
<NO>12</NO>
<PG>1401-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2014-12-01 12:50:00 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<STUDY DATA_SOURCE="PUB" ID="STD-Aelfers-2013" MODIFIED="2014-05-16 14:27:46 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Aelfers 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-05-16 14:27:46 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aelfers E, Bosma H, Houkes I, Eijk JT van</AU>
<TI>Effectiveness of a minimal psychological intervention to reduce mild to moderate depression and chronic fatigue in a working population: the design of a randomized trial</TI>
<SO>BMC Public Health</SO>
<YR>2013</YR>
<VL>13</VL>
<PG>129</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ahola-2012" MODIFIED="2014-11-08 15:14:41 +0200" MODIFIED_BY="[Empty name]" NAME="Ahola 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-11-08 15:14:41 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ahola, K, Vuori J, Toppinen-Tanner S, Mutanen P, Honkonen T</AU>
<TI>Resrcource-enhancing group intervention against depression at workplace: who benefits? A randomized controlled study with a 7-month follow-up</TI>
<SO>Occupational and Environmental Medicine</SO>
<YR>2012</YR>
<VL>69</VL>
<PG>870-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Alexopoulos" MODIFIED="2014-11-08 15:13:33 +0200" MODIFIED_BY="[Empty name]" NAME="Alexopoulos" YEAR="2013">
<REFERENCE MODIFIED="2014-11-08 15:13:33 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alexopoulos GS, Raue PJ, Kiosses DN, Mackin RS, Kanellopulos D, McCulloch C et al</AU>
<TI>Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction</TI>
<SO>Archives of General Psychiatry</SO>
<YR>2011</YR>
<VL>68</VL>
<NO>1</NO>
<PG>33-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Amore-2001" MODIFIED="2014-06-10 19:31:34 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Amore 2001" YEAR="2001">
<REFERENCE MODIFIED="2014-06-10 19:31:34 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Amore M, Jori MC,</AU>
<TI>Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study</TI>
<SO>International Clinical Psychopharmacology</SO>
<YR>2001</YR>
<VL>16</VL>
<PG>317-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bakker-2007" MODIFIED="2014-11-08 15:10:59 +0200" MODIFIED_BY="[Empty name]" NAME="Bakker 2007" YEAR="2007">
<REFERENCE MODIFIED="2014-11-08 15:10:59 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bakker IM, Terluin B, Marwijk HWJ van, Windt DAWM, Rijmen F van der, Mechelen W van et al</AU>
<TI>A cluster-randomized trial evaluating an intervention for patients with stress-related mental disorders and sick leave in primary care</TI>
<SO>PLOS Clinical Trials</SO>
<YR>2007</YR>
<VL>26</VL>
<PG>1-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barbui-2009" MODIFIED="2014-05-15 22:06:36 +0300" MODIFIED_BY="[Empty name]" NAME="Barbui 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-05-15 22:06:36 +0300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barbui C, Ostuzzi G, Cipriani A</AU>
<TI>SSRI plus supportive care more effective than supportive care alone for mild to moderate depression</TI>
<SO>Evidence Based Mental Health</SO>
<YR>2009</YR>
<VL>12</VL>
<NO>4</NO>
<PG>109</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bech-2000" MODIFIED="2014-11-08 15:10:22 +0200" MODIFIED_BY="[Empty name]" NAME="Bech 2000" YEAR="2000">
<REFERENCE MODIFIED="2014-11-08 15:10:22 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bech P, Cialdella P, Haugh MC, Birkett MA, Hours A, Boissel JP et al</AU>
<TI>Meta-analysis of randomized controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2000</YR>
<VL>176</VL>
<PG>421-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Becker-1998" MODIFIED="2014-05-16 16:47:52 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Becker 1998" YEAR="1998">
<REFERENCE MODIFIED="2014-05-16 16:47:50 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Becker DR, Drake RE, Bond GR, Xie H, Dain BJ, Harrison K</AU>
<TI>Job terminations among persons with severe mental illness</TI>
<SO>Community Mental Health Journal</SO>
<YR>1998</YR>
<VL>34</VL>
<PG>71-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Blonk-2007" MODIFIED="2014-06-10 19:36:39 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Blonk 2007" YEAR="2007">
<REFERENCE MODIFIED="2014-06-10 19:36:39 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Blonk RWB, Brenninkmeijer V, Lagerveld SE, Houtman ILD</AU>
<TI>Return to work: a comparison of two cognitive behavioural interventions in cases of work-related psychological complaints among the self-employed</TI>
<SO>Work &amp; Stress</SO>
<YR>2006</YR>
<VL>20</VL>
<PG>129-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Boyer-1998" MODIFIED="2014-12-01 12:47:36 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Boyer 1998" YEAR="1998">
<REFERENCE MODIFIED="2014-12-01 12:47:36 +0200" MODIFIED_BY="Jani H Ruotsalainen" NOTES="&lt;p&gt;DA - 19980305&lt;/p&gt;" NOTES_MODIFIED="2014-12-01 12:47:36 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boyer P, Danion JM, Bisserbe JC, Hotton JM, Troy S</AU>
<TI>Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression. A 6-month double-blind study in a primary-care setting in France</TI>
<SO>Pharmacoeconomics</SO>
<YR>1998</YR>
<VL>13</VL>
<NO>1 Pt 2</NO>
<PG>157-69</PG>
<IDENTIFIERS MODIFIED="2014-12-01 12:47:36 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brandes-2011" MODIFIED="2014-11-08 15:09:40 +0200" MODIFIED_BY="[Empty name]" NAME="Brandes 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-11-08 15:09:40 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Brandes VMT</AU>
<TI>Efficacy of auditory stimulation programs for the treatment of depression, dysthymia and symptoms of burnout - RCT results</TI>
<SO>European Psychiatry conference</SO>
<YR>2011</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brouwers-2007" MODIFIED="2014-06-03 23:39:56 +0300" MODIFIED_BY="[Empty name]" NAME="Brouwers 2007" YEAR="2007">
<REFERENCE MODIFIED="2014-06-03 23:39:34 +0300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brouwers EPM, Bruijne MC de, Terluin B, Tiemens BG, Verhaak PFM</AU>
<TI>Cost-effectiveness of an activating intervention by social workers for patients with minor mental disorders on sick leave: a randomized controlled trial</TI>
<SO>The European Journal of Public Health</SO>
<YR>2007</YR>
<VL>17</VL>
<NO>2</NO>
<PG>214-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carlin-2010" MODIFIED="2014-05-15 21:53:19 +0300" MODIFIED_BY="[Empty name]" NAME="Carlin 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-05-15 21:53:19 +0300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Carlin E</AU>
<TI>The effect of a motivational interviewing style in cognitive therapy for depression</TI>
<TO>Dissertation</TO>
<SO>http://gradworks.umi.com/34/53/3453319.html</SO>
<YR>2010</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Castillo_x002d_P_x00e9_rez-2010" MODIFIED="2014-06-10 19:37:42 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Castillo-Pérez 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-06-10 19:37:42 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Castillo-Pérez S, Gómez-Pérez V, Calvillo Velasco M, Pérez-Campos E, Mayoral M</AU>
<TI>Effects of music therapy on depression compared with psychotherapy</TI>
<SO>The Arts in Psychotherapy</SO>
<YR>2010</YR>
<VL>37</VL>
<PG>387-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dick-1985" MODIFIED="2014-06-03 23:42:14 +0300" MODIFIED_BY="[Empty name]" NAME="Dick 1985" YEAR="1985">
<REFERENCE MODIFIED="2014-06-03 23:42:14 +0300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dick P, Cameron L, Cohen D, Barlow M</AU>
<TI>Day and full time psychiatric treatment</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1985</YR>
<VL>147</VL>
<PG>246-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dunlop-2011" MODIFIED="2014-06-10 19:38:06 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Dunlop 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-06-10 19:38:06 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dunlop BW, Reddy S, Yang L, Lubaczwewski S, Focht K, Guico-Pabia CJ</AU>
<TI>Symptomatic and functional improvement in employed depressed patients</TI>
<SO>Journal of Clinical Psychopharmacology</SO>
<YR>2011</YR>
<VL>31</VL>
<PG>569-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eklund-2012" MODIFIED="2014-05-13 18:46:52 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Eklund 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-05-13 18:46:51 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eklund M, Wästberg BA, Erlandsson L</AU>
<TI>Work outcomes and their predictors in the Redesigning Daily Occupations (ReDO) rehabilitation programme for women with stress-related disorders</TI>
<SO>Australian Occupational Therapy Journal</SO>
<YR>2013</YR>
<VL>60</VL>
<PG>85-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Erkkil_x00e4_-2011" MODIFIED="2014-11-08 15:08:49 +0200" MODIFIED_BY="[Empty name]" NAME="Erkkilä 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-11-08 15:08:49 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Erkkilä J, Punkanen M, Fachner J, Ala-Ruona E, Pöntiö I, Tervaniemi M et al</AU>
<TI>Individual music therapy for depression: randomized controlled trial</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2011</YR>
<VL>199</VL>
<PG>132-39</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Finley-2003" MODIFIED="2014-06-10 19:39:02 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Finley 2003" YEAR="2003">
<REFERENCE MODIFIED="2014-06-10 19:39:02 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Finley PR, Rens HR, Pont JT, Gess SL, Louie CL, Bull SA et al</AU>
<TI>Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial</TI>
<SO>Pharmocotherapy</SO>
<YR>2003</YR>
<VL>23</VL>
<PG>1175-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Folke-2012" MODIFIED="2014-06-10 19:39:19 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Folke 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-06-10 19:39:19 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Folke F, Parling T, Melin L</AU>
<TI>Acceptance and commitment therapy for depression: a preliminary randomized clinical trial for unemployed on long-term sick leave</TI>
<SO>Cognitive and Behavioural Practice</SO>
<YR>2012</YR>
<VL>19</VL>
<PG>583-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Forman-2012" MODIFIED="2014-11-08 15:07:47 +0200" MODIFIED_BY="[Empty name]" NAME="Forman 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-11-08 15:07:47 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Forman EM, Shaw JA, Goetter EM, Herbert JD, Park JA, Yuen EK</AU>
<TI>Long-term follow up of a randomized controlled trial comparing acceptance and commitment therapy and standard cognitive behaviour therapy for anxiety and depression</TI>
<SO>Behavior Therapy</SO>
<YR>2012</YR>
<VL>43</VL>
<PG>801-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Furukawa-2012" MODIFIED="2014-11-08 15:06:22 +0200" MODIFIED_BY="[Empty name]" NAME="Furukawa 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-11-08 15:06:22 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Furukawa TA, Horikoshi M, Kawakami N, Kadota M, Sasaki M, Sekiya Y et al</AU>
<TI>Telephone cognitive-behavioural therapy for subthreshold depression and presenteeism in workplace: a randomized controlled trial</TI>
<SO>PLOS ONE</SO>
<YR>2012</YR>
<VL>7</VL>
<PG>1-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gournay-1995" MODIFIED="2014-12-01 12:47:56 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Gournay 1995" YEAR="1995">
<REFERENCE MODIFIED="2014-12-01 12:47:56 +0200" MODIFIED_BY="Jani H Ruotsalainen" NOTES="&lt;p&gt;DA - 19960909&lt;/p&gt;" NOTES_MODIFIED="2014-12-01 12:47:56 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gournay K, Brooking J</AU>
<TI>The community psychiatric nurse in primary care: an economic analysis</TI>
<SO>Journal of Advanced Nursing</SO>
<YR>1995</YR>
<VL>22</VL>
<NO>4</NO>
<PG>769-78</PG>
<IDENTIFIERS MODIFIED="2014-12-01 12:47:56 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hackett-1987" MODIFIED="2014-11-08 15:04:41 +0200" MODIFIED_BY="[Empty name]" NAME="Hackett 1987" YEAR="1987">
<REFERENCE MODIFIED="2014-11-08 15:04:41 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hackett GI, Boddie HG, Harrison P</AU>
<TI>Chronic muscle contraction: the importance of depression and anxiety</TI>
<SO>Journal of the Royal Society of Medicine</SO>
<YR>1987</YR>
<VL>80</VL>
<PG>689-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hirani-2010" MODIFIED="2014-11-08 15:04:18 +0200" MODIFIED_BY="[Empty name]" NAME="Hirani 2010" YEAR="">
<REFERENCE MODIFIED="2014-11-08 15:04:18 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hirani SS, Karmaliani R, McFarlane J, Asad N, Madhani F, Shehzad S</AU>
<TI>Testing a community derived intervention to promote women's health: preliminary results of a 3-arm randomized controlled trial in Karachi, Pakistan</TI>
<SO>Southern Online Journal of Nursing Research</SO>
<YR>2010</YR>
<VL>10</VL>
<NO>3</NO>
<PG>n.a</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hordern-1964" MODIFIED="2014-11-08 15:03:46 +0200" MODIFIED_BY="[Empty name]" NAME="Hordern 1964" YEAR="1964">
<REFERENCE MODIFIED="2014-11-08 15:03:46 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hordern A, Burt CG, Gordon WF, Holt NF</AU>
<TI>Amitriptyline in depressive states: Six-month treatment results</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1964</YR>
<VL>110</VL>
<PG>641-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Knekt-2011" MODIFIED="2014-06-10 19:40:53 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Knekt 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-06-10 19:40:53 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Knekt P, Lindfors O, Laaksonen MA, Renlund C, Haaramo P, Härkänen et al</AU>
<TI>Quasi-experimental study on the effectiveness of psychoanalysis, long-term and short-term psychotherapy on psychiatric symptoms, work ability and functional capacity during a 5-year follow-up</TI>
<SO>Journal of Affective Disorders</SO>
<YR>2011</YR>
<VL>132</VL>
<PG>37-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kojima-2010" MODIFIED="2014-06-10 19:41:11 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Kojima 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-06-10 19:41:11 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kojima R, Fujisawa D, Tajima M, Shibaoka M, Kakinuma M, Shima S et al</AU>
<TI>Efficacy of cognitive behavioral therapy training using brief e-mail sessions in the workplace: a controlled clinical trial</TI>
<SO>Industrial Health</SO>
<YR>2010</YR>
<VL>48</VL>
<PG>495-502</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kroenke-2001" MODIFIED="2014-06-10 19:41:39 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Kroenke 2001" YEAR="2001">
<REFERENCE MODIFIED="2014-06-10 19:41:39 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kroenke K, West SL, Swindle R, Gilsenan A, Eckert GJ, Dolor R et al</AU>
<TI>Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care - a randomized trial</TI>
<SO>JAMA</SO>
<YR>2001</YR>
<VL>286</VL>
<PG>2947-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kuhs-1996" MODIFIED="2014-05-16 17:35:55 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Kuhs 1996" YEAR="1996">
<REFERENCE MODIFIED="2014-05-16 17:35:55 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kuhs H, Färber D, Borgstädt S, Mrosek S, Tölle R</AU>
<TI>Amitriptyline in combination with repeated late deep deprivation versus amitriptyline alone in major depression. A randomized study</TI>
<SO>Journal of Affective Disorders</SO>
<YR>1996</YR>
<VL>37</VL>
<PG>31-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lagerveld-2012" MODIFIED="2014-06-10 19:41:58 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Lagerveld 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-06-10 19:41:58 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lagerveld SE, Blonk RWB, Brenninkmeijer V, Wijngaards-de Meij L, Schaufeli WB</AU>
<TI>Work-focused treatment of common mental disorders and return to work: a comparative outcome study</TI>
<SO>Journal of Occupational Psychology</SO>
<YR>2012</YR>
<VL>17</VL>
<PG>220-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lam-2012" MODIFIED="2014-06-03 23:47:39 +0300" MODIFIED_BY="[Empty name]" NAME="Lam 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-06-03 23:47:39 +0300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Lam RW, McLeod J, Woo C, Michalak EE, Yatham LN, Bond DJ</AU>
<TI>A systematic review of the treatment effects of antidepressants on occupational functioning</TI>
<SO>Presented at the International Society for Affective Disorders</SO>
<YR>2012</YR>
<CY>UK</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lexis-2011" MODIFIED="2014-11-08 15:02:53 +0200" MODIFIED_BY="[Empty name]" NAME="Lexis 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-11-08 15:02:53 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lexis MAS, Jansen NWH, Huibers MJH, Amelsvoort LGPM van, Berkouwer A, Tjin A, Ton G et al</AU>
<TI>Prevention of long-term sickness absence and major depression in high-risk employees: a randomised controlled trial</TI>
<SO>Occupational and Environmental Medicine</SO>
<YR>2011</YR>
<VL>68</VL>
<PG>400-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martinez-2011" MODIFIED="2014-06-10 19:43:02 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Martinez 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-06-10 19:43:02 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martinez JM, Katon W, Greist JH, Kroenke K, Thase ME, Meyers AL et al</AU>
<TI>A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode</TI>
<SO>International Clinical Psychopharmacology</SO>
<YR>2012</YR>
<VL>27</VL>
<PG>17-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meyer-2009" MODIFIED="2014-06-10 19:43:20 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Meyer 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-06-10 19:43:20 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meyer B, Berger T, Caspar F, Beevers CG, Andersson G, Weiss M</AU>
<TI>Effectiveness of a novel integrative online treatment for depression (Deprexis): randomized controlled trial</TI>
<SO>Journal of Medical Internet Research</SO>
<YR>2009</YR>
<VL>11</VL>
<PG>e15</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mino-2006" MODIFIED="2014-06-10 19:43:34 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Mino 2006" YEAR="2006">
<REFERENCE MODIFIED="2014-06-10 19:43:34 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mino Y, Babazono A, Tsuda T, Yasuda N</AU>
<TI>Can stress management at the workplace prevent depression? A randomized controlled trial</TI>
<SO>Psychotherapy and Psychosomatics</SO>
<YR>2006</YR>
<VL>75</VL>
<PG>177-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Morgan-2011" MODIFIED="2014-05-16 14:28:08 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Morgan 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-05-16 14:28:08 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Morgan AJ, Form AF, Mackinnon AJ</AU>
<TI>Protocol for a randomized controlled trial investigating self-help email messages for sub-treshold depression: the Mood Memos study</TI>
<SO>Trials</SO>
<YR>2011</YR>
<VL>12</VL>
<PG>1-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mundt-2001" MODIFIED="2014-05-16 17:35:45 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Mundt 2001" YEAR="2001">
<REFERENCE MODIFIED="2014-05-16 17:35:45 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mundt JC, Clarke GN, Burroughs D, Brenneman DO, Griest JH</AU>
<TI>Effectiveness of antidepressant pharmacotherapy: the impact of medication compliance and patient education</TI>
<SO>Depression and Anxiety</SO>
<YR>2001</YR>
<VL>13</VL>
<PG>1-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oakes-2012" MODIFIED="2014-05-15 12:54:41 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Oakes 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-05-15 12:54:38 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oakes TMM, Meyers AL, Marangell LB, Ahl J, Prakash A, Thase ME, Kornstein SG</AU>
<TI>Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo</TI>
<SO>Human Psychopharmacology: Clinical and Experimental</SO>
<YR>2012</YR>
<VL>27</VL>
<PG>47-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Salminen-2008" MODIFIED="2014-06-10 19:44:26 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Salminen 2008" YEAR="2008">
<REFERENCE MODIFIED="2014-06-10 19:44:26 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Salminen JK, Karlsson H, Hietala J, Kajander J, Aalto S, Markkula J et al</AU>
<TI>Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study</TI>
<SO>Psychotherapy and Psychosomatics</SO>
<YR>2008</YR>
<VL>77</VL>
<PG>351-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sandahl-2011" MODIFIED="2014-11-08 15:01:42 +0200" MODIFIED_BY="[Empty name]" NAME="Sandahl 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-11-08 15:01:42 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sandahl C, Lundberg U, Lindgren A, Rylander G, Herlofsen J, Nygren ÅN</AU>
<TI>Two forms of group therapy and individual treatment of work-related depression: a one-year follow-up study</TI>
<SO>International Journal of Group Psychotherapy</SO>
<YR>2011</YR>
<VL>61</VL>
<PG>539-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schmitt-2008" MODIFIED="2014-12-01 12:50:00 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Schmitt 2008" YEAR="2008">
<REFERENCE MODIFIED="2014-12-01 12:50:00 +0200" MODIFIED_BY="Jani H Ruotsalainen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schmitt AB, Volz HP, Wiedemann K, Fritze J, Loeschmann PA</AU>
<TI>Therapy effects on working ability by venlafaxine compared to serotonin reuptake inhibitors in the treatment of major depressive disorder of different severity</TI>
<SO>Gesundheitsökonomie &amp; Qualitätsmanagement</SO>
<YR>2008</YR>
<VL>13</VL>
<PG>269-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schoenbaum-2002" MODIFIED="2014-12-01 12:48:17 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Schoenbaum 2002" YEAR="2002">
<REFERENCE MODIFIED="2014-12-01 12:48:17 +0200" MODIFIED_BY="Jani H Ruotsalainen" NOTES="&lt;p&gt;2002434074&amp;#182;&lt;/p&gt;" NOTES_MODIFIED="2014-12-01 12:48:17 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schoenbaum M, Unutzer J, McCaffrey D, Duan N, Sherbourne C, Wells KB</AU>
<TI>The effects of primary care depression treatment on patients' clinical status and employment</TI>
<SO>Health Services Research</SO>
<YR>2002</YR>
<VL>37</VL>
<NO>5</NO>
<PG>1145-58</PG>
<IDENTIFIERS MODIFIED="2014-12-01 12:48:17 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Simon-2000" NAME="Simon 2000" YEAR="2000">
<REFERENCE NOTES="&lt;p&gt;unsufficient absenteeism data&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Simon GE, Revicki D, Heiligenstein J, Grothaus L, Von Korff M, Katon WJ et al</AU>
<TI>Recovery from depression, work productivity, and health care costs among primary care patients</TI>
<SO>General Hospital Psychiatry</SO>
<YR>2000</YR>
<VL>22</VL>
<NO>3</NO>
<PG>153-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sir-2005" MODIFIED="2014-06-10 19:45:57 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Sir 2005" YEAR="2005">
<REFERENCE MODIFIED="2014-06-10 19:45:57 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sir A, D'Souza RF, Uguz S, George T, Psych MRC, Vahip S et al</AU>
<TI>Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2005</YR>
<VL>66</VL>
<PG>1312-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stant-2009" MODIFIED="2014-06-10 19:46:35 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Stant 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-06-10 19:46:35 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stant AD, TenVergert EM, Kluiter H, Conradi HJ, Smit A, Ormel J</AU>
<TI>Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care</TI>
<SO>The Journal of Mental Health Policy and Economics</SO>
<YR>2009</YR>
<VL>12</VL>
<PG>195-204</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wells-2000" MODIFIED="2014-12-01 12:48:32 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Wells 2000" YEAR="1945">
<REFERENCE MODIFIED="2014-12-01 12:48:32 +0200" MODIFIED_BY="Jani H Ruotsalainen" NOTES="&lt;p&gt;2000033364 NLM Unique Identifier: 10634337&amp;#182;&lt;/p&gt;" NOTES_MODIFIED="2014-12-01 12:48:32 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wells KB, Sherbourne C, Schoenbaum M, Duan N, Meredith L, Unutzer J et al</AU>
<TI>Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial</TI>
<SO>JAMA</SO>
<YR>2000</YR>
<VL>283</VL>
<NO>2</NO>
<PG>212-20</PG>
<IDENTIFIERS MODIFIED="2014-12-01 12:48:32 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zambori-2002" MODIFIED="2014-12-01 12:48:39 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Zambori 2002" YEAR="2002">
<REFERENCE MODIFIED="2014-12-01 12:48:39 +0200" MODIFIED_BY="Jani H Ruotsalainen" NOTES="&lt;p&gt;2003120227&amp;#182;&lt;/p&gt;" NOTES_MODIFIED="2014-12-01 12:48:39 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zambori J, Szadoczky E, Rozsa S, Furedi J</AU>
<TI>Cost-outcome of anxiety treatment intervention in primary care in Hungary</TI>
<SO>The Journal of Mental Health Policy and Economics</SO>
<YR>2002</YR>
<VL>5</VL>
<NO>3</NO>
<PG>115-20</PG>
<IDENTIFIERS MODIFIED="2014-12-01 12:48:39 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zeeuw-2010" MODIFIED="2014-06-10 19:49:24 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Zeeuw 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-06-10 19:49:24 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zeeuw ELEJ de, Tak ECPM, Dusseldorp E, Hendriksen IJM</AU>
<TI>Workplace exercise intervention to prevent depression: a pilot randomized controlled trial</TI>
<SO>Mental Health and Physical Activity</SO>
<YR>2010</YR>
<VL>3</VL>
<PG>72-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2014-02-17 13:48:00 +0200" MODIFIED_BY="Babs J.M.  Faber"/>
<ONGOING_STUDIES MODIFIED="2014-06-10 19:50:22 +0300" MODIFIED_BY="Babs J.M.  Faber">
<STUDY DATA_SOURCE="PUB" ID="STD-Beurden-2013" MODIFIED="2014-06-03 23:54:20 +0300" MODIFIED_BY="[Empty name]" NAME="Beurden 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-06-03 23:54:20 +0300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Beurden KM, Brouwers EP, Joosen MC, Terluin B, Klink JJ, Weeghel J</AU>
<TI>Effectiveness of guideline-based care by occupational physicians on the return-to-work of workers with common mental disorders: design of a cluster-randomized controlled trial</TI>
<SO>BMC Public Health</SO>
<YR>2013</YR>
<VL>13</VL>
<PG>1-8</PG>
<IDENTIFIERS MODIFIED="2014-05-12 10:39:29 +0300" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Geraedts-2013" MODIFIED="2014-05-16 13:11:08 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Geraedts 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-05-16 13:11:06 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Geraedts AS, Kleiboer AM, Wiezer NM, Mechelen W van, Cuijpers P</AU>
<TI>Web-based guided self-help for employees with depressive symptoms (Happy@Work): design of a randomized controlled trial</TI>
<SO>BMC Psychiatry</SO>
<YR>2013</YR>
<VL>13</VL>
<PG>1-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Heer-2013" MODIFIED="2014-06-10 19:50:22 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Heer 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-06-10 19:50:22 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Heer EW de, Dekker J, Van Eck-Sluijs JF van der, Beekman ATF, Marwijk HWJ van, Holwerda TJ et al</AU>
<TI>Effectiveness and cost-effectiveness of transmural collaborative care with consultation letter (TCCCL) and duloxetine for major depressive disorder (MDD) and (sub)chronic pain in collaboration with primary care: design of a randomized placebo-controlled muli-Centre trial: TCC: PAINDIP</TI>
<SO>BMC Psychiatry</SO>
<YR>2013</YR>
<VL>13</VL>
<PG>1-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hellstrom-2013" MODIFIED="2014-05-16 13:21:05 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Hellstrom 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-05-16 13:21:04 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hellstrom L, Bech P, Nordentoft M, Lindschou J, Eplov LF</AU>
<TI>The effect of IPS-modified, an early intervention for people with mood and anxiety disorders: study protocol for a randomized clinical superiority trial</TI>
<SO>Trials</SO>
<YR>2013</YR>
<VL>14</VL>
<PG>1-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Warmerdam-2007" MODIFIED="2014-05-16 13:30:59 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Warmerdam 2007" YEAR="2007">
<REFERENCE MODIFIED="2014-05-16 13:30:37 +0300" MODIFIED_BY="Babs J.M.  Faber" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Warmerdam L, Straten A van, Cuijpers P</AU>
<TI>Internet-based treatment for adults with depressive symptoms</TI>
<SO>BMC Psychiatry</SO>
<YR>2007</YR>
<VL>7</VL>
<PG>1-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2014-12-02 10:41:33 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<ADDITIONAL_REFERENCES MODIFIED="2014-12-02 10:41:33 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<REFERENCE ID="REF-Adler-2006" MODIFIED="2014-12-02 10:37:41 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Adler 2006" TYPE="JOURNAL_ARTICLE">
<AU>Adler DA, McLaughlin TJ, Rogers WH, Chang H, Lapitsky L, Lerner D</AU>
<TI>Job performance deficits due to depression</TI>
<SO>American.Journal of.Psychiatry</SO>
<YR>2006</YR>
<VL>163</VL>
<NO>9</NO>
<PG>1569-76</PG>
<IDENTIFIERS MODIFIED="2014-12-02 10:37:41 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<REFERENCE ID="REF-APA-1994" NAME="APA 1994" TYPE="BOOK">
<AU>American Psychiatric Association</AU>
<SO>Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)</SO>
<YR>1994</YR>
<EN>4th</EN>
<PB>American Psychiatric Association</PB>
<CY>Washington, DC</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-APA-2010" MODIFIED="2014-11-08 15:00:06 +0200" MODIFIED_BY="[Empty name]" NAME="APA 2010" TYPE="OTHER">
<AU>American Psychiatric Association (APA)</AU>
<TI>Practice guideline for the treatment of patients with major depressive disorder. 3rd edition</TI>
<SO>American Journal of Psychiatry</SO>
<YR>2010</YR>
<PG>152</PG>
<PB>American Psychiatric Association (APA)</PB>
<CY>Arlington (VA)</CY>
<IDENTIFIERS MODIFIED="2013-09-10 12:44:29 +0300" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-APA-2013" MODIFIED="2014-11-08 14:59:34 +0200" MODIFIED_BY="[Empty name]" NAME="APA 2013" TYPE="BOOK">
<AU>American Psychiatric Association</AU>
<SO>Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition</SO>
<YR>2013</YR>
<PB>American Psychiatric Association</PB>
<CY>Arlington, VA</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Beck-1987" NAME="Beck 1987" TYPE="BOOK">
<AU>Beck AT, Steer RA</AU>
<SO>BDI: Beck Depression Inventory Manual</SO>
<YR>1987</YR>
<PB>Psychological Corporation</PB>
<CY>New York, NY</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bowling-1995" NAME="Bowling 1995" TYPE="JOURNAL_ARTICLE">
<AU>Bowling A</AU>
<TI>What things are important in people's lives? A survey of the public's judgements to inform scales of health related quality of life</TI>
<SO>Social Science and Medicine</SO>
<YR>1995</YR>
<VL>41</VL>
<NO>10</NO>
<PG>1447-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Brown-2013" MODIFIED="2014-11-08 14:58:13 +0200" MODIFIED_BY="[Empty name]" NAME="Brown 2013" TYPE="JOURNAL_ARTICLE">
<AU>Brown MM, Brown GC</AU>
<TI>Update on value-based medicine</TI>
<SO>Current Opinion in Ophthalmology</SO>
<YR>2013</YR>
<VL>24</VL>
<NO>3</NO>
<PG>183-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Burton-2004" MODIFIED="2014-06-10 19:52:21 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Burton 2004" TYPE="JOURNAL_ARTICLE">
<AU>Burton WN, Pransky G, Conti DJ, Chen CY, Edington DW</AU>
<TI>The association of medical conditions and presenteeism</TI>
<SO>Journal of Occupational and Environmental Medicine</SO>
<YR>2004</YR>
<VL>46</VL>
<NO>6 Suppl</NO>
<PG>S38-S45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cooney-2013" MODIFIED="2014-11-08 14:57:20 +0200" MODIFIED_BY="[Empty name]" NAME="Cooney 2013" TYPE="JOURNAL_ARTICLE">
<AU>Cooney GM, Dwan K, Greig CA, Lawlor DA, Rimer J, Waugh FR et al</AU>
<TI>Exercise for depression</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<VL>Sep 12;9:CD004366</VL>
<PG>doi: 10.1002/14651858.CD004366.pub6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dewa-2000" NAME="Dewa 2000" TYPE="JOURNAL_ARTICLE">
<AU>Dewa CS, Lin E</AU>
<TI>Chronic physical illness, psychiatric disorder and disability in the workplace</TI>
<SO>Social Science and Medicine</SO>
<YR>2000</YR>
<VL>51</VL>
<NO>1</NO>
<PG>41-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Donner-2002" MODIFIED="2014-06-10 19:53:06 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Donner 2002" TYPE="JOURNAL_ARTICLE">
<AU>Donner A, Klar N</AU>
<TI>Issues in the meta-analysis of cluster randomized trials</TI>
<SO>Statistics in Medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<PG>2971-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Endicott-1997" NAME="Endicott 1997" TYPE="JOURNAL_ARTICLE">
<AU>Endicott J, Nee J</AU>
<TI>Endicott Work Productivity Scale (EWPS): a new measure to assess treatment effects</TI>
<SO>Psychopharmacology Bulletin</SO>
<YR>1997</YR>
<VL>33</VL>
<NO>1</NO>
<PG>13-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ferrari-2013" MODIFIED="2014-06-10 19:53:26 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Ferrari 2013" TYPE="JOURNAL_ARTICLE">
<AU>Ferrari AJ, Charlson FJ, Norman RE, Flaxman AD, Patten SB, Vos T et al</AU>
<TI>The epidemiological modelling of major depressive disorder: application for the Global Burden of Disease Study 2010</TI>
<SO>PLoS One</SO>
<YR>2013</YR>
<VL>8</VL>
<NO>7</NO>
<PG>e69637. doi: 10.1371/journal.pone.0069637</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ferrie-2005" MODIFIED="2014-12-01 12:50:18 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Ferrie 2005" TYPE="JOURNAL_ARTICLE">
<AU>Ferrie JE, Kivimaki M, Head J, Shipley MJ, Vahtera J, Marmot MG</AU>
<TI>A comparison of self-reported sickness absence with absences recorded in employers' registers: evidence from the Whitehall II study</TI>
<SO>Occupational and Environmental Medicine</SO>
<YR>2005</YR>
<VL>62</VL>
<NO>2</NO>
<PG>74-9</PG>
<IDENTIFIERS MODIFIED="2014-12-01 12:50:18 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<REFERENCE ID="REF-Freemantle-2001" NAME="Freemantle 2001" TYPE="JOURNAL_ARTICLE">
<AU>Freemantle N</AU>
<TI>Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic?</TI>
<SO>BMJ</SO>
<YR>2001</YR>
<VL>322</VL>
<NO>7292</NO>
<PG>989-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Furlan-2012" MODIFIED="2014-06-10 19:54:04 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Furlan 2012" TYPE="JOURNAL_ARTICLE">
<AU>Furlan AD, Gnam WH, Carnide N, Irvin E, Amick BC 3rd, DeRango K et al</AU>
<TI>Systematic review of intervention practices for depression in the workplace</TI>
<SO>Journal of Occupational Rehabilitation</SO>
<YR>2012</YR>
<VL>22</VL>
<NO>3</NO>
<PG>312-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-GRADEpro-2008" MODIFIED="2014-06-17 10:09:29 +0300" MODIFIED_BY="Jani H Ruotsalainen" NAME="GRADEpro 2008" TYPE="COMPUTER_PROGRAM">
<AU>Brozek J, Oxman A, Schünemann H</AU>
<TI>GRADEpro</TI>
<YR>2008</YR>
<EN>3.2 for Windows</EN>
<PB>GRADE working group</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Haafkens-2006" NAME="Haafkens 2006" TYPE="JOURNAL_ARTICLE">
<AU>Haafkens J, Moerman C, Schuring M, van Dijk F</AU>
<TI>Searching bibliographic databases for literature on chronic disease and work participation</TI>
<SO>Occupational Medicine</SO>
<YR>2006</YR>
<VL>56</VL>
<NO>1</NO>
<PG>39-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hamilton-1967" NAME="Hamilton 1967" TYPE="JOURNAL_ARTICLE">
<AU>Hamilton M</AU>
<TI>Development of a rating scale for primary depressive illness</TI>
<SO>British Journal of Social and Clinical Psychology</SO>
<YR>1967</YR>
<VL>6</VL>
<NO>4</NO>
<PG>278-96</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Haslam-2005" MODIFIED="2014-05-18 11:58:32 +0300" MODIFIED_BY="[Empty name]" NAME="Haslam 2005" TYPE="JOURNAL_ARTICLE">
<AU>Haslam C, Atkinson S, Brown S, Haslam RA</AU>
<TI>Perceptions of the impact of depression and anxiety and the medication for these conditions on safety in the workplace</TI>
<SO>Occupational and Environmental Medicine</SO>
<YR>2005</YR>
<VL>62</VL>
<NO>8</NO>
<PG>538-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hees-2013b" MODIFIED="2014-06-05 10:32:43 +0300" MODIFIED_BY="[Empty name]" NAME="Hees 2013b" TYPE="JOURNAL_ARTICLE">
<AU>Hees HL, Koeter MW, Schene AH</AU>
<TI>Longitudinal relationship between depressive symptoms and work outcomes in clinically treated patients with long-term sickness absence related to major depressive disorder</TI>
<SO>Journal of Affective Disorders</SO>
<YR>2013</YR>
<VL>148</VL>
<NO>2-3</NO>
<PG>272-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2014-11-21 08:35:51 +0200" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="BOOK">
<AU>Higgins JPT, Green S (editors). The Cochrane Collaboration, 2011</AU>
<SO>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0, 2011</SO>
<YR>2011</YR>
<PB>Available from www.cochrane-handbook.org</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hirschfeld-2000" NAME="Hirschfeld 2000" TYPE="JOURNAL_ARTICLE">
<AU>Hirschfeld RM, Montgomery SA, Keller MB, Kasper S, Schatzberg AF, Moller HJ et al</AU>
<TI>Social functioning in depression: a review</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2000</YR>
<VL>61</VL>
<NO>4</NO>
<PG>268-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kessler-2006" MODIFIED="2014-06-10 19:55:20 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Kessler 2006" TYPE="JOURNAL_ARTICLE">
<AU>Kessler RC, Akiskal HS, Ames M, Birnbaum H, Greenberg P, Hirschfeld RM et al</AU>
<TI>Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers</TI>
<SO>American Journal of Psychiatry</SO>
<YR>2006</YR>
<VL>163</VL>
<NO>9</NO>
<PG>1561-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kessler-2009" MODIFIED="2014-06-10 19:55:35 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Kessler 2009" TYPE="JOURNAL_ARTICLE">
<AU>Kessler RC, Aguilar-Gaxioloa S, Alonso J, Chatterji S, Lee S, Ormel J et al</AU>
<TI>The global burden of mental disorders: An update from the WHO World Mental Health (WMH) Suveys</TI>
<SO>Epidemiologia e Psichiatria Sociale</SO>
<YR>2009</YR>
<VL>18</VL>
<NO>1</NO>
<PG>23-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lagerveld-2010" MODIFIED="2014-06-10 19:56:08 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Lagerveld 2010" TYPE="JOURNAL_ARTICLE">
<AU>Lagerveld SE, Bültmann U, Franche RL, van Dijk FJ, Vlasveld MC, van der Feltz-Cornelis CM et al</AU>
<TI>Factors associated with work participation and work functioning in depressed workers: a systematic review</TI>
<SO>Journal of Occupational Rehabilitation</SO>
<YR>2010</YR>
<VL>20</VL>
<NO>3</NO>
<PG>275-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lerner-2008" MODIFIED="2014-11-08 14:53:54 +0200" MODIFIED_BY="[Empty name]" NAME="Lerner 2008" TYPE="JOURNAL_ARTICLE">
<AU>Lerner D, Henke RM</AU>
<TI>What does research tell us about depression, job performance, and work productivity?</TI>
<SO>Journal of Occupational and Environmental Medicine</SO>
<YR>2008</YR>
<VL>50</VL>
<NO>4</NO>
<PG>401-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Montgomery-1979" MODIFIED="2014-06-10 19:56:36 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Montgomery 1979" TYPE="JOURNAL_ARTICLE">
<AU>Montgomery SA, Asberg M</AU>
<TI>A new depression scale designed to be sensitive to change</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1979</YR>
<VL>134</VL>
<PG>382&#8211;9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Murray-2012" MODIFIED="2014-11-08 14:53:34 +0200" MODIFIED_BY="[Empty name]" NAME="Murray 2012" TYPE="JOURNAL_ARTICLE">
<AU>Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C et al</AU>
<TI>Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010</TI>
<SO>Lancet.</SO>
<YR>2012</YR>
<VL>380</VL>
<NO>9859</NO>
<PG>2197-223</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NICE-2010" MODIFIED="2014-05-18 12:18:54 +0300" MODIFIED_BY="[Empty name]" NAME="NICE 2010" TYPE="BOOK">
<AU>National Collaborating Centre for Mental Health</AU>
<TI>The treatment and management of depression in adults (updated edition)</TI>
<SO>http://www.nice.org.uk/nicemedia/live/12329/45896/45896.pdf</SO>
<YR>2010</YR>
<PB>The British Psychological Society and The Royal College of Psychiatrists</PB>
<CY>Leicester &amp; London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nieuwenhuijsen-2010" MODIFIED="2014-06-10 19:57:11 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Nieuwenhuijsen 2010" TYPE="JOURNAL_ARTICLE">
<AU>Nieuwenhuijsen K, Franche RL, van Dijk FJH</AU>
<TI>Work functioning measurement: tools for occupational mental health research</TI>
<SO>Journal of Occupational and Environmental Medicine</SO>
<YR>2010</YR>
<VL>52</VL>
<NO>8</NO>
<PG>778-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pole-2006" MODIFIED="2014-12-02 10:38:01 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Pole 2006" TYPE="JOURNAL_ARTICLE">
<AU>Pole JD, Franche RL, Hogg-Johnson S, Vidmar M, Krause N</AU>
<TI>Duration of work disability: a comparison of self-report and administrative data</TI>
<SO>American Journal of Industrial Medicine</SO>
<YR>2006</YR>
<VL>49</VL>
<NO>5</NO>
<PG>394-401</PG>
<IDENTIFIERS MODIFIED="2014-12-02 10:38:01 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2012" MODIFIED="2014-06-17 10:03:31 +0300" MODIFIED_BY="Jani H Ruotsalainen" NAME="RevMan 2012" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2012</YR>
<EN>5.2</EN>
<PB>The Nordic Cochrane Centre. The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Severens-2000" MODIFIED="2014-06-10 19:57:28 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Severens 2000" TYPE="JOURNAL_ARTICLE">
<AU>Severens JL, Mulder J, Laheij RJ, Verbeek AL</AU>
<TI>Precision and accuracy in measuring absence from work as a basis for calculating productivity costs in The Netherlands</TI>
<SO>Social Science and Medicine</SO>
<YR>2000</YR>
<VL>51</VL>
<NO>2</NO>
<PG>243-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sheehan-1996" NAME="Sheehan 1996" TYPE="JOURNAL_ARTICLE">
<AU>Sheehan DV, Harnett-Sheehan K, Raj BA</AU>
<TI>The measurement of disability</TI>
<SO>International Clinical Psychopharmacology</SO>
<YR>1996</YR>
<VL>11 Suppl 3</VL>
<PG>89-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Spitzer-1979" NAME="Spitzer 1979" TYPE="JOURNAL_ARTICLE">
<AU>Spitzer RL, Endicott J, Williams JB</AU>
<TI>Research diagnostic criteria</TI>
<SO>Archive of General Psychiatry</SO>
<YR>1979</YR>
<VL>36</VL>
<NO>12</NO>
<PG>1381-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Suzuki-2004" MODIFIED="2014-06-10 19:58:03 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Suzuki 2004" TYPE="JOURNAL_ARTICLE">
<AU>Suzuki K, Ohida T, Kaneita Y, Yokoyama E, Miyake T, Harano S et al</AU>
<TI>Mental health status, shift work, and occupational accidents among hospital nurses in Japan</TI>
<SO>Journal of Occupational Health</SO>
<YR>2004</YR>
<VL>46</VL>
<NO>6</NO>
<PG>448&#8211;54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Timbie-2006" MODIFIED="2014-12-01 12:50:44 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Timbie 2006" NOTES="&lt;p&gt;DA - 20060202&lt;/p&gt;" NOTES_MODIFIED="2014-12-01 12:50:44 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" TYPE="JOURNAL_ARTICLE">
<AU>Timbie JW, Horvitz-Lennon M, Frank RG, Normand SL</AU>
<TI>A meta-analysis of labor supply effects of interventions for major depressive disorder</TI>
<SO>Psychiatric Services</SO>
<YR>2006</YR>
<VL>57</VL>
<NO>2</NO>
<PG>212-8</PG>
<IDENTIFIERS MODIFIED="2014-12-01 12:50:44 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<REFERENCE ID="REF-van-Poppel-2002" NAME="van Poppel 2002" TYPE="JOURNAL_ARTICLE">
<AU>van Poppel MN, de Vet HC, Koes BW, Smid T, Bouter LM</AU>
<TI>Measuring sick leave: a comparison of self-reported data on sick leave and data from company records</TI>
<SO>Occupational Medicine</SO>
<YR>2002</YR>
<VL>52</VL>
<NO>8</NO>
<PG>485-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Verbeek-2005" MODIFIED="2014-06-10 19:58:35 +0300" MODIFIED_BY="Babs J.M.  Faber" NAME="Verbeek 2005" TYPE="JOURNAL_ARTICLE">
<AU>Verbeek J, Salmi J, Pasternack I, Jauhiainen M, Laamanen I, Schaafsma F et al</AU>
<TI>A search strategy for occupational health intervention studies</TI>
<SO>Occupational and Environmental Medicine</SO>
<YR>2005</YR>
<VL>62</VL>
<NO>10</NO>
<PG>682-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wells-1989" MODIFIED="2014-12-02 10:41:33 +0200" MODIFIED_BY="Jani H Ruotsalainen" NAME="Wells 1989" NOTES="&lt;p&gt;DA - 19890830&lt;/p&gt;" NOTES_MODIFIED="2014-12-02 10:41:33 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" TYPE="JOURNAL_ARTICLE">
<AU>Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, Daniels M et al</AU>
<TI>The functioning and well-being of depressed patients. Results from the Medical Outcomes Study</TI>
<SO>JAMA</SO>
<YR>1989</YR>
<VL>262</VL>
<NO>7</NO>
<PG>914-9</PG>
<IDENTIFIERS MODIFIED="2014-12-02 10:41:33 +0200" MODIFIED_BY="Jani H Ruotsalainen"/>
</REFERENCE>
<REFERENCE ID="REF-WHO-1992" NAME="WHO 1992" TYPE="BOOK">
<AU>World Health Organization</AU>
<SO>The ICD-10 Classification of Mental and Behavioural Disorders</SO>
<YR>1992</YR>
<PB>World Health Organization</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2014-06-05 11:56:38 +0300" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Nieuwenhuijsen-2008" MODIFIED="2014-06-05 11:56:38 +0300" MODIFIED_BY="[Empty name]" NAME="Nieuwenhuijsen 2008" TYPE="COCHRANE_REVIEW">
<AU>Nieuwenhuijsen K, Bültmann U, Neumeyer-Gromen A, Verhoeven AC, Verbeek JH, Feltz-Cornelis CM</AU>
<TI>Interventions to improve occupational health in depressed people</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2014-06-05 11:56:20 +0300" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-06-05 11:56:20 +0300" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006237.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2014-11-21 08:53:34 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2014-11-21 08:31:31 +0200" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2014-11-08 13:11:16 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Agosti-1991">
<CHAR_METHODS MODIFIED="2014-11-08 06:43:11 +0200" MODIFIED_BY="[Empty name]">
<P>Double-blind randomised trial with four arms (3 treatment and one placebo). Recruitment: unclear. Follow up: 6 weeks. Lost to follow up: 29.5%<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 13:11:02 +0200" MODIFIED_BY="[Empty name]">
<P>61 were randomised (T1: 38, C: 23). Setting: Outpatients in New York, USA</P>
<P>Inclusion:</P>
<P>- DSM-III diagnosis of depressive disorder<BR/>- mood reactivity (i.e. significant lifting of mood in response to positive environmental events)<BR/>- onset prior to age 21 yrs<BR/>- rated by experienced clinician to be depressed for most or virtually all of the time through adulthood<BR/>Mean age: 35 yrs (SD 8.9)</P>
<P>Female: 52%</P>
<P>Single: 57%</P>
<P>Married: 23%</P>
<P>Divorced or separated: 19.6%</P>
<P>Working: 70%<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 13:11:16 +0200" MODIFIED_BY="[Empty name]">
<P>T1: Treatment with increasing dose of either TCA or MAO<BR/>- 60 to 90 mg/day of phenelzine (T1a)<BR/>- 200 to 3000 mg/day of imipramine (T1b)<BR/>- 40 mg/day of L-deprenyl (T1c)<BR/>Duration: 6 weeks.<BR/>C: 4 to 6 placebo pills/day. Duration: 6 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 06:45:33 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:</P>
<P>1) hours worked in past week (baseline and at 6 weeks)<BR/>Clinical:</P>
<P>1) CGI (measured but not reported!)<BR/>2) HAM-D (measured but not reported!)<BR/>Productivity:<BR/>1) work functioning of the LIFE scale (psychosocial functioning part) (baseline and at 6 weeks)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-13 10:26:51 +0300" MODIFIED_BY="Babs J.M.  Faber"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 13:17:09 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bee-2010">
<CHAR_METHODS MODIFIED="2014-11-08 13:12:46 +0200" MODIFIED_BY="[Empty name]">
<P>RCT. Recruitment: over 10 months, human resources mailed all potential participants a study information pack. Follow up: 3 months. Lost to follow up: overall 40%, subgroup depressed workers: 0%</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 13:14:33 +0200" MODIFIED_BY="[Empty name]">
<P>53 were randomised (T1: 26; T2: 27). Subgroup of depressed workers: 12. Setting: large communications company. Inclusion: employees of a large communications company absent from work with mild to moderate mental health difficulties for 8 to 90 days authorised by general practitioner certificate Exclusion: severe or complex disorders (psychosis, comorbid personality disorder), degenerative cognitive disorders, substance misuse or active self-harm</P>
<P>For the subgroup of depressed workers:</P>
<P>mean age: 50.9 (SD 10.04)</P>
<P>male: 58%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 13:16:41 +0200" MODIFIED_BY="[Empty name]">
<P>T1: Telephone CBT, delivered over 12 weeks by one of two registered graduate mental health workers. Participants worked with therapists through regular phone calls to identify and challenge negative thoughts, develop self-care skills and complete workbook exercises emphasizing behavioural activation. Therapists received 12 h of didactic instruction and role play and weekly supervision from a senior CBT therapist.</P>
<P>T2: Usual care, primary and occupational health services.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 13:17:09 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:</P>
<P>1) self-reported actual working hours (HPQ) in last four weeks</P>
<P>Clinical:</P>
<P>1) depression, assessed by the HADS</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-13 10:26:57 +0300" MODIFIED_BY="Babs J.M.  Faber"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 13:23:47 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Burnand-2002">
<CHAR_METHODS MODIFIED="2014-11-08 13:18:47 +0200" MODIFIED_BY="[Empty name]">
<P>RCT, random assignment stratified by presence of personality disorder, past major depressive syndrome and gender; two conditions. Recruitment: screening by nurse and psychiatrist of consecutive patients referred for acute outpatient treatment. Follow up: 10 weeks. Lost to follow up: 22%</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 13:20:30 +0200" MODIFIED_BY="[Empty name]">
<P>95 were randomised (T1: 35; C: 39); Setting: outpatient community mental health centre in Switzerland; Inclusion: age 20 to 65 years, new episode of care, MDD DSM-IV (SCID) + HDRS at least 20; Exclusion: bipolar disorder, psychotic symptoms, severe substance dependence, organic disorder, mental retardation, history of severe intolerance to clomipramine, poor command of French language<BR/>Age: T1: 36 (SD 9.5); C: 36.7 (SD 10.4)</P>
<P>Female: T1: 66%; C: 56%</P>
<P>Stable employment: T1: 71%; C: 82%<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 13:23:34 +0200" MODIFIED_BY="[Empty name]">
<P>T1: Psychodynamic psychotherapy: individual sessions by nurse + clomipramine: 25 mg first day, gradually increasing to 125 mg on fifth day (dosage adjustment allowed). Refusal or severe side effects: 20 to 40 mg citalopram per day. Duration: 10-week program, frequency psychotherapy sessions not fixed, duration of clomipramine 10 weeks<BR/>C: Supportive care: individual sessions: empathic listening, guidance and support. + clomipramine: 25 mg first day, gradually increasing to 125 mg by fifth day (dosage adjustment allowed). Refusal or severe side effects: 20 to 40 mg citalopram per day. Duration supportive care: not fixed, duration clomipramine 10 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 13:23:47 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:</P>
<P>1) number of days of sick leave in 10 weeks<BR/>Clinical:<BR/>1) full remission (at most 7 HDRS) (at 10 weeks)<BR/>2) severity of depression (HDRS score; GAS) (at 10 weeks)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-13 10:30:12 +0300" MODIFIED_BY="Babs J.M.  Faber"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 13:27:56 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fantino-2007">
<CHAR_METHODS MODIFIED="2014-11-08 13:25:45 +0200" MODIFIED_BY="[Empty name]">
<P>RCT. Recruitment: patients were recruited by psychiatrists or by general practitioners. Follow up: 8 weeks. Lost to follow up: 8.1%</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 13:26:15 +0200" MODIFIED_BY="[Empty name]">
<P>280 were randomised (T1: 138; T2: 142). Setting: outpatient; general or psychiatric practices in France. Inclusion: all patients fulfilling the DSM-IV criteria for MDD and having a baseline MADRS total score of at least 30 were eligible for the study. Exclusion: patients meeting DSM-IV for primary diagnoses for any axis I disorder other than MDD or those with a history of mania, bipolar disorder, schizophrenia or other psychotic disorder, obsessive-compulsive disorder, cognitive disorder including mental retardation or personality disorder, patients who met the DMS-IV criteria for substance abuse or dependence within the past 12 months, or used a depot antipsychotic within 6 months before study inclusion or any antipsychotic or anticonvulsant medications within 2 weeks before the first administration of study medication</P>
<P>Male: T1: 28.3%; T2: 38.0%</P>
<P>Age: T1: 44.1 (SD 10.9); T2: 46.2 (SD 11.1)</P>
<P>Family situation:</P>
<P>T1: 23.9% single; T2: 16.2% single</P>
<P>T1: 49.3% married, living with partner; T2: 50.7% married living with partner</P>
<P>T1: 26.8% separated, divorced, widowed; T2: 33.1% separated, divorced, widowed</P>
<P>Occupational status:</P>
<P>T1: 35.5% unemployed; T2: 29.6% unemployed</P>
<P>T1: 64.5% employed; T2: 70.4%</P>
<P>T1: 4.5% craftsman, tradesman; T2: 7.0% craftsman, tradesman</P>
<P>T1: 9.0% manager; T2: 12.0% manager</P>
<P>T1: 21.3% technician; T2: 30.0% technician</P>
<P>T1: 9.0% workman; T2: 4.0% workman</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 13:27:32 +0200" MODIFIED_BY="[Empty name]">
<P>T1: Escitalopram (SSRI) 10 mg daily during the first week, 20 mg per day for the remaining 7 weeks</P>
<P>T2: Citalopram (SSRI) 20 mg/day daily during the first week, 40 mg per day for the remaining 7 weeks</P>
<P>All study medications were provided in identical blister packs of identical capsules administered as one capsule per day, regardless of dose or<BR/>treatment group. No adjustment of dosage was allowed</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 13:27:56 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:</P>
<P>1) says of sick leave for the 2-month pre-study period and for the 8-week study period (percentage of patients and mean consumption of those patients)</P>
<P>Clinical:</P>
<P>1) sepression severity, assessed by the Montgomery-Asberg Depression Scale (MADRS)</P>
<P>2) remission, defined as the total score MADRS of &#8804; 12</P>
<P>3) MADRS-S, the self-reported version of MADRS</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-13 10:30:58 +0300" MODIFIED_BY="Babs J.M.  Faber"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 13:33:41 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fernandez-2005">
<CHAR_METHODS MODIFIED="2014-11-08 13:30:22 +0200" MODIFIED_BY="[Empty name]">
<P>Randomised, double-blind, flexible-dose, multinational, clinical trial with a one-week run-in period with no treatment. After randomisation: two treatment arms Recruitment: patient were asked to participate by GP. Follow up: 8 weeks. Lost to follow up: 16%</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 13:31:53 +0200" MODIFIED_BY="[Empty name]">
<P>293 were randomised (T1: 148; T2: 145). Setting: primary care at 44 sites in 8 European countries. Inclusion: patients in primary care<BR/>Age 18 to 85 yrs, DSM-IV diagnosis of MDD (current or first), Minimal MADRS score of 18. Exclusion: History of mania or any bipolar disorder, schizophrenia or any psychotic disorder, Currently suffering from obsessive-compulsive disorder, eating disorder, mental retardation, any pervasive development disorder, or cognitive disorder (DSM-IV criteria), MADRS of at least 5 on item 10 (suicidal thoughts), Alcohol or drug abuse problems within the previous 12 months, Having had treatment with: antipsychotics, antidepressants, psychotropics (except zolpidem or stable low doses of benzodiazepines for insomnia), serotonin receptor antagonists, lithium, carbamazepine, valproate, or valpromide, ECT, treatment with CBT or psychotherapy, Being pregnant or breastfeeding, Medications likely to interfere with the study<BR/>Mean age T1: 48.4; T2: 46.5</P>
<P>Sex: T1: 75.4% female; T2: 71.2% female</P>
<P>Married or cohabiting: T1: 61.9%; T2: 56%</P>
<P>Employed: T1: 51.5%; T2: 60%</P>
<P>Long-term sickness absence: T1: 11.1%; T2: 11.2%</P>
<P>Higher education: T1: 9.5%. T2: 11.2%<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 13:33:22 +0200" MODIFIED_BY="[Empty name]">
<P>T1: Escitalopram (SSRI): initial 10 mg/day. At week 2 or 4 dose could be increased to 20 mg/day at the investigator's discretion if patient's response was unsatisfactory. After 8 weeks of treatment, 1 week run-out period. Patients on 20 mg/day were down-tapered to 10 mg for the first 4 days and placebo the last 3. Patients on lower dose received 7 days of placebo<BR/>T2: Venlafaxine XR (SNRI), initially 75 mg/day. At week 2 or 4 dose could be increased to 150 mg/day at the investigator's discretion if patient's response was unsatisfactorily. After 8 weeks of treatment, 1-week run-out period. Patients on 150 mg/day were down-tapered to 75 mg for the first 4 days and placebo the last 3. Patients on lower dose received 7 days of placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 13:33:41 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:</P>
<P>1) % of patients on sick leave and average length of sick leave per week (3 months prior baseline and during 8 weeks of study)</P>
<P>2) personal communication; days of sick leave during 8 weeks of study, for workers only<BR/>Clinical:</P>
<P>1) MADRS (at 8 weeks)</P>
<P>2) HAM-D (at 8 weeks)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 13:43:04 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hees-2013">
<CHAR_METHODS MODIFIED="2014-11-08 13:34:59 +0200" MODIFIED_BY="[Empty name]">
<P>Two armed RCT. Recruitment: Between December 2007 and October 2009, participants were referred by occupational physicians from several occupational health services. Follow up: 18 months. Lost to follow up: 13.7%</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 13:39:54 +0200" MODIFIED_BY="[Empty name]">
<P>117 were randomised (T1: 39; T2: 78); Setting: Outpatient; Department of Psychiatry, Academic Medical Center, Amsterdam; Inclusion: Age 18 to 65, DSM-IV diagnosis of MDD, Absent from work at least 25% of their contract hours due to their depression. In addition, the duration of the depression had to be at least 3 months or the duration of their sickness absence had to be at least 8 weeks. Finally, there had to be a relation between the depressive disorder en the work situation, that is, work was one of the determinants of depressive disorder and contributed substantially (&gt; 25%), or the depressive symptoms reduced productivity or hindered RTW. </P>
<P>Exclusion: severe alcohol or drug dependence, bipolar disorder, psychotic disorder, depression with psychotic characteristics, indication of inpatient treatment<BR/>Age: T1: 41.5 (SD 9.6); T2: 43.8 (SD 9.0)</P>
<P>Male: T1: 41%; T2: 53%</P>
<P>Education (years): T1: 13.9 (SD 3.7); T2: 13.5 (SD 3.1)</P>
<P>Martital status: T1: 59% married or living together; T2: 58% married or living together; T1: 23% single; T2: 28% single; T1: 18% divorced or widowed; T2: 14% divorced or widowed</P>
<P>Contract (number of hours): T1: 32.7 (SD 5.8); T2: 35.0 (SD 5.0)</P>
<P>Absenteeism (number of hours): T1: 27.1 (SD 8.8); T2: 27.6 (SD 10.0)</P>
<P>Duration of absenteeism (months): T1: 3.8 (IQR 2.0 - 6.5); T2: 5.0 (IQR 2.8 - 5.0)</P>
<P>Occupational sector: financial or insurance: T1: 54%; T2: 58%; Health care: T1: 18%; T2: 9%; Other: T1: 28%; T2: 33%</P>
<P>Work experience (years): T1: 14.1 (SD 9.6); T2: 15.9 (SD 11.0)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 13:41:03 +0200" MODIFIED_BY="[Empty name]">
<P>T1: Treatment as usual: treatment by psychiatric residents in an outpatient university clinic according to a treatment protocol consistent with the APA guidelines. 19 visits consisted of clinical management, including psycho education, supportive therapy and cognitive behavioural interventions. Therapies were supervised on a weekly basis by an experienced senior psychiatrist specialised in depression. If needed, participants received pharmacotherapy according to a protocolised algorithm. If the participant's condition deteriorated and outpatient treatment was no longer deemed adequate, he or she was referred to day treatment or inpatient treatment<BR/>T2: Adjuvant occupational therapy: consisted of 18 sessions (nine individual sessions, eight group sessions and a meeting with the employer), and was conducted by two experienced occupational therapists who had received extensive training in the intervention protocol. During the intervention, the occupational therapist frequently communicated with the occupational physician and the resident treating psychiatric. Employees were recruited to work at least 2 hours per week when starting OT, so that employees were able to directly practise the things learned (e.g. new coping strategies) during therapy</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 13:43:04 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:</P>
<P>1) work participation, defined in: a) average number of hours of absenteeism over each 6-month period and b) duration of sick leave due to depression in calender days from the start of treatment until partial (or full) RTW. Time until partial or full RTW was operationalised as the duration of sick leave due to depression in calendar days from the start of treatment until partial (or full) RTW. Partial RTW was defined as working an increment of at least 5 hours (compared with hours worked at baseline), for at least 4 weeks without partial or full recurrence. Full RTW was defined as working the full number of contract hours in own or other work for at least 4 weeks, without partial or full recurrence</P>
<P>Clinical:</P>
<P>1) severity of depression, assessed by the Hamilton Rating Scale for depression (HRSD)</P>
<P>2) depression remission, defined as having HRSD &#8804; 7</P>
<P>3) severity of depression, assessed by the Questionnaire Inventory of Depressive Symptoms Self-Report (StIDS-SR)</P>
<P>Functioning:</P>
<P>1) at work functioning: weekly self-report records of work efficiency on a scale 1-0 and 3 sub scales of WLQ: Output, time, mental-interpersonal</P>
<P>2) health-related functioning, 3 subscales of MOS-SF 36: role limitations due to emotional problems, mental health, role limitations due to physical problems</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 13:48:40 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hollinghurst-2010">
<CHAR_METHODS MODIFIED="2014-11-08 13:44:33 +0200" MODIFIED_BY="[Empty name]">
<P>RCT. Recruitment: patients were recruited from 55 general practices in Bristol, London, and Warwickshire between October 2005 and February 2008. Follow up: 8 months. Lost to follow up: 53% for sickness absence and 29% for clinical outcomes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 13:46:43 +0200" MODIFIED_BY="[Empty name]">
<P>297 were randomised (T1: 149; T2: 148). Setting: patients between who where identified in primary care as having a new episode of depression</P>
<P>Inclusion: patients between 18 and 75 who where identified in primary care as having a new episode of depression which was defined as being diagnosed within the 4 weeks preceding referral. Depression was defined as a score of 14 or more on the BDI12 and an ICD-10 diagnosis of depression using the CIS-R) Exclusion: patients treated for depression in the 3 months before the present episode, patients with a history of bipolar disorder, psychotic disorder, alcohol or substance misuse, and those already receiving psychotherapy</P>
<P>Female: T1: 69%; T2: 67%</P>
<P>Age: T1: 35.6 (SD 11.9); T2: 34.4 (SD 11.3)</P>
<P>Marital status:</P>
<P>T1: 34% married; T2: 39% married</P>
<P>T1: 50% single; T2: 47% single</P>
<P>T1: 16% separated or divorced or widowed; T2: 15% separated or divorced or widowed</P>
<P>Employment status:</P>
<P>T1: 65% employed; T2: 56% employed</P>
<P>T1: 15% student; T2: 24% student</P>
<P>T1: 20% not in employment; T2: 20% not in employment</P>
<P>Highest educational level:</P>
<P>T1: 65% A level or above; T2: 63% A level or above</P>
<P>T1: 32% other; T2: 33% other</P>
<P>T1: 3% no educational qualifications; T2: 4% no educational qualifications</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 13:48:40 +0200" MODIFIED_BY="[Empty name]">
<P>T1: Online CBT in addition to usual care: participants receiving online CBT were offered up to ten sessions of 55 minutes, to be completed within 4 months from the date of randomisation when possible. Each participant was assigned their own therapist for the duration of the study. Participants and therapists typed free text into the computer, with messages sent instantaneously, using only this means of communication</P>
<P>T2: Usual care from GP while on a 8-month waiting list for online CBT: participants on the waiting list were not to receive psychotherapy during the study follow-up period. Those on the waiting list who had still an eligible Beck Depression Inventory (BDI) score after 8 months were offered the intervention at that time</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 13:48:22 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:</P>
<P>1) the number of working days lost because of depression (time off work) over 8 months</P>
<P>Clinical:</P>
<P>1) depression severity, assessed by the BDI</P>
<P>2) recovery, defined as a score of less than 10 on the BDI</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 14:48:47 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kendrick-2005">
<CHAR_METHODS MODIFIED="2014-11-08 14:48:47 +0200" MODIFIED_BY="[Empty name]">
<P>RCT, randomisation on the level of patients stratified for referring GP; 3 conditions. Recruitment: general practices referred patients to the study. CMHNs were employed by local NHS trusts. Follow up: 26 weeks. Lost to follow up: 26%<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 13:52:01 +0200" MODIFIED_BY="[Empty name]">
<P>247 randomised (T1: 90; T2: 79; T3: 78). Setting: community mental health, UK. Inclusion: age: 18-65; new episode of anxiety, depression or reaction to life difficulties; minimum duration symptoms: 4 weeks; maximum duration symptoms: 6 months; GHQ-12 score at least 3<BR/>Exclusion: patient already in contact with psychiatric services; Patient already receiving psychological treatment; Severe mental illness such as schizophrenia, manic-depressive psychosis; severe substance misuse, dementia or severe depression with active suicidal ideas; housebound patients; patients without the spoken and written language skills necessary to participate; seriously ill and terminally ill patients; temporary residents<BR/>Mean age: T1: 35.8 (SD 10.92); T2: 34.2 (SD 11.33); T3: 34.9 (SD 11.77)<BR/>Female: T1: 72%; T2: 70%;T3: 69%<BR/>Married or cohabiting: T1: 60%; T2: 58%; T3: 48%<BR/>Fulltime or part-time employed: T1: 66%; T2: 75%; T3: 69%<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 13:53:23 +0200" MODIFIED_BY="[Empty name]">
<P>T1: CMHN problem-solving treatment:<BR/>1. explanation of treatment and rationale<BR/>2. clarification and definition of problems<BR/>3. choice of achievable goals<BR/>4. generations of alternative solutions<BR/>5. selection of preferred solution<BR/>6. clarification of necessary steps to implement solution<BR/>7. evaluation of progress; Initial 1-hour session + 5 follow-up sessions of 30-45 minutes.<BR/>T2: Generic CMHN; nurses were asked to use whatever treatment they were experienced in giving; initial 1-hour session + 5 follow-up sessions of 30 to 45 minutes. Range 0 to 8 sessions<BR/>T3: GP care: usual care, but asked not to refer patients to a psychological therapist during the study period unless absolutely necessary<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 13:53:42 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:<BR/>1) number of days off paid work<BR/>Clinical:<BR/>1) CIS-R<BR/>2) HADS-D<BR/>Productivity:</P>
<P>1) SAS, however, subscale "work outside the home" not separately reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-11-08 13:53:49 +0200" MODIFIED_BY="[Empty name]">
<P>Personal communication: data for depressed subsample was provided<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 14:48:20 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Knekt-2013">
<CHAR_METHODS MODIFIED="2014-11-08 13:56:53 +0200" MODIFIED_BY="[Empty name]">
<P>RCT. Recruitment: a total of 459 eligible outpatients were referred to the Helsinki Psychotherapy Study from psychiatric services in the Helsinki region from June 1994 to June 2000. Follow up: 5 years. Lost to follow up: 19% (for all participants over five years), lost to follow up for the subgroup of people with depressive disorder: 51% (over five years)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 14:48:20 +0200" MODIFIED_BY="[Empty name]">
<P>326 were randomised (T: 97; T2: 101; T3: 128). Subgroup of people with depressive disorder: 161. Setting: outpatient. Inclusion: 20 to 45 years of age and suffered from a longstanding (&gt; 1 year) disorder causing dysfunction in work ability. They were also required to meet DSM-IV criteria for anxiety or mood disorders</P>
<P>Exclusion: psychotic disorder or severe personality disorder, adjustment disorder, substance-related disorder, organic brain disease or other diagnosed severe organic disease, and mental retardation. Individuals treated with psychotherapy within the previous 2 years and psychiatric health employees were also excluded</P>
<P>Age: T1: 33.6 (SD 7.2); T2: 32.1 (SD 7.0); T3: 31.6 (SD 6.6)</P>
<P>Male: T1: 25.8%; T2: 25.7%; T3: 21.1%</P>
<P>Employed or student: T1: 83.2%; T2: 85.1%; T3: 75.4%</P>
<P>Academic education: T: 28.9%; T2: 19.8%; T3: 75.4%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 13:58:24 +0200" MODIFIED_BY="[Empty name]">
<P>T1: Solution-focused therapy: is a brief, focal, transference-based therapeutic approach which helps patients by exploring and working through specific intrapsychic and interpersonal conflicts. The therapy included one session every second or third week, with a limit of 12 sessions, over no more than 8 months</P>
<P>T2: Short-term psychodynamic psychotherapy: is characterized by the exploration of a focus, which can be identified by both the therapist and the patient. This consists of material from current and past interpersonal and intrapsychic conflicts and the application of confrontation, clarification, and interpretation in a process in which the therapist is active in creating the alliance and ensuring the time-limited focus. The therapy was scheduled for 20 weekly treatment sessions over 5 to 6 months</P>
<P>T3: Long-term psychodynamic psychotherapy: is an open-ended, intensive, transference-based therapeutic approach which helps patients by exploring and working through a broad area of intrapsychic and interpersonal conflicts. The therapy is characterized by a framework in which the central elements are exploration of unconscious conflicts, developmental deficits, and distortions of intrapsychic structures. Confrontation, clarification and interpretation are major elements, as well as the therapist's actions in ensuring alliance and working through the therapeutic relationship to attain conflict resolution and greater self-awareness. Therapy includes both expressive and supportive elements, the use of which depends on patient needs. The frequency of sessions was 2 to 3 times a week, and the duration of the therapy was up to 3 years</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 13:58:40 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:</P>
<P>1) number of sick-leave days during last 3 months</P>
<P>Clinical:</P>
<P>1) depressive symptoms assessed by the Beck Depression Inventory (BDI)</P>
<P>2) depressive symptoms assessed by the Hamilton Depression Rating Scale (HDRS)</P>
<P>Functioning:</P>
<P>1) the work-subscale (SAS-work) of the social adjustment scale (SAS-SR)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 14:47:29 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Krogh-2009">
<CHAR_METHODS MODIFIED="2014-11-08 13:59:46 +0200" MODIFIED_BY="[Empty name]">
<P>Randomized pragmatic trial. Recruitment: between January 2005 and July 2006. Follow-up: 12 months. Lost to follow up: 17% at 4 months and 22% at 12 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 14:01:09 +0200" MODIFIED_BY="[Empty name]">
<P>165 were randomised (T1:55; T2:55; T3:55); Setting: outpatient; this trial was carried out at a single location at Copenhagen University. Inclusion: age 18-55 years, referred by a medical doctor or psychologist, meeting ICD-10 criteria for unipolar depression, living in the Greater Copenhagen catchment area, able to read and understand informed consent. Exclusion: being engaged in regular sports activity for more than 1 hour per week, ongoing alcohol or substance abuse judged to be at risk of suicide, poor Danish language skills, having a medical condition that contraindicated physical exercise, or had been on sickness leave for than 24 consecutive months<BR/>Age: T1: 41.9 (SD 8.7); T2: 38.1 (SD 9.0); T3: 36.7 (SD 8.7)</P>
<P>Female: T1: 81.8%; T2: 78.2%; T3: 61.8%</P>
<P>Ethnicity: T1: 90.9% Caucasian; T2: 92.7% Caucasian; T3: 90.9% Caucasian</P>
<P>Occupational status:</P>
<P>T1: 41.8% unemployed; 40% fulltime work; 14.5% part-time work; 3.6% &lt; 20 hrs/wk</P>
<P>T2: 54.5% unemployed; 32.7% fulltime work; 10.9% part-time work; 1.8% &lt; 20 hrs/wk</P>
<P>T3: 36.4% unemployed; 41.8% fulltime work; 18.2% part-time work; 3.6% &gt; 20 hrs/wk</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 14:47:29 +0200" MODIFIED_BY="[Empty name]">
<P>T1: Supervised strength training. Designed to increase muscular strength, initially with 12 repetitions of 50% of repetition maximum 2 or 3 times per exercise. As the patients progressed, the numbers of repetitions were reduced to 10 and 8, with an increase of RM to 75%. The training was a circuit-training program with 6 exercise on machines involving large muscle groups. As a supplement to this, free weights and sandbags were used for exercising the calf muscles, the arm abductors, the triceps muscles, and the hip abductors. All patients were scheduled to meet twice per week during a 4-month period for a total of 32 sessions</P>
<P>T2: Aerobic training. Designed to increase fitness as measured by maximal oxygen uptake. The program involved 10 different aerobic exercises using large muscle groups. Machines were used for cycling, running, stepping, abdominal exercises, and rowing. Additional exercises were sliding movements on small carpets, trampoline, step bench, jump rope, and Ski Fitter. During the first 8 sessions, each exercise was done twice for 2 minutes with a 2-minute rest at an intensity level of 70% of maximal heart rate. This gradually increased to a level at which exercise was done for 3 minutes with a 1-minute rest at an intensity level of 89% during the last 8 sessions. All patients were scheduled to meet twice per week during a 4-month period for a total of 32 sessions</P>
<P>T3: Relaxation training. Designed to avoid muscular contractions or stimulation of the cardiovascular system, and the patients did not engage in activities perceived higher than 12 on the Borg Scale. The first 20 to 30 minutes were used for exercises on mattresses or Bobath Balls or back massage using a Ball Stick Ball. This was followed by light balance exercises for 10 to 20 minutes and by relaxation exercises with alternating muscle contraction and relaxation in different muscle groups while lying down for 20 to 30 minutes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 14:47:04 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:</P>
<P>1) self-reported percentage of days absent from work during the last 10 working days at 4 and 12 months</P>
<P>Clinical:</P>
<P>1) severity of depression, assessed by the Hamilton Rating Scale for Depression (HAM-D17)</P>
<P>2) remission, defined as not fulfilling the ICD-10 criteria for depression and having a HAM-D17 &lt; 8</P>
<P>3) severity of depression, assessed by the Beck Depression Inventory (BDI)</P>
<P>Employment status:</P>
<P>1) % on sick leave</P>
<P>2) % unemployed</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 14:45:33 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Krogh-2012">
<CHAR_METHODS MODIFIED="2014-11-08 14:44:58 +0200" MODIFIED_BY="[Empty name]">
<P>A single-centre, two-armed, parallel-group, observer-blinded randomised clinical superiority trial. Recruitment: between September 2008 and April 2011, participants were referred to trial site from various clinical settings. Follow up: 3 months. Lost to follow up: 13%</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 14:45:33 +0200" MODIFIED_BY="[Empty name]">
<P>115 were randomised (T1: 56; T2: 59). Setting: outpatient; the participants were enrolled at the trial site in Copenhagen (Denmark) from various clinical settings. Inclusion: men and women between 18 and 60 years of age, referred from a clinical setting by a physician or a psychologist, a diagnose of major depression (DSM-IV) based on the Danish version of the Mini International Neuropsychiatric Interview, score above 12 on the HAM-D17 and living in the Greater Copenhagen catchments area, able to comprehend and sign the informed consent statement. </P>
<P>Exclusion: current drugs abuse, any antidepressant medication within the last two months, current psychotherapeutic treatment, contraindications to physical exercise, more than 1 hour or recreational exercise per week, suicidal behaviour according to the 17-item Hamilton depression rating scale (HAM-D17 item 3 &gt; 2), pregnancy, current/previous psychotic or manic symptoms, or lack of informed consent</P>
<P>Age: T1: 39.7 (SD11.3); T2: 43.4 (SD 11.2)</P>
<P>Female: T1: 71.4%; T2: 62.7%</P>
<P>Occupational status:</P>
<P>T1: 35.7% unemployed; T2: 45.7%</P>
<P>T1: 35.7% sickness leave; T2: 30.5% sickness leave</P>
<P>T1: 74.3% job attendance, last 10 days; T2: 73.8% job attendance, last 10 days</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 14:44:34 +0200" MODIFIED_BY="[Empty name]">
<P>T1: Aerobic training group: designed to increase fitness as measured by maximal oxygen uptake. After initial 10 minutes of general low-intensity warm-up, the participants did 30 minutes of aerobic exercise on a stationary cycle ergometer followed by five minutes low-intensity cool down period. During the initial four weeks, the aim was to work out at intensity levels corresponding to at least 65% to their maximal capacity, progressing to 70% and 80% during the second and third month, respectively. The participants carried a pulse monitor during exercise to guide and document intensity levels</P>
<P>T2: Stretching exercise group: designed as an attention control group with the purpose of providing the same level of social interaction and contact with health care professionals as in the aerobic exercise group. This was done in order to assess the potential antidepressant effect of aerobic exercise in it self, and not the effect of aerobic exercise plus social interaction. This stretching exercise group performed low intensity exercise, which we did not expect to contain any antidepressant effect per se. The initial 10 minutes were low-intensity warm-up on a stationary bike, then a 20 minutes program of stretching, followed by 15 minutes of various low intensity exercises such as throwing and catching balls</P>
<P>Both groups were scheduled to meet three times per week for three months for a total of 36 sessions</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 14:44:16 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:</P>
<P>1) the number of days spent on the job within the last ten working days, expressed as a percentage</P>
<P>Clinical:</P>
<P>1) depression severity, assessed by the HAM-D17</P>
<P>2) core depression items, assessed by HAM-D6</P>
<P>3) remission, defined as not fulfilling the DSM-IV criteria for major depression and a HAM-D17 score below 8</P>
<P>4) self-reported depression, assessed by the Beck Depression Inventory (BDI)</P>
<P>Employment status:</P>
<P>1) employment status or sick leave at the time of the interview</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 14:42:54 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lerner-2012">
<CHAR_METHODS MODIFIED="2014-11-08 14:42:36 +0200" MODIFIED_BY="[Empty name]">
<P>RCT. Recruitment: 6 months. Follow up: 4 months. Lost to follow up: 8.9%</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 14:42:54 +0200" MODIFIED_BY="[Empty name]">
<P>79 were randomised (T1:52; T2:27); Setting: workplace; this study involved State Government in Maine</P>
<P>Inclusion: ages 18 to 62 years and employed 15 hours per week or more and fulfilled the criteria for current MDD and/or dysthymia, a WLQ productivity loss of at least 5% in the past 2 weeks (this score is consistent with an impaired ability to work approximately 20% of the time over 2 weeks). Exclusion: planning to retire within 2 years, receiving work disability benefits, active alcoholism or drugs-abuse based on the five-item CAGE, pregnant or 6 months postpartum, schizophrenia or bipolar disorder, non-English speaking and/or reading, and/or diagnosed with one or more of 12 medical conditions that have symptoms that potentially interfere with working (e.g. angina, congestive hart failure, stroke, diabetes, chronic obstructive lung disease)<BR/>Comorbidity: T1: 80.8%; T2: 71.1%</P>
<P>Age: T1: 45.5 (SD 9.8); T2: 45.9 (SD 8.6)</P>
<P>Male: T1: 23.1%; T2: 18.5%</P>
<P>Ethinicity: T1: 100% white; 96.3% white</P>
<P>Marital status: T1: 47.1% married; T2: 48.1% married</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 14:41:41 +0200" MODIFIED_BY="[Empty name]">
<P>T1: Work and Health Initiative (WHI) intervention. Provided over the phone by EAP counsellors trained in its methods. The program lasts for 8 weeks with 1-hour visits occurring every 2 weeks. This multi component work-focused programs consists of: 1) work coaching and modification, 2) care coordination, 3) cognitive-behavioral strategies. In the WHI, the counsellor and employee co-create a care plan for dealing with each functional problem and review specific assignments and progress at each session. A motivational enhancement approach is utilized to promote and solidify change. In both groups: electronic feedback on depression and advise to seek care</P>
<P>T2: Usual care. Primary care, specialty care, behavioral health programs, and/or standard EAP services. In both groups: electronic feedback on depression and advise to seek care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 14:41:09 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:</P>
<P>1) the WLQ Work Absence Module measured self-reported time missed from work in the past 2 weeks because of health or medical care</P>
<P>Clinical:</P>
<P>1) change in depression symptom severity as measured by the PHQ-9</P>
<P>Functioning:</P>
<P>1) Work limitations Questionnaires Short Form (WLQ), a self-report survey tool for assessing the impact of health problems, including at-work performance. 4 Dimensions of performance are measured</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-11-28 10:55:25 +0200" MODIFIED_BY="Babs J.M.  Faber"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 14:40:20 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McCrone-2004">
<CHAR_METHODS MODIFIED="2014-11-08 14:40:20 +0200" MODIFIED_BY="[Empty name]">
<P>RCT, 2 conditions. Recruitment: by screening in the GP waiting rooms and of GP referrals using the GHQ-12. Score at least 4: seen by GP who administered inclusion and exclusion criteria. Follow up: 6 months. Lost to follow up at 6 months: T1: 27%; T2: 24%<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 14:39:33 +0200" MODIFIED_BY="[Empty name]">
<P>274 were randomised (T1: 146; T2: 128). Setting: Primary care, UK </P>
<P>Inclusion: GP patients aged 18 to 75 years; diagnosis (ICD): depression, mixed anxiety/depression or anxiety disorder. CIS-R score at least 12<BR/>Exclusion: active suicidal ideas, Psychotic disorder, organic mental disorder or alcohol or drug dependence. Having taken medication for anxiety or depression continuously for at least 6 months immediately prior to entry; unable to read or write; unable to attend 8 sessions at practice<BR/>Mean age: T1: 43.6 (SD 14.3); T2: 43.4 (SD 13.7)<BR/>Female: T1: 73% T2: 75%</P>
<P>Married or cohabiting: T1: 54%; T2: 52%</P>
<P>Employed: T1: 66%; T2: 58%<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 14:38:00 +0200" MODIFIED_BY="[Empty name]">
<P>T1: Computerised CBT: interactive, multimedia. Feedback to patient and GP after each session. 15 minute introductory video, 8 x 50 minute sessions of CBT, with homework projects between sessions<BR/>T2: TAU: General practitioner care as usual: no constraints. Could include medication, discussion of problems with GP, practical or social help, referral to counsellor, practice nurse, mental health professional, or further physical examination</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-05-18 13:55:45 +0300" MODIFIED_BY="[Empty name]">
<P>Absenteeism:</P>
<P>1) Number of days of absence from work (certified by GP) during 8 months<BR/>Clinical:</P>
<P>1) BDI<BR/>Productivity:</P>
<P>1) Work and Social Adjustment Scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 15:26:12 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Miller-1998">
<CHAR_METHODS MODIFIED="2014-11-08 14:35:04 +0200" MODIFIED_BY="[Empty name]">
<P>RCT. multicentre, 2 conditions. Recruitment: referrals from physicians or mental health professionals, media advertising, and word of mouth. Follow up: 12 weeks. Lost to follow up: 2%</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 15:26:12 +0200" MODIFIED_BY="[Empty name]">
<P>635 were randomised: (T1: 426; T2: 209). Setting: 12 outpatient centres in USA</P>
<P>Inclusion: age 21 to 65 years; Diagnosis of chronic MDD with two or less cumulative depression-free months and who had not met DSM-II-R criteria for dysthymia within 2 months of the onset of current MD episode OR of concurrent MD episode superimposed on antecedent DSM-III-R dysthymia; Premenopausal women: adequate contraception<BR/>Exclusion: organic mental syndrome, current or lifetime diagnosis of bipolar disorder or cyclothymia, schizophrenia, other psychotic disorders, obsessive-compulsive disorder, antisocial, schizotypical or severe borderline personality disorder; Principal DSM-III-R diagnosis of panic disorder, generalized anxiety disorder or PTSD within the past 6 months; DSM-II-R defined anorexia or bulimia nervosa within the past year; Drug or alcohol abuse or dependence within the past 6 months; Patients deemed at immediate suicide risk/ medical contraindications to antidepressants; Significant general medical disorder;Concomitant therapy with any psychotropic drug (except chloral hydrate or temazepam); Failure of adequate trial of sertraline or imipramine; Treatment with MOA-inhibitors within 3 weeks; Any depot neuroleptic within 6 months'; Fluoxetine within 1 month; Regular daily neuroleptic, anxiolytic, or antidepressant medication within 2 weeks; ECT within 3 months<BR/>Mean age: 41.1 (SD 10.1)<BR/>Female: 63%</P>
<P>Married: 38%</P>
<P>Employed: 71%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 14:34:20 +0200" MODIFIED_BY="[Empty name]">
<P>T1: sertraline (SSRI). Week 1-3: 50 mg/day, then weekly titration in 50 mg/day increments (max 200 mg/day). 12 weeks, visits every week for the first 6 weeks and every 2 weeks for last 6 weeks. Before this, 1 week placebo run-in<BR/>T2: Imipramine (TCA). Week 1: 50 mg/day, week 2: 100 mg/day, week 3: 150 mg/day. Then weekly titration 50 mg/day increments with a max of 300 mg/day by week 6. 12 weeks, visits every week for the first 6 weeks and every 2 weeks for last 6 weeks. Before this, 1 week placebo run-in</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 15:25:51 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:</P>
<P>1) hours worked per week (12 weeks)</P>
<P>Clinical:</P>
<P>1) full remission, both CGI-I (=sub scale CGI) score of 1 or2 AND total HAM-D score of 7 (or less) at last visit<BR/>2) satisfactory therapeutic response, at last visit: both CGI-I (=sub scale CGI) score of 1 or 2 AND total HAM-D score of 15 or less AND HAM-D-score reduction of at least 50% since baseline AND final GSI-S (= subscale CGI) score of 3 or less<BR/>3) 24-HAM-D<BR/>4) MADRS<BR/>5) BDI</P>
<P>Employment status:</P>
<P>1) employed (yes or no)<BR/>Work functioning:<BR/>1) SAS work composite</P>
<P>2) LIFE work functioning<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 14:32:04 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Noordik-2013">
<CHAR_METHODS MODIFIED="2014-11-08 14:31:52 +0200" MODIFIED_BY="[Empty name]">
<P>Two-armed cluster randomised trial. Recruitment: Recruitment of workers started in November 2006 and ended in December 2007. Workers eligible according to the OP were invited to participate. Follow up: 12 months. Lost to follow up main outcome: 10.6% for all participants and 11% for depressed subgroup</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 14:32:04 +0200" MODIFIED_BY="[Empty name]">
<P>160 were randomised (T1: 75; T2: 85). Subgroup of depressed workers: 37 (T1: 18; T2:19). Setting: Occupational healthcare. This study was conducted in the Netherlands, where most of the workers on sick leave due to CMD visit an OP. The OP offers RTW interventions to these workers according to the evidence-based (Dutch) guidelines</P>
<P>Inclusion: workers who were on sick leave due to CMD between 2 and 8 weeks. CMD were defined as stress-related, adjustment, anxiety or depressive disorders. Stress-related disorders were classified according to the Dutch guidelines for OP (19). Anxiety, depressive, and adjustment disorders were classified by the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)</P>
<P>Exclusion: workers with a primary somatic disorder according to the OP and those who were not able to speak Dutch</P>
<P>Mean age: T1: 44.9 (SD 9.8); T2: 45.9 (SD 9.8)</P>
<P>Female: T1: 75.7%; T2: 66.7%</P>
<P>Educational level:</P>
<P>Low: T1: 8.7%; T2: 17.9%</P>
<P>Middle: T1: 24.6%; T2: 23.1%</P>
<P>High: 66.7%; T2: 59.0%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 14:30:54 +0200" MODIFIED_BY="[Empty name]">
<P>T1: Exposure based return to work intervention (RTW-E): In the RTW-E program, workers received CAU and were gradually exposed in vivo to more demanding work situations structured by a hierarchy of tasks evoking increasing levels of anxiety, stress, or anger. The RTW-E program provided workers with several homework assignments aimed at preparing, executing, and evaluating an exposure-based RTW plan</P>
<P>T2: Care as usual (CAU): aims to help workers regain control and rebuild social and occupational contacts and activities, according to the OP practice guidelines for CMD. The OP can support this process by using recommended methods such as stress inoculation training, cognitive restructuring, graded activity, and time contingency during the RTW</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 14:30:48 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:</P>
<P>1) the time-to-full RTW, calculated as the number of calendar days from the first day of sick leave to the first day of full RTW. Full RTW was defined as the total number of contracted working hours per week lasting &#8805;28 calendar days without a recurrence of sick leave</P>
<P>Clinical:</P>
<P>1) symptoms of depression, assessed by the Four-Dimensional Symptom Questionnaire (4DSQ)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 14:29:07 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Romeo-2004">
<CHAR_METHODS MODIFIED="2014-11-08 14:29:07 +0200" MODIFIED_BY="[Empty name]">
<P>RCT. multicenter, 2 conditions. Recruitment: from general practitioners' practices. Follow up: 24 weeks. Lost to follow up: T1: 6%; T2: 14%</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 14:28:55 +0200" MODIFIED_BY="[Empty name]">
<P>177 were randomised: (T1:93; T2:84). Setting: primary care, outpatients in Scotland, UK. Inclusion: &gt; 18 years old; Depressive episode according to DSM-IV checklist; 17-HAM-D score &gt; 18 </P>
<P>Exclusion: schizophrenia, Bipolar, suicidal, illicit drug abuse or alcohol dependence; Treatment with any other psychotropic drug within 1 week before entry, or mirtazapine or paroxetine during the present episode, or treatment within 5 weeks before entry with fluoxetine, or any other antidepressant within 2 weeks before entry; renal, hepatic, respiratory, cardiovascular, or cerebrovascular disease; pregnancy or lactating, or no contraception<BR/>Age: T1: 40 (SD 14.3); T2: 40 (SD 11.7)<BR/>Female: T1: 75%; T2: 71%</P>
<P>Fulltime or part-time employed: T1: 48%; T2: 58%<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 14:27:35 +0200" MODIFIED_BY="[Empty name]">
<P>T1: Mirtazapine (TCA): 30 tto 45 mg/day oral<BR/>Week 1 - 4 30 mg/day<BR/>Week 5 - 24: optional increase to 45 mg/day (discretion of the investigator)<BR/>T2: Paroxetine (SSRI): 20-30 mg/day oral<BR/>Week 1 - 4: 20 mg/day<BR/>Week 5 - 26 optional increase to 30 mg/day (discretion of the investigator)<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 14:26:49 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:</P>
<P>1) total mean days lost due to illness in 24 weeks<BR/>Clinical:</P>
<P>1) primary: change from baseline on 17-HAM-D; Secondary: 17-HAM-D responder rates (= at least 50% change from baseline to endpoint); 17 HAM-D remitter rates (= % with score of 8 or less on two assessments after the first score of 8 or less)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-21 08:31:21 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rost-2004">
<CHAR_METHODS MODIFIED="2014-11-21 08:31:21 +0200" MODIFIED_BY="[Empty name]">
<P>RCT, randomisation on the level of practice, 12 practices were randomised. Recruitment: Trained administrative staff recruited patients who made routine-length visits to physicians. They asked eligible (see inclusion) patients to participate in 2 min first stage depression screener. Patients who screened positive and did not meet exclusion criteria were immediately invited to complete 5 min second stage screener. If they screened positive, they were asked to participate in study. Follow up: 24 months. Lost to follow up: 27%</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 14:20:51 +0200" MODIFIED_BY="[Empty name]">
<P>326 employed persons were randomised: (T1: 158; T2: 168). Setting: Community primary care practices across the US.<BR/>Inclusion: Age &gt; 18, sufficient literacy in English and cognitive function to complete surveys requiring 6-months recall, acces to telephone; Positive first screen: 2 weeks or more depressed or loss of interest in past year AND 1 week or more of this in last month; Second screen: 5 or more of 9 criteria for major depression in past 2 weeks on Inventory to diagnose depression.<BR/>Exclusion: pregnant, breastfeeding or &lt;3 months postpartum; Acute life-threatening physical conditions; Pos screeners who reported that symptoms started after loss of a loved one; pos screeners who did not intend to receive ongoing care in the clinic in the next year; Second stage screener: self-report lifetime mania, use of lithium or current alcohol dependence<BR/>Age: T1: 37.9 (SD 10.9); T2: 40.2 (SD 10.3)</P>
<P>Female: T1: 84.2%; T2: 85.7%<BR/>Married: T1: 45%; T2: 51%</P>
<P>Employed: 100%<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 14:20:32 +0200" MODIFIED_BY="[Empty name]">
<P>T1: Enhanced care. Primary care team was trained to provide high quality depression treatment. After enrolment, patients were evaluated for depression by physician and asked to return within one week to nurse care manager. Subsequent visit: education about treatment, addressing treatment barriers, checklist for physician's review, scheduling of next appointment in one week. This continued for 5-7 weeks. Then patients were monitored (symptoms and treatment adherence) for one year. Physicians reviewed patients monthly based on report of nurses to see whether guideline recommendations were followed. Medication algorithm of guideline: initially SSRI or secondary amine tricyclic. Switch drug classes when response failure</P>
<P>T2: Usual Care. Regular Primary physicians care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 14:20:23 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:</P>
<P>1) total number of work hours lost due to illness or doctor visits over past 4 weeks<BR/>Clinical:</P>
<P>1) depression severity: CES-D (adapted)</P>
<P>Productivity:</P>
<P>1) subjective rating on 0 to 10 scale of productivity at work</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 14:25:51 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schene-2006">
<CHAR_METHODS MODIFIED="2014-11-08 14:25:51 +0200" MODIFIED_BY="[Empty name]">
<P>RCT, two conditions; Regular referrals (including from occupational physicians), 48 weeks treatment. Follow up: 42 months. Lost to follow up at 12 months: T1: 13%; T2: 3%; at 42 months: T1: 25%; T2: 20%<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 14:19:07 +0200" MODIFIED_BY="[Empty name]">
<P>62 were randomised (T1:32; T2:30). Setting: outpatient unit of Psychiatric department of Academic hospital. The Netherlands </P>
<P>Inclusion:18 years; MDD (single episode or recurrent); BDI score &gt;15; Work absenteeism due to depression of at least 50% of regular hours worked per week with a duration between 10 weeks and 2 years;Clinically estimated contribution of work to the onset and/or continuation of depression of &gt; 50% of supposed causal factors<BR/>Exclusion: MDD with psychotic features;history of psychosis, manic, hypomanic, or cyclothymic features; history of active drug or alcohol abuse or dependence; personality disorder according to DSM-IV<BR/>Age: T1: 45.2 (SD 7.5); T2: 46.6 (SD 7.4)<BR/>Female: T1: 53%; T2: 50%<BR/>Married: T1: 63%; T2: 53%</P>
<P>Mean hours employment: T1: 36.5 (SD 10.4); T2: 36.4 (SD 7.8)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 14:25:11 +0200" MODIFIED_BY="[Empty name]">
<P>T1: Treatment as usual (TAU) following evidence-based guidelines (APA Guideline);This consisted of clinical management according to APA Guideline and antidepressants, if indicated and accepted by patients, according to our standardized stepwise drug treatment regimen or algorithm. Visits consisted of symptom assessment, psycho-education, general support and cognitive behavioral techniques, and if indicated medication prescription, dose titration and review of adverse effects. In case of any clinical significant deterioration in condition patients could be referred for partial or full-time hospitalisation within the Program. Patients were treated by three supervised senior psychiatric residents. Visits regularly took 30 minutes every 2 to 4 weeks<BR/>T2: Treatment as usual + occupational therapy (TAU + OT) TAU plus occupational therapy (OT): same outpatient treatment; OT: diagnostic phase (4 weeks): occupational history, video observation in a role-played work situation, contact with occupational physician of patient's employer and written conclusions including a plan for work reintegration<BR/>therapeutic phase (24 weeks): this phase had three sub-phases: preparation of work reintegration, contacting the working place and if possible starting to work. In the individual sessions these three phases were followed: further analyses of the relationship between work and depression, exploration of work problems, and support and evaluation of work resume. Specific individual issues from the group sessions were elaborated. The first half of these two-hour group sessions were spend on discussing and exchanging individual progress. In the second half seven themes were successively discussed: being passive, stress on the work place, personal bounds and limits, powerful and powerless, perfectionism, conflicts and prevention. Patients were treated by three supervised senior psychiatric residents. + two occupational therapists<BR/>diagnostic phase (4 weeks): 5 visits<BR/>therapeutic phase (24 weeks): 24 weekly group sessions (8-10 patients) and 12 individual sessions (45 minutes)<BR/>follow-up phase (20 weeks): 3 individual visits</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 14:23:48 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:<BR/>1) total number of hours worked during 6-month periods up to 42nd month (primary outcome)<BR/>2) proportion of patients working at least 1 hour per week<BR/>3) proportion of patients working at least 16 hours per week<BR/>4) time from T1 to partial or full return to work<BR/>Clinical:<BR/>1) % meeting DSM IV criteria at 6/42 months<BR/>2) change in BDI at 6/42 months<BR/>1) depression according to DSM-IV at 12 months<BR/>2) change in BDI-score (baseline-12 months)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 14:22:18 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schoenbaum-2001">
<CHAR_METHODS MODIFIED="2014-11-08 14:16:58 +0200" MODIFIED_BY="[Empty name]">
<P>RCT with randomisation on the level of clinic. Clinic clusters were matched based on patient demographics, clinician specialty, and distance to mental health providers. Recruitment: study staff screened consecutive patient visitors. Follow up: 24 months. Lost to follow-up: T1: 15%; T2: 13%</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 14:17:10 +0200" MODIFIED_BY="[Empty name]">
<P>1356 were randomised (T1:913; T2: 443). Setting: 46 Primary care clinics in 6 community-based managed care organisations in the US<BR/>Inclusion: depressed, intend to use clinic for next 12 months; Probable depressive disorder:at least 2-weeks depressed mood or loss of interest in last year or persistent over year + at least 1 week depression in last 30 days<BR/>Exclusion: &lt; 18 years, acute medical emergency, did not speak English or Spanish, no insurance or public pay arrangement that covered care delivered by mental health specialists<BR/>Age: T1: 44.5 (SD15.5); T2: 42.2 (SD 13.9)<BR/>Female: T1: 74%; T2: 69%<BR/>Married: T1: 54%; T2: 55%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 14:16:30 +0200" MODIFIED_BY="[Empty name]">
<P>T1: Quality improvement program (QI meds or QI therapy). Treatment type or content<BR/>Quality improvement (QI) program: practices were provided with training and resources to initiate and monitor QI programs according to local practice goals and resources. For both interventions (QI-meds and QI therapy): local practice teams were trained in a 2-day workshop to provide clinician education and to supervise intervention staff. Practice nurses were trained as depression specialists, following a written protocol, to assist in initial patient assessment, education and motivation for treatment. Practice teams were given patient education pamphlets and videotapes, patient tracking forms, and clinician manuals and pocket reminder cards and were encouraged to distribute them. The materials described guideline-concordant care and described antidepressant medication and psychotherapy as equally effective. In both conditions resources were made available to obtain specific form of therapy (medication or psychotherapy)<BR/>For QI-meds: nurse specialists were trained to support medication adherence through monthly telephone contacts or visits for 6 or 12 months, randomised at patient level<BR/>In QI-therapy: practice therapists were trained to provide individual and group CBT, following a protocol<BR/>T2: Usual care: mailing of practice guidelines to primary care professionals<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 14:22:18 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:</P>
<P>1) days worked during 24 months follow-up for whole sample<BR/>2) number of reported sick days for employed subsample in previous 4 weeks at each 6 months period<BR/>Clinical:</P>
<P>1) CES-D</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 14:14:38 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Simon-1998">
<CHAR_METHODS MODIFIED="2014-11-08 14:13:45 +0200" MODIFIED_BY="[Empty name]">
<P>RCT (consisting of 2 substudies) with two conditions. Recruitment: participating primary care physicians were asked to refer any adult outpatient initiating care for depression and willing to consider treatment with antidepressant medication. The research assistant screened for eligibility<BR/>Follow up: 7 months. Lost to follow up: substudy 1: 15%; substudy 2: 23%</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 14:14:38 +0200" MODIFIED_BY="[Empty name]">
<P>156 patients with MDD were randomised (T1: 80; T2: 76). Setting: Large primary care clinic in managed care setting in US<BR/>Inclusion: diagnosis definite or probable major depression by primary care physician; Agreed to antidepressant medication; SCL-score of at least 0.75; Age 18 to 80 yrs<BR/>Exclusion: current alcohol abuse (score at least 2 CAGE questionnaire); current psychotic symptoms or serious suicidal ideation or plan; dementia; pregnancy; terminal illness; limited; command of English; plan to disenrol from insurance plan within 12 months<BR/>Age: substudy1: T1: 43.2 (SD 15.4); T2: 42.3 (SD 12.7); substudy2: T1: 43.1 (SD 9.3); T2: 44.8 (SD 15.9)<BR/>Female: substudy1: T1: 78%; T2: 88%; substudy: 77%; T2: 74%<BR/>Married or cohabiting: substudy1: T1: 47%; T2: 55%; substudy2: T1: 48%; T2: 32%<BR/>Employed: substudy 1: T1: 71%; T2: 63% substudy 2: T1: 87%; T2: 74%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 14:13:13 +0200" MODIFIED_BY="[Empty name]">
<P>T1: Multifaceted intervention. Goal: increase likelihood that treatment would be conform primary care depression guidelines</P>
<P>Components:<BR/>(1) written and videotaped patient education material (2) increased frequency of follow-up visits during first 8 weeks (3) advice to physicians regarding changes in pharmacotherapy (4) monitoring of medication side-effects, medication adherence, treatment response and follow-up visits frequency by study staff to treating physician<BR/>substudy1, psychiatrist-liaison collaborative intervention:<BR/>(a) co-management by consulting psychiatrist and physicians during first 6 weeks of treatment, (b) 1 week after start treatment all patients attended an extended structured visit with physician to review symptoms, barriers to adherence, side-effects, and goals for behavioural activation. (c) after 2 weeks: consultation with study psychiatrist discussing treatment response and medication (adjustment if needed), (d) week 3 physician visit, (e) week 4 psychiatrist visit (f) monthly case conferences between psychiatrist and physician<BR/>substudy 2, psychologist-liaison collaborative intervention:<BR/>Standardised brief psychotherapy program. Face-to-face psychiatric consultation on as-needed basis. Components psychotherapy: (a) education, skills training, and written homework (b) interventions to enhance medication adherence (c) behavioural activation and (d) brief cognitive interventions. Weekly meetings between therapists and study psychiatrists. Study clinicians communicated with physicians throughout study about progress and changes in medication<BR/>psychotherapy: 4-6 visits over 6 weeks (total time 2,5 to 3,5 hour) Telephone contacts at 2, 4, 12 and 24 weeks after last face-to-face session<BR/>T2: Usual primary care. Could include any service normally available including pharmacotherapy, referral to mental health service or self-referral to non-GHC services<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 14:10:17 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:<BR/>1) % unable to work due to illness<BR/>2) n of days of missed work or school out of last 90 for employed subsample<BR/>Clinical:</P>
<P>1) proportion of patients with MDD who experienced at least 50% reduction in depressive symptoms on IDS<BR/>2) SCL for employed subsample<BR/>3) IDS for employed subsample<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-11-08 14:10:02 +0200" MODIFIED_BY="[Empty name]">
<P>Data are provided for subgroup of MDD only, both substudies combined</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 14:09:16 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vlasveld-2013">
<CHAR_METHODS MODIFIED="2014-11-08 14:01:41 +0200" MODIFIED_BY="[Empty name]">
<P>RCT. Recruitment: 22 months. Follow up: 12 months. Lost to follow up: 41.3%</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 14:09:16 +0200" MODIFIED_BY="[Empty name]">
<P>126 were randomised (T1:65; T2:61); Setting: the study was carried out within a large occupational health service in the Netherlands</P>
<P>Inclusion: workers on sickness absence between 4 and 12 weeks, whose absence was diagnosed by occupational physicians (OPs) as due to mental disorder, who screened positively for depressive disorder (i.e. score &#8805; 10 on 9-item 0 to 27 depression subscale of Patient Health Questionnaire), who have informed consent and who met the DSM-IV criteria for MDD and gave written informed consent</P>
<P>Exclusion: workers who were suicidal, psychotic or had a primary diagnosis of substance abuse or dependence, as assessed by the MINI<BR/>Age: T1: 43.4 (SD 11.4); T2: 41.9 (SD 11.4)</P>
<P>Male: T1: 45.9%; T2: 46.2%</P>
<P>Marital status: T1: 73.3% married or cohabiting; T2: 60.0% married or cohabiting</P>
<P>Educational level: T1: 35.0% high; T2: 36.1% high; T1 30.0% average; T2: 36.0% average; T1: 35.0% low; T2: 27.9% low</P>
<P>Dutch nationality: T1: 91.8%; T2: 95.4%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 14:08:55 +0200" MODIFIED_BY="[Empty name]">
<P>T1: Collaborative care intervention. Provided by the Occupational Physician Care Manager (OP-CM), contained the following elements: 6 to 12 sessions of Problem Solving Therapy, manual-guided self-help, a workplace intervention and, depending on patient preference, prescription of antidepressant medication according to a treatment algorithm. In order to enhance the adherence to the treatment model, ongoing supervision and psychiatric consultation was provided to the OP-CMs. Also, a web-based tracking system was developed to support the OP-CM in monitoring treatment outcomes and in adhering to the stepped care protocol. In case of questions regarding the treatment, prescription of antidepressants, or (lack of) progress of the worker, the OP-CM was prompted by the web-based tracking system to consult the psychiatrist</P>
<P>T2: Usual care. Sick-listed workers start to visit the company's OP before the 6th week of sickness absence. The guidance of company's OP is protocolised according to the OP guidelines of the Dutch Board for Occupational Medicine. In practice, whether or not sick-listed workers will receive treatment for MDD may vary considerable. The actual care that was provided was assessed by questionnaires in both groups</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 14:08:31 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:</P>
<P>1) the duration until lasting, full RTW. The duration until lasting, full RTW was defined as the duration of sickness absence due to MDD in calendar days, from the day of randomisation until full RTW for at least 4 weeks without partial or full recurrence</P>
<P>2) the total number of sickness absence days, calculated for the entire follow up</P>
<P>Clinical:</P>
<P>1) severity of depression, assessed by the PHQ-9</P>
<P>2) time to first response on depressive symptoms. Response is defined as a reduction in depressive symptoms of at least 50%</P>
<P>3) time to first remission, defined as a score of less than 5 on the PHQ-9</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 14:07:07 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wade-2008">
<CHAR_METHODS MODIFIED="2014-11-08 06:50:49 +0200" MODIFIED_BY="[Empty name]">
<P>A double-blind, multinational randomised study. Recruitment: outpatients with MDD were recruited in psychiatric and general practice settings, from September 2005 to September 2006. Follow up: 24 weeks. Lost to follow up: 23% (clinical outcome) and 24.4% (sick leave)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 14:07:07 +0200" MODIFIED_BY="[Empty name]">
<P>295 were randomised (T1: 144; T2: 151). Setting: outpatients of 35 centra of psychiatric and general practice settings. Inclusion: patients with MDD (current episode assessed with the MINI), according to the DSM IV-TR criteria, outpatient of either sex, aged 18-65 years, with a MADRS total score &#8805; 26 and a CGI-S score &#8805; 4 at baseline visit. Patients with a secondary current comorbid anxiety disorder (DSM-IV TR criteria) could be included in the study, expect for obsessive-compulsive disorder, post-traumatic stress disorder, or panic disorder. Exclusion: if they met one or more of the DSM IV-TR criteria for any of the following: bipolar disorder, psychotic disorder or features, current eating disorders (anorexia nervosa, bulimia), mental retardation, any pervasive developmental disorder or cognitive disorder, or alcohol or drug abuse-related disorders within 12 months prior to baseline. In addition, patients at serious suicide risk, based on the investigator's clinical judgement, or who had a score of &#8805; 5 on item 10 of the MADRS scale, were also excluded, as were those receiving formal behavioural therapy, or systematic psychotherapy, or were pregnant or breast feeding, or had a history of lactose intolerance. Patients with a history of hypersensitivity or non-response to citalopram, or escitalopram, or duloxetine, or with increased intra-ocular pressure, or at risk of acute narrow-angle glaucoma, were also excluded. Patients were also excluded if they were taking the following psychotropic drugs within 2 weeks prior to baseline or during the study: MAOI or RIMA, SSRI (fluoxetine within 5 weeks), SNRIs, and tricyclic antidepressants, tryptophan, psychoactive herbal remedies, any drug used for augmentation of antidepressant action or any other antidepressant drugs, oral antipsychotic and anti-manic drugs (including lithium), or ECT (within 6 months), dopamine antagonists, any anxiolytics (including benzodiazepines), any anticonvulsant drug, serotonergic agonists, narcotic analgesics, cardiac glycosides, type 1c anti-arrhythmics, oral anticoagulants, cimetidine, potent inhibitors of CYP2C19, CYP1A2, or medicinal products with a narrow therapeutic index predominantly metabolised by CYP2D6.</P>
<P>Female:</P>
<P>T1: 73.8%; T2: 71.2%</P>
<P>Age:</P>
<P>T1: 43.3 (SD 11.6); T2: 44.5 (SD 11.0)</P>
<P>Marital status:</P>
<P>T1: 27.0% single; T2: 20.5% single</P>
<P>T1: 50.4% married or living as a couple; T2: 50.7% married or living as a couple</P>
<P>T1: 17.7% divorced or separated; T2: 25.3% divorced or separated</P>
<P>T1: 5.0% widowed; T2: 3.4% widowed</P>
<P>Level of education:</P>
<P>T1: 5.0% no degree or diploma; T2: 4.1% no degree or diploma</P>
<P>T1: 29.1% elementary school; T2: 26.0% elementary school</P>
<P>T1: 43.3% high school; T2: 45.2% high school</P>
<P>T1: 11.3% non-university degree; T2: 15.1% non university degree</P>
<P>T1: 11.3% university; T2: 9.6% university</P>
<P>Employment status:</P>
<P>T1: 58.9% paid employment or self-employed; T2: 60.3% paid employment or self-employed</P>
<P>T1: 15.6% unemployed; T2: 18.5% unemployed</P>
<P>T1: 5.0% student; T2: 4.8% student</P>
<P>T1: 6.4% non-working spouse; T2: 3.4% non-working spouse</P>
<P>T1: 7.8% retired; T2: 10.3% retired</P>
<P>T1: 6.4% other; T2: 2.7% other</P>
<P>Occupational status:</P>
<P>T1: 34.8% no data available; T2: 36.3% no data available</P>
<P>T1: 6.5% manager or administrator; T2: 12.9% manager or administrator</P>
<P>T1: 16.3% professional; T2: 15.1% professional</P>
<P>T1: 10.9% associate professional; T2: 10.8% associate professional</P>
<P>T1: 8.7% clerical worker/secretary; T2: 10.8% clerical worker/secretary</P>
<P>T1: 26.1% skilled labourer or factory worker; T2: 17.2% skilled labourer or factory worker</P>
<P>T1: 27.2% services/sales (retail); T2: 24.7% services/sales</P>
<P>T1: 4.3% other; T2: 8.6% other</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 06:49:20 +0200" MODIFIED_BY="[Empty name]">
<P>T1: escitalopram (SSRI), 10 mg/day for the first 2 weeks, and 20 mg/day for the rest of the period</P>
<P>T2: duloxetine (SNRI), 60 mg/day for the 24 weeks, in accordance with the recommendations in the package insert for duloxetine in the participating countries</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 06:48:58 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:</P>
<P>1) percentage of patients taking sick leave</P>
<P>2) mean per patient sick leave duration in days</P>
<P>Clinical:</P>
<P>1) adjusted mean change in the MADRS total score</P>
<P>2) MADRS total score</P>
<P>3) HAMD-17</P>
<P>4) remission, defined as MADRS &#8804; 12 or post hoc as HAMD-17 &#8804; 7)</P>
<P>5) response, defined as &#8805;50% decrease from baseline in MADRS or (post hoc) HAMD total score</P>
<P>Work functioning:</P>
<P>1) impairment, assessed by the Sheehan Disability Scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-08 06:47:41 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2007">
<CHAR_METHODS MODIFIED="2014-11-08 06:47:41 +0200" MODIFIED_BY="[Empty name]">
<P>RCT. Recruitment: occurred between January 2004 and February 2005 using a 2-phase procedure. Follow up: 12 months. Lost to follow up: 12.3%</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 06:47:37 +0200" MODIFIED_BY="[Empty name]">
<P>604 were randomised (T1:304; T2:300); Setting: Participants included 604 depressed workers 18 years and older and enrolled in United Behavioural Health (UBH), a large managed behavioral health care company; Inclusion: Respondents with at least moderate depression (phase 1: K-6 &#8805; 9; Phase 2: QIDS-SR &#8805; 8); Exclusion: employees with lifetime bipolar disorder, substance disorder, recent mental health specialty care or suicidally<BR/>Age: T1: 40.7 (SD 10.5); T2: 42.4 (SD 10.8)</P>
<P>Female: T1: 70.7 %; T2: 77.0%%</P>
<P>College graduates: T1: 38.0%; T2: 43.8% (24.6%)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 06:47:24 +0200" MODIFIED_BY="[Empty name]">
<P>T1: The structured telephone intervention: telephone outreach and care management program. Systematically assessed needs for treatment, facilitated entry into in-person treatment (both psychotherapy and antidepressant medication), monitored and supported treatment adherence, and (for those declining in-person treatment) provided a structured psychotherapy intervention by telephone. Intervention participants declining in-person treatment and experiencing significant depressive symptoms after 2 months were offered a structured 8-session cognitive behavioural psychotherapy program</P>
<P>T2: Usual care. Patients were advised to consult a clinician and could receive any normally available insurance benefit or service (eg, psychotherapy or pharmacotherapy), just not the additional telephone care management components provided to those in the intervention group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 06:47:13 +0200" MODIFIED_BY="[Empty name]">
<P>Absenteeism:</P>
<P>1) actual weekly hours worked among the employed, assessed by Health and Productivity Questionnaire (HPQ), a validated self-report instrument</P>
<P>Clinical:</P>
<P>1) depression severity, assessed by QIDS-SR</P>
<P>Functioning:</P>
<P>1) on-the-job performance, assessed by HPQ</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>BDI = Back Depression Inventory</P>
<P>CAGE = The name of which is an acronym of its four questions, is a widely used method of screening for alcoholism</P>
<P>CAU = Care as usual</P>
<P>CES-D = Center for Epidemiologic Studies Depression scale</P>
<P>CMD = Common mental disorders</P>
<P>CMHN = Community Mental Health Nursing</P>
<P>CIS-R = Clinical Interview Schedule-Revised</P>
<P>CTU = Copenhagen Trial Unit</P>
<P>DSM-IV = Diagnostic and Statistical Manual of Mental Disorders</P>
<P>4DSQ = Four-Dimensional Symptom Questionnaire</P>
<P>EAP = Employee Assistance Programme</P>
<P>ECT = Electroconvulsive therapy</P>
<P>FDA = Food and Drug Administration</P>
<P>GAS = Global Assessment Scale</P>
<P>GCI = Clinical Global Impression Scale</P>
<P>GEE = Generalized Estimating Equation</P>
<P>GP = General practitioner</P>
<P>GHQ-12 = General Health Questionnaire</P>
<P>HADS(-D)= Hospital Anxiety en Depression Scale</P>
<P>HAMD-D(17) = Hamilton Rating Scale for Depression</P>
<P>HDRS = Hamilton Rating Scale for Depression</P>
<P>HPQ = Health and Work Performance Questionnaire</P>
<P>HRSD = Hamilton Rating Scale for Depression</P>
<P>ICD-10 = International Statistical Classification of Diseases and Related Health Problems</P>
<P>IDS = Inventory of Depressive Symptomatology</P>
<P>LOCF = Last Observation Carrierd Forward</P>
<P>MADRS = Montgomery-Asberg Depression Scale</P>
<P>MAO = Monoamine oxidase</P>
<P>MAOI = Monoamine oxidase inhibitor</P>
<P>MINI = Mini International Neuropsychiatric Interview</P>
<P>MOS-SF 36 = Medical Outcomes Study 36-Item Short Form Health Survey</P>
<P>MDD = Major depressive disorder</P>
<P>OP = Occupational Physician</P>
<P>OT = Occupational therapy</P>
<P>PHQ = Patient Health Questionnaire</P>
<P>PST = Problem Solving Therapy</P>
<P>QI = Quality improvement</P>
<P>QIDS-SR = Quick Inventory of Depressive Symptomatology-Self Report</P>
<P>RCT = Randomized controlled trial</P>
<P>RIMA = Reversible inhibitors of monoamine oxidase A</P>
<P>RTW = Return to work</P>
<P>RTW-E = Exposure based return to work program</P>
<P>SAS = Social Adjustment Scale</P>
<P>SCL = Symptom Checklist Score</P>
<P>SNRI = Selective Serotonin and Noradrenalin Reuptake Inhibitor</P>
<P>SSRI = Delective serotonin reuptake inhibitor</P>
<P>TAU = Treatment as usual</P>
<P>TCA = Tricyclic antidepressant</P>
<P>WLQ = Work Limitations Questionnaire</P>
<P>WHI = Work and Health Initiative</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2014-11-08 06:42:27 +0200" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:40:01 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Aelfers-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:40:01 +0200" MODIFIED_BY="[Empty name]">
<P>Participants are people with a mild to moderate depression</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:40:04 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ahola-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:40:04 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:40:07 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Alexopoulos">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:40:07 +0200" MODIFIED_BY="[Empty name]">
<P>No worker population and sickness absence not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:40:10 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Amore-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:40:10 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:40:18 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bakker-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:40:18 +0200" MODIFIED_BY="[Empty name]">
<P>Patients suffered from mental health problems, less than 50% of these are patients with a depressive disorder</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:40:21 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barbui-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:40:21 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:40:24 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bech-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:40:24 +0200" MODIFIED_BY="[Empty name]">
<P>It is a meta-analysis instead of a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:40:27 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Becker-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:40:27 +0200" MODIFIED_BY="[Empty name]">
<P>Participants were people with severe mental ilness such as schizophrenia</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:40:30 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Blonk-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:40:30 +0200" MODIFIED_BY="[Empty name]">
<P>Patients suffered from psychological complaints, including adjustment disorders. Patients with a major depression were excluded from the study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:40:34 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Boyer-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:40:34 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:40:51 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Brandes-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:40:51 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:40:52 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Brouwers-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:40:52 +0200" MODIFIED_BY="[Empty name]">
<P>It is meta-analysis instead of a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:40:54 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Carlin-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:40:54 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:40:55 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Castillo_x002d_P_x00e9_rez-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:40:55 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:01 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dick-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:01 +0200" MODIFIED_BY="[Empty name]">
<P>This study took place in an inpatient care setting</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:03 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dunlop-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:03 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:04 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Eklund-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:04 +0200" MODIFIED_BY="[Empty name]">
<P>No RCT but a matched-control design was used</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:05 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Erkkil_x00e4_-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:05 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:07 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Finley-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:07 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:13 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Folke-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:13 +0200" MODIFIED_BY="[Empty name]">
<P>This study is done in a sample of unemployed individuals</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:15 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Forman-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:15 +0200" MODIFIED_BY="[Empty name]">
<P>Participants were students</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:17 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Furukawa-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:17 +0200" MODIFIED_BY="[Empty name]">
<P>Participants with mild depression were included in this study; people with a major depressive disorder were excluded</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:18 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gournay-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:18 +0200" MODIFIED_BY="[Empty name]">
<P>Participants suffered from a range of non-psychotic symptoms, data for the depressed subgroup only could not be provided</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:29 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hackett-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:29 +0200" MODIFIED_BY="[Empty name]">
<P>Inclusion criterion in this study was 'clinical diagnosis of chronic muscle contraction headache'</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:35 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hirani-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:35 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:37 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hordern-1964">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:37 +0200" MODIFIED_BY="[Empty name]">
<P>This study took place in a hospital setting</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:38 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Knekt-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:38 +0200" MODIFIED_BY="[Empty name]">
<P>It is quasi-experimental study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:40 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kojima-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:40 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:41 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kroenke-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:41 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:42 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kuhs-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:42 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:49 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lagerveld-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:49 +0200" MODIFIED_BY="[Empty name]">
<P>Major depressive disorder was excluded in this study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:50 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lam-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:50 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:51 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lexis-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:51 +0200" MODIFIED_BY="[Empty name]">
<P>The focus in this study is on relatively mild complaints</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:53 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Martinez-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:53 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:54 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Meyer-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:54 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:41:55 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mino-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:41:55 +0200" MODIFIED_BY="[Empty name]">
<P>Prevention study; subjects were not depressed</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:42:00 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Morgan-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:42:00 +0200" MODIFIED_BY="[Empty name]">
<P>Participants are people with sub-threshold depression</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:42:01 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mundt-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:42:01 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:42:03 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Oakes-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:42:03 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:42:04 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Salminen-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:42:04 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:42:10 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sandahl-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:42:10 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:42:12 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schmitt-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:42:12 +0200" MODIFIED_BY="[Empty name]">
<P>It is not a RCT but a review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:42:14 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schoenbaum-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:42:14 +0200" MODIFIED_BY="[Empty name]">
<P>This study turned out to be a publication on the same study as Schoenbaum 2001 (which was also included)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:42:16 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Simon-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:42:16 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:42:17 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sir-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:42:17 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:42:23 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stant-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:42:23 +0200" MODIFIED_BY="[Empty name]">
<P>Sickness absence was not measured as outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:42:24 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wells-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:42:24 +0200" MODIFIED_BY="[Empty name]">
<P>This trial is the basis of the economic evaluation of Schoenbaum 2001</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:42:25 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zambori-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:42:25 +0200" MODIFIED_BY="[Empty name]">
<P>Design was CCT instead of RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-11-08 06:42:27 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zeeuw-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-11-08 06:42:27 +0200" MODIFIED_BY="[Empty name]">
<P>This study focuses on employees with minimal symptoms of depression</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2014-02-17 13:48:00 +0200" MODIFIED_BY="Babs J.M.  Faber" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2014-11-21 08:53:34 +0200" MODIFIED_BY="Jani H Ruotsalainen" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2014-11-08 14:51:56 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Beurden-2013">
<CHAR_STUDY_NAME MODIFIED="2014-11-08 14:51:56 +0200" MODIFIED_BY="[Empty name]">
<P>Not yet assessed</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-11-08 14:51:41 +0200" MODIFIED_BY="[Empty name]">
<P>Cluster RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-03 23:55:00 +0300" MODIFIED_BY="[Empty name]">
<P>common mental disorders</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-03 23:55:32 +0300" MODIFIED_BY="[Empty name]">
<P>guideline-based care by occupational physicians</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-03 23:55:40 +0300" MODIFIED_BY="[Empty name]">
<P>Return-to-work</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2014-06-10 17:04:15 +0300" MODIFIED_BY="[Empty name]">
<P>2011</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2014-11-08 06:38:41 +0200" MODIFIED_BY="[Empty name]">
<P>Department of Social and Behavioral Sciences, Tranzo Scientific Center for Care and Welfare, Tilburg University, PO Box 90153, Tilburg, 5000 LE, the Netherlands</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2014-06-03 23:55:22 +0300" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2014-11-08 14:51:49 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Geraedts-2013">
<CHAR_STUDY_NAME MODIFIED="2014-06-04 00:00:39 +0300" MODIFIED_BY="[Empty name]">
<P>Happy@Work </P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-11-08 14:51:49 +0200" MODIFIED_BY="[Empty name]">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-04 00:00:18 +0300" MODIFIED_BY="[Empty name]">
<P>Employees with depressive symptoms</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 06:38:50 +0200" MODIFIED_BY="[Empty name]">
<P>Web-based guided self-help</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-04 00:02:09 +0300" MODIFIED_BY="[Empty name]">
<P>Health and Work Performance Questionnaire</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2014-11-08 14:51:17 +0200" MODIFIED_BY="[Empty name]">
<P>Not yet assessed</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2014-06-04 00:03:14 +0300" MODIFIED_BY="[Empty name]">
<P>a.s.geraedts@vu.nl</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2014-06-04 00:00:25 +0300" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2014-11-08 14:51:13 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Heer-2013">
<CHAR_STUDY_NAME MODIFIED="2014-06-04 00:04:52 +0300" MODIFIED_BY="[Empty name]">
<P>TCC: PAINDIP</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-11-08 14:50:57 +0200" MODIFIED_BY="[Empty name]">
<P>Randomised placebo-controlled multicentre trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-08 14:51:02 +0200" MODIFIED_BY="[Empty name]">
<P>Major depressive disorder (MDD) and (sub)chronic pain</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 14:51:05 +0200" MODIFIED_BY="[Empty name]">
<P>Transmural collaborative care with consultation letter (TCCCL) and duloxetine in collaboration with primary care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-11-08 14:51:08 +0200" MODIFIED_BY="[Empty name]">
<P>Not yet assessed</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2014-11-08 14:51:11 +0200" MODIFIED_BY="[Empty name]">
<P>Not yet assessed</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2014-11-08 14:51:13 +0200" MODIFIED_BY="[Empty name]">
<P>Not yet assessed</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2014-06-04 00:05:33 +0300" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2014-11-21 08:53:34 +0200" MODIFIED_BY="Jani H Ruotsalainen" STUDY_ID="STD-Hellstrom-2013">
<CHAR_STUDY_NAME MODIFIED="2014-11-21 08:53:34 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<P>The effect of IPS-modified, an early intervention for people with mood and anxiety disorders: study protocol for a randomised clinical superiority trial. Trials 2013, 14:442. doi:10.1186/1745-6215-14-442</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-06-04 07:45:51 +0300" MODIFIED_BY="[Empty name]">
<P>Randomized clinical superiority trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-04 07:49:17 +0300" MODIFIED_BY="[Empty name]">
<P>Participants with mood and anxiety disorders recently employed or enrolled in education</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-04 07:47:55 +0300" MODIFIED_BY="[Empty name]">
<P>IPS-modified; an individualised supported employment intervention, aiming at supporting people with recently diagnosed anxiety or affective disorders to obtain and sustain competitive employment through mentor support.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-04 07:47:06 +0300" MODIFIED_BY="[Empty name]">
<P>Competitive employment or education at 24 months</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2014-11-08 14:50:27 +0200" MODIFIED_BY="[Empty name]">
<P>Not yet assessed</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2014-06-04 07:51:13 +0300" MODIFIED_BY="[Empty name]">
<P>lone.hellstroem@regionh.dk</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2014-11-08 15:23:58 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Warmerdam-2007">
<CHAR_STUDY_NAME MODIFIED="2014-11-08 14:50:31 +0200" MODIFIED_BY="[Empty name]">
<P>Not yet assessed</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-11-08 06:39:22 +0200" MODIFIED_BY="[Empty name]">
<P>RCT with three conditions: two treatment conditions and one waiting list control group</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-04 07:57:29 +0300" MODIFIED_BY="[Empty name]">
<P>Subjects with symptoms of depression (&#8805; 16 on the Center for Epidemiological Studies Depression scale) from the general population</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-08 06:39:39 +0200" MODIFIED_BY="[Empty name]">
<P>Two Internet-based treatments for depression, namely cognitive behavioural therapy and problem-solving therapy</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-04 07:57:59 +0300" MODIFIED_BY="[Empty name]">
<P>Absence at work</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2014-11-08 14:50:39 +0200" MODIFIED_BY="[Empty name]">
<P>Not yet assessed</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2014-06-04 08:00:52 +0300" MODIFIED_BY="[Empty name]">
<P>eh.warmerdam@psy.vu.nl</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2014-11-08 15:23:58 +0200" MODIFIED_BY="[Empty name]">
<P>Results at 12 weeks are published: https://ce1ul13jdba-qne8l9ebidp.sec.amc.nl/pmc/articles/PMC2629364/</P>
<P>This did not include the work outcome</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2014-11-08 14:46:34 +0200" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2014-11-08 14:46:34 +0200" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:11:44 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Agosti-1991">
<DESCRIPTION>
<P>Random sequence generation not reported</P>
<P>"Following baseline evaluation, patients were treated with single-blind placebo for 1-2 weeks, those who were still depressed were randomly assigned to 6 weeks of treatment with increasing doses of one of four agents in a double blind design."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-02-18 16:16:59 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Bee-2010">
<DESCRIPTION>
<P>Personal communication: "Yes there was a random component in the sequence generation &#8211; and the sequence was held by an independent trial units."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:23:57 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burnand-2002">
<DESCRIPTION>
<P>Randomisation procedure not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-14 15:54:38 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Fantino-2007">
<DESCRIPTION>
<P>Personal communication: "Allocation was random. This includes random allocation using equal block sizes."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-07 22:33:53 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fernandez-2005">
<DESCRIPTION>
<P>Personal communication with first author: "Patients who met the selection criteria at the baseline visit were assigned to 8 weeks of double-blind treatment according to a computer-generated randomisation list."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-21 16:11:46 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Hees-2013">
<DESCRIPTION>
<P>"Randomization was conducted by an independent research assistant, using software based on a minimization randomization procedure."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-03 14:44:18 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Hollinghurst-2010">
<DESCRIPTION>
<P>"Randomization was by means of a computer-generated code, implemented by an individual who was not involved in the recruitment process, and communicated to the participant within 48 h of the baseline interview."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-07 22:50:02 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kendrick-2005">
<DESCRIPTION>
<P>"The telephone randomisation service at the university of York was contracted."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-14 11:06:32 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Knekt-2013">
<DESCRIPTION>
<P>"Concealed assignment codes were given sequentially to patients in consecutively numbered envelopes."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:46:34 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Krogh-2009">
<DESCRIPTION>
<P>"Randomization was carried out by the CTU using computerized restricted randomization with a block size of 6. The block size and thus the allocation sequence were unknown to the DEMO trial staff." "The strengths of our trial were the centralized randomization, which provided adequate generation of the allocation sequence and adequate allocation concealment"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-04 11:03:52 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Krogh-2012">
<DESCRIPTION>
<P>"The randomization was centralized and carried out by the Copenhagen Trial Unit (CTU) using a computerized randomization sequence with alternating block sizes unknown to the investigators." </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-29 14:53:44 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Lerner-2012">
<DESCRIPTION>
<P>"Employees were allocated by electronic randomization."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-11 16:57:51 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McCrone-2004">
<DESCRIPTION>
<P>"The random allocation schedule was generated at the Institute of Psychiatry. An individual unit of randomization was used."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:32:43 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Miller-1998">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-05-14 22:45:45 +0300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Noordik-2013">
<DESCRIPTION>
<P>"We performed a restricted randomization with blocks of four OPs." After randomization researcher KN informed EN about the allocation of every OP and saved the randomization file." Personal communication: "The randomization followed a schedule generation by randomization software."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:26:35 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Romeo-2004">
<DESCRIPTION>
<P>A randomisation list was used that was prepared in advance</P>
<P>"Randomization was performed according to centrally prepared randomization lists."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-09 17:26:55 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="UNKNOWN" STUDY_ID="STD-Rost-2004">
<DESCRIPTION>
<P>"The practices were stratified and matched into six pairs." "Within each pair, one practice was randomized to the 'enhanced' care condition and the other practice delivered usual care to study participants." </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-11 12:12:57 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Schene-2006">
<DESCRIPTION>
<P>"Patients who met the inclusion criteria were randomly assigned to TAU or TAU +OT in blocks of 20 by use of computer-generated cards stored as concealed assignment codes in consecutively number sealed envelopes under the responsibility of an independent research associate."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-11 11:55:10 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Schoenbaum-2001">
<DESCRIPTION>
<P>"Within blocks, we used a random number table to assign clusters to usual care or QI interventions."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-11 11:30:16 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Simon-1998">
<DESCRIPTION>
<P>"Patients were randomly assigned using computer generated random numbers."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-26 12:52:14 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Vlasveld-2013">
<DESCRIPTION>
<P>"The randomization scheme was prepared by a computer, with blocks of four, by an independent statistician."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-05 11:06:50 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Wade-2008">
<DESCRIPTION>
<P>"Patients who met the selection criteria at the baseline visit were assigned to 24 weeks of double-blind treatment in a 1:1 ratio of escitalopram or duloxetine treatment according to a computer-generation randomization list." "At each study centre, sequentially enrolled patients were assigned to the lowest randomization number available in blocks of 4."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-26 16:43:05 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Wang-2007">
<DESCRIPTION>
<P>"Randomization was carried out by the survey research firm conducting eligibility assessments with a computerized procedure that classified respondents for eligibility and used a random number generator to assign participants to intervention or usual care." </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2014-11-08 14:46:32 +0200" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:11:50 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Agosti-1991">
<DESCRIPTION>
<P>Allocation concealment not reported</P>
<P>"Following baseline evaluation, patients were treated with single-blind placebo for 1-2 weeks, those who were still depressed were randomly assigned to 6 weeks of treatment with increasing doses of one of four agents in a double blind design."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:17:25 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bee-2010">
<DESCRIPTION>
<P>"Randomization was conducted centrally by an independent service, with minimization on age, gender and illness severity". "[...] internal validity was heightened trough allocation concealment via central randomization [ .. ]"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:24:04 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burnand-2002">
<DESCRIPTION>
<P>Randomisation procedure not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-21 16:08:29 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Fantino-2007">
<DESCRIPTION>
<P>Personal communication: "Allocation was concealed. Investigators allotted patients to a treatment defined by the patient inclusion number. All treatments were prepared and identical, the only difference being the treatment number, corresponding to the allocation table, which was kept by the person who prepared the treatments. The investigators were not aware of the nature of the treatments."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-14 12:04:53 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fernandez-2005">
<DESCRIPTION>
<P>Personal communication with first author: "The details of the randomisation series were unknown to any of the investigators and were contained in a set of sealed opaque envelopes."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-21 17:04:07 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Hees-2013">
<DESCRIPTION>
<P>"Randomization was conducted by an independent research assistant, using software based on a minimization randomization procedure."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-03 14:45:25 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Hollinghurst-2010">
<DESCRIPTION>
<P>"Randomization was by means of a computer-generated code, implemented by an individual who was not involved in the recruitment process, and communicated to the participant within 48 h of the baseline interview." "The allocation was concealed in advance from participants, researchers involved in recruitment, and therapists."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-07 22:48:52 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kendrick-2005">
<DESCRIPTION>
<P>"Remote central randomisation was provided by telephone"</P>
<P>"Randomisation sequences were in block sizes of either three or six, to prevent practitioners from guessing to which arm the next referral would be."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-14 11:06:59 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Knekt-2013">
<DESCRIPTION>
<P>"The patients who fulfilled the selection criteria at baseline were randomized into solution-focused therapy, short-term psychodynamic psychotherapy or long-term psychodynamic psychotherapy or long-term psychodynamic psychotherapy in a 1:1:1.3 ratio using a central computerized randomization schedule. Concealed assignment codes were given sequentially to patients in consecutively numbered envelopes."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:46:32 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Krogh-2009">
<DESCRIPTION>
<P>"Randomization was centralized and stratified according to medicine status." "The strengths of our trial were the centralized randomization, which provided adequate generation of the allocation sequence and adequate allocation concealment"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-09 10:34:45 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Krogh-2012">
<DESCRIPTION>
<P>"The randomization was centralized and carried out by the Copenhagen Trial Unit (CTU) using a computerized randomization sequence with alternating block sizes unknown to the investigators."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:40:38 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lerner-2012">
<DESCRIPTION>
<P>Web-based randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-14 12:06:37 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McCrone-2004">
<DESCRIPTION>
<P>"Random allocation schedule was generated at the Institute of Psychiatry, before the study commenced and away from GP practices. Cards in sealed and numbered envelopes were used. Only to be opened by practice nurse who ran study. Integrity was checked by the first author on her regular visits to the practices."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:32:41 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Miller-1998">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:30:19 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Noordik-2013">
<DESCRIPTION>
<P>"The validity of the results of this study may have been limited due to a selection bias because of the absence of allocation for each OP. As a result, the potential for the selective inclusion of workers was rather high." "However, we could not prevent some OP from including zero workers, which could have introduced selection bias."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-08 15:20:23 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Romeo-2004">
<DESCRIPTION>
<P>"Randomization was performed according to centrally prepared randomization lists." Personal communication: "The person assessing eligibility for inclusion was blind to allocation concealment."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-09 17:20:46 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="NO" STUDY_ID="STD-Rost-2004">
<DESCRIPTION>
<P>Personal communication: "The allocation of the practice was known to the administrative staff who screened patients."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-11 12:13:08 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Schene-2006">
<DESCRIPTION>
<P>"Patients who met the inclusion criteria were them randomly assigned to TAU or TAU +OT in blocks of 20 by use of computer-generated cards stored as concealed assignment codes in consecutively number sealed envelopes under the responsibility of an independent research associate."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:15:17 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schoenbaum-2001">
<DESCRIPTION>
<P>Randomisation was on the level of practice and primary care clinicians were not blinded for allocation during enrolment of patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-09 15:04:24 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Simon-1998">
<DESCRIPTION>
<P>Personal communication: "The primary care physicians or the research assistant did not know anything about the randomization status of the next patient. Randomization was performed 1-7 days after the baseline assessment by the study manager." </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-26 12:54:17 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Vlasveld-2013">
<DESCRIPTION>
<P>"While assessing eligibility for the study, both the research assistant and the participant were blinded for the allocation."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-05 11:01:07 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Wade-2008">
<DESCRIPTION>
<P>"The details of the randomization series were unknown to any of the investigators and were contained in a set of sealed opaque envelopes."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-26 16:45:22 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Wang-2007">
<DESCRIPTION>
<P>"Patient treatment allocation was concealed."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2013-10-18 08:43:05 +0300" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2014-11-08 14:46:30 +0200" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.02" NO="2">
<NAME>Sick Leave</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-11-08 13:11:54 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Agosti-1991">
<DESCRIPTION>
<P>A double blind design was used</P>
<P>"Following baseline evaluation, patients were treated with single-blind placebo for 1-2 weeks, those who were still depressed were randomly assigned to 6 weeks of treatment with increasing doses of one of four agents in a double blind design."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-11-08 13:17:27 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bee-2010">
<DESCRIPTION>
<P>Due to the nature of the intervention, the participants could not be blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-11-08 13:24:07 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Burnand-2002">
<DESCRIPTION>
<P>No blinding but risk of performance bias low as both treatments can be considered equally desirable for patients</P>
<P>"Both treatments involved the same clomipramine protocol and intensive nursing in a specialized milieu. In addition, the amount of structured psychodynamic psychotherapy provided during combined treatment was comparable to the amount of supportive care provided during treatment with clomipramine alone."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-01-21 16:10:38 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Fantino-2007">
<DESCRIPTION>
<P>Trial is double-blind: "Those meeting the eligibility criteria were randomly assigned to receive double-blind, fixed doses of either escitalopram 20 mg daily or citalopram 40 mg daily during 8 weeks, with equal block randomization at baseline." "All study medications were provided in identical blister packs of identical capsules administered as one capsule per day, regardless of dose or treatment group." Personal communication: "The psychiatrist or GP both included the patient, dispensed the study medication, and did the assessments. Patient and investigator were both blind to the treatment, which were identical in aspect. Since this was not placebo-controlled, both comparators were active and quite similar, differing only be the presence of 20 mg R-citalopram in the 40 mg citalopram.This actually reduces the risk of unblinding by recognizable drug effects or side-effects."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2013-12-10 17:25:47 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fernandez-2005">
<DESCRIPTION>
<P>An economic evaluation was conducted alongside a double-blind,multinational, randomised clinical trial. Personal communication with first author: "This means that both investigator and patient were blinded regarding allocation to treatment."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-11-08 13:43:20 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hees-2013">
<DESCRIPTION>
<P>"Due to the nature of the intervention, neither patients nor therapists could be blinded to the patient's allocation status." Both treatments cannot be considered equally desirable for patients, so risk of performance bias high</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-01-09 17:08:07 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="NO" STUDY_ID="STD-Hollinghurst-2010">
<DESCRIPTION>
<P>Risk of performance bias is considered high as patients were aware of their allocation status and both treatments are not equally desirable for patients: "Randomization was by means of a computer-generated code, implemented by an individual who was not involved in the recruitment process, and communicated to the participant within 48 h of the baseline interview."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-11-08 13:54:16 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kendrick-2005">
<DESCRIPTION>
<P>High risk for the comparison with the GP usual care group (T3) as this treatment cannot be considered equally desirable as T1 and T1 for patients and patients were not blinded. "Table 16: n = 50 received their preferred treatment; n = 114 did not receive their preferred treatment; n = 83 reported no preference"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-11-08 13:59:05 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Knekt-2013">
<DESCRIPTION>
<P>Due to the nature of the intervention, the participants and personnel could not be blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-11-08 14:46:30 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Krogh-2009">
<DESCRIPTION>
<P>"The same 2 physiotherapists were used throughout the trial period. The type and number of exercise interventions were distributed evenly between the two, and thus the physiotherapists were not blinded to allocation". "And the patients were instructed not to reveal their group assignment." "The lack of blinding of treatment allocation for patients and psychotherapists could lead to collateral interventions, possibly confounding our results." As the relaxation condition was not equally desirable to patients as the other two groups, the risk of performance bias is considered high</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-01-09 14:03:43 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="NO" STUDY_ID="STD-Krogh-2012">
<DESCRIPTION>
<P>"Prior to the first training session of the participant, the trial psychotherapist would contact the CTU by phone for participant allocation." "Neither participants nor the physiotherapist conducting the intervention were blinded to the allocation." </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-11-08 14:40:41 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lerner-2012">
<DESCRIPTION>
<P>Participants received information about the RCT and were thus aware of the treatment condition to which they were randomised. Seven counsellors volunteered to conduct the WHI intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2013-11-14 12:06:40 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-McCrone-2004">
<DESCRIPTION>
<P>No blinding, risk of performance bias considered high as the treatment of interest (T1) cannot be considered equally desirable as Treatment as usual (T2) for patients. "Patients randomized to 'Beating the Blues' (T1) also received pharmacotherapy, if prescribed by their GP, and/or general GP support and practical/social help", offered as part of treatment as usual, with the exception of any face-to-face counselling or psychological intervention. We did not constrain the interventions received by patients allocated to treatment as usual (T2)." Moreover, patients in the Treatment as Usual (T2) group were found to attend other health care professionals more often. "Large differences were observed for the proportion of patients attending accident and emergency or outpatient departments, and having contacts with community psychiatric nurses, counsellors and other therapists. Greater use was made by the TAU group for all these services."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-06-05 12:05:58 +0300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Miller-1998">
<DESCRIPTION>
<P>"A novel statistical method was employed for unblinding patients who experienced recurrence or clinically significant worsening of symptoms." "In consultation with FDA personnel, the sponsor's statistician monitored the ability of each investigator to guess the treatment assignment of their patients still in the study. When breaking the blind for any patient, the statistician (R.J.M.) examined the effect of unblinding on our ability to guess the treatment assignment for the remaining patients at that site. If any of these probabilities exceeded 75%, the site agreed to refer all subsequent relapsers to a third party for treatment."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-05-18 15:04:10 +0300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Noordik-2013">
<DESCRIPTION>
<P>Blinding of participants and researchers, but not of personnel was ensured: "The workers were blind to the differences in RTW-E and CAU." "The researchers were blind to the allocation and outcome measurement."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2013-11-08 15:29:03 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Romeo-2004">
<DESCRIPTION>
<P>Double-blind study design. Personal communication: "Medication was dispensed by the GP who was blinded to treatment allocation."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-01-09 14:19:27 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="UNKNOWN" STUDY_ID="STD-Rost-2004">
<DESCRIPTION>
<P>Personal communication: "The allocation of the practice was known to patients eligible to participate. However, these patients did not know that there was another arm of the study that other practices participated in." </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2013-11-14 15:04:08 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="NO" STUDY_ID="STD-Schene-2006">
<DESCRIPTION>
<P>Risk of performance bias considered high as the TAU cannot be considered equally desirable as TAU +OT for patients. Personal communication: "patients and clinical personnel were not blinded."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-11-08 14:15:07 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schoenbaum-2001">
<DESCRIPTION>
<P>Patients and personnel were not blinded: "We asked all primary care clinicians to enrolls prior to their knowledge of intervention status." "Patients learned of their intervention status after enrolment." Personal communication: "Subjects in the interviews were not blinded, but may or may not have known their intervention status given the nature of interventions." Interventions were not equally desirable for patients, so risk of performance bias high</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-11-08 14:09:48 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Simon-1998">
<DESCRIPTION>
<P>Personal communication: "Patient participants and their treating clinicians were not blinded &#8211; and it would not have been possible to do so." Interventions were not equally desirable for patients, so risk of performance bias high</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-01-09 15:14:36 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="NO" STUDY_ID="STD-Vlasveld-2013">
<DESCRIPTION>
<P>Participants were not blinded and both interventions were not equally desirable for them, so risk of performance bias was high. "Then, the participant was informed about the computer generated allocation status by the research assistant. Next, the baseline questionnaire was sent by mail."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2013-12-05 11:01:53 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Wade-2008">
<DESCRIPTION>
<P>"All study personnel and participants were blinded to treatment assignment for the duration of the entire study."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-01-09 15:30:46 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="NO" STUDY_ID="STD-Wang-2007">
<DESCRIPTION>
<P>Participants were not blinded. "Participants were advised not to offer information information to their interviewers regarding their intervention status." Interventions not equally desirable for both groups which entails a high risk of bias. "Respondents were told they might be invited to participate in an innovative treatment program."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2014-11-08 14:46:28 +0200" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>Sick Leave</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.02" NO="2">
<NAME>Depressive symptoms</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-08 13:12:00 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Agosti-1991">
<DESCRIPTION>
<P>Patients reported sick leave in an interview, but were blinded to treatment allocation</P>
<P>"Sick leave was assessed by the LIFE. The LIFE is a semi-structured interview which tracks episodes of psychiatric illness. The portion of the LIFE which we used assessed the psychosocial functioning during the week in five areas; employment..etc. The LIFE was administered to the patient by the treating physician."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-11-08 13:12:03 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Agosti-1991">
<DESCRIPTION>
<P>Depressive symptoms were determined by personnel, were blinded to treatment allocation</P>
<P>"Clinical outcome was determined by the treating psychiatrist on the basis of Clinical Global Improvement."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-08 13:17:31 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bee-2010">
<DESCRIPTION>
<P>The actual working hours were assessed by the participants themselves. As they were aware of the allocation status, risk of detection bias is considered to be high</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-11-08 13:17:33 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bee-2010">
<DESCRIPTION>
<P>Depression is assessed by the HADS, which is a self-reported instrument. As the participants were aware of their allocation status, risk of detection bias is considered to be high</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-08 13:24:13 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Burnand-2002">
<DESCRIPTION>
<P>Outcome assessor for sick leave was blinded, but (non-blinded) patients had to report the number of sick leave days to them</P>
<P>"The psychologists who made the assessments of hospitalizations, number of days of sick leave, and GAS scores were blinded to each patient's treatment assignment."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2013-11-07 22:31:48 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Burnand-2002">
<DESCRIPTION>
<P>"The individuals who rated the presence and severity of major depression and HSRS scores at ten weeks were not blinded to treatment assignment."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-08 13:29:07 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fantino-2007">
<DESCRIPTION>
<P>"A standardized form was used by trained investigators to record healthcare services and days of sick leave for the 2-month pre-study period and for the 8-week study period." Since the investigators were blinded, the risk of bias is considered to be low</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-11-08 13:29:10 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fantino-2007">
<DESCRIPTION>
<P>The MADSR was done by investigators who are trained or confirmed in the proper use of the MADSR scores and who were blinded for the allocation status. The MADSR-S is a self-reported version, but patients were also blinded for treatment allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-12-10 17:26:23 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fernandez-2005">
<DESCRIPTION>
<P>"Data at baseline consisted of self-reported patient questionnaires recording use of healthcare services and days of sick leave ...."</P>
<P>Personal communication with first author: "Patients were blinded regarding allocation to treatment."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2013-12-10 17:26:38 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fernandez-2005">
<DESCRIPTION>
<P>"Depressive symptoms were assessed by trained raters." Personal communication with first author: "Outcome assessors were blinded for the allocation of patients."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-08 13:43:24 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hees-2013">
<DESCRIPTION>
<P>Sickness absence data are measured by the use of self-report. As patients are not blinded for the allocation status, risk of bias is high</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-11-08 13:43:30 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hees-2013">
<DESCRIPTION>
<P>"Study assessment were conducted by a psychiatrist and a researcher who where blind to group allocation." As the HRSD is a clinician-rated instrument, there is a low risk of bias for the HRSD outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-08 13:49:03 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hollinghurst-2010">
<DESCRIPTION>
<P>The number of working days lost because of depression was recorded in a diary by the participants themselves. As participants were aware of their intervention status, risk of bias high</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-11-08 13:49:06 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hollinghurst-2010">
<DESCRIPTION>
<P>The BDI is a self-report inventory. As participants were aware of their intervention status, risk of bias high</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-08 13:54:22 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kendrick-2005">
<DESCRIPTION>
<P>Sick leave was measured by self-report and patients were not blinded to treatment allocation</P>
<P>"Number of days off paid work was captured by a resource-use questionnaire filled out by patients."</P>
<P>"Patients were reminded not to reveal their allocation at the follow-up assessments."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-11-08 13:54:35 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kendrick-2005">
<DESCRIPTION>
<P>Depression symptom score (CIS-R and HADS-D) were measured by self-report and patients were not blinded. "The computerised version of the CIS-R, which is self-complete, was used in this study." "Patients were reminded not to reveal their allocation at the follow-up assessments."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-08 13:59:10 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Knekt-2013">
<DESCRIPTION>
<P>Sick leave was measured by self-report and the patients were not blinded for their allocation status. Outcome is likely to be influenced by this lack of blinding. "The number of sick leave days from work during the past 3 months were collected by single-item questions included in a follow-up questionnaire developed in the project." "Unavoidable weaknesses in a study like this are [...] the lack of blindness of assessments."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-03-18 22:22:44 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Knekt-2013">
<DESCRIPTION>
<P>The BDI is a self-report inventory and patient were not blinded for their allocation status. Outcome is likely to be influenced by this lack of blinding. The HDRS is a clinician-administered scale but clinicians were also not blinded: "raters were not blinded since they were provided with information on the treatment group at the five interview sessions during the 3-year follow up."<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-08 14:46:28 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Krogh-2009">
<DESCRIPTION>
<P>Absenteeism measured by self-report. As patients were aware of their allocation status, risk of bias high</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-11-08 14:46:22 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Krogh-2009">
<DESCRIPTION>
<P>For HAM-D17: "The assessor was blinded to intervention group, and the patients were instructed not to reveal their group assignment. After assessment the assessor was requested to guess which group the patient has been assigned to, making it possible to examine whether the blinding was successful [ .. ] This indicated that the blinding of the assessors was successful"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-08 14:43:29 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Krogh-2012">
<DESCRIPTION>
<P>The outcome assessors were all blinded to participant allocation</P>
<P>"Prior to the follow up interview, participants were instructed not to reveal their allocation to the outcome assessors. The statistical analysis and preparation of the first draft was carried out blinded to group assignment."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-11-08 14:43:33 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Krogh-2012">
<DESCRIPTION>
<P>The outcome assessors were all blinded to participant allocation. The HAM-D17 is a structured interviewer based questionnaire, so risk of bias low (this does not apply to the BDI as this is a self-report instrument)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-08 14:40:43 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lerner-2012">
<DESCRIPTION>
<P>The WLQ Work absence module is a self-report measure. As participants were aware of their allocation status, risk of bias high</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-11-08 14:40:44 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lerner-2012">
<DESCRIPTION>
<P>The PHQ-9 relies on patient self-report. As participants were aware of their allocation status, risk of bias high</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-08 14:36:58 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-McCrone-2004">
<DESCRIPTION>
<P>No blinding of outcome assessors was reported. Sick leave was based on the sick leave certificates of the GP, who was also the treatment provider of treatment as usual. "We recorded the number of days of absence from work during the baseline and follow-up periods on the basis of an issue of a certificate by the general practitioner."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-11-08 14:36:25 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-McCrone-2004">
<DESCRIPTION>
<P>No blinding of patients was reported and depressive symptoms were measured by self-report</P>
<P>"Depressive symptoms were measured with self-report and participants were not blinded to treatment allocation."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-11-14 12:11:24 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Miller-1998">
<DESCRIPTION>
<P>Sick leave was assessed by the LIFE interview. Interviewers were blind to treatment condition. "Finally, it should be noted that while blind to treatment condition, patients and interviewers were not blind to the fact that patients were receiving active medication nor were they blind to the time of assessment (baseline, week 4, endpoint)."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2013-11-14 12:08:52 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Miller-1998">
<DESCRIPTION>
<P>Depressive symptoms were measured with the 24 HAM-D (clinician-rated). Interviewers were blind to treatment condition. "Finally, it should be noted that while blind to treatment condition, patients and interviewers were not blind to the fact that patients were receiving active medication nor were they blind to the time of assessment (baseline, week 4, endpoint)."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-08 14:29:59 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Noordik-2013">
<DESCRIPTION>
<P>Sick leave was assessed by workers' diaries. As workers are blinded to allocation status, risk of detection bias for sick leave is considered to be low</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-11-08 14:29:57 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Noordik-2013">
<DESCRIPTION>
<P>Depression is assessed by the 4DSQ, a self-report questionnaire. As the participants were blinded to allocation status, risk of detection bias for depressive symptoms is considered to be low</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-08 14:26:30 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Romeo-2004">
<DESCRIPTION>
<P>Double-blind study design. Sick leave was assessed by questionnaires filled out by patients, who were blinded to treatment allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2013-11-08 15:36:14 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Romeo-2004">
<DESCRIPTION>
<P>Double-blind study design. Personal communication: "Outcomes were assessed by trained research nurses who were blind to treatment allocation."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-08 14:17:35 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rost-2004">
<DESCRIPTION>
<P>Sick leave was measured by self-report and patients were not blinded to treatment allocation</P>
<P>"We measured absenteeism at baseline, 6, 12, 18, and 24 months by calculating lost work hours from employee reports of how many full workdays and part workdays they missed due to illness or doctor visits, reflecting that employee reports demonstrate high agreement with employer records of absenteeism."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-11-08 14:17:45 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rost-2004">
<DESCRIPTION>
<P>Depression was measured by self-report (CESD-D) and patients were not blinded to treatment allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-08 14:22:40 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schene-2006">
<DESCRIPTION>
<P>Sick leave was measured by self-report and patients were not blinded to treatment allocation</P>
<P>"Work resumption data were assessed by a study-specific questionnaire at T2, T3, T4 and T5."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-11-08 14:22:42 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schene-2006">
<DESCRIPTION>
<P>"Depression was assessed by the BDI, a self-report measure of severity of depressive symptoms." Patients were not blinded to treatment allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-08 14:15:04 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schoenbaum-2001">
<DESCRIPTION>
<P>Sick leave was measured by self-report and patients were not blinded to treatment allocation</P>
<P>"We also examined days missed from work due to illness, which patients reported for the 4 weeks preceding each follow-up study."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2013-11-15 11:39:00 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="NO" STUDY_ID="STD-Schoenbaum-2001">
<DESCRIPTION>
<P>Depression was measured by self-report and patients were not blinded to treatment allocation.</P>
<P>'We assessed depressive symptoms at baseline and follow-up using a 23-item version of the Center of Epidemiologic Studies Depression (CES-D) Scale, developed by Daniel Ford. This version drops 6 items and adds others to approximate DSM-IV criteria. Items responses were summed."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-12-13 12:28:43 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="NO" STUDY_ID="STD-Simon-1998">
<DESCRIPTION>
<P>Sick leave was measured by self-report and patients were not blinded to treatment allocation.</P>
<P>"One of the four assessments included questions adapted from the National Health Interview Survey regarding days of missed work or school due to health."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2013-11-11 11:36:15 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Simon-1998">
<DESCRIPTION>
<P>"Folllow-up telephone interviewers were blinded to treatments assignment." "Two of the assessments included a 20-item depression scale extracted from the Hopkins Symptom Checklist or SCL and a version of the clinician-rated Inventory of Depressive Symptoms or IDS modified for telephone administration."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-01-08 22:39:00 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Vlasveld-2013">
<DESCRIPTION>
<P>Low risk as sickness absence data were based on registration database. "Sickness absence data were derived from the register of the occupational service 1 year after randomization."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-11-08 14:07:51 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Vlasveld-2013">
<DESCRIPTION>
<P>Data about depressive symptoms were collected by a self-report questionnaire and patients were not blinded to treatment allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-08 06:48:04 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wade-2008">
<DESCRIPTION>
<P>Sick leave was assessed by physicians, who are blinded for allocation status</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-11-08 06:48:02 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wade-2008">
<DESCRIPTION>
<P>The MADRS and HAMD-17 are assessed by a doctor, who were blinded for allocation status</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-11-08 06:46:44 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wang-2007">
<DESCRIPTION>
<P>HPQ is a self-report instrument. As patients were aware of their allocation status, risk of bias high</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-11-08 06:46:42 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wang-2007">
<DESCRIPTION>
<P>QID-SR is a self-report instrument. As patients were aware of their allocation status, risk of bias high</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2014-11-08 14:46:16 +0200" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>Depressive symptoms</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.02" NO="2">
<NAME>Sick Leave</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-08 13:12:06 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Agosti-1991">
<DESCRIPTION>
<P>Outcome not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-11-08 13:12:35 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Agosti-1991">
<DESCRIPTION>
<P>Loss to follow up is considered to be high: T1: 28.9%; T2: 30.4%, even though the proportion of incomplete data was comparable in both groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-08 13:18:04 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bee-2010">
<DESCRIPTION>
<P>Personal communication: "For the subgroup of depressed workers, there is no loss to follow up."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-11-08 13:18:08 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bee-2010">
<DESCRIPTION>
<P>Personal communication: "For the subgroup of depressed workers, there is no loss to follow up."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-08 13:25:08 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Burnand-2002">
<DESCRIPTION>
<P>Loss to follow up is high: 22%. Risk of attrition bias due to follow up losses is therefore considered to be high, although multiple analyses were used to study the effect on the findings and the authors conclude otherwise: "Twenty-one patients (12 in the experimental and nine in the control group, or 22 percent) were excluded from the analysis--four who did not return for treatment (three in the experimental group and one in the control group), three who dropped out against medical advice (two in the experimental group and one in the control group), and 14 who were discharged because they had exclusion characteristics that were not detected at entry, including severe alcohol or drug dependence (five in each group) and adverse effects (two in each group). These patients were not significantly different from the other patients in terms of the main outcome variables at intake. The 74 patients who completed the study were not significantly different from the 21 who were withdrawn or from the group of 95 as a whole. To control for intent to treat, the analyses were repeated with all 95 patients who had been randomly assigned to treatment."</P>
<P>"This finding was unchanged when we repeated the analyses and controlled for age, gender, initial severity of depression, GAS score at intake, compliance and intent to treat"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-11-08 13:25:19 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Burnand-2002">
<DESCRIPTION>
<P>Loss to follow up is high: 22%. Risk of attrition bias due to follow up losses is therefore considered to be high, although multiple analyses were used to study the effect on the findings and the authors conclude otherwise: "Twenty-one patients (12 in the experimental and nine in the control group, or 22 percent) were excluded from the analysis--four who did not return for treatment (three in the experimental group and one in the control group), three who dropped out against medical advice (two in the experimental group and one in the control group), and 14 who were discharged because they had exclusion characteristics that were not detected at entry, including severe alcohol or drug dependence (five in each group) and adverse effects (two in each group). These patients were not significantly different from the other patients in terms of the main outcome variables at intake. The 74 patients who completed the study were not significantly different from the 21 who were withdrawn or from the group of 95 as a whole. To control for intent to treat, the analyses were repeated with all 95 patients who had been randomly assigned to treatment."</P>
<P>"This finding was unchanged when we repeated the analyses and controlled for age, gender, initial severity of depression, GAS score at intake, compliance and intent to treat"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-08 13:29:36 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fantino-2007">
<DESCRIPTION>
<P>Loss to follow up is considered to be low. T1: 4.3%; T2: 10.6%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-06-05 12:03:31 +0300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fantino-2007">
<DESCRIPTION>
<P>No missing sick leave data: "Valid resource utilization information corresponding to the pre study and study periods was thus available for 280 patients."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-08 13:34:16 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fernandez-2005">
<DESCRIPTION>
<P>Loss to follow-up depression data is 15%, which we consider high and no appropriate method has been used to account for attrition.</P>
<P>"Efficacy analyses were conducted on the intention-to-treat (ITT) population, which included all randomised patients who took at least<BR/>1 dose of double-blind study medication and who had at least 1 valid post-baseline assessment of the MADRS total score. The ITT<BR/>population thus comprised 146 patients in the escitalopram group and 142 patients in the venlafaxine group. A total of 249 patients (of 293) completed the study."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-01-21 16:22:32 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fernandez-2005">
<DESCRIPTION>
<P>Lost to follow-up sick leave data is 16%, which we consider high and no appropriate method has been used to account for attrition.</P>
<P>"Data at baseline consisted of self-reported patient questionnaires recording use of healthcare services and days of sick leave.</P>
<P>Of the 293 patients in the trial, valid cost information in the 3-month pre-study period was available for 251 patients; for 22 patients in the escitalopram arm and 20 patients in the venlafaxine arm, either the physician or patient did not fill in the resource use questionnaire. Of the 251 evaluable patients, 126 received escitalopram and 125 received venlafaxine. Of these, 245 patients reported valid cost information for the 8-week duration of the trial (four escitalopram and two venlafaxine patients were lost relative to the pre-study period).</P>
<P>"Given the very low rate of attrition in the sample during the trial, patients with missing data were unlikely to represent serious bias to the results of the present analysis. As a result, no attempt was made to impute missing data."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-21 16:23:14 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Hees-2013">
<DESCRIPTION>
<P>Lost to follow up: T1: 15.4%; T2: 12.8% but appropriate imputation methods have been used. "To take potential biased outcomes caused by selective loss to follow up into account, we used multiple imputation (five imputed datasets), which, assuming missing at random for missing values, gives unbiased results with correct SEs." </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2013-11-29 14:16:15 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Hees-2013">
<DESCRIPTION>
<P>Lost to follow up: T1: 15.4%; T2: 12.8% but appropriate imputation methods have been used. "To take potential biased outcomes caused by selective loss to follow up into account, we used multiple imputation (five imputed datasets), which, assuming missing at random for missing values, gives unbiased results with correct SEs."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-08 13:49:13 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hollinghurst-2010">
<DESCRIPTION>
<P>Loss to follow up is high: T1: 27%; T2: 32% even though appropriate method has been used to account for these missing data: "Fourth, a sensitivity analysis investigated the effect of missing data with multiple imputation by chained equation methods in Stata." "Analyses imputing missing values suggested that differences in attrition between the groups did not introduce any noticeable bias."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-11-08 13:49:38 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hollinghurst-2010">
<DESCRIPTION>
<P>Loss to follow up is high: T1: 50%; T2: 55% even though appropriate method has been used to account for this missing data: "we imputed missing observations of cost and QALYs using the multiple imputation by chained equation procedure in Stata release 10." "We acknowledge that more complete data would have been available if we had used questionnaires completed face to face or data from practice records. However, the results of the imputation suggest that any information lost is unlikely to have a major influence on the results or conclusions."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-08 13:55:42 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kendrick-2005">
<DESCRIPTION>
<P>Loss to follow up is considered to be high (26%). Risk of attrition bias due to follow-up losses is therefore considered to be high, although sensitivity analyses were conducted and the authors conclude otherwise; "sensitivity analyses were conducted to see whether the result changed depending on what assumptions were made about the missing data". "Table 12 shows that the main findings are not particularly sensitive to the different assumptions about missing data that were investigated."</P>
<P>It was harder to retain patients in the GP care (thus higher loss to follow up in that group): "Although the overall follow-up rates were good, there was a lower follow-up rate in the GP arm. It is difficult to tell whether this biased the findings in a particular direction. Follow-up rates were better among those patients who received the treatment they preferred, so it is likely that there were more disaffected patients in the GP care arm. However, it is not known whether those who dropped out remained more symptomatic than those who were followed up. Failing to receive their treatment of preference was not associated with a worse outcome on the CIS-R among those who were followed up. The sensitivity analyses suggest that CMHN care, whether generic care or specific PST, is unlikely to be more effective than GP care, unless one believes the LOCF analysis and makes the extreme assumption that all the dropouts remained as symptomatic as they were at the time of last assessment."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-11-08 13:56:24 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kendrick-2005">
<DESCRIPTION>
<P>Loss to follow up for sick leave data is considered to be high (26%). Risk of attrition bias due to follow-up losses is therefore considered to be high, although sensitivity analyses were conducted and the authors conclude otherwise; "cost results from this analysis were validated by substituting where possible data from the GP case notes in place of imputed values for missing data, and repeating the analysis. Overall, the results did not change significantly."</P>
<P>"36% had at least one resource item missing over the 6-month follow up. Therefore, complete resource use data were available for 159 (64%) of the patients. The results presented here are based mainly on the 184 patients for whom complete CIS-R data were available over the 6-month period. To achieve this sample, 25 (14%) of the patients who had CIS-R data but not resource-use information had to be imputed. The results were then compared with those obtained using data from GP notes where available instead of imputation, and those obtained using only the 159 patients with complete resource-use data. After imputing missing values for the 25 patients with missing resource-use data, the numbers of patients included in the economic analysis in each group were as follows: 51 patients in GP care (28%), 62 patients in generic CMHN care (34%) and 71 patients in PS CMHN care (38%)."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-08 13:59:19 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Knekt-2013">
<DESCRIPTION>
<P>Loss to follow up is 19% and missing values were replaced by multiple imputation; this did not alter the results. "Analyses based on multiple imputation and taking into account the need for treatment at the time of dropout did not, however, notably alter the results, suggesting that the results presented are unbiased (data not shown)."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-11-08 13:59:34 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Knekt-2013">
<DESCRIPTION>
<P>Loss to follow up is considered to be high: 39% at one year and 52% at five years</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-08 14:46:08 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Krogh-2009">
<DESCRIPTION>
<P>Loss to follow up at endpoint was high: 22% (36/165) and skewed. Risk of attrition bias was therefore considered high although an appropriate method was used to deal with missing values in the analyses and the authors conclude otherwise</P>
<P>"Analysis of age, sex, HAM-D17, or absence from work during the last 10 working days at entry did not suggest any significant differences between missing participants and participants included in the analysis at either 4 months or 12 months." "It is then plausible to consider the missing data as 'missing at random', making the mixed effect model a plausible approach to estimate the effect, based on the total sample with missing cases included."</P>
<P>"This approach uses data from all included patients (intention-to-treat), handles entry differences, and is able to handle missing data (restricted maximum likelihood procedure) with higher precision and power compared to more traditional methods such as the last observation carried forward." "There was skewed attrition, and the follow-up assessment was significantly later than 4 months in the control group."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-11-08 14:46:16 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Krogh-2009">
<DESCRIPTION>
<P>Loss to follow up at endpoint was high: 22% (36/165) and skewed. Risk of attrition bias was therefore considered high although an appropriate method was used to deal with missing values in the analyses and the authors conclude otherwise.</P>
<P>"Analysis of age, sex, HAM-D17, or absence from work during the last 10 working days at entry did not suggest any significant differences between missing participants and participants included in the analysis at either 4 months or 12 months." "It is then plausible to consider the missing data as 'missing at random', making the mixed effect model a plausible approach to estimate the effect, based on the total sample with missing cases included."</P>
<P>"This approach uses data from all included patients (intention-to-treat), handles entry differences, and is able to handle missing data (restricted maximum likelihood procedure) with higher precision and power compared to more traditional methods such as the last observation carried forward." "There was skewed attrition, and the follow-up assessment was significantly later than 4 months in the control group."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-19 09:59:16 +0300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Krogh-2012">
<DESCRIPTION>
<P>Lost to follow up: T1: 16.1%; T2: 10.2% but appropriate method has been used to account for these missing data: "All continuous outcome measures were analyzed using a repeated measurement linear mixed effect model with an unstructured variance matrix [ .. ] The mixed effects function is able to handle missing continuous data using a likelihood estimation of missing data."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-05-19 09:59:14 +0300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Krogh-2012">
<DESCRIPTION>
<P>Lost to follow up: T1: 16.1%; T2: 10.2% but appropriate method has been used to account for these missing data: " "All continuous outcome measures were analyzed using a repeated measurement linear mixed effect model with an unstructured variance matrix [ .. ] The mixed effects function is able to handle missing continuous data using a likelihood estimation of missing data."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-09 14:11:54 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Lerner-2012">
<DESCRIPTION>
<P>"Five (9.6%) employees in the WHI treatment group and 2 (7.4%) of the usual group did not complete the follow-up questionnaire and were considered dropouts." "Sensitivity analyses including the seven employees that were lost to follow-up confirmed the results." </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-01-09 14:11:55 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Lerner-2012">
<DESCRIPTION>
<P>"Five (9.6%) employees in the WHI treatment group and 2 (7.4%) of the usual group did not complete the follow-up questionnaire and were considered dropouts." "Sensitivity analyses including the seven employees that were lost to follow-up confirmed the results." </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-08 14:36:12 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-McCrone-2004">
<DESCRIPTION>
<P>Loss to follow up was relatively high (&gt; 20%) for the depression outcome</P>
<P>From Figure 2 of the publication on depression outcome (Proudfoot et al 2004): Loss to follow up: T1: 27%; T2: 24%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-11-08 14:35:30 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McCrone-2004">
<DESCRIPTION>
<P>Sick leave data were part of the cost data, and a high percentage of the cost data were complete at follow up. "A total of 274 patients were randomised into two groups (BtB, n = 146; TAU, n = 128), with cost data available for both baseline and follow-up periods for 261 (95%) patients (138 BtB, 123 TAU)."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-08 14:32:26 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Miller-1998">
<DESCRIPTION>
<P>For depressive symptoms, ITT rates of remission could be calculated for 623 (of the 635) patients, which is 98%. "See Figure 1, Keller et al, 1998."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2013-12-13 12:01:31 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Miller-1998">
<DESCRIPTION>
<P>Completeness of sick leave data not reported. "Sample sizes [on psychosocial variables] vary due to sporadic missing data."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-08 14:29:45 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Noordik-2013">
<DESCRIPTION>
<P>Loss to follow-up for depression for the subgroup of depressed workers: 52%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-11-08 14:29:35 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Noordik-2013">
<DESCRIPTION>
<P>Loss to follow up of sick leave data for the subgroup of depressed workers was: 11%. No appropriate method was used to take selective attrition into account</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-08 14:26:26 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Romeo-2004">
<DESCRIPTION>
<P>Lost to follow-up: T1: 6%; T2: 14% and no appropriate imputation methods have been used</P>
<P>"Six excluded mirtazapine patients, four were lost to follow-up, one dropped out early, and one refused participation in the study. Of the 14 excluded paroxetine patients, five were lost to follow-up, four were early drop outs, two did not participate any further, one discontinued due to the lack of efficacy, one was hospitalized as a results of a concomitant disease and one did not fulfil the selection criteria." "The high attrition rate observed in our study should be taken in to account when interpreting efficacy results due to possible influence on overall efficacy results."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-05-19 10:59:49 +0300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Romeo-2004">
<DESCRIPTION>
<P>Lost to follow-up: T1: 6%; T2: 14% and no appropriate imputation methods have been used.</P>
<P>"Six excluded mirtazapine patients, four were lost to follow-up, one dropped out early, and one refused participation in the study. Of the 14 excluded paroxetine patients, five were lost to follow-up, four were early drop outs, two did not participate any further, one discontinued due to the lack of efficacy, one was hospitalized as a results of a concomitant disease and one did not fulfil the selection criteria." "The high attrition rate observed in our study should be taken in to account when interpreting efficacy results due to possible influence on overall efficacy results."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-08 14:19:38 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rost-2004">
<DESCRIPTION>
<P>Loss to follow up at endpoint is considered to be high (27%). Risk of attrition bias was therefore deemed high although analyses accounted sufficiently for missing data according to authors: "Because analysis of missing data patterns produced no evidence of non ignorable missingness, we present unweighted models, noting that weighted models produce closely comparable results."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-11-08 14:17:52 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rost-2004">
<DESCRIPTION>
<P>Loss to follow up at endpoint is considered to be high (27%). Risk of attrition bias was therefore deemed high although although analyses accounted sufficiently for missing data according to authors: "Because analysis of missing data patterns produced no evidence of non ignorable missingness, we present unweighted models, noting that weighted models produce closely comparable results."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-08 14:22:59 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schene-2006">
<DESCRIPTION>
<P>Loss to follow up was high: T1: 25%; T2: 20%. Risk of attrition bias was therefore deemed high even though appropriate imputation methods have been used: "Complete T4 data were obtained on 28 (88%) of TAU patients and on 29 (97%) of TAU +OT patients. For T5 these figures were 24 (75%) for TAU and 24 (80%) for TAU + OT." "Both GEE and Proc Mixed give unbiased effect estimates taking into account missing data."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-11-08 14:23:08 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schene-2006">
<DESCRIPTION>
<P>Loss to follow up was high: T1:25%; T2: 20%. Risk of attrition bias was therefore deemed high even though appropriate imputation methods have been used: "Complete T4 data were obtained on 28 (88%) of TAU patients and on 29 (97%) of TAU +OT patients. For T5 these figures were 24 (75%) for TAU and 24 (80%) for TAU +OT." "Both GEE and Proc Mixed give unbiased effect estimates taking into account missing data."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-19 11:00:33 +0300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schoenbaum-2001">
<DESCRIPTION>
<P>Lost to follow up for the depressive symptoms is 15% but appropriate imputation methods have been used. "The data are weighted for the probability of study enrolment and follow-up response to the characteristics of the eligible sample. We used multiple imputations for missing items at each wave."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-05-19 11:00:31 +0300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schoenbaum-2001">
<DESCRIPTION>
<P>Lost to follow for the economic survey is 15% but appropriate imputation methods have been used. "The data are weighted for the probability of study enrolment and follow-up response to the characteristics of the eligible sample. We used multiple imputations for missing items at each wave."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-08 14:03:12 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Simon-1998">
<DESCRIPTION>
<P>Lost to follow-up is considered to be high: T1: 17%; T2: 21%. Risk of attrition bias was therefore deemed high although appropriate imputation methods have been used: "Model were estimated using generalized estimating equations (GEE) to account for multiple assessments and to allow for missing data"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-11-08 14:03:08 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Simon-1998">
<DESCRIPTION>
<P>Lost to follow-up is considered to be high: T1: 17%; T2: 21%. Risk of attrition bias was therefore deemed high although appropriate imputation methods have been used: "Model were estimated using generalized estimating equations (GEE) to account for multiple assessments and to allow for missing data"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-21 22:41:08 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="NO" STUDY_ID="STD-Vlasveld-2013">
<DESCRIPTION>
<P>Lost to follow up was high. "Lost to follow-up rates at 3,6, 9 and 12 months were respectively 22.2%, 28.6%, 33.3% and 41.3%." Risk of attrition bias was considered high even though an appropriate method has been described to account for this missing data: 'If there is missing data on costs and/or effects, and the additional uncertainty it introduces, multiple imputation will be used."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-11-08 14:03:35 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vlasveld-2013">
<DESCRIPTION>
<P>No missing sickness absence data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-21 22:41:34 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="NO" STUDY_ID="STD-Wade-2008">
<DESCRIPTION>
<P>Lost to follow up is considered to be high (23%). Risk of attrition bias was therefore deemed high and no appropriate method has been used to account for this missing data: "The primary endpoint was the adjusted mean change in MADRS total score from baseline to week 24, based on the intention-to-treat set (ITT), comprising all patients who took at least one valid post-baseline MADRS assessment, and using last-observation-carried-forward (LOCF) analysis."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-01-21 22:41:53 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="NO" STUDY_ID="STD-Wade-2008">
<DESCRIPTION>
<P>Lost to follow up is considered to be high (24.4%) Risk of attrition bias was therefore deemed high and no appropriate method has been used to account for this missing data: "In cases of premature study withdrawal, patients were assigned zero sick leave for missing assessments."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-05-19 11:01:30 +0300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2007">
<DESCRIPTION>
<P>Lost to follow up: T1: 14.5%; T2: 10% but appropriate method has been used to account for missing data: "Multiple imputation was used to adjust for some participants not completing either 6-months (35 intervention and 22 usual care) or 12 month (44 intervention and 30 usual care) interviews." "Intervention effects on depression severity were estimated using multiple imputation linear regression with simulated standard errors."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-01-09 15:34:34 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="YES" STUDY_ID="STD-Wang-2007">
<DESCRIPTION>
<P>Lost to follow up: T1: 14.5%; T2: 10% but appropriate method has been used to account for missing data: "Multiple imputation was used to adjust for some participants not completing either 6-months (35 intervention and 22 usual care) or 12 month (44 intervention and 30 usual care) interviews." "Comparable multiple imputation regression analyses were used to estimate intervention effects on work outcomes.''</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2014-11-08 14:45:53 +0200" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:12:40 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Agosti-1991">
<DESCRIPTION>
<P>No design paper or trial registration could be identified to assess this risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:18:15 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bee-2010">
<DESCRIPTION>
<P>No design paper or trial registration could be identified to assess this risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:25:22 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burnand-2002">
<DESCRIPTION>
<P>No design paper or trial registration could be identified to assess this risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:29:56 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fantino-2007">
<DESCRIPTION>
<P>No design paper or trial registration could be identified to assess this risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:34:46 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fernandez-2005">
<DESCRIPTION>
<P>No design paper or trial registration could be identified to assess this risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:44:12 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hees-2013">
<DESCRIPTION>
<P>The study protocol is available and all of the study&#8217;s pre-specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre-specified way</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:49:58 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hollinghurst-2010">
<DESCRIPTION>
<P>No design paper or trial registration could be identified to assess this risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:56:34 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kendrick-2005">
<DESCRIPTION>
<P>No indication for selective reporting could be identified. However, in the design study, the comparisons of T1 with T2 was not pre-specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:59:35 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Knekt-2013">
<DESCRIPTION>
<P>No design paper or trial registration could be identified to assess this risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:45:53 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Krogh-2009">
<DESCRIPTION>
<P>In the study protocol, no report was made regarding the third treatment group (relaxation)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:43:07 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Krogh-2012">
<DESCRIPTION>
<P>No design paper or trial registration could be identified to assess this risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:40:27 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lerner-2012">
<DESCRIPTION>
<P>No design paper or trial registration could be identified to assess this risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:35:11 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McCrone-2004">
<DESCRIPTION>
<P>No design paper or trial registration could be identified to assess this risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:32:18 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Miller-1998">
<DESCRIPTION>
<P>No indication for selective reporting could be identified. The design was published in a paper by Rush et al, albeit concurrently with the publications on the outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:29:18 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Noordik-2013">
<DESCRIPTION>
<P>Not all (secondary) outcomes measures announced in the design paper were reported in the effect study, of which the data on the HADS-depression subscale</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:26:15 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Romeo-2004">
<DESCRIPTION>
<P>No design paper or trial registration could be identified to assess this risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:18:03 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rost-2004">
<DESCRIPTION>
<P>No design paper or trial registration could be identified to assess this risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:17:22 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schene-2006">
<DESCRIPTION>
<P>No design paper or trial registration could be identified to assess this risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:14:53 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schoenbaum-2001">
<DESCRIPTION>
<P>No design paper or trial registration could be identified to assess this risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:03:06 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Simon-1998">
<DESCRIPTION>
<P>No design paper or trial registration could be identified to assess this risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:03:37 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vlasveld-2013">
<DESCRIPTION>
<P>The study protocol is available and all of the study&#8217;s pre-specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre-specified way</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 06:47:58 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wade-2008">
<DESCRIPTION>
<P>No design paper or trial registration could be identified to assess this risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 06:46:39 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2007">
<DESCRIPTION>
<P>No design paper or trial registration could be identified to assess this risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2014-11-08 14:45:51 +0200" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:12:42 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Agosti-1991">
<DESCRIPTION>
<P>None Identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:18:22 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bee-2010">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:25:23 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burnand-2002">
<DESCRIPTION>
<P>None Identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:29:57 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fantino-2007">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:34:48 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fernandez-2005">
<DESCRIPTION>
<P>None Identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:44:15 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hees-2013">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 13:50:05 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hollinghurst-2010">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-14 13:52:39 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="UNKNOWN" STUDY_ID="STD-Kendrick-2005">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-14 13:52:48 +0200" MODIFIED_BY="Babs J.M.  Faber" RESULT="UNKNOWN" STUDY_ID="STD-Knekt-2013">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:45:51 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Krogh-2009">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:43:05 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Krogh-2012">
<DESCRIPTION>
<P>None reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:40:26 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lerner-2012">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:35:09 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McCrone-2004">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:32:12 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Miller-1998">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:29:14 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Noordik-2013">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:26:13 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Romeo-2004">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:18:04 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rost-2004">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:17:20 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schene-2006">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:14:51 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schoenbaum-2001">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:03:04 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Simon-1998">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 14:03:39 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vlasveld-2013">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 06:47:55 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wade-2008">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-08 06:46:37 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2007">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2014-12-01 14:02:10 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<SOF_TABLE ID="SOF-01" MODIFIED="2014-12-01 14:01:20 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" READONLY="YES">
<TITLE MODIFIED="2014-11-21 14:29:51 +0200" MODIFIED_BY="Jos H Verbeek">Work-directed intervention plus clinical intervention compared to clinical intervention alone for depressive disorder</TITLE>
<TABLE COLS="7" ROWS="8">
<TR>
<TD COLSPAN="7">
<P>
<B>Work-directed intervention plus clinical intervention compared to clinical intervention alone for depressive disorder</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> Persons with depressive disorder<BR/>
<B>Settings: </B>Two studies were conducted in outpatient and one in a workplace or Employee Assistance Program<BR/>
<B>Intervention:</B> Work-directed intervention plus clinical intervention<BR/>
<B>Comparison: </B>Clinical intervention alone</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Clinical intervention</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Work-directed intervention plus clinical intervention</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Days of sickness absence</B>
<BR/>Follow up: 4 - 12 months</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean days of sickness absence in the intervention groups was<BR/>
<B>0.4 standard deviations lower</B>
<BR/>(0.66 to 0.14 lower)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD -0.4 (-0.66 to -0.14)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>251<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>A standard deviation of 0.5 represents a moderate difference between groups</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>SMD</B>: Standardised Mean Difference</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Intervention description:</B>
</P>
<P>In two studies, an occupational therapy program focusing on work reintegration, combining modified work and supportive interventions was added to clinical care. In one study a regular Employee Assistance program was expanded and incorporated work coaching and modification.</P>
<P/>
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1 </SUP> Downgraded one level because N &lt; 400</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2014-12-01 14:01:45 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" READONLY="YES">
<TITLE MODIFIED="2014-11-21 14:31:58 +0200" MODIFIED_BY="Jos H Verbeek">Any psychological intervention versus no intervention or care as usual for depressive disorder</TITLE>
<TABLE COLS="7" ROWS="8">
<TR>
<TD COLSPAN="7">
<P>
<B>Any psychological intervention versus no intervention or care as usual for depressive disorder</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> Persons with depressive disorder<BR/>
<B>Settings: </B>One study was conducted in a workplace setting and two in primary care<BR/>
<B>Intervention:</B> Any psychological intervention versus no intervention or care as usual (medium term)<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Care As Usual (CAU)</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Any psychological intervention</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Days of sickness absence</B>
<BR/>Follow up: 3 - 8 months</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean days of sickness absence in the intervention groups was<BR/>
<B>0.23 standard deviations lower</B>
<BR/>(0.45 to 0.01 lower)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD -0.23 (-0.45 to -0.01)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>326<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>A standard deviation of 0.2 represents a small difference between groups</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CBT</B>: Cognitive-Behavioral Therapy; <B>CAU</B>: Care As Usual; <B>CI:</B> Confidence interval; <B>SMD</B>: Standardised Mean Difference</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Intervention description</B>
</P>
<P>All three interventions were cognitive-behavioral therapy, one by telephone and two online. Each of the interventions were interactive, with therapists or specialised nurses providing feedback.</P>
<P/>
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Downgraded one level because N &lt; 400</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-03" MODIFIED="2014-12-01 14:02:10 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="3" READONLY="YES">
<TITLE MODIFIED="2014-11-21 14:35:18 +0200" MODIFIED_BY="Jos H Verbeek">Psychological intervention combined with antidepressant medication versus no intervention or usual care for depressive disorder</TITLE>
<TABLE COLS="7" ROWS="9">
<TR>
<TD COLSPAN="7">
<P>
<B>Psychological intervention combined with antidepressant medication versus no intervention or usual care for depressive disorder</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> Persons with depressive disorders<BR/>
<B>Settings: </B>Two studies were conducted in a primary care and one in a managed care setting<BR/>
<B>Intervention:</B> Psychological intervention combined with antidepressant medication versus no intervention or usual care (medium term)<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Care As Usual (CAU)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Psychological intervention combined with antidepressant medication</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Days of sickness absence - Enhanced primary care versus CAU</B>
<BR/>Follow up: 7 - 12 months</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean days of sickness absence in the intervention groups was<BR/>
<B>0.02 standard deviations lower</B>
<BR/>(0.15 lower to 0.12 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD -0.02 (-0.15 to 0.12)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>969<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>1,2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>A standard deviation of 0.2 represents a small difference between groups</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Days of sickness absence - Telephone outreach and care management program versus CAU</B>
<BR/>Follow up: mean 12 months</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean days of sickness absence in the intervention groups was<BR/>
<B>0.21 standard deviations lower</B>
<BR/>(0.37 to 0.05 lower)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>SMD -0.21 (-0.37 to -0.05)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>604<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>A standard deviation of 0.2 represents a small difference between groups</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CAU</B>: Care As Usual; <B>CI:</B> Confidence interval; <B>SMD</B>: Standardised Mean Difference</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Intervention description</B>
</P>
<P>
<I>Enhanced primary care</I>
</P>
<P>General practitioners were enrolled in a quality improvement program and were expected to provide enhanced care including antidepressant medication and psychological interventions, according to primary care guidelines.</P>
<P/>
<P>
<I>Telephone outreach and care management</I>
</P>
<P>This program systematically assessed needs for treatment, facilitated entry into in-person treatment (both psychotherapy and antidepressant medication), monitored and supported treatment adherence, and (for those declining in-person treatment) provided a structured psychotherapy intervention by telephone.</P>
<P/>
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Downgraded with one level because all studies were of low quality<BR/>
<SUP>2</SUP> Downgraded with one level because in one study allocation concealment not adequate</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2014-12-01 12:45:08 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2014-12-01 12:45:08 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1">
<TITLE MODIFIED="2014-05-17 08:30:36 +0300" MODIFIED_BY="[Empty name]">Quality of the evidence (GRADE)</TITLE>
<TABLE COLS="8" ROWS="23">
<TR>
<TH>
<P>Comparison</P>
</TH>
<TH>
<P>Studies in comparison</P>
</TH>
<TH>
<P>Risk of Bias</P>
</TH>
<TH>
<P>Inconsistency</P>
</TH>
<TH>
<P>Indirectness</P>
</TH>
<TH>
<P>Imprecision</P>
</TH>
<TH>
<P>Publication bias</P>
</TH>
<TH>
<P>Quality of the</P>
<P>evidence</P>
</TH>
</TR>
<TR>
<TH>
<P>Work-directed</P>
</TH>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Work-directed + clinical intervention versus clinical (medium)</P>
</TD>
<TD>
<P>
<LINK REF="STD-Hees-2013" TYPE="STUDY">Hees 2013</LINK>; <LINK REF="STD-Lerner-2012" TYPE="STUDY">Lerner 2012</LINK>; <LINK REF="STD-Schene-2006" TYPE="STUDY">Schene 2006</LINK>
</P>
</TD>
<TD>
<P>No: Majority low risk of bias</P>
</TD>
<TD>
<P>No: I² &lt; 50%</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes:</P>
<P>N &lt; -400</P>
<P>Downgrade: -1</P>
</TD>
<TD>
<P>Undetected</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD>
<P>Work-directed + clinical intervention versus clinical (long)</P>
</TD>
<TD>
<P>
<LINK REF="STD-Hees-2013" TYPE="STUDY">Hees 2013</LINK>; <LINK REF="STD-Schene-2006" TYPE="STUDY">Schene 2006</LINK>
</P>
</TD>
<TD>
<P>No: Majority low risk of bias</P>
</TD>
<TD>
<P>No: I² &lt; 50%</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes:</P>
<P>N &lt; -400</P>
<P>Downgrade: -1</P>
</TD>
<TD>
<P>Undetected</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD>
<P>Work-directed + clinical versus work-directed</P>
</TD>
<TD>
<P>
<LINK REF="STD-Vlasveld-2013" TYPE="STUDY">Vlasveld 2013</LINK>
</P>
</TD>
<TD>
<P>No: study with low risk of bias</P>
</TD>
<TD>
<P>N.a.</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes:</P>
<P>Single study</P>
<P>Downgrade:</P>
<P>-1</P>
</TD>
<TD>
<P>Undetected</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD>
<P>Work-directed versus work-directed</P>
</TD>
<TD>
<P>
<LINK REF="STD-Noordik-2013" TYPE="STUDY">Noordik 2013</LINK>
</P>
</TD>
<TD>
<P>Yes: very serious</P>
<P>Downgrade</P>
<P>-2</P>
</TD>
<TD>
<P>N.a.</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes: wide CI</P>
<P>Downgrade:</P>
<P>-1</P>
</TD>
<TD>
<P>Undetected</P>
</TD>
<TD>
<P>Very low</P>
</TD>
</TR>
<TR>
<TH>
<P>Clinical, medication</P>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
</TR>
<TR>
<TD>
<P>Medication:</P>
<P>SSRI versus SNRI</P>
</TD>
<TD>
<P>
<LINK REF="STD-Fernandez-2005" TYPE="STUDY">Fernandez 2005</LINK>; <LINK REF="STD-Romeo-2004" TYPE="STUDY">Romeo 2004</LINK>; <LINK REF="STD-Wade-2008" TYPE="STUDY">Wade 2008</LINK>
</P>
</TD>
<TD>
<P>Fernandez: low</P>
<P>Romeo: high</P>
<P>Wade: high</P>
</TD>
<TD>
<P>Yes: 83%, pooling not feasible</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes:</P>
<P>Single studies</P>
<P>Downgrade:</P>
<P>-1</P>
</TD>
<TD>
<P>Undetected</P>
</TD>
<TD>
<P>Fernandez: moderate</P>
<P>Romeo: Low</P>
<P>Wade: Low</P>
</TD>
</TR>
<TR>
<TD>
<P>SSRI versus TCA</P>
</TD>
<TD>
<P>
<LINK REF="STD-Miller-1998" TYPE="STUDY">Miller 1998</LINK>
</P>
</TD>
<TD>
<P>Yes: very serious</P>
<P>Downgrade -2</P>
</TD>
<TD>
<P>N.a.</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Undetected</P>
</TD>
<TD>
<P>Low</P>
</TD>
</TR>
<TR>
<TD>
<P>SSRI versus SSRI</P>
</TD>
<TD>
<P>
<LINK REF="STD-Fantino-2007" TYPE="STUDY">Fantino 2007</LINK>
</P>
</TD>
<TD>
<P>No: study with low risk of bias</P>
</TD>
<TD>
<P>N.a.</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes:</P>
<P>N&lt; -400</P>
<P>Downgrade: -1</P>
</TD>
<TD>
<P>Undetected</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD>
<P>TCA or MAO versus placebo</P>
</TD>
<TD>
<P>
<LINK REF="STD-Agosti-1991" TYPE="STUDY">Agosti 1991</LINK>
</P>
</TD>
<TD>
<P>Yes: very serious</P>
<P>Downgrade -2</P>
</TD>
<TD>
<P>N.a.</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes:</P>
<P>N &lt; -400</P>
<P>Downgrade: -1</P>
</TD>
<TD>
<P>Undetected</P>
</TD>
<TD>
<P>Very low</P>
</TD>
</TR>
<TR>
<TH>
<P>Clinical, psychological</P>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
</TR>
<TR>
<TD>
<P>Any psych versus other psych (medium)</P>
</TD>
<TD>
<P>
<LINK REF="STD-Knekt-2013" TYPE="STUDY">Knekt 2013</LINK> (three arms)</P>
</TD>
<TD>
<P>Yes: serious Downgrade -1</P>
</TD>
<TD>
<P>Yes: 99% pooling not feasible</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes: single study arms</P>
<P>Downgrade -1</P>
</TD>
<TD>
<P>Undetected</P>
</TD>
<TD>
<P>Knekt I: Low</P>
<P>Knekt II: Low</P>
</TD>
</TR>
<TR>
<TD>
<P>Any psych versus other psych (medium)</P>
</TD>
<TD>
<P>
<LINK REF="STD-Knekt-2013" TYPE="STUDY">Knekt 2013</LINK> (three arms)</P>
</TD>
<TD>
<P>Yes: serious Downgrade -1</P>
</TD>
<TD>
<P>Yes: 99% pooling not feasible</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes: single study arms</P>
<P>Downgrade -1</P>
</TD>
<TD>
<P>Undetected</P>
</TD>
<TD>
<P>Knekt I: Low</P>
<P>Knekt II: Low</P>
</TD>
</TR>
<TR>
<TD>
<P>Any psych versus CAU</P>
</TD>
<TD>
<P>
<LINK REF="STD-Bee-2010" TYPE="STUDY">Bee 2010</LINK>; <LINK REF="STD-Hollinghurst-2010" TYPE="STUDY">Hollinghurst 2010</LINK>; <LINK REF="STD-McCrone-2004" TYPE="STUDY">McCrone 2004</LINK>
</P>
</TD>
<TD>
<P>No: Majority low risk of bias</P>
</TD>
<TD>
<P>No: I² &lt; 50%</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes:</P>
<P>N &lt; -400</P>
<P>Downgrade: -1</P>
</TD>
<TD>
<P>Undetected</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD>
<P>CMHN versus CAU</P>
</TD>
<TD>
<P>
<LINK REF="STD-Kendrick-2005" TYPE="STUDY">Kendrick 2005</LINK> (three arms)</P>
</TD>
<TD>
<P>Yes: serious Downgrade -1</P>
</TD>
<TD>
<P>No: I² &lt; 50%</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes: wide CI</P>
<P>Downgrade:</P>
<P>-1</P>
</TD>
<TD>
<P>Undetected</P>
</TD>
<TD>
<P>Low</P>
</TD>
</TR>
<TR>
<TH>
<P>Clinical, psychological and medication</P>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
</TR>
<TR>
<TD>
<P>Psych + med versus medicine</P>
</TD>
<TD>
<P>
<LINK REF="STD-Burnand-2002" TYPE="STUDY">Burnand 2002</LINK>
</P>
</TD>
<TD>
<P>Yes: very serious</P>
<P>Downgrade</P>
<P>-2</P>
</TD>
<TD>
<P>N.a.</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes:</P>
<P>N &lt; -400</P>
<P>Downgrade: -1</P>
</TD>
<TD>
<P>Undetected</P>
</TD>
<TD>
<P>Very low</P>
</TD>
</TR>
<TR>
<TD>
<P>Enhanced primary care versus CAU</P>
</TD>
<TD>
<P>
<LINK REF="STD-Rost-2004" TYPE="STUDY">Rost 2004</LINK>; <LINK REF="STD-Schoenbaum-2001" TYPE="STUDY">Schoenbaum 2001</LINK>; <LINK REF="STD-Simon-1998" TYPE="STUDY">Simon 1998</LINK>
</P>
</TD>
<TD>
<P>Yes: very serious</P>
<P>Downgrade</P>
<P>-2</P>
</TD>
<TD>
<P>No: I² &lt; 50%</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Undetected</P>
</TD>
<TD>
<P>Low</P>
</TD>
</TR>
<TR>
<TD>
<P>Telephone outreach versus CAU</P>
</TD>
<TD>
<P>
<LINK REF="STD-Wang-2007" TYPE="STUDY">Wang 2007</LINK>
</P>
</TD>
<TD>
<P>No: study with low risk of bias</P>
</TD>
<TD>
<P>N.a.</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No (n &gt; 400 * CI not wide)</P>
</TD>
<TD>
<P>Undetected</P>
</TD>
<TD>
<P>High</P>
</TD>
</TR>
<TR>
<TH>
<P>Clinical, exercise</P>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
</TR>
<TR>
<TD>
<P>Strength versus relax</P>
</TD>
<TD>
<P>
<LINK REF="STD-Krogh-2009" TYPE="STUDY">Krogh 2009</LINK>
</P>
</TD>
<TD>
<P>Yes: serious Downgrade -1</P>
</TD>
<TD>
<P>N.a.</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes:</P>
<P>N &lt; -400</P>
<P>Downgrade: -1</P>
</TD>
<TD>
<P>Undetected</P>
</TD>
<TD>
<P>Low</P>
</TD>
</TR>
<TR>
<TD>
<P>Aerobic versus relax or stretching</P>
</TD>
<TD>
<P>
<LINK REF="STD-Krogh-2009" TYPE="STUDY">Krogh 2009</LINK>; <LINK REF="STD-Krogh-2012" TYPE="STUDY">Krogh 2012</LINK>
</P>
</TD>
<TD>
<P>No: Majority low risk of bias</P>
</TD>
<TD>
<P>No: I² &lt; 50%</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes:</P>
<P>N &lt; -400</P>
<P>Downgrade: -1</P>
</TD>
<TD>
<P>Undetected</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2014-12-02 10:52:59 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<COMPARISON ID="CMP-001" MODIFIED="2014-12-02 10:29:41 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1">
<NAME>Work-directed plus clinical versus clinical alone (medium term)</NAME>
<CONT_OUTCOME CHI2="1.7212761875239135" CI_END="-0.13769963827610981" CI_START="-0.6592254337721444" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.39846253602412707" ESTIMABLE="YES" I2="0.0" I2_Q="30.099734345974895" ID="CMP-001.01" MODIFIED="2014-11-21 09:08:20 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="0.42289248142544467" P_Q="0.2316652132431758" P_Z="0.002744885242626153" Q="1.430609727507404" RANDOM="YES" SCALE="1.93" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="155" TOTAL_2="96" UNITS="" WEIGHT="99.99999999999999" Z="2.9949514541384605">
<NAME>Days of sickness absence</NAME>
<GROUP_LABEL_1>Work plus clinical</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Work + Clinical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Clinical</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.2906664600165094" CI_END="0.005635859600107818" CI_START="-0.606718394895217" DF="1" EFFECT_SIZE="-0.30054126764755457" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.01" MODIFIED="2014-03-11 15:27:11 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5897938392226476" P_Z="0.054368804093972524" STUDIES="2" TAU2="0.0" TOTAL_1="108" TOTAL_2="71" WEIGHT="72.53474844834092" Z="1.9238865611954927">
<NAME>Occupational therapy plus CAU vs. CAU</NAME>
<CONT_DATA CI_END="0.149550358477383" CI_START="-0.6216696902872337" EFFECT_SIZE="-0.23605966590492536" ESTIMABLE="YES" MEAN_1="1.7625" MEAN_2="2.125" MODIFIED="2014-02-07 17:38:55 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="33" SD_1="1.4875" SD_2="1.6" SE="0.19674342356489763" STUDY_ID="STD-Hees-2013" TOTAL_1="78" TOTAL_2="39" WEIGHT="45.72934346957435"/>
<CONT_DATA CI_END="0.09311144520040543" CI_START="-0.9142019464928766" EFFECT_SIZE="-0.41054525064623554" ESTIMABLE="YES" MEAN_1="66.19" MEAN_2="83.28" MODIFIED="2014-03-11 15:27:11 +0200" MODIFIED_BY="[Empty name]" ORDER="44" SD_1="40.36" SD_2="41.79" SE="0.25697242389116365" STUDY_ID="STD-Schene-2006" TOTAL_1="30" TOTAL_2="32" WEIGHT="26.805404978766564"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.1594993143217594" CI_START="-1.1546389029312853" DF="0" EFFECT_SIZE="-0.6570691086265223" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.02" MODIFIED="2014-03-11 11:46:13 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.009646676031364978" STUDIES="1" TAU2="0.0" TOTAL_1="47" TOTAL_2="25" WEIGHT="27.46525155165907" Z="2.5882435047353773">
<NAME>Multi-component work-focused program vs. CAU</NAME>
<CONT_DATA CI_END="-0.1594993143217594" CI_START="-1.1546389029312853" EFFECT_SIZE="-0.6570691086265223" ESTIMABLE="YES" MEAN_1="1.0" MEAN_2="2.2" MODIFIED="2014-02-10 15:04:16 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="34" SD_1="1.2" SD_2="2.6" SE="0.2538668048135221" STUDY_ID="STD-Lerner-2012" TOTAL_1="47" TOTAL_2="25" WEIGHT="27.46525155165907"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="8.935946629452872" CI_END="0.24781816567604437" CI_START="-0.8802905494750874" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.3162361918995215" ESTIMABLE="YES" I2="77.61848763277075" I2_Q="73.56564419905442" ID="CMP-001.02" MODIFIED="2014-11-21 09:07:53 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="0.011470599488508593" P_Q="0.051777159840852516" P_Z="0.27183319445169785" Q="3.7829558152660905" RANDOM="YES" SCALE="1.79" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.1922819874538394" TOTALS="YES" TOTAL_1="155" TOTAL_2="96" UNITS="" WEIGHT="100.0" Z="1.0988507373566807">
<NAME>Depressive symptoms</NAME>
<GROUP_LABEL_1>Work plus clinical</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Work + Clinical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Clinical</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.377091682952801" CI_END="0.5032088438880062" CI_START="-0.6556581420971097" DF="1" EFFECT_SIZE="-0.07622464910455179" ESTIMABLE="YES" I2="70.38872219407328" ID="CMP-001.02.01" MODIFIED="2014-03-11 15:56:22 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.06610869993794488" P_Z="0.7965351410029881" STUDIES="2" TAU2="0.12372049086027159" TOTAL_1="108" TOTAL_2="71" WEIGHT="67.98918932678527" Z="0.257833847690685">
<NAME>Occupational therapy plus CAU vs. CAU</NAME>
<CONT_DATA CI_END="0.036408221319535417" CI_START="-0.7377690639962091" EFFECT_SIZE="-0.3506804213383369" ESTIMABLE="YES" MEAN_1="7.1" MEAN_2="9.6" MODIFIED="2014-02-11 12:04:43 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="43" SD_1="6.7" SD_2="7.8" SE="0.19749783450674507" STUDY_ID="STD-Hees-2013" TOTAL_1="78" TOTAL_2="39" WEIGHT="35.8091320757462"/>
<CONT_DATA CI_END="0.7422586301545198" CI_START="-0.25781176202441825" EFFECT_SIZE="0.24222343406505079" ESTIMABLE="YES" MEAN_1="18.2" MEAN_2="15.5" MODIFIED="2014-02-11 12:23:28 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="45" SD_1="11.9" SD_2="10.1" SE="0.2551246859808052" STUDY_ID="STD-Schene-2006" TOTAL_1="30" TOTAL_2="32" WEIGHT="32.180057251039074"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.33388209246790124" CI_START="-1.3443522962726453" DF="0" EFFECT_SIZE="-0.8391171943702732" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.02" MODIFIED="2014-03-11 11:45:11 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.0011331397958260572" STUDIES="1" TAU2="0.0" TOTAL_1="47" TOTAL_2="25" WEIGHT="32.01081067321473" Z="3.2551963899211227">
<NAME>Multi-component work-focused program vs. CAU</NAME>
<CONT_DATA CI_END="-0.33388209246790124" CI_START="-1.3443522962726453" EFFECT_SIZE="-0.8391171943702732" ESTIMABLE="YES" MEAN_1="7.7" MEAN_2="12.8" MODIFIED="2014-02-11 12:21:31 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="47" SD_1="5.8" SD_2="6.4" SE="0.257777747901289" STUDY_ID="STD-Lerner-2012" TOTAL_1="47" TOTAL_2="25" WEIGHT="32.01081067321473"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.3400290672453963" CI_END="0.16302017666185326" CI_START="-0.7904975046434508" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.31373866399079875" ESTIMABLE="YES" I2="57.2654881087795" I2_Q="57.265488108779515" ID="CMP-001.03" MODIFIED="2014-12-02 10:29:41 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="3" P_CHI2="0.12608735203703691" P_Q="0.12608735203703691" P_Z="0.19712525863646982" Q="2.3400290672453967" RANDOM="YES" SCALE="1.48" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.06853259584374617" TOTALS="YES" TOTAL_1="125" TOTAL_2="64" UNITS="" WEIGHT="100.00000000000001" Z="1.2897851692438431">
<NAME>Work functioning</NAME>
<GROUP_LABEL_1>Work plus clinical</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Work + Clinical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Clinical</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.2896196511486874" CI_START="-0.4795399148680607" DF="0" EFFECT_SIZE="-0.09496013185968669" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.01" MODIFIED="2014-03-11 11:46:55 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.6284194138495167" STUDIES="1" TAU2="0.0" TOTAL_1="78" TOTAL_2="39" WEIGHT="55.28146178139409" Z="0.48395273655897775">
<NAME>Occupational therapy plus CAU vs. CAU</NAME>
<CONT_DATA CI_END="0.2896196511486874" CI_START="-0.4795399148680607" EFFECT_SIZE="-0.09496013185968669" ESTIMABLE="YES" MEAN_1="33.1" MEAN_2="34.7" MODIFIED="2014-02-18 10:51:34 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="57" SD_1="15.0" SD_2="19.8" SE="0.1962177805520358" STUDY_ID="STD-Hees-2013" TOTAL_1="78" TOTAL_2="39" WEIGHT="55.28146178139409"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.08919676788352948" CI_START="-1.0791925641296976" DF="0" EFFECT_SIZE="-0.5841946660066135" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.02" MODIFIED="2014-03-11 11:47:13 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.02071482460552096" STUDIES="1" TAU2="0.0" TOTAL_1="47" TOTAL_2="25" WEIGHT="44.71853821860592" Z="2.3131421561080194">
<NAME>Multi-component work-focused program vs. CAU</NAME>
<CONT_DATA CI_END="-0.08919676788352948" CI_START="-1.0791925641296976" EFFECT_SIZE="-0.5841946660066135" ESTIMABLE="YES" MEAN_1="26.5" MEAN_2="40.1" MODIFIED="2014-02-18 11:07:42 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="61" SD_1="23.5" SD_2="22.1" SE="0.25255458877181636" STUDY_ID="STD-Lerner-2012" TOTAL_1="47" TOTAL_2="25" WEIGHT="44.71853821860592"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2014-12-02 10:46:53 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2">
<NAME>Work-directed plus clinical versus clinical alone (long term)</NAME>
<CONT_OUTCOME CHI2="0.31561736049846095" CI_END="0.1181477466777612" CI_START="-0.49213785184487335" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.18699505258355606" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.01" MODIFIED="2014-12-02 10:30:04 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="0.5742535501226451" P_Q="1.0" P_Z="0.2297168174171732" Q="0.0" RANDOM="YES" SCALE="1.07" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="108" TOTAL_2="71" UNITS="" WEIGHT="100.0" Z="1.2010887008907534">
<NAME>Days of sickness absence</NAME>
<GROUP_LABEL_1>Work plus clinical</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Work + Clinical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Clinical</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.31561736049846095" CI_END="0.1181477466777612" CI_START="-0.49213785184487335" DF="1" EFFECT_SIZE="-0.18699505258355606" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.01" MODIFIED="2014-03-11 15:57:03 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5742535501226451" P_Z="0.2297168174171732" STUDIES="2" TAU2="0.0" TOTAL_1="108" TOTAL_2="71" WEIGHT="100.0" Z="1.2010887008907534">
<NAME>Occupational therapy plus CAU vs. CAU</NAME>
<CONT_DATA CI_END="0.2648519401942786" CI_START="-0.5045437288285215" EFFECT_SIZE="-0.11984589431712142" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.4875" MODIFIED="2014-02-10 16:02:16 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="35" SD_1="1.5625" SD_2="1.5375" SE="0.19627801201748984" STUDY_ID="STD-Hees-2013" TOTAL_1="78" TOTAL_2="39" WEIGHT="62.91682067315941"/>
<CONT_DATA CI_END="0.20016571357959506" CI_START="-0.8020117699188858" EFFECT_SIZE="-0.3009230281696454" ESTIMABLE="YES" MEAN_1="49.81" MEAN_2="65.5" MODIFIED="2014-02-11 17:18:04 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="55" SD_1="50.21" SD_2="52.65" SE="0.25566221915390513" STUDY_ID="STD-Schene-2006" TOTAL_1="30" TOTAL_2="32" WEIGHT="37.08317932684059"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.23737526622496646" CI_START="-1.0235066230030938" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.6304409446140301" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.02" MODIFIED="2014-12-02 10:30:13 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.0016688297959810278" Q="0.0" RANDOM="YES" SCALE="1.93" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="78" TOTAL_2="39" UNITS="" WEIGHT="100.0" Z="3.1436007104132084">
<NAME>Depressive symptoms</NAME>
<GROUP_LABEL_1>Work plus clinical</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Work + Clinical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Clinical</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.23737526622496646" CI_START="-1.0235066230030938" DF="0" EFFECT_SIZE="-0.6304409446140301" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.01" MODIFIED="2014-03-11 15:57:13 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.0016688297959810278" STUDIES="1" TAU2="0.0" TOTAL_1="78" TOTAL_2="39" WEIGHT="100.0" Z="3.1436007104132084">
<NAME>Occupational therapy plus CAU vs. CAU</NAME>
<CONT_DATA CI_END="-0.23737526622496646" CI_START="-1.0235066230030938" EFFECT_SIZE="-0.6304409446140301" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="8.8" MODIFIED="2014-02-11 12:06:41 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="46" SD_1="5.4" SD_2="8.2" SE="0.20054739856931839" STUDY_ID="STD-Hees-2013" TOTAL_1="78" TOTAL_2="39" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.989112638200727E-32" CI_END="0.13959590720743698" CI_START="-0.6318378455950531" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.24612096919380805" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2014-12-02 10:46:53 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="3" P_CHI2="0.0" P_Q="1.0" P_Z="0.2110703398157281" Q="0.0" RANDOM="YES" SCALE="3.2995291614234183" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="78" TOTAL_2="39" UNITS="" WEIGHT="100.0" Z="1.250627766046067">
<NAME>Work functioning</NAME>
<GROUP_LABEL_1>Work plus clinical</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Work + Clinical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Clinical</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.989112638200727E-32" CI_END="0.13959590720743698" CI_START="-0.6318378455950531" DF="0" EFFECT_SIZE="-0.24612096919380805" ESTIMABLE="YES" I2="100.0" ID="CMP-002.03.01" MODIFIED="2014-03-11 11:49:11 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.2110703398157281" STUDIES="1" TAU2="0.0" TOTAL_1="78" TOTAL_2="39" WEIGHT="100.0" Z="1.250627766046067">
<NAME>Occupational therapy plus CAU vs. CAU</NAME>
<CONT_DATA CI_END="0.13959590720743695" CI_START="-0.6318378455950531" EFFECT_SIZE="-0.24612096919380808" ESTIMABLE="YES" MEAN_1="31.2" MEAN_2="35.7" MODIFIED="2014-02-18 10:56:48 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="58" SD_1="17.3" SD_2="19.8" SE="0.19679794090285868" STUDY_ID="STD-Hees-2013" TOTAL_1="78" TOTAL_2="39" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2014-12-02 10:30:36 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="3">
<NAME>Work-directed plus clinical versus work-directed (medium term)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.20789663290739788" CI_START="-0.49179234898842283" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.1419478580405125" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2014-11-21 09:08:54 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.4264699976357156" Q="0.0" RANDOM="YES" SCALE="0.81" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="65" TOTAL_2="61" UNITS="" WEIGHT="100.0" Z="0.7952467357373164">
<NAME>Days of sickness absence</NAME>
<GROUP_LABEL_1>Work plus clinical</GROUP_LABEL_1>
<GROUP_LABEL_2>Work</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Work + Clinical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Work</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.20789663290739788" CI_START="-0.49179234898842283" DF="0" EFFECT_SIZE="-0.1419478580405125" ESTIMABLE="YES" I2="0.0" ID="CMP-003.01.01" MODIFIED="2014-03-11 11:49:51 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.4264699976357156" STUDIES="1" TAU2="0.0" TOTAL_1="65" TOTAL_2="61" WEIGHT="100.0" Z="0.7952467357373164">
<NAME>Collaborative care vs. CAU</NAME>
<CONT_DATA CI_END="0.20789663290739788" CI_START="-0.49179234898842283" EFFECT_SIZE="-0.1419478580405125" ESTIMABLE="YES" MEAN_1="198.0" MEAN_2="215.0" MODIFIED="2014-02-10 16:11:35 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="36" SD_1="120.0" SD_2="118.0" SE="0.17849536711257913" STUDY_ID="STD-Vlasveld-2013" TOTAL_1="65" TOTAL_2="61" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.7175341507624126" CI_START="-0.2008348126409375" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.25834966906073753" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.02" MODIFIED="2014-12-02 10:30:36 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.27014488420977767" Q="0.0" RANDOM="YES" SCALE="0.57" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="34" TOTAL_2="40" UNITS="" WEIGHT="100.0" Z="1.102729005345305">
<NAME>Depressive symptoms</NAME>
<GROUP_LABEL_1>Work plus clinical</GROUP_LABEL_1>
<GROUP_LABEL_2>Work</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Work + Clinical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Work</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.7175341507624126" CI_START="-0.2008348126409375" DF="0" EFFECT_SIZE="0.25834966906073753" ESTIMABLE="YES" I2="0.0" ID="CMP-003.02.01" MODIFIED="2014-03-11 11:50:01 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.27014488420977767" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="40" WEIGHT="100.0" Z="1.102729005345305">
<NAME>Collaborative care vs. CAU</NAME>
<CONT_DATA CI_END="0.7175341507624126" CI_START="-0.2008348126409375" EFFECT_SIZE="0.25834966906073753" ESTIMABLE="YES" MEAN_1="7.7" MEAN_2="5.9" MODIFIED="2014-02-11 12:44:16 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="48" SD_1="5.8" SD_2="7.7" SE="0.2342821017751671" STUDY_ID="STD-Vlasveld-2013" TOTAL_1="34" TOTAL_2="40" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2014-12-02 10:48:57 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="4">
<NAME>Any work-directed versus alternative work-directed</NAME>
<CONT_OUTCOME CHI2="5.615805807482069E-32" CI_END="0.9135222138767791" CI_START="-0.00470948237477864" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.45440636575100024" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-004.01" MODIFIED="2014-12-02 10:48:57 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="0.0" P_Q="1.0" P_Z="0.0523968012119661" Q="0.0" RANDOM="YES" SCALE="5.407522122194801" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="39" TOTAL_2="36" UNITS="" WEIGHT="100.0" Z="1.9398592203981213">
<NAME>Days of sickness absence</NAME>
<GROUP_LABEL_1>Work-directed</GROUP_LABEL_1>
<GROUP_LABEL_2>Altern. work-directed</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Work</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Alternative Work</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="5.615805807482069E-32" CI_END="0.9135222138767791" CI_START="-0.00470948237477864" DF="0" EFFECT_SIZE="0.45440636575100024" ESTIMABLE="YES" I2="100.0" ID="CMP-004.01.01" MODIFIED="2014-11-21 09:31:54 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="0.0" P_Z="0.0523968012119661" STUDIES="1" TAU2="0.0" TOTAL_1="39" TOTAL_2="36" WEIGHT="100.0" Z="1.9398592203981213">
<NAME>RTW-E vs. CAU</NAME>
<CONT_DATA CI_END="0.9135222138767791" CI_START="-0.004709482374778695" EFFECT_SIZE="0.4544063657510002" ESTIMABLE="YES" MEAN_1="234.54" MEAN_2="173.44" MODIFIED="2014-05-15 12:19:34 +0300" MODIFIED_BY="[Empty name]" ORDER="71" SD_1="140.38" SD_2="124.66" SE="0.23424708400114802" STUDY_ID="STD-Noordik-2013" TOTAL_1="39" TOTAL_2="36" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.4867849156336737" CI_START="-0.83899789194562" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.17610648815597313" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.02" MODIFIED="2014-12-02 10:20:20 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.602581220652383" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="13" TOTAL_2="27" UNITS="" WEIGHT="100.0" Z="0.5206921861654827">
<NAME>Depressive symptoms</NAME>
<GROUP_LABEL_1>Work-directed</GROUP_LABEL_1>
<GROUP_LABEL_2>Altern. work-directed</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Work</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Alternative Work</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.4867849156336737" CI_START="-0.83899789194562" DF="0" EFFECT_SIZE="-0.17610648815597313" ESTIMABLE="YES" I2="0.0" ID="CMP-004.02.01" MODIFIED="2014-11-21 09:32:03 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="1.0" P_Z="0.602581220652383" STUDIES="1" TAU2="0.0" TOTAL_1="13" TOTAL_2="27" WEIGHT="100.0" Z="0.5206921861654827">
<NAME>RTW-E vs. CAU</NAME>
<CONT_DATA CI_END="0.4867849156336737" CI_START="-0.83899789194562" EFFECT_SIZE="-0.17610648815597313" ESTIMABLE="YES" MEAN_1="0.46" MEAN_2="0.85" MODIFIED="2014-05-15 12:22:19 +0300" MODIFIED_BY="[Empty name]" ORDER="72" SD_1="0.97" SD_2="2.54" SE="0.3382161146931523" STUDY_ID="STD-Noordik-2013" TOTAL_1="13" TOTAL_2="27" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2014-12-02 10:49:39 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="5">
<NAME>Any antidepressant medication versus any other antidepressant medication</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.01" MODIFIED="2014-11-21 09:32:17 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1.56" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="758" TOTAL_2="557" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Days of sickness absence</NAME>
<GROUP_LABEL_1>Antidepressant</GROUP_LABEL_1>
<GROUP_LABEL_2>Other antidepressant</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SSRI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Alternative</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="2" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.01.01" MODIFIED="2014-11-21 09:32:09 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" NOTES="&lt;p&gt;Wade SD van sickness absence in mail gekregen:&lt;/p&gt;&lt;p&gt;Please find the SD for sick leave at week 24&lt;/p&gt;&lt;p&gt;Escitalopram Duloxetine&lt;/p&gt;&lt;table rows=&quot;0&quot; cols=&quot;0&quot;&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot;&gt;&lt;p&gt;23.43 &amp;#177; 27.87&lt;/p&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot;&gt;&lt;p&gt;41.69 &amp;#177; 35.41&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" NOTES_MODIFIED="2014-11-21 09:32:09 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" P_CHI2="0.0" P_Z="0.0" STUDIES="3" TAU2="0.0" TOTAL_1="194" TOTAL_2="206" WEIGHT="0.0" Z="0.0">
<NAME>SSRI vs. SNRI</NAME>
<CONT_DATA CI_END="0.3114732603151316" CI_START="-0.3655568827911562" EFFECT_SIZE="-0.02704181123801231" ESTIMABLE="YES" MEAN_1="12.37" MEAN_2="12.97" ORDER="57" SD_1="21.51" SD_2="22.52" SE="0.17271494487822614" STUDY_ID="STD-Fernandez-2005" TOTAL_1="62" TOTAL_2="73" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.6856725031986981" CI_START="-0.12777059584174993" EFFECT_SIZE="0.2789509536784741" ESTIMABLE="YES" MEAN_1="28.0" MEAN_2="19.0" MODIFIED="2014-02-07 18:03:49 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="58" SD_1="32.0" SD_2="32.0" SE="0.20751480778646533" STUDY_ID="STD-Romeo-2004" TOTAL_1="49" TOTAL_2="45" WEIGHT="0.0"/>
<CONT_DATA CI_END="-0.26373687897492787" CI_START="-0.8758423429217117" EFFECT_SIZE="-0.5697896109483198" ESTIMABLE="YES" MEAN_1="23.4" MEAN_2="41.7" MODIFIED="2014-03-21 11:47:38 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="38" SD_1="27.87" SD_2="35.41" SE="0.15615222238137885" STUDY_ID="STD-Wade-2008" TOTAL_1="83" TOTAL_2="88" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.01.02" MODIFIED="2014-11-21 09:32:13 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="426" TOTAL_2="209" WEIGHT="0.0" Z="0.0">
<NAME>SSRI vs. TCA</NAME>
<CONT_DATA CI_END="0.2473682254483714" CI_START="-0.0837997241086475" EFFECT_SIZE="0.08178425066986195" ESTIMABLE="YES" MEAN_1="0.4" MEAN_2="0.23" ORDER="59" SD_1="1.98" SD_2="2.26" SE="0.084483172183068" STUDY_ID="STD-Miller-1998" TOTAL_1="426" TOTAL_2="209" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.01.03" MODIFIED="2014-11-21 09:32:17 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="3" NOTES="&lt;p&gt;SD van sickness absence Fantino was onbekend, hebben we berekend door p=0.01 in te vullen in spreadsheet met p=0.01: SD=1.99999, afgerond 2&lt;/p&gt;" NOTES_MODIFIED="2014-11-21 09:32:17 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="138" TOTAL_2="142" WEIGHT="0.0" Z="0.0">
<NAME>SSRI vs. SSRI</NAME>
<CONT_DATA CI_END="-0.07346351176445162" CI_START="-0.5448623208188059" EFFECT_SIZE="-0.3091629162916288" ESTIMABLE="YES" MEAN_1="11.56" MEAN_2="12.18" MODIFIED="2014-02-27 16:50:22 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="37" SD_1="2.0" SD_2="2.0" SE="0.12025700797889348" STUDY_ID="STD-Fantino-2007" TOTAL_1="138" TOTAL_2="142" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="27.38338427913228" CI_END="0.48195771418575173" CI_START="-0.3400800126892506" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.07093885074825054" ESTIMABLE="YES" I2="89.0444513014917" I2_Q="45.86934210034294" ID="CMP-005.02" MODIFIED="2014-12-02 10:44:25 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="4.892496147546055E-6" P_Q="0.1740883776648503" P_Z="0.7351556201197526" Q="1.8473819436181937" RANDOM="YES" SCALE="0.57" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.15557568043570869" TOTALS="YES" TOTAL_1="851" TOTAL_2="663" UNITS="" WEIGHT="100.0" Z="0.33827545385243657">
<NAME>Depressive symptoms</NAME>
<GROUP_LABEL_1>Antidepressant</GROUP_LABEL_1>
<GROUP_LABEL_2>Other antidepressant</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SSRI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Alternative</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="21.596429053874868" CI_END="0.7278730301477155" CI_START="-0.3695872340679959" DF="2" EFFECT_SIZE="0.1791428980398598" ESTIMABLE="YES" I2="90.73920973226286" ID="CMP-005.02.01" MODIFIED="2014-11-21 09:32:32 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="2.043605836876683E-5" P_Z="0.5222598734662318" STUDIES="3" TAU2="0.21268113202853134" TOTAL_1="287" TOTAL_2="312" WEIGHT="74.12562490106168" Z="0.6398657695277487">
<NAME>SSRI vs. SNRI</NAME>
<CONT_DATA CI_END="0.367174032284176" CI_START="-0.30986000566243443" EFFECT_SIZE="0.028657013310870793" ESTIMABLE="YES" MEAN_1="5.95" MEAN_2="5.79" ORDER="61" SD_1="4.78" SD_2="6.13" SE="0.17271593847819872" STUDY_ID="STD-Fernandez-2005" TOTAL_1="62" TOTAL_2="73" WEIGHT="23.719330522579405"/>
<CONT_DATA CI_END="1.0154391361931796" CI_START="0.4066727238707316" EFFECT_SIZE="0.7110559300319557" ESTIMABLE="YES" MEAN_1="16.42" MEAN_2="10.99" ORDER="62" SD_1="7.63" SD_2="7.58" SE="0.15530040784532773" STUDY_ID="STD-Romeo-2004" TOTAL_1="84" TOTAL_2="93" WEIGHT="24.473382525182572"/>
<CONT_DATA CI_END="0.04255890505221094" CI_START="-0.42133389987321485" EFFECT_SIZE="-0.18938749741050195" ESTIMABLE="YES" MEAN_1="8.89" MEAN_2="10.58" MODIFIED="2014-02-27 16:44:36 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="50" SD_1="8.9" SD_2="8.9" SE="0.1183421758217378" STUDY_ID="STD-Wade-2008" TOTAL_1="141" TOTAL_2="146" WEIGHT="25.932911853299707"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.02.02" MODIFIED="2014-11-21 09:32:36 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="426" TOTAL_2="209" WEIGHT="0.0" Z="0.0">
<NAME>SSRI vs. TCA</NAME>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="12.6" MEAN_2="12.9" ORDER="63" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Miller-1998" TOTAL_1="426" TOTAL_2="209" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="2.5895919724056027E-4" CI_START="-0.46994486028342447" DF="0" EFFECT_SIZE="-0.23484295054309196" ESTIMABLE="YES" I2="0.0" ID="CMP-005.02.03" MODIFIED="2014-11-21 09:32:40 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="3" P_CHI2="1.0" P_Z="0.05025288318403657" STUDIES="1" TAU2="0.0" TOTAL_1="138" TOTAL_2="142" WEIGHT="25.874375098938312" Z="1.957805130532371">
<NAME>SSRI vs. SSRI</NAME>
<CONT_DATA CI_END="2.589591972405325E-4" CI_START="-0.4699448602834245" EFFECT_SIZE="-0.23484295054309198" ESTIMABLE="YES" MEAN_1="13.9" MEAN_2="15.4" MODIFIED="2014-03-11 21:40:48 +0200" MODIFIED_BY="[Empty name]" ORDER="49" SD_1="6.37" SD_2="6.37" SE="0.11995215809820302" STUDY_ID="STD-Fantino-2007" TOTAL_1="138" TOTAL_2="142" WEIGHT="25.874375098938312"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.06094546150143966" CI_START="-0.1609454615014393" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.04999999999999982" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.03" MODIFIED="2014-12-02 10:49:39 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.3770738575188415" Q="0.0" RANDOM="YES" SCALE="0.9058080313134498" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="426" TOTAL_2="209" UNITS="" WEIGHT="100.0" Z="0.8833006587270887">
<NAME>Work functioning</NAME>
<GROUP_LABEL_1>Antidepressant</GROUP_LABEL_1>
<GROUP_LABEL_2>Other antidepressant</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SSRI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Alternative</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.06094546150143966" CI_START="-0.1609454615014393" DF="0" EFFECT_SIZE="-0.04999999999999982" ESTIMABLE="YES" I2="0.0" ID="CMP-005.03.01" MODIFIED="2014-11-21 09:32:46 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="1.0" P_Z="0.3770738575188415" STUDIES="1" TAU2="0.0" TOTAL_1="426" TOTAL_2="209" WEIGHT="100.0" Z="0.8833006587270887">
<NAME>SSRI vs. TCA</NAME>
<CONT_DATA CI_END="0.06094546150143966" CI_START="-0.1609454615014393" EFFECT_SIZE="-0.04999999999999982" ESTIMABLE="YES" MEAN_1="1.84" MEAN_2="1.89" ORDER="60" SD_1="0.65" SD_2="0.68" SE="0.05660586744275054" STUDY_ID="STD-Miller-1998" TOTAL_1="426" TOTAL_2="209" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2014-12-02 10:50:21 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="6">
<NAME>Any antidepressant medication versus placebo</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.0004348529270854" CI_START="-0.049740317428803416" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.475347267749141" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.01" MODIFIED="2014-11-21 09:32:54 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.07601334457038916" Q="0.0" RANDOM="YES" SCALE="1.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="38" TOTAL_2="23" UNITS="" WEIGHT="100.0" Z="1.7743011856243136">
<NAME>Days of sickness absence</NAME>
<GROUP_LABEL_1>Antidepressant</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Antidepressant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.0004348529270854" CI_START="-0.049740317428803416" DF="0" EFFECT_SIZE="0.475347267749141" ESTIMABLE="YES" I2="0.0" ID="CMP-006.01.01" MODIFIED="2014-11-21 09:32:54 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="1.0" P_Z="0.07601334457038916" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="23" WEIGHT="100.0" Z="1.7743011856243136">
<NAME>TCA or MAO vs. placebo</NAME>
<CONT_DATA CI_END="1.0004348529270854" CI_START="-0.049740317428803416" EFFECT_SIZE="0.475347267749141" ESTIMABLE="YES" MEAN_1="1.48" MEAN_2="0.29" MODIFIED="2014-02-20 14:26:55 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="58" SD_1="2.49" SD_2="2.44" SE="0.26790675202185765" STUDY_ID="STD-Agosti-1991" TOTAL_1="38" TOTAL_2="23" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.0506191278306658" CI_START="-1.1077922041926456" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.5792056660116557" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.02" MODIFIED="2014-12-02 10:50:21 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.03174106389567032" Q="0.0" RANDOM="YES" SCALE="2.442218569992257" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="38" TOTAL_2="23" UNITS="" WEIGHT="100.0" Z="2.147656368493585">
<NAME>Work functioning</NAME>
<GROUP_LABEL_1>Antidepressant</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Antidepressant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.0506191278306658" CI_START="-1.1077922041926456" DF="0" EFFECT_SIZE="-0.5792056660116557" ESTIMABLE="YES" I2="0.0" ID="CMP-006.02.01" MODIFIED="2014-11-21 09:33:00 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="1.0" P_Z="0.03174106389567032" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="23" WEIGHT="100.0" Z="2.147656368493585">
<NAME>TCA or MAO vs. placebo</NAME>
<CONT_DATA CI_END="-0.0506191278306658" CI_START="-1.1077922041926456" EFFECT_SIZE="-0.5792056660116557" ESTIMABLE="YES" MEAN_1="1.8" MEAN_2="2.6" ORDER="65" SD_1="1.4" SD_2="1.3" SE="0.2696919649291584" STUDY_ID="STD-Agosti-1991" TOTAL_1="38" TOTAL_2="23" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2014-12-02 10:22:31 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="7">
<NAME>Any psychological versus other psychological (medium term)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.01" MODIFIED="2014-12-02 10:21:49 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="0.96" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="72" TOTAL_2="26" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Days of sickness absence</NAME>
<GROUP_LABEL_1>Psychodynamic</GROUP_LABEL_1>
<GROUP_LABEL_2>Solution-focused</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Psychodynamic</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Solution-focused</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.01.01" MODIFIED="2014-11-21 09:33:08 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="13" WEIGHT="0.0" Z="0.0">
<NAME>Short-term psychodynamic therapy vs. solution-focused therapy</NAME>
<CONT_DATA CI_END="0.8902292463207829" CI_START="-0.3923389682692099" EFFECT_SIZE="0.2489451390257865" ESTIMABLE="YES" MEAN_1="2.79" MEAN_2="2.58" MODIFIED="2014-04-04 10:24:03 +0300" MODIFIED_BY="Babs J.M.  Faber" ORDER="59" SD_1="0.85" SD_2="0.77" SE="0.32719178125382076" STUDY_ID="STD-Knekt-2013" TOTAL_1="34" TOTAL_2="13" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.01.02" MODIFIED="2014-11-21 09:33:12 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="13" WEIGHT="0.0" Z="0.0">
<NAME>Long-term psychodynamic therapy vs. solution-focused therapy</NAME>
<CONT_DATA CI_END="1.8320205292633327" CI_START="0.4881237354373975" EFFECT_SIZE="1.160072132350365" ESTIMABLE="YES" MEAN_1="4.18" MEAN_2="2.58" MODIFIED="2014-04-04 10:24:30 +0300" MODIFIED_BY="Babs J.M.  Faber" ORDER="62" SD_1="1.5" SD_2="0.77" SE="0.34283711446394466" STUDY_ID="STD-Knekt-2013" TOTAL_1="38" TOTAL_2="13" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.02" MODIFIED="2014-12-02 10:22:10 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="5.67" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="206" TOTAL_2="90" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Depressive symptoms</NAME>
<GROUP_LABEL_1>Psychodynamic</GROUP_LABEL_1>
<GROUP_LABEL_2>Solution-focused</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Psychodynamic</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Solution-focused</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.02.01" MODIFIED="2014-11-21 09:33:23 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="91" TOTAL_2="45" WEIGHT="0.0" Z="0.0">
<NAME>Short-term psychodynamic therapy vs. solution-focused therapy</NAME>
<CONT_DATA CI_END="-0.8081875950628702" CI_START="-1.578354461011895" EFFECT_SIZE="-1.1932710280373826" ESTIMABLE="YES" MEAN_1="9.5" MEAN_2="10.7" MODIFIED="2014-03-14 16:58:08 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="61" SD_1="1.0" SD_2="1.0" SE="0.19647474954233923" STUDY_ID="STD-Knekt-2013" TOTAL_1="91" TOTAL_2="45" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.02.02" MODIFIED="2014-11-21 09:33:28 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="115" TOTAL_2="45" WEIGHT="0.0" Z="0.0">
<NAME>Long-term psychodynamic therapy vs. solution-focused therapy</NAME>
<CONT_DATA CI_END="2.447671189869855" CI_START="1.6236070101365931" EFFECT_SIZE="2.035639100003224" ESTIMABLE="YES" MEAN_1="12.6" MEAN_2="10.7" MODIFIED="2014-03-14 16:59:16 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="63" SD_1="0.9" SD_2="1.0" SE="0.21022431693474347" STUDY_ID="STD-Knekt-2013" TOTAL_1="115" TOTAL_2="45" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.03" MODIFIED="2014-12-02 10:22:31 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="3.02" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="206" TOTAL_2="90" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Work functioning</NAME>
<GROUP_LABEL_1>Psychodynamic</GROUP_LABEL_1>
<GROUP_LABEL_2>Solution-focused</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Psychodynamic</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Solution-focused</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.03.01" MODIFIED="2014-03-21 17:42:50 +0200" MODIFIED_BY="Babs J.M.  Faber" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="91" TOTAL_2="45" WEIGHT="0.0" Z="0.0">
<NAME>Short-term psychodynamic therapy vs solution-focused therapy</NAME>
<CONT_DATA CI_END="-0.29690723358996723" CI_START="-1.0289494642293489" EFFECT_SIZE="-0.662928348909658" ESTIMABLE="YES" MEAN_1="1.91" MEAN_2="1.95" MODIFIED="2014-03-21 17:42:50 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="67" SD_1="0.06" SD_2="0.06" SE="0.18674889855467683" STUDY_ID="STD-Knekt-2013" TOTAL_1="91" TOTAL_2="45" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.03.02" MODIFIED="2014-03-21 17:43:03 +0200" MODIFIED_BY="Babs J.M.  Faber" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="115" TOTAL_2="45" WEIGHT="0.0" Z="0.0">
<NAME>Long-term psychodynamic therapy vs solution-focused therapy</NAME>
<CONT_DATA CI_END="1.3571304633261096" CI_START="0.6333608203505885" EFFECT_SIZE="0.9952456418383491" ESTIMABLE="YES" MEAN_1="2.01" MEAN_2="1.95" MODIFIED="2014-03-21 17:43:03 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="68" SD_1="0.06" SD_2="0.06" SE="0.18463850577983157" STUDY_ID="STD-Knekt-2013" TOTAL_1="115" TOTAL_2="45" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" MODIFIED="2014-12-02 10:51:25 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="8">
<NAME>Any psychological versus other psychological (long term)</NAME>
<CONT_OUTCOME CHI2="26.196880630354894" CI_END="-1.2315231349029556" CI_START="-2.467262500965144" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="SMD" EFFECT_SIZE="-1.8493928179340497" ESTIMABLE="YES" I2="96.18275162562188" I2_Q="96.18275162562188" ID="CMP-008.01" MODIFIED="2014-11-21 09:33:45 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="3.0832856368068207E-7" P_Q="3.08328564013749E-7" P_Z="4.450432795705202E-9" Q="26.19688063035489" RANDOM="YES" SCALE="3.47" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="6.604838853376319" TOTALS="SUB" TOTAL_1="52" TOTAL_2="26" UNITS="" WEIGHT="200.0" Z="5.866517513265602">
<NAME>Days of sickness absence</NAME>
<GROUP_LABEL_1>Psychodynamic</GROUP_LABEL_1>
<GROUP_LABEL_2>Solution-focused</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Psychodynamic</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Solution-focused</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.19205432240473863" CI_START="-1.6229364485066105" DF="0" EFFECT_SIZE="-0.9074953854556745" ESTIMABLE="YES" I2="0.0" ID="CMP-008.01.01" MODIFIED="2014-11-21 09:33:41 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="1.0" P_Z="0.012915154418890856" STUDIES="1" TAU2="0.0" TOTAL_1="23" TOTAL_2="13" WEIGHT="100.0" Z="2.486100342136477">
<NAME>Short-term psychodynamic therapy vs. solution-focused therapy</NAME>
<CONT_DATA CI_END="-0.19205432240473863" CI_START="-1.6229364485066105" EFFECT_SIZE="-0.9074953854556745" ESTIMABLE="YES" MEAN_1="4.13" MEAN_2="5.5" MODIFIED="2014-04-04 10:26:03 +0300" MODIFIED_BY="Babs J.M.  Faber" ORDER="64" SD_1="1.55" SD_2="1.33" SE="0.36502765800506726" STUDY_ID="STD-Knekt-2013" TOTAL_1="23" TOTAL_2="13" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-3.3878418229481446" CI_START="-5.83901407399463" DF="0" EFFECT_SIZE="-4.613427948471387" ESTIMABLE="YES" I2="0.0" ID="CMP-008.01.02" MODIFIED="2014-11-21 09:33:45 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="1.0" P_Z="1.6090348411978138E-13" STUDIES="1" TAU2="0.0" TOTAL_1="29" TOTAL_2="13" WEIGHT="100.0" Z="7.3778190173408165">
<NAME>Long-term psychodynamic therapy vs. solution-focused therapy</NAME>
<CONT_DATA CI_END="-3.3878418229481446" CI_START="-5.83901407399463" EFFECT_SIZE="-4.613427948471387" ESTIMABLE="YES" MEAN_1="1.55" MEAN_2="5.5" MODIFIED="2014-04-04 10:27:44 +0300" MODIFIED_BY="Babs J.M.  Faber" ORDER="65" SD_1="0.5" SD_2="1.33" SE="0.6253105338621064" STUDY_ID="STD-Knekt-2013" TOTAL_1="29" TOTAL_2="13" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="13.227812222905836" CI_END="-0.7157114422604958" CI_START="-2.987168047035702" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="SMD" EFFECT_SIZE="-1.851439744648099" ESTIMABLE="YES" I2="92.44017088276807" I2_Q="92.44017088276807" ID="CMP-008.02" MODIFIED="2014-12-02 10:50:59 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="2.7583023151023234E-4" P_Q="2.7583023151023234E-4" P_Z="0.0013978678217705493" Q="13.227812222905836" RANDOM="YES" SCALE="7.038092663391631" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.620827282351213" TOTALS="YES" TOTAL_1="185" TOTAL_2="78" UNITS="" WEIGHT="100.0" Z="3.1950909486253876">
<NAME>Depressive symptoms</NAME>
<GROUP_LABEL_1>Psychodynamic</GROUP_LABEL_1>
<GROUP_LABEL_2>Solution-focused</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Psychodynamic</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Solution-focused</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.8587437217048975" CI_START="-1.6943675292583404" DF="0" EFFECT_SIZE="-1.276555625481619" ESTIMABLE="YES" I2="0.0" ID="CMP-008.02.01" MODIFIED="2014-11-21 09:33:54 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="1.0" P_Z="2.1198320560249168E-9" STUDIES="1" TAU2="0.0" TOTAL_1="79" TOTAL_2="39" WEIGHT="50.396732363788" Z="5.988347932621481">
<NAME>Short-term psychodynamic therapy vs. solution-focused therapy</NAME>
<CONT_DATA CI_END="-0.8587437217048975" CI_START="-1.6943675292583404" EFFECT_SIZE="-1.276555625481619" ESTIMABLE="YES" MEAN_1="8.5" MEAN_2="9.7" MODIFIED="2014-03-14 17:31:03 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="66" SD_1="0.9" SD_2="1.0" SE="0.21317325577019194" STUDY_ID="STD-Knekt-2013" TOTAL_1="79" TOTAL_2="39" WEIGHT="50.396732363788"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-1.9712911240255386" CI_START="-2.89974854803549" DF="0" EFFECT_SIZE="-2.4355198360305144" ESTIMABLE="YES" I2="0.0" ID="CMP-008.02.02" MODIFIED="2014-11-21 09:33:57 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="1.0" P_Z="8.43190200247393E-25" STUDIES="1" TAU2="0.0" TOTAL_1="106" TOTAL_2="39" WEIGHT="49.603267636212" Z="10.282714185505919">
<NAME>Long-term psychodynamic therapy vs. solution-focused therapy</NAME>
<CONT_DATA CI_END="-1.9712911240255386" CI_START="-2.89974854803549" EFFECT_SIZE="-2.4355198360305144" ESTIMABLE="YES" MEAN_1="7.6" MEAN_2="9.7" MODIFIED="2014-03-14 17:32:29 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="67" SD_1="0.8" SD_2="1.0" SE="0.23685573595573828" STUDY_ID="STD-Knekt-2013" TOTAL_1="106" TOTAL_2="39" WEIGHT="49.603267636212"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-008.03" MODIFIED="2014-12-02 10:51:25 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="3.713003304483282" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="185" TOTAL_2="78" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Work functioning</NAME>
<GROUP_LABEL_1>Psychodynamic</GROUP_LABEL_1>
<GROUP_LABEL_2>Solution-focused</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Psychodynamic</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Solution-focused</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.03.01" MODIFIED="2014-11-21 09:34:04 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="79" TOTAL_2="39" WEIGHT="0.0" Z="0.0">
<NAME>Short-term psychodynamic therapy vs. solution-focused therapy</NAME>
<CONT_DATA CI_END="0.054795285021335405" CI_START="-0.7171422972603569" EFFECT_SIZE="-0.33117350611951074" ESTIMABLE="YES" MEAN_1="1.8" MEAN_2="1.82" MODIFIED="2014-03-21 17:47:21 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="69" SD_1="0.06" SD_2="0.06" SE="0.19692647119300083" STUDY_ID="STD-Knekt-2013" TOTAL_1="79" TOTAL_2="39" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.03.02" MODIFIED="2014-11-21 09:34:12 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="106" TOTAL_2="39" WEIGHT="0.0" Z="0.0">
<NAME>Long-term psychodynamic therapy vs. solution-focused therapy</NAME>
<CONT_DATA CI_END="0.17947687070102353" CI_START="-0.5559730616568472" EFFECT_SIZE="-0.18824809547791183" ESTIMABLE="YES" MEAN_1="1.81" MEAN_2="1.82" MODIFIED="2014-03-21 17:47:42 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="70" SD_1="0.05" SD_2="0.06" SE="0.18761822619165605" STUDY_ID="STD-Knekt-2013" TOTAL_1="106" TOTAL_2="39" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-009" MODIFIED="2014-12-02 10:24:07 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="9">
<NAME>Any psychological versus no intervention or care as usual</NAME>
<CONT_OUTCOME CHI2="2.083889359484199" CI_END="0.02780182647087512" CI_START="-0.38020754621584596" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.17620285987248543" ESTIMABLE="YES" I2="0.0" I2_Q="51.152466857012115" ID="CMP-009.01" MODIFIED="2014-11-21 09:34:25 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="0.7203328897498386" P_Q="0.15248821681788594" P_Z="0.09048222508933411" Q="2.047186286916008" RANDOM="YES" SCALE="0.63" SORT_BY="EFFECT_SIZE" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="210" TOTAL_2="175" UNITS="" WEIGHT="200.0" Z="1.6928594411883668">
<NAME>Days of sickness absence</NAME>
<GROUP_LABEL_1>Psychological</GROUP_LABEL_1>
<GROUP_LABEL_2>CAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Psychological</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CAU</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.036247450993682456" CI_END="-0.014472913323637815" CI_START="-0.45078780806757895" DF="2" EFFECT_SIZE="-0.23263036069560838" ESTIMABLE="YES" I2="0.0" ID="CMP-009.01.01" MODIFIED="2014-11-21 09:34:19 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" NOTES="&lt;p&gt;Email Bee: depressed subgroup (HADS&amp;gt;11'&lt;/p&gt;&lt;p&gt;TCBT: Mean (SD) HADS at 3-months 7.50 (4.43), Mean (SD) Hours worked 7.86 (14.10)&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;UC: HADS at 3-months 10.80 (3.70), Hours worked 2.00 (4.47)&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;* average working hours UK: 36.3 http://www.theguardian.com/news/datablog/2011/dec/08/europe-working-hours#data&lt;/p&gt;&lt;p&gt;TBCT: 36.3-7.68=28.6 hours absent= 28.6/8=3.58 days absent. SD 14.10/8=1.76&lt;/p&gt;&lt;p&gt;C: 36.3-2=34.3 hours absent. 34.3/8= 4.29 days absent SD 4.47/8= 0.56&lt;/p&gt;" NOTES_MODIFIED="2014-11-21 09:34:19 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" P_CHI2="0.9820395259445601" P_Z="0.036618597025564484" STUDIES="3" TAU2="0.0" TOTAL_1="167" TOTAL_2="159" WEIGHT="100.0" Z="2.089991124146862">
<NAME>Online/telephone CBT vs. CAU</NAME>
<CONT_DATA CI_END="0.8195997068179173" CI_START="-1.4995515374646873" EFFECT_SIZE="-0.33997591532338495" ESTIMABLE="YES" MEAN_1="3.85" MEAN_2="4.29" MODIFIED="2014-03-21 15:40:29 +0200" MODIFIED_BY="[Empty name]" ORDER="68" SD_1="1.76" SD_2="0.56" SE="0.59163108673827" STUDY_ID="STD-Bee-2010" TOTAL_1="5" TOTAL_2="7" WEIGHT="3.539500137684857"/>
<CONT_DATA CI_END="0.06485663439412134" CI_START="-0.5315866655054828" EFFECT_SIZE="-0.23336501555568076" ESTIMABLE="YES" MEAN_1="3.84" MEAN_2="11.22" MODIFIED="2014-03-21 15:38:51 +0200" MODIFIED_BY="[Empty name]" ORDER="67" SD_1="19.01" SD_2="40.45" SE="0.15215669895066256" STUDY_ID="STD-McCrone-2004" TOTAL_1="88" TOTAL_2="86" WEIGHT="53.51330196626818"/>
<CONT_DATA CI_END="0.11002337800643472" CI_START="-0.5557595002017864" EFFECT_SIZE="-0.22286806109767585" ESTIMABLE="YES" MEAN_1="7.6" MEAN_2="12.7" MODIFIED="2014-02-10 17:10:10 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="37" SD_1="17.9" SD_2="27.2" SE="0.16984569192593116" STUDY_ID="STD-Hollinghurst-2010" TOTAL_1="74" TOTAL_2="66" WEIGHT="42.947197896046966"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.556215745090143E-4" CI_END="0.7926209553869921" CI_START="-0.35892151023563623" DF="1" EFFECT_SIZE="0.2168497225756779" ESTIMABLE="YES" I2="0.0" ID="CMP-009.01.02" MODIFIED="2014-11-21 09:34:25 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="0.9829702129336985" P_Z="0.46041052812980365" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="16" WEIGHT="100.0" Z="0.7381710340591354">
<NAME>CMHN vs. usual GP care</NAME>
<CONT_DATA CI_END="1.0325248408071233" CI_START="-0.6116056398380523" EFFECT_SIZE="0.21045960048453555" ESTIMABLE="YES" MEAN_1="17.6" MEAN_2="10.93" MODIFIED="2014-02-10 17:21:34 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="38" SD_1="35.07" SD_2="13.35" SE="0.4194287480825839" STUDY_ID="STD-Kendrick-2005" TOTAL_1="20" TOTAL_2="8" WEIGHT="49.055460239833856"/>
<CONT_DATA CI_END="1.029682615712399" CI_START="-0.5836768318780181" EFFECT_SIZE="0.22300289191719042" ESTIMABLE="YES" MEAN_1="17.7" MEAN_2="10.93" MODIFIED="2014-03-21 15:48:02 +0200" MODIFIED_BY="[Empty name]" ORDER="69" SD_1="33.1" SD_2="13.35" SE="0.41157885050857834" STUDY_ID="STD-Kendrick-2005" TOTAL_1="23" TOTAL_2="8" WEIGHT="50.94453976016615"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="9.83199340799381" CI_END="-0.28008001905475965" CI_START="-0.6512050626667256" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.46564254086074264" ESTIMABLE="YES" I2="59.31649021705164" I2_Q="86.54634133919552" ID="CMP-009.02" MODIFIED="2014-12-02 10:24:07 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="0.043354910877195674" P_Q="0.006404163946585939" P_Z="8.732197872760814E-7" Q="7.432922338912705" RANDOM="YES" SCALE="1.16" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.07986021986756317" TOTALS="SUB" TOTAL_1="262" TOTAL_2="224" UNITS="" WEIGHT="200.0" Z="4.918248582065511">
<NAME>Depressive symptoms</NAME>
<GROUP_LABEL_1>Psychological</GROUP_LABEL_1>
<GROUP_LABEL_2>CAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Psychological</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CAU</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.10613220524377792" CI_END="-0.36428876800720816" CI_START="-0.7606721151793396" DF="2" EFFECT_SIZE="-0.5624804415932739" ESTIMABLE="YES" I2="0.0" ID="CMP-009.02.01" MODIFIED="2014-11-21 09:34:29 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="0.948317327504028" P_Z="2.6593531479066548E-8" STUDIES="3" TAU2="0.0" TOTAL_1="208" TOTAL_2="200" WEIGHT="100.0" Z="5.562501126225475">
<NAME>Online/telephone CBT vs. CAU</NAME>
<CONT_DATA CI_END="0.44609830144235574" CI_START="-1.9661400712628199" EFFECT_SIZE="-0.760020884910232" ESTIMABLE="YES" MEAN_1="7.5" MEAN_2="10.8" MODIFIED="2014-03-21 15:51:14 +0200" MODIFIED_BY="[Empty name]" ORDER="71" SD_1="4.43" SD_2="3.7" SE="0.6153782395321047" STUDY_ID="STD-Bee-2010" TOTAL_1="5" TOTAL_2="7" WEIGHT="2.7001653374877086"/>
<CONT_DATA CI_END="-0.27958334663371043" CI_START="-0.8315028191229642" EFFECT_SIZE="-0.5555430828783373" ESTIMABLE="YES" MEAN_1="14.7" MEAN_2="22.2" MODIFIED="2014-02-11 15:26:17 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="51" SD_1="11.6" SD_2="15.2" SE="0.14079837100138679" STUDY_ID="STD-Hollinghurst-2010" TOTAL_1="109" TOTAL_2="101" WEIGHT="51.579766004377866"/>
<CONT_DATA CI_END="-0.2655295541506291" CI_START="-0.8517513528790894" EFFECT_SIZE="-0.5586404535148592" ESTIMABLE="YES" MEAN_1="9.3" MEAN_2="14.9" MODIFIED="2014-03-21 15:49:54 +0200" MODIFIED_BY="[Empty name]" ORDER="70" SD_1="8.5" SD_2="11.3" SE="0.14954912522691818" STUDY_ID="STD-McCrone-2004" TOTAL_1="94" TOTAL_2="92" WEIGHT="45.72006865813442"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.1819333610215468" CI_END="0.7506508992757831" CI_START="-0.30590385121835373" DF="1" EFFECT_SIZE="0.2223735240287147" ESTIMABLE="YES" I2="15.39286113933712" ID="CMP-009.02.02" MODIFIED="2014-11-21 09:34:38 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="0.27696280948223306" P_Z="0.40935519512285257" STUDIES="1" TAU2="0.02242754145878687" TOTAL_1="54" TOTAL_2="24" WEIGHT="100.0" Z="0.8250288932167398">
<NAME>CMHN vs. usual GP care</NAME>
<CONT_DATA CI_END="1.215714660761164" CI_START="-0.2027423181145076" EFFECT_SIZE="0.5064861713233282" ESTIMABLE="YES" MEAN_1="21.9" MEAN_2="14.2" MODIFIED="2014-02-18 14:19:56 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="52" SD_1="15.7" SD_2="13.0" SE="0.3618579193455286" STUDY_ID="STD-Kendrick-2005" TOTAL_1="23" TOTAL_2="12" WEIGHT="47.36866202050219"/>
<CONT_DATA CI_END="0.633073618489425" CI_START="-0.6997342785427483" EFFECT_SIZE="-0.03333033002666165" ESTIMABLE="YES" MEAN_1="13.8" MEAN_2="14.2" MODIFIED="2014-03-21 15:51:50 +0200" MODIFIED_BY="[Empty name]" ORDER="72" SD_1="11.3" SD_2="13.0" SE="0.34000826228063163" STUDY_ID="STD-Kendrick-2005" TOTAL_1="31" TOTAL_2="12" WEIGHT="52.63133797949781"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-010" MODIFIED="2014-12-02 10:51:50 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="10">
<NAME>Psychological combined with antidepressant medication versus antidepressant medication alone</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.17083204370360994" CI_START="-1.2515993646776706" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.7112157041906403" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-010.01" MODIFIED="2014-12-02 10:31:34 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.009892357358487673" Q="0.0" RANDOM="YES" SCALE="1.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="32" UNITS="" WEIGHT="100.0" Z="2.579569419616832">
<NAME>Days of sickness absence</NAME>
<GROUP_LABEL_1>Psychodynamic+TCA</GROUP_LABEL_1>
<GROUP_LABEL_2>TCA alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Psychodynamic + TCA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TCA alone</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.17083204370360994" CI_START="-1.2515993646776706" DF="0" EFFECT_SIZE="-0.7112157041906403" ESTIMABLE="YES" I2="0.0" ID="CMP-010.01.01" MODIFIED="2014-11-21 09:34:46 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="1.0" P_Z="0.009892357358487673" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="32" WEIGHT="100.0" Z="2.579569419616832">
<NAME>Psychodynamic therapy plus TCA vs. TCA</NAME>
<CONT_DATA CI_END="-0.17083204370360994" CI_START="-1.2515993646776706" EFFECT_SIZE="-0.7112157041906403" ESTIMABLE="YES" MEAN_1="34.5" MEAN_2="56.2" ORDER="66" SD_1="23.0" SD_2="34.6" SE="0.27571101548268623" STUDY_ID="STD-Burnand-2002" TOTAL_1="25" TOTAL_2="32" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.190122020208218E-32" CI_END="0.038363659951556606" CI_START="-1.0246650298145703" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.4931506849315069" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-010.02" MODIFIED="2014-12-02 10:51:50 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="0.0" P_Q="1.0" P_Z="0.06898810720709192" Q="0.0" RANDOM="YES" SCALE="2.442218569992257" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="32" UNITS="" WEIGHT="100.0" Z="1.8184976392869732">
<NAME>Work functioning or productivity</NAME>
<GROUP_LABEL_1>Psychodynamic+TCA</GROUP_LABEL_1>
<GROUP_LABEL_2>TCA alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Psychodynamic + TCA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TCA alone</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.190122020208218E-32" CI_END="0.038363659951556606" CI_START="-1.0246650298145703" DF="0" EFFECT_SIZE="-0.4931506849315069" ESTIMABLE="YES" I2="100.0" ID="CMP-010.02.01" MODIFIED="2014-11-21 09:34:55 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="0.0" P_Z="0.06898810720709192" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="32" WEIGHT="100.0" Z="1.8184976392869732">
<NAME>Psychodynamic therapy plus TCA vs. TCA</NAME>
<CONT_DATA CI_END="0.03836365995155655" CI_START="-1.0246650298145705" EFFECT_SIZE="-0.49315068493150693" ESTIMABLE="YES" MEAN_1="1.7" MEAN_2="2.1" ORDER="67" SD_1="0.8" SD_2="0.8" SE="0.27118577130783056" STUDY_ID="STD-Burnand-2002" TOTAL_1="25" TOTAL_2="32" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.3461511443269121" CI_START="-0.5672820654386904" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.11056546055588917" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-010.03" MODIFIED="2014-12-02 10:31:51 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6351554324078621" Q="0.0" RANDOM="YES" SCALE="1.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="35" TOTAL_2="39" UNITS="" WEIGHT="100.00000000000001" Z="0.47448312215238064">
<NAME>Depressive symptoms</NAME>
<GROUP_LABEL_1>Psychodynamic+TCA</GROUP_LABEL_1>
<GROUP_LABEL_2>TCA alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Psychodynamic + TCA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TCA alone</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.346151144326912" CI_START="-0.5672820654386903" EFFECT_SIZE="-0.11056546055588917" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="9.7" ORDER="68" SD_1="7.0" SD_2="7.3" SE="0.23302295781214527" STUDY_ID="STD-Burnand-2002" TOTAL_1="35" TOTAL_2="39" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-011" MODIFIED="2014-12-02 10:52:35 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="11">
<NAME>Psychological combined with antidepressant medication versus no intervention or usual care (medium term)</NAME>
<CONT_OUTCOME CHI2="3.7522222822887654" CI_END="0.007335782763156912" CI_START="-0.19762579543050252" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.0951450063336728" ESTIMABLE="YES" I2="46.6982537404461" I2_Q="68.28745692904748" ID="CMP-011.01" MODIFIED="2014-12-02 10:32:19 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="0.15318476365030442" P_Q="0.0757726754474567" P_Z="0.06880991655037598" Q="3.1533264228057507" RANDOM="YES" SCALE="0.59" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.008757819740218407" TOTALS="SUB" TOTAL_1="945" TOTAL_2="628" UNITS="" WEIGHT="200.0" Z="1.8196657867908914">
<NAME>Days of sickness absence</NAME>
<GROUP_LABEL_1>Psych.+ Antidepressant</GROUP_LABEL_1>
<GROUP_LABEL_2>CAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Psych + Antidepressant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CAU</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.5988958594830148" CI_END="0.11583988074314898" CI_START="-0.15113452996158958" DF="1" EFFECT_SIZE="-0.017647324609220295" ESTIMABLE="YES" I2="0.0" ID="CMP-011.01.01" MODIFIED="2014-11-21 09:35:06 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="0.4389997788147454" P_Z="0.7955489195445816" STUDIES="2" TAU2="0.0" TOTAL_1="641" TOTAL_2="328" WEIGHT="100.0" Z="0.25911187942137304">
<NAME>Enhanced primary care vs. CAU</NAME>
<CONT_DATA CI_END="0.14077075979157794" CI_START="-0.14077075979157794" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="1.2" ORDER="69" SD_1="3.94" SD_2="3.94" SE="0.07182313598717105" STUDY_ID="STD-Schoenbaum-2001" TOTAL_1="593" TOTAL_2="288" WEIGHT="89.91960127568214"/>
<CONT_DATA CI_END="0.2453711216796321" CI_START="-0.5955026014324727" EFFECT_SIZE="-0.17506573987642032" ESTIMABLE="YES" MEAN_1="2.02" MEAN_2="4.02" ORDER="70" SD_1="7.82" SD_2="14.46" SE="0.21451254455306562" STUDY_ID="STD-Simon-1998" TOTAL_1="48" TOTAL_2="40" WEIGHT="10.080398724317858"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.046457113487993446" CI_START="-0.36631698624240483" DF="0" EFFECT_SIZE="-0.20638704986519912" ESTIMABLE="YES" I2="0.0" ID="CMP-011.01.02" MODIFIED="2014-11-21 09:35:13 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" NOTES="&lt;p&gt;&lt;b&gt;Average working hours US: 38&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;a href=&quot;http://money.cnn.com/gallery/news/economy/2013/07/10/worlds-shortest-work-weeks/index.html?iid=F_Jump&quot; protected=&quot;true&quot;&gt;&lt;b&gt;http://money.cnn.com/gallery/news/economy/2013/07/10/worlds-shortest-work-weeks/index.html?iid=F_Jump&lt;/b&gt;&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;CAU: 38-39.5= -1.5 hours absent/8= -0.1875 days absent (SD 1.7125)&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;I: 38-42.3= -4.3/8= -0.5375 (SD 13.4/8)= 1.675&lt;/b&gt;&lt;/p&gt;" NOTES_MODIFIED="2014-11-21 09:35:13 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" P_CHI2="1.0" P_Z="0.01142894831117633" STUDIES="1" TAU2="0.0" TOTAL_1="304" TOTAL_2="300" WEIGHT="99.99999999999999" Z="2.5293024794132055">
<NAME>Telephone outreach and care management program vs. CAU</NAME>
<CONT_DATA CI_END="-0.046457113487993446" CI_START="-0.36631698624240483" EFFECT_SIZE="-0.20638704986519912" ESTIMABLE="YES" MEAN_1="-0.5375" MEAN_2="-0.1875" MODIFIED="2014-03-12 07:56:26 +0200" MODIFIED_BY="[Empty name]" ORDER="41" SD_1="1.675" SD_2="1.7125" SE="0.08159840570475407" STUDY_ID="STD-Wang-2007" TOTAL_1="304" TOTAL_2="300" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.1822178981219735" CI_START="0.9907550806518921" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0822607768010195" ESTIMABLE="YES" EVENTS_1="600" EVENTS_2="269" I2="0.0" I2_Q="0.0" ID="CMP-011.02" LOG_CI_END="0.0726975300397417" LOG_CI_START="-0.004033691899729173" LOG_EFFECT_SIZE="0.034331919070006246" METHOD="MH" MODIFIED="2014-12-02 10:52:15 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.0794481804672008" Q="0.0" RANDOM="YES" SCALE="2.529366156181873" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="913" TOTAL_2="443" WEIGHT="100.0" Z="1.75389686744301">
<NAME>Employment status</NAME>
<GROUP_LABEL_1>Psych.+ antidepressant</GROUP_LABEL_1>
<GROUP_LABEL_2>CAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Psych + Antidepressant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CAU</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1822178981219735" CI_START="0.9907550806518921" DF="0" EFFECT_SIZE="1.0822607768010195" ESTIMABLE="YES" EVENTS_1="600" EVENTS_2="269" I2="0.0" ID="CMP-011.02.01" LOG_CI_END="0.0726975300397417" LOG_CI_START="-0.004033691899729173" LOG_EFFECT_SIZE="0.034331919070006246" MODIFIED="2014-11-21 09:35:24 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="1.0" P_Z="0.0794481804672008" STUDIES="1" TAU2="0.0" TOTAL_1="913" TOTAL_2="443" WEIGHT="100.0" Z="1.75389686744301">
<NAME>Enhanced primary care vs. CAU</NAME>
<DICH_DATA CI_END="1.1822178981219735" CI_START="0.9907550806518921" EFFECT_SIZE="1.0822607768010195" ESTIMABLE="YES" EVENTS_1="600" EVENTS_2="269" LOG_CI_END="0.0726975300397417" LOG_CI_START="-0.004033691899729173" LOG_EFFECT_SIZE="0.034331919070006246" ORDER="72" O_E="0.0" SE="0.045072299592919515" STUDY_ID="STD-Schoenbaum-2001" TOTAL_1="913" TOTAL_2="443" VAR="0.0020315121905938927" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.16583693193767524" CI_END="-0.0699094373523402" CI_START="-0.36884260285113757" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.2193760201017389" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-011.03" MODIFIED="2014-12-02 10:27:18 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="3" P_CHI2="0.6838387184166806" P_Q="0.6838387184166806" P_Z="0.004018695444463415" Q="0.16583693193767524" RANDOM="YES" SCALE="1.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="353" TOTAL_2="340" UNITS="" WEIGHT="99.99999999999999" Z="2.8766904987186708">
<NAME>Depressive symptoms</NAME>
<GROUP_LABEL_1>Psych.+ antidepressant</GROUP_LABEL_1>
<GROUP_LABEL_2>CAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Psych + Antidepressant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CAU</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.279937864687174" CI_START="-0.5563995298074715" DF="0" EFFECT_SIZE="-0.1382308325601488" ESTIMABLE="YES" I2="0.0" ID="CMP-011.03.01" MODIFIED="2014-11-21 09:35:35 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="1.0" P_Z="0.5170558924330864" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="40" WEIGHT="12.775713707966501" Z="0.6478903254937809">
<NAME>Enhanced primary care vs. CAU</NAME>
<CONT_DATA CI_END="0.279937864687174" CI_START="-0.5563995298074715" EFFECT_SIZE="-0.1382308325601488" ESTIMABLE="YES" MEAN_1="16.98" MEAN_2="18.79" ORDER="73" SD_1="12.8" SD_2="13.2" SE="0.21335529660023558" STUDY_ID="STD-Simon-1998" TOTAL_1="49" TOTAL_2="40" WEIGHT="12.775713707966501"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.07122249077704604" CI_START="-0.3913001694883649" DF="0" EFFECT_SIZE="-0.23126133013270547" ESTIMABLE="YES" I2="0.0" ID="CMP-011.03.02" MODIFIED="2014-11-21 09:35:51 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="1.0" P_Z="0.004622722743121188" STUDIES="1" TAU2="0.0" TOTAL_1="304" TOTAL_2="300" WEIGHT="87.22428629203348" Z="2.8322117299890404">
<NAME>Telephone outreach and care management program vs. CAU</NAME>
<CONT_DATA CI_END="-0.07122249077704604" CI_START="-0.3913001694883649" EFFECT_SIZE="-0.23126133013270547" ESTIMABLE="YES" MEAN_1="8.9" MEAN_2="10.0" MODIFIED="2014-02-11 17:08:00 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="54" SD_1="4.8" SD_2="4.7" SE="0.08165396946986035" STUDY_ID="STD-Wang-2007" TOTAL_1="304" TOTAL_2="300" WEIGHT="87.22428629203348"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="6.689906210818313E-30" CI_END="0.9765567519197228" CI_START="0.8081449952660383" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8883689839572193" ESTIMABLE="YES" EVENTS_1="498" EVENTS_2="272" I2="100.0" I2_Q="0.0" ID="CMP-011.04" LOG_CI_END="-0.010302512919510162" LOG_CI_START="-0.0925107122519109" LOG_EFFECT_SIZE="-0.05140661258571053" METHOD="MH" MODIFIED="2014-12-02 10:52:35 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="4" P_CHI2="0.0" P_Q="1.0" P_Z="0.014237369466693756" Q="0.0" RANDOM="YES" SCALE="2.682581969469343" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="913" TOTAL_2="443" WEIGHT="100.0" Z="2.451218006315958">
<NAME>Depressed yes/no</NAME>
<GROUP_LABEL_1>Psych.+ antidepressant</GROUP_LABEL_1>
<GROUP_LABEL_2>CAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Psych + Antidepressant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CAU</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.689906210818313E-30" CI_END="0.9765567519197228" CI_START="0.8081449952660383" DF="0" EFFECT_SIZE="0.8883689839572193" ESTIMABLE="YES" EVENTS_1="498" EVENTS_2="272" I2="100.0" ID="CMP-011.04.01" LOG_CI_END="-0.010302512919510162" LOG_CI_START="-0.0925107122519109" LOG_EFFECT_SIZE="-0.05140661258571053" MODIFIED="2014-11-21 09:35:58 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="0.0" P_Z="0.014237369466693756" STUDIES="1" TAU2="0.0" TOTAL_1="913" TOTAL_2="443" WEIGHT="100.0" Z="2.451218006315958">
<NAME>Enhanced primary care vs. CAU</NAME>
<DICH_DATA CI_END="0.9765567519197228" CI_START="0.8081449952660383" EFFECT_SIZE="0.8883689839572193" ESTIMABLE="YES" EVENTS_1="498" EVENTS_2="272" LOG_CI_END="-0.010302512919510162" LOG_CI_START="-0.0925107122519109" LOG_EFFECT_SIZE="-0.05140661258571053" ORDER="75" O_E="0.0" SE="0.04828950322500189" STUDY_ID="STD-Schoenbaum-2001" TOTAL_1="913" TOTAL_2="443" VAR="0.0023318761217174682" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="4.511298642790223E-31" CI_END="0.6613628381084944" CI_START="0.33739079712208386" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.4993768176152891" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-011.05" MODIFIED="2014-12-02 10:28:14 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="5" P_CHI2="0.0" P_Q="1.0" P_Z="1.519765601264071E-9" Q="0.0" RANDOM="YES" SCALE="1.2418919409997504" SORT_BY="WEIGHT" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="304" TOTAL_2="300" UNITS="" WEIGHT="100.0" Z="6.042253363963895">
<NAME>Work functioning</NAME>
<GROUP_LABEL_1>Psych.+ antidepressant</GROUP_LABEL_1>
<GROUP_LABEL_2>CAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Psych + Antidepressant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CAU</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.511298642790223E-31" CI_END="0.6613628381084944" CI_START="0.33739079712208386" DF="0" EFFECT_SIZE="0.4993768176152891" ESTIMABLE="YES" I2="100.0" ID="CMP-011.05.01" MODIFIED="2014-11-21 09:36:06 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="0.0" P_Z="1.519765601264071E-9" STUDIES="1" TAU2="0.0" TOTAL_1="304" TOTAL_2="300" WEIGHT="100.0" Z="6.042253363963895">
<NAME>Telephone outreach and care management program vs. CAU</NAME>
<CONT_DATA CI_END="0.6613628381084945" CI_START="0.33739079712208386" EFFECT_SIZE="0.4993768176152892" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="0.7" MODIFIED="2014-02-18 14:52:48 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="62" SD_1="0.2" SD_2="0.2" SE="0.0826474474893061" STUDY_ID="STD-Wang-2007" TOTAL_1="304" TOTAL_2="300" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-012" MODIFIED="2014-12-02 10:52:59 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="12">
<NAME>Exercise intervention versus no intervention or care as usual</NAME>
<CONT_OUTCOME CHI2="10.443049508335438" CI_END="-0.021621577557523586" CI_START="-0.5551621322961489" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.2883918549268362" ESTIMABLE="YES" I2="80.8485060000564" I2_Q="90.20834199556629" ID="CMP-012.01" MODIFIED="2014-11-21 09:36:49 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="0.0053990991600546545" P_Q="0.0013947238852091148" P_Z="0.03410585616358028" Q="10.212774992214758" RANDOM="YES" SCALE="2.49" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.2577300239784892" TOTALS="SUB" TOTAL_1="148" TOTAL_2="97" UNITS="" WEIGHT="200.0" Z="2.1188179382847547">
<NAME>Days of sickness absence</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Relaxation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Relaxation</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.5393190720350476" CI_START="-1.67838791615313" DF="0" EFFECT_SIZE="-1.1088534940940888" ESTIMABLE="YES" I2="0.0" ID="CMP-012.01.01" MODIFIED="2014-11-21 09:36:49 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" NOTES="&lt;p&gt;Krogh 2009: relaxation wordt twee keer gebruikt, daarom n/2 in de meta-analyse (oorspronkelijke n=37)&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2014-11-21 09:36:49 +0200" NOTES_MODIFIED_BY="Jani H Ruotsalainen" P_CHI2="1.0" P_Z="1.3566187140087933E-4" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="19" WEIGHT="100.0" Z="3.8159465492860303">
<NAME>Supervised strength training vs. relaxation</NAME>
<CONT_DATA CI_END="-0.5393190720350476" CI_START="-1.67838791615313" EFFECT_SIZE="-1.1088534940940888" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="14.5" MODIFIED="2014-02-10 18:07:56 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="42" SD_1="4.4" SD_2="20.7" SE="0.2905841263163283" STUDY_ID="STD-Krogh-2009" TOTAL_1="46" TOTAL_2="19" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.2302745161206753" CI_END="0.24415231918067148" CI_START="-0.3597308477754144" DF="1" EFFECT_SIZE="-0.057789264297371454" ESTIMABLE="YES" I2="0.0" ID="CMP-012.01.02" MODIFIED="2014-11-21 09:36:41 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="0.6313203752469352" P_Z="0.7075698697968531" STUDIES="2" TAU2="0.0" TOTAL_1="102" TOTAL_2="78" WEIGHT="100.0" Z="0.37512182128484806">
<NAME>Aerobic exercise vs. relaxation/stretching</NAME>
<CONT_DATA CI_END="0.36929809486155396" CI_START="-0.7013259782026063" EFFECT_SIZE="-0.16601394167052622" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="14.5" MODIFIED="2014-02-10 18:08:33 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="43" SD_1="19.2" SD_2="20.7" SE="0.27312340469240926" STUDY_ID="STD-Krogh-2009" TOTAL_1="46" TOTAL_2="19" WEIGHT="31.814993534912833"/>
<CONT_DATA CI_END="0.3583690305920878" CI_START="-0.3729527044687937" EFFECT_SIZE="-0.007291836938352947" ESTIMABLE="YES" MEAN_1="25.22" MEAN_2="25.24" MODIFIED="2014-03-21 16:51:52 +0200" MODIFIED_BY="[Empty name]" ORDER="205" SD_1="2.85" SD_2="2.6" SE="0.1865650952847741" STUDY_ID="STD-Krogh-2012" TOTAL_1="56" TOTAL_2="59" WEIGHT="68.18500646508717"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.29734912481207576" CI_END="0.4343998772906067" CI_START="-0.09223624894880478" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.17108181417090096" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-012.02" MODIFIED="2014-12-02 10:52:59 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="0.8618495607153178" P_Q="0.9204477818617189" P_Z="0.20286946518375581" Q="0.00997395467400576" RANDOM="YES" SCALE="3.365383185362445" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="148" TOTAL_2="97" UNITS="" WEIGHT="200.0" Z="1.2734188844169971">
<NAME>Depressive symptoms</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Relaxation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Relaxation</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.6824833833143722" CI_START="-0.38779683763611145" DF="0" EFFECT_SIZE="0.14734327283913035" ESTIMABLE="YES" I2="0.0" ID="CMP-012.02.01" MODIFIED="2014-11-21 09:37:03 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" P_CHI2="1.0" P_Z="0.5894395289782676" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="19" WEIGHT="100.0" Z="0.5396484069797923">
<NAME>Supervised strength training vs. relaxation</NAME>
<CONT_DATA CI_END="0.6824833833143722" CI_START="-0.38779683763611145" EFFECT_SIZE="0.14734327283913035" ESTIMABLE="YES" MEAN_1="11.0" MEAN_2="10.0" MODIFIED="2014-02-11 17:34:36 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="56" SD_1="7.1" SD_2="5.6" SE="0.2730356857046143" STUDY_ID="STD-Krogh-2009" TOTAL_1="46" TOTAL_2="19" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.28737517013807" CI_END="0.4811336739011056" CI_START="-0.12380273852100943" DF="1" EFFECT_SIZE="0.1786654676900481" ESTIMABLE="YES" I2="0.0" ID="CMP-012.02.02" MODIFIED="2014-11-21 09:37:14 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="2" P_CHI2="0.5919075851700883" P_Z="0.24697241416362126" STUDIES="2" TAU2="0.0" TOTAL_1="102" TOTAL_2="78" WEIGHT="100.0" Z="1.1577345147778952">
<NAME>Aerobic exercise vs. relaxation/stretching</NAME>
<CONT_DATA CI_END="0.8372192573831763" CI_START="-0.2370702790580581" EFFECT_SIZE="0.3000744891625591" ESTIMABLE="YES" MEAN_1="11.9" MEAN_2="10.0" MODIFIED="2014-02-11 17:35:43 +0200" MODIFIED_BY="Babs J.M.  Faber" ORDER="57" SD_1="6.5" SD_2="5.6" SE="0.2740584890628331" STUDY_ID="STD-Krogh-2009" TOTAL_1="46" TOTAL_2="19" WEIGHT="31.70857765142007"/>
<CONT_DATA CI_END="0.4883068305356293" CI_START="-0.2437194067870226" EFFECT_SIZE="0.12229371187430335" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="10.5" MODIFIED="2014-03-21 17:15:42 +0200" MODIFIED_BY="[Empty name]" ORDER="67" SD_1="6.6" SD_2="6.4" SE="0.18674481855196867" STUDY_ID="STD-Krogh-2012" TOTAL_1="56" TOTAL_2="59" WEIGHT="68.29142234857993"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2014-12-01 14:21:38 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2014-12-01 14:21:38 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>PRISMA Study flow diagram of the study selection process.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAZIAAAJtCAYAAAAcrvarAAA+kElEQVR42u2df4RV2/vHPyRJkkgy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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2014-11-08 14:46:35 +0200" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArIAAAEyCAMAAAAx/8P3AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2014-11-08 14:46:35 +0200" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAZAAAARbCAIAAAAmymBLAABOhklEQVR42u2dv07sSraHLSEhgg4I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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2014-11-21 09:08:21 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="4" REF_ID="CMP-001.01" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;SHOW_ROB_TABLE:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Work-directed plus clinical versus clinical alone (medium term), outcome: 1.1 Days of sickness absence.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA3YAAAEwCAMAAADM7RPnAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2014-11-21 09:32:18 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="5" REF_ID="CMP-005.01" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;SHOW_ROB_TABLE:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 5 Any antidepressant medication versus any other antidepressant medication, outcome: 5.1 Days of sickness absence.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAysAAAEACAMAAACEfRmyAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2014-11-21 09:34:26 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="6" REF_ID="CMP-009.01" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;SHOW_ROB_TABLE:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 9 Any psychological versus no intervention or care as usual, outcome: 9.1 Days of sickness absence.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA00AAAFACAMAAABX3GfpAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2014-12-01 12:51:31 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<APPENDIX ID="APP-01" MODIFIED="2014-12-01 12:51:31 +0200" MODIFIED_BY="Jani H Ruotsalainen" NO="1">
<TITLE MODIFIED="2014-11-08 06:25:25 +0200" MODIFIED_BY="[Empty name]">Search strategy update 2006 to 2014</TITLE>
<APPENDIX_BODY MODIFIED="2014-12-01 12:51:31 +0200" MODIFIED_BY="Jani H Ruotsalainen">
<SUBSECTION>
<HEADING LEVEL="3">MEDLINE (via Ovid)</HEADING>
<P>1. exp Depressive Disorder/</P>
<P>2. exp DEPRESSION/</P>
<P>3. exp Adjustment Disorders/</P>
<P>4. exp Mood Disorders/</P>
<P>5. exp Affective Symptoms/</P>
<P>6. 1 or 2 or 3 or 4 or 5</P>
<P>7. exp Occupational Therapy/</P>
<P>8. exp Occupational Diseases/</P>
<P>9. exp Occupational Medicine/</P>
<P>10. exp Disability Evaluation/</P>
<P>11. exp WORK/</P>
<P>12. return to work.mp.</P>
<P>13. occupational therap$.mp.</P>
<P>14. occupational intervention$.mp.</P>
<P>15. supported employment.mp.</P>
<P>16. employment.mp.</P>
<P>17. vocational rehabilitation.mp.</P>
<P>18. work capacity evaluation.mp.</P>
<P>19. vocational guidance.mp.</P>
<P>20. absenteeism.mp.</P>
<P>21. occupational health services.mp.</P>
<P>22. occupational health.mp.</P>
<P>23. unemployed.mp.</P>
<P>24. employed.mp.</P>
<P>25. unemployment.mp.</P>
<P>26. sick leave.mp.</P>
<P>27. sick$ absence.mp.</P>
<P>28. retirement.mp.</P>
<P>29. disability pension.mp.</P>
<P>30. occupation$.mp.</P>
<P>31. job.mp.</P>
<P>32. vocational.mp.</P>
<P>33. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32</P>
<P>34. randomized controlled trial.pt. OR randomized.mp. OR placebo.mp.</P>
<P>35. 6 and 33 and 34</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">EMBASE (via Ovid)</HEADING>
<P>1. exp depression/</P>
<P>2. exp mood disorder/</P>
<P>3. exp adjustment disorder/</P>
<P>4. 1 or 2 or 3</P>
<P>5. occupational therapy.mp.</P>
<P>6. occupational disease.mp.</P>
<P>7. occupational medicine.mp.</P>
<P>8. employment.mp.</P>
<P>9. vocational rehabilitation.mp.</P>
<P>10. work capacity.mp.</P>
<P>11. vocational guidance.mp.</P>
<P>12. absenteeism.mp.</P>
<P>13. occupational health service.mp.</P>
<P>14. occupational health.mp.</P>
<P>15. unemployment.mp.</P>
<P>16. retirement.mp.</P>
<P>17. occupation.mp.</P>
<P>18. vocation.mp.</P>
<P>19. disability evaluation.mp.</P>
<P>20. return to work.mp.</P>
<P>21. occupational intervention$.mp.</P>
<P>22. supported employment.mp.</P>
<P>23. unemployed.mp.</P>
<P>24. employed.mp.</P>
<P>25. sick leave.mp.</P>
<P>26. sick$ absence.mp.</P>
<P>27. disability pension.mp.</P>
<P>28. job.mp.</P>
<P>29. vocational.mp.</P>
<P>30. exp work/</P>
<P>31. (disability adj (work or occupation$ or vocation$ or job)).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer name]</P>
<P>32. 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31</P>
<P>33. Random:.tw. OR placebo:.mp. OR double-blind:.tw.</P>
<P>34. 4 and 32 and 33</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">PsycINFO (via Ovid)</HEADING>
<P>1. exp Affective Disorders/</P>
<P>2. exp Major Depression/</P>
<P>3. "depression (emotion)".mp.</P>
<P>4. exp Dysthymic Disorder/</P>
<P>5. Neurotic Depressive Reaction.mp.</P>
<P>6. exp Reactive Depression/</P>
<P>7. exp Recurrent Depression/</P>
<P>8. 1 or 2 or 3 or 4 or 5 or 6 or 7</P>
<P>9. exp Disability Evaluation/</P>
<P>10. exp Employability/</P>
<P>11. exp Employee Leave Benefits/</P>
<P>12. exp Job Satisfaction/</P>
<P>13. exp Occupational Guidance/</P>
<P>14. exp Vocational Rehabilitation/</P>
<P>15. exp Disability Management/</P>
<P>16. exp Employee Absenteeism/</P>
<P>17. exp Occupational Status/</P>
<P>18. exp Occupational Stress/</P>
<P>19. exp Occupational Therapy/</P>
<P>20. exp Reemployment/</P>
<P>21. exp Work Related Illnesses/</P>
<P>22. return to work.ti,ab,tc.</P>
<P>23. occupational therap*.ti,ab,tc.</P>
<P>24. occupational intervention*.ti,ab,tc.</P>
<P>25. Supported employment.ti,ab,tc.</P>
<P>26. employment.ti,ab,tc.</P>
<P>27. vocational rehabilitation.ti,ab,tc.</P>
<P>28. work capacity evaluation.ti,ab,tc.</P>
<P>29. vocational guidance.ti,ab,tc.</P>
<P>30. Absenteeism.ti,ab,tc.</P>
<P>31. Occupational health services.ti,ab,tc.</P>
<P>32. Occupational health.ti,ab,tc.</P>
<P>33. Unemployed.ti,ab,tc.</P>
<P>34. Employed.ti,ab,tc.</P>
<P>35. Unemployment.ti,ab,tc.</P>
<P>36. Sick leave.ti,ab,tc.</P>
<P>37. Sick* absence.ti,ab,tc.</P>
<P>38. Retirement.ti,ab,tc.</P>
<P>39. Disability pension.ti,ab,tc.</P>
<P>40. Occupation*.ti,ab,tc.</P>
<P>41. Job.ti,ab,tc.</P>
<P>42. Vocational.ti,ab,tc.</P>
<P>43. 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42</P>
<P>44. random*.ti,ab,tc.</P>
<P>45. ((singl* or doubl* or trebl* or tripl*) adj26 (blind* or dummy or mask*)).ti,ab,tc.</P>
<P>46. placebo*.ti,ab,tc.</P>
<P>47. Crossover.ti,ab,tc.</P>
<P>48. Assign*.ti,ab,tc.</P>
<P>49. Allocat*.ti,ab,tc.</P>
<P>50. ((clin* or control* or compare* or evaluat* or prospective*) adj26 (trial* or studi* or study)).ti,ab,tc.</P>
<P>51. exp Placebo/</P>
<P>52. exp Treatment Effectiveness Evaluation/</P>
<P>53. exp Mental Health Program Evaluation/</P>
<P>54. exp Experimental Design/</P>
<P>55. (assign* or crossover or placebo* or ((singl* or doubl* or trebl* or tripl*) adj26 (blind* or dummy or mask*))).ti,ab,tc. or explode experimental design/ or random*.ti,ab,tc. or explode mental health program evaluation/ or explode treatment effectiveness evaluation/ or explode placebo/ or ((clin* or control* or compare* or evaluat* or prospective*) adj26 (trial* or studi* or study)).ti,ab,tc. or allocat*.ti,ab,tc.</P>
<P>56. Animal.po.</P>
<P>57. (human or inpatient or outpatient).po.</P>
<P>58. ((human or inpatient or outpatient) and animal).po.</P>
<P>59. (56 not 58)</P>
<P>60. (55 not 59)</P>
<P>61. 8 and 43 and 60</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">CINAHL (via EBSCOhost)</HEADING>
<P>1. "Depression"</P>
<P>2. (MH "Affective Disorders+")</P>
<P>3. (MH "Affective Symptoms+")</P>
<P>4. (MH "Adjustment Disorders+")</P>
<P>5. (MH "Neurotic Disorders+")</P>
<P>6. S1 OR S2 OR S3 OR S4 OR S5</P>
<P>7. (MH "Job Performance")</P>
<P>8. (MH "Job Re-Entry")</P>
<P>9. (MH "Employment+")</P>
<P>10. (MH "Occupational Health+")</P>
<P>11. (MH "Rehabilitation, Vocational+")</P>
<P>12. (MH "Sick Leave")</P>
<P>13. (MH "Work")</P>
<P>14. (MH "Disability Evaluation+")</P>
<P>15. (MH "Occupational Therapy+")</P>
<P>16. TI Return to work OR AB Return to work OR SU Return to work</P>
<P>17. TI Occupational therap* OR AB Occupational therap* OR SU Occupational therap*</P>
<P>18. TI Occupational intervention* OR AB Occupational intervention* OR SU Occupational intervention*</P>
<P>19. TI Supported employment OR AB Supported employment OR SU Supported employment</P>
<P>20. TI employment OR AB Employment OR SU Employment</P>
<P>21. TI vocational rehabilitation OR AB vocational rehabilitation OR SU vocational rehabilitation</P>
<P>22. TI Work capacity evaluation OR AB Work capacity evaluation OR SU Work capacity evaluation</P>
<P>23. TI vocational guidance OR AB vocational guidance OR SU vocational guidance</P>
<P>24. TI absenteeism OR AB absenteeism OR SU absenteeism</P>
<P>25. TI occupational health services OR AB occupational health services OR SU occupational health services</P>
<P>26. TI occupational health OR AB occupational health OR SU occupational health</P>
<P>27. TI unemployed OR AB unemployed OR SU unemployed</P>
<P>28. TI employed OR AB employed OR SU employed</P>
<P>29. TI unemployment OR AB unemployment OR SU unemployment</P>
<P>30. TI Sick leave OR AB sick leave OR SU sick leave</P>
<P>31. TI Sick* absence OR AB sick* absence OR SU sick* absence</P>
<P>32. TI retirement OR AB retirement OR SU retirement</P>
<P>33. TI Disability pension OR AB Disability pension OR SU Disability pension</P>
<P>34. TI Occupation* OR AB Occupation* OR SU Occupation</P>
<P>35. TI Job OR AB Job OR SU Job</P>
<P>36. TI vocational OR AB vocational OR SU vocational</P>
<P>37. S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36</P>
<P>38. PT clinical trial</P>
<P>39. (MH "Clinical Trials+")</P>
<P>40. TI (clin* N24 trial*) OR AB (clin* N24 trial*)</P>
<P>41. TI ( ((singl* or doubl8 or tripl* or trebl*) N24 (blind* or mask* or dummy*)) ) OR AB ( ((singl* or doubl8 or tripl* or trebl*) N24 (blind* or mask* or dummy*)) ) OR SU ( ((singl* or doubl8 or tripl* or trebl*) N24 (blind* or mask* or dummy*)) )</P>
<P>42. (MH "Placebos")</P>
<P>43. TI placebo* OR AB placebo*</P>
<P>44. TI random* OR AB random*</P>
<P>45. (MH "Evaluation Research+")</P>
<P>46. (MH "Prospective Studies")</P>
<P>47. TI ( (control* or prospectiv* or volunteer*) ) OR AB ( (control* or prospectiv* or volunteer*) )</P>
<P>48. S38 OR S39 OR S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47</P>
<P>49. S6 AND S37 AND S48</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">CENTRAL (The Cochrane Library)</HEADING>
<P>#1 depressive disorder<BR/>#2 depression<BR/>#3 Mood Disorders<BR/>#4 #1 or #2 or #3<BR/>#5 Occupational Therapy<BR/>#6 Occupational Diseases<BR/>#7 Occupational Medicine<BR/>#8 return to work<BR/>#9 occupational intervention$<BR/>#10 absenteeism<BR/>#11 occupational health services<BR/>#12 occupational health<BR/>#13 disability pension<BR/>#14 sick leave<BR/>#15 sick$ absence<BR/>#16 #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15<BR/>#17 #4 and #16 in Trials<BR/>
</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2014-11-08 06:22:34 +0200" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2014-05-12 09:39:53 +0300" MODIFIED_BY="[Empty name]">Search strategy up until 2006</TITLE>
<APPENDIX_BODY MODIFIED="2014-11-08 06:22:34 +0200" MODIFIED_BY="[Empty name]">
<P>First, we searched two Cochrane Depression Anxiety Neurosis Group specialised registers (study-based and reference-based) to identify all potentially eligible studies. We used both work terms as well as terms relating to depression:</P>
<P>CCDANCTR-Studies (searched on 2/8/2006)<BR/>Diagnosis = Depress* or Dysthymi* or "Mood Disorder*" or "Affective Disorder" or "Affective Symptoms"<BR/>and<BR/>Setting = work*<BR/>or<BR/>Outcomes = Work* or employ* or vocation* or occupat* or "sick days" or "Sick Leave" or "Sick Absence" or "Time Off"</P>
<P>CCDANCTR-References (searched on 2/8/2006)<BR/>Keyword = Depress* or Dysthymi* or "Mood Disorder*" or "Affective Disorder" or "Affective Symptoms"<BR/>and<BR/>Free-text = ("occupational" and (intervention* or therap* or treatment*)) and (work* or employe* or employment* or vocation* or "sick leave" or disabil* or absentee*)</P>
<P>Second, we searched the following electronic databases up to August 2006: CENTRAL, MEDLINE, EMBASE, CINAHL, PsycINFO, OSH-ROM (Occupational Safety and Health; all databases except for MEDLINE), NHS-EED (1994 to August 2006), and the Database of Abstracts of Reviews of Effectiveness (DARE).</P>
<P>In MEDLINE, PsycINFO, EMBASE and CINAHL and OSH-ROM we used three types of terms: depression-related words (see CCDAN search strategy) combined with work-related words and database-specific methodological filters terms (see CCDAN search strategy).</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;22 studies included in quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;1 study included in qualitative synthesis only (&lt;a href=&quot;Rost 2004&quot; link_type=&quot;STUDY&quot; protected=&quot;true&quot;&gt;Rost 2004&lt;/a&gt;)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;73 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;10776 unique records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;11309 records identified through database searching&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;35 additional records identified through other sources&lt;/p&gt;" WIDTH="120"/>
<OUT TEXT="&lt;p&gt;10704 records excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;50 full-text articles excluded with reasons (see &lt;a href=&quot;EXCLUDED_STUDIES_DESCR&quot; link_type=&quot;SECTION&quot; protected=&quot;true&quot;&gt;Excluded studies&lt;/a&gt;)&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>